,data,description,cluster
4115,world hepatitis alliance,world hepatitis alliance,0
10402,actual virus,actual virus,0
4654,delta virus infection,delta virus infection,0
5403,virus shedding,virus shedding,0
4657,acute nonfulminant hepatitis b cases,acute nonfulminant hepatitis b cases,0
4659,fulminant hepatitis b cases,fulminant hepatitis b cases,0
4660,chronic hepatitis b cases,chronic hepatitis b cases,0
3063,rift valley fever virus,rift valley fever virus,0
3065,zika virus,zika virus,0
3074,hepatitis c.,hepatitis c.,0
5394,virus multiplies,virus multiplies,0
3093,virus families,virus families,0
3095,b,b,0
3096,c,c,0
5783,virus symptoms,virus symptoms,0
497,high mortality rate,high mortality rate,0
8329,influenza c,infectious disease,0
8326,reduced rate,reduced rate,0
10438,global mortality,global mortality,0
8322,influenza b serotype,infectious disease,0
8320,b infection,b infection,0
9935,run rate,run rate,0
8315,influenza b viruses,infectious disease,0
4153,hepatitis c infection,hepatitis c infection,0
9087,respiratory syncytial virus predominant effect,respiratory syncytial virus predominant effect,0
4148,acute hepatitis c,acute hepatitis c,0
7147,average casefatality rate,average casefatality rate,0
6358,2013.each virus subtype,2013.each virus subtype,0
3034,enveloped rna virus,structural class chemical compounds,0
3033,nipah virus,nipah virus,0
5701,h5n2 virus,h5n2 virus,0
2928,chronic hepatitis c virus,chronic hepatitis c virus,0
7476,trivalent virus vaccines,trivalent virus vaccines,0
2344,rate,rate,0
2949,genotype 1 chronic hepatitis c infection,genotype 1 chronic hepatitis c infection,0
4248,hepatitis c andtheblood stestingpositivedependingon method,hepatitis c andtheblood stestingpositivedependingon method,0
2961,hepatitis c. deleobuvir,chemical compound,0
2962,nonnucleoside hepatitis c virus ns5b polymerase inhibitor,group class enzymes,0
587,mortality,mortality,0
9994,hepatitis c. similarly,hepatitis c. similarly,0
2973,semliki forest virus,semliki forest virus,0
2974,junin virus,junin virus,0
4732,geographicallydistinct mortality patterns,geographicallydistinct mortality patterns,0
2976,measles virus,infectious disease france,0
10369,mortality figures,mortality figures,0
4622,hepatitis d.lábrea fever,hepatitis d.lábrea fever,0
8965,lactone intermediate b,lactone intermediate b,0
8423,resistant virus,resistant virus,0
4629,fulminant hepatitis,fulminant hepatitis,0
8975,intermediate b,intermediate b,0
8977,intermediate c dropwise,intermediate c dropwise,0
8408,category b,category b,0
4220,virus core protein,virus core protein,0
6367,virus particle,virus particle,0
3021,ebola virus disease,infectious disease,0
7519,growing virus,growing virus,0
2977,respiratory syncytial virus,respiratory syncytial virus,0
2926,chronic hepatitis c virus genotype,chronic hepatitis c virus genotype,0
8290,subcategory negativesense ssrna virus,subcategory negativesense ssrna virus,0
4738,human mortality,organisms known particular common homo sapiens homo sapiens sapiens homo,0
1981,h3n2 virus,subtype,0
7026,vitamin c,vitamin c,0
5291,h3n2 virus isolates,subtype,0
4842,mortality curve,mortality curve,0
9812,efficacy rate,efficacy rate,0
4028,hepatitis crelated diseases,hepatitis crelated diseases,0
9796,hepatitis c treatments,hepatitis c treatments,0
8117,chronic hepatitis c.,chronic hepatitis c.,0
5933,h7n9 virus,taxon,0
10611,|mortality rate,|mortality rate,0
8114,genotype 1 virus,genotype 1 virus,0
4876,predicting pandemic mortality rate,predicting pandemic mortality rate,0
5270,influenza b,infectious disease,0
1286,deadly virus,deadly virus,0
4877,actual rate,actual rate,0
5946,virus designation,virus designation,0
4003,slower rate,slower rate,0
9775,antihepatitis c treatments,antihepatitis c treatments,0
4889,overall fatality rate,overall fatality rate,0
10632,case rate,case rate,0
3994,hepatitis,hepatitis,0
9315,hepatitis ribavirin,chemical compound medication essential medicine 1 april 1990,0
1312,pandemic h1n1/09 virus,pandemic h1n1/09 virus,0
9326,herpes simplex virus,herpes simplex virus,0
4910,assumed contraction rate,assumed contraction rate,0
4827,higher case fatality rate,higher case fatality rate,0
8184,dengue virus,dengue virus,0
6259,human human transfer virus,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common homo sapiens homo sapiens sapiens homo,0
8186,yellow fever virus,yellow fever virus,0
5365,h3n8 virus,h3n8 virus,0
4740,casefatality rate,casefatality rate,0
9105,mouse hepatitis virus rna replicase,structural class chemical compounds,0
9109,ebola virus,infectious disease,0
4758,true casefatality rate,true casefatality rate,0
10492,half mortality rate,half mortality rate,0
4114,world hepatitis day,world hepatitis day,0
5338,virus vaccines,virus vaccines,0
5335,influenza virus vaccines,infectious disease,0
8247,progeny virus,progeny virus,0
3235,rna virus families,structural class chemical compounds,0
4094,virus presence,virus presence,0
8289,category rna virus,structural class chemical compounds,0
4082,posttransfusion hepatitis cases,posttransfusion hepatitis cases,0
8211,hepatitis c. odalasvir,chemical compound,0
6680,variable mortality,variable mortality,0
10539,transmission rate,transmission rate,0
4805,zero mortality rate,zero mortality rate,0
4806,33% mortality rate,33% mortality rate,0
5306,epidemic virus,epidemic virus,0
5305,vaccine virus,vaccine virus,0
8198,hepatitis c virus polyprotein,hepatitis c virus polyprotein,0
9839,higher cure rate,higher cure rate,0
8189,omsk hemorrhagic fever virus,omsk hemorrhagic fever virus,0
8188,kyasanur forest disease virus,kyasanur forest disease virus,0
8187,powassan virus,powassan virus,0
5319,low death rate,stock character psychopomp literary character,0
10019,higherthanexpected mortality rate,higherthanexpected mortality rate,0
8906,marburg virus infections,location identifier q28791882 masculine plural 8 november 1919gregorian,0
2918,chronic hepatitis c infection,chronic hepatitis c infection,0
805,virus strains,virus strains,0
6489,virus assembly,virus assembly,0
4404,increased rate,increased rate,0
8663,melanoma hepatitis c,rare disease,0
4396,vertical transmission rate,vertical transmission rate,0
4393,hepatitis c virus infection,hepatitis c virus infection,0
8658,hepatitis e.,hepatitis e.,0
6535,virus ability,virus ability,0
8656,genotype 1 hepatitis c virus,genotype 1 hepatitis c virus,0
4494,hepatitis b antigen,group class chemical substances,0
8650,genotype 1 hepatitis c patients,genotype 1 hepatitis c patients,0
10194,high mortality,high mortality,0
6538,type c virus,type c virus,0
8645,1 hepatitis c,1 hepatitis c,0
10203,respiratory virus,respiratory virus,0
6541,d virus,d virus,0
8633,hepatitis c hepatitis c,hepatitis c hepatitis c,0
6542,slower mutation rate,slower mutation rate,0
6467,influenza virus c,infectious disease,0
6543,c d growth requirements,c d growth requirements,0
4371,previous hepatitis c treatment,previous hepatitis c treatment,0
2738,chronic hepatitis d,chronic hepatitis d,0
6546,influenza viruses c,infectious disease,0
926,virus cultures,virus cultures,0
6462,ad.this virus,ad.this virus,0
6532,humans.influenza d virus,humans.influenza d virus,0
8765,animal virus,taxon,0
6531,b virus,b virus,0
819,patterns mortality,patterns mortality,0
6512,type c,type c,0
4449,known hepatitis viruses,known hepatitis viruses,0
4452,chronic hepatitis b,chronic hepatitis b,0
4453,hepatitis b carrier state,hepatitis b carrier state,0
4456,hepatitis b. infection,hepatitis b. infection,0
5548,rna virus,structural class chemical compounds,0
4457,hepatitis b infection,hepatitis b infection,0
4445,hepatitis delta virus,hepatitis delta virus,0
4444,viral hepatitis,viral hepatitis,0
842,case fatality rate,case fatality rate,0
840,mortality estimates,mortality estimates,0
7315,patient mortality,patient mortality,0
10219,precursor virus,precursor virus,0
4464,hepatitis b protects,hepatitis b protects,0
8745,orphan virus,orphan virus,0
2622,hepatitis c. asunaprevir,chemical compound carbocyclic compound heterocyclic compound,0
6502,virus isolation,virus isolation,0
4465,hepatitis d virus,hepatitis d virus,0
6501,influenza virus c growth requirements,infectious disease,0
8702,cytochrome c,cytochrome c,0
5562,high mutation rate,high mutation rate,0
2626,hepatitis c virus,hepatitis c virus,0
2629,influenza b flu,infectious diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,0
6525,virus genus deltainfluenzavirus,virus genus deltainfluenzavirus,0
4468,delta virus,delta virus,0
8695,mitochondrial cytochrome c release,mitochondrial cytochrome c release,0
4431,hepatitis research,hepatitis research,0
2743,hepatitis delta,hepatitis delta,0
2744,hepatitis b viruses,hepatitis b viruses,0
4364,chronic hepatitis,chronic hepatitis,0
4532,hepatitis d antigen,group class chemical substances,0
4327,hepatitis c testing,hepatitis c testing,0
2813,hepatitis b,hepatitis b,0
2814,hepatitis b c viruses,hepatitis b c viruses,0
2816,hepatitis c,hepatitis c,0
2817,hepatitis b reactivation,hepatitis b reactivation,0
8557,inactivated virus,inactivated virus,0
10057,gender mortality gap,gender mortality gap,0
2430,intracellular virus,intracellular virus,0
10282,combined mortality rate,combined mortality rate,0
6430,influenza b virus capsid,infectious diseasecellular component,0
8548,h1n1 influenza,virusinfectious disease,0
2805,virus genotype,virus genotype,0
4543,large hepatitis b surface antigen,group class chemical substances,0
6427,influenza b virus,infectious disease,0
5664,h5n1 virus genome,subtypescientific model natural environment,0
969,morbidity rate,morbidity rate,0
2843,heart rate,heart rate,0
2849,bovine viral diarrhea virus,bovine viral diarrhea virus,0
2405,influenza virus particles,infectious disease,0
8879,97% clearup rate,97% clearup rate,0
990,estimated influenza mortality rate,infectious disease,0
996,h5n1 virus,subtype,0
4285,hepatitis c transmission,hepatitis c transmission,0
6402,virus genome,scientific model natural environment,0
4268,highest rate,highest rate,0
7243,virus prevalence,virus prevalence,0
4911,severity rate,severity rate,0
2448,influenza b infections,infectious disease,0
2801,hepatitis c genotype,hepatitis c genotype,0
4513,substitution rate,substitution rate,0
6459,viruses b,viruses b,0
4515,overall evolution rate,overall evolution rate,0
6457,482 ad.influenza virus,482 ad.influenza virus,0
2756,hepatitis b virus,hepatitis b virus,0
2757,hepatitis b virus surface,hepatitis b virus surface,0
6453,d,d,0
6452,types c,types c,0
735,peak mortality,peak mortality,0
2758,myrcludex b,myrcludex b,0
2760,hepatitis d,hepatitis d,0
6449,influenza d virus,infectious disease,0
10064,tuberculosis mortality rate,notifiable disease valid place switzerland endemic disease,0
2761,hepatitis b virus infection,hepatitis b virus infection,0
4517,mutation rate,mutation rate,0
6447,c virus,c virus,0
5628,virus isolate,virus isolate,0
2777,cathepsin b,cathepsin b,0
10248,low flu mortality rate,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,0
2459,continued high rate,continued high rate,0
4523,hepadnaviridae virus,hepadnaviridae virus,0
2790,virus type,virus type,0
6443,influenza c virus,infectious disease,0
5636,avian influenza virus,infectious disease,0
8829,virus types,virus types,0
10065,death rate,stock character psychopomp literary character,0
2763,hepatitis c. ciluprevir,chemical compound,0
8066,recently zika virus,recently zika virus,0
856,lower mortality rate,lower mortality rate,0
3925,hepatitis c. prevention,hepatitis c. prevention,0
9635,4 chronic hepatitis c,4 chronic hepatitis c,0
3947,small enveloped singlestranded positivesense rna virus,structural class chemical compounds,0
3952,virus particles,virus particles,0
9631,hepatitis c virus protease inhibitor,hepatitis c virus protease inhibitor,0
3956,1012 virus particles,1012 virus particles,0
7806,epsteinbarr virus,epsteinbarr virus,0
1654,h1n1 virus,virus,0
10689,newly mutated virus,newly mutated virus,0
4953,virus replication,virus replication,0
7979,inactivated virus vaccines,inactivated virus vaccines,0
7803,2 virus,2 virus,0
10771,b viruses,b viruses,0
6746,potential virus,potential virus,0
1660,h1n1 influenza virus,virusinfectious disease,0
4952,total rate,total rate,0
1663,symptoms.the h1n1 virus,virus,0
7812,vaccinia virus,infectious disease,0
5197,1957 h2n2 virus,wikimedia disambiguation page,0
4948,avianadapted h5n1 influenza virus,subtypeinfectious disease,0
6050,...an unusually dangerous virus,...an unusually dangerous virus,0
6168,h5n1 avian influenza virus,subtypeinfectious disease,0
5233,human h2n2 virus,organisms known particular common homo sapiens homo sapiens sapiens homowikimedia disambiguation page,0
7977,living virus,living virus,0
3862,relatively high mutation rate,relatively high mutation rate,0
10811,influenza virus replication,infectious disease,0
10810,influenza virus host cell,infectious disease,0
5217,triple reassortant h2n3 virus,triple reassortant h2n3 virus,0
10783,vitro effectivenessatpreventingentryofzaireebolavirustacaribearenavirusandkaposi ssarcomaassociatedherpesvirusinmammaliancellcultureswhileconfirmingumifenovir ssuppressiveeffectinvitroon hepatitis b,vitro effectivenessatpreventingentryofzaireebolavirustacaribearenavirusandkaposi ssarcomaassociatedherpesvirusinmammaliancellcultureswhileconfirmingumifenovir ssuppressiveeffectinvitroon hepatitis b,0
5167,19 influenza h1n2 virus isolates,infectious diseasesubtype,0
3931,cure rate,cure rate,0
10790,macrocyclic hepatitis c virus,macrocyclic hepatitis c virus,0
5055,virus samples,virus samples,0
5069,novel virus,novel virus,0
6056,reported mortality rate,reported mortality rate,0
7922,hepatitis c genotypes,hepatitis c genotypes,0
3585,virus subtype,virus subtype,0
6158,novel h7n9 virus,taxon,0
10778,hepatitis c.more recent studies,hepatitis c.more recent studies,0
3876,virus encodes,virus encodes,0
10707,53% fatality rate,53% fatality rate,0
9497,virus m2 protein,virus m2 protein,0
3724,influenza virus vaccine,infectious disease,0
1766,new virus,new virus,0
1466,pandemic h1n1 virus,virus,0
4981,pandemic mortality,pandemic mortality,0
71,fatality rate,fatality rate,0
1469,pandemic virus,pandemic virus,0
9394,dna virus,dna virus,0
5223,avian virus,avian virus,0
6818,nipah virus outbreak,nipah virus outbreak,0
6128,candidate virus,candidate virus,0
9656,hepatitis c. simeprevir,chemical compound medication essential medicine,0
9614,chronic hepatic c infection,chronic hepatic c infection,0
3659,inactivated h5n1 virus,subtype,0
3840,h5n1 influenza virus,subtypeinfectious disease,0
7840,virus growth,virus growth,0
1416,specifically 2009 h1n1 virus,virus,0
1398,high rate,high rate,0
3976,chronic hepatitis c,chronic hepatitis c,0
5982,h5 virus,h5 virus,0
5023,increased mortality,increased mortality,0
5193,overall mortality rate,overall mortality rate,0
3784,influenzavirus c,influenzavirus c,0
9598,egggrown vaccine virus,egggrown vaccine virus,0
3788,virusa virus,virusa virus,0
7845,heatinactivated influenza virus,infectious disease,0
223,virus,virus,0
28,mortality rate,mortality rate,0
5185,h2n2 virus,wikimedia disambiguation page,0
6044,unusually high rate,unusually high rate,0
5985,human virus,organisms known particular common homo sapiens homo sapiens sapiens homo,0
7825,virus e3l gene,virus e3l gene,0
6127,new transgenic virus,new transgenic virus,0
3783,influenzavirus b,influenzavirus b,0
9606,previous hepatitis b infection,previous hepatitis b infection,0
8036,flumist core virus,brand,0
5128,g4 virus,g4 virus,0
7841,heatinactivated virus,heatinactivated virus,0
2393,vaccine administration,vaccine administration,1
2295,prevalent strains,prevalent strains,1
4626,neurological symptoms,neurological symptoms,1
7230,genetic determinants,genetic determinants,1
8881,new combinations,new combinations,1
2400,amantadineresistant strains,amantadineresistant strains,1
2390,viral replication,viral replication,1
7171,older people,older people,1
2389,live attenuated vaccines,live attenuated vaccines,1
1649,severe outcome,severe outcome,1
7225,future pandemic,future pandemic,1
2386,anticholinergic effects,anticholinergic effects,1
1679,genetic code,genetic code,1
2385,end stage renal disease,end stage renal disease,1
2392,administered vaccines,administered vaccines,1
8874,phase ii clinical trials,phase ii clinical trials,1
8942,cytochrome p450 inducers,cytochrome p450 inducers,1
6864,low pathogenic strain,low pathogenic strain,1
9511,solid state nmr studies,solid state nmr studies,1
2431,newly formed viral proteins,group class chemical substances second-order class,1
5060,human history,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7246,mismatched vaccine,mismatched vaccine,1
5059,unusually severe deadly strain,unusually severe deadly strain,1
5057,short term adverse effects,short term adverse effects,1
6888,vaccine candidates,vaccine candidates,1
5056,2009 h1n1 pandemic,virus,1
8854,viral capsid proteins,cellular componentgroup class chemical substances second-order class,1
7241,vaccinated people,vaccinated people,1
8857,viral protein (vpg),viral protein (vpg),1
1686,antiviral medication,antiviral medication,1
6860,hpai strain,hpai strain,1
6887,seed viruses,seed viruses,1
8971,halogenlithium exchange reaction,halogenlithium exchange reaction,1
8858,viral protein,viral protein,1
8968,amine group,amine group,1
2292,antiviral agents,antiviral agents,1
8859,7methylguanosine cap,7methylguanosine cap,1
8860,cellular mrnas,cellular mrnas,1
8864,hydroxyl group,hydroxyl group,1
4552,rna polymerase,structural class chemical compoundsgroup class enzymes,1
9470,dtxsid2023561,dtxsid2023561,1
4566,large hdag,large hdag,1
8868,virus rna viruses,structural class chemical compounds,1
4554,rna polymerase ii,structural class chemical compoundsgroup class enzymes,1
8870,foot mouth disease,foot mouth disease,1
7231,current vaccine methods,current vaccine methods,1
4553,host cellular rna polymerases,structural class chemical compounds,1
9496,genetic studies,genetic studies,1
6882,intranasal influenza vaccine candidate,infectious disease,1
1664,animals,animals,1
7204,livestock vaccine,livestock vaccine,1
7203,human vaccine,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4587,hbv surface proteins,group class chemical substances second-order class,1
5043,h1n1 infection,virus,1
7200,chicken eggs,chicken eggs,1
7199,winter flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
8923,common adverse effects,common adverse effects,1
8924,blood biomarkers,biogenic substance type,1
8926,low albumin,low albumin,1
8928,low count,low count,1
7180,largescale availability,largescale availability,1
7206,seasonal influenza vaccination,infectious disease,1
7196,fertilized chicken eggs,fertilized chicken eggs,1
2333,amantadineresistant influenza viruses,infectious disease,1
8931,reported adverse effects,reported adverse effects,1
8949,vitro data,vitro data,1
8932,gastrointestinal distress,gastrointestinal distress,1
2330,antiviral properties,antiviral properties,1
4597,large protein,large protein,1
2325,antiviral mechanism,antiviral mechanism,1
8938,possible effects,possible effects,1
8939,cytochrome p450,cytochrome p450,1
7189,24 months,24 months,1
5042,respiratory disease,respiratory disease,1
6875,h5n1 speed,subtype,1
4611,lethal tropical viral infection,lethal tropical viral infection,1
8911,rna.the u.s. food drug administration,rna.the u.s. food drug administration,1
6871,h5n1 vaccination effectiveness,subtype,1
6879,live attenuated influenza vaccine,infectious disease,1
1650,radiologically confirmed pneumonia,cause death infectious disease,1
2378,concurrent use,concurrent use,1
8890,rna act,structural class chemical compounds,1
4609,host cell,host cell,1
7173,severe allergy,severe allergy,1
1674,confirmed case,confirmed case,1
7217,circulating strains,circulating strains,1
8895,nonhereditary genetic change,nonhereditary genetic change,1
5035,red blood cells,biogenic substance type,1
7216,seasonal variability,seasonal variability,1
7215,disease burden,disease burden,1
2369,mild sideeffect profile,mild sideeffect profile,1
2368,adverse effects,adverse effects,1
8900,emergency use,emergency use,1
2362,endstage renal disease,endstage renal disease,1
1653,transmission,transmission,1
7209,published studies,published studies,1
7175,viral forms,viral forms,1
5047,h1n1 infection immune,virus,1
7176,live weakened vaccine,live weakened vaccine,1
4581,cellular enzymes,cellular enzymes,1
4614,amazon river,amazon river,1
5036,infected cell,infected cell,1
4613,brazilian amazon basin,brazilian amazon basin,1
8909,infusionrelated reaction,infusionrelated reaction,1
8910,low blood pressure,biogenic substance type,1
6869,poultry farming protection funds,organisms known particular common,1
8887,cell exchange genetic material,cell exchange genetic material,1
4930,h5n1 virus genetic offspring,subtype,1
7260,clinical evidence,clinical evidence,1
7250,certain influenza subtypes,infectious disease,1
8766,rna dependent rna polymerase,structural class chemical compoundsstructural class chemical compoundsgroup class enzymes,1
9579,pediatric use,pediatric use,1
8768,picornavirus family,taxon,1
1556,2009 outbreak,2009 outbreak,1
4480,medicinal products,medicinal products,1
4481,human use,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4482,antiviral hepcludex,antiviral hepcludex,1
7290,35 months,35 months,1
2520,case reports,case reports,1
4487,low income regions,low income regions,1
4489,hbv infection,hbv infection,1
4490,currently amazon basin,currently amazon basin,1
5111,h1n1 cases,virus,1
5110,2017–18 pakistan outbreak,sovereign state country,1
1552,drug,drug,1
7287,36 months,36 months,1
6824,host immune responses,host immune responses,1
4493,severe liver disease,organ type,1
5105,30 confirmed cases,30 confirmed cases,1
5102,2017 myanmar outbreak,sovereign state country,1
7284,dose volume,dose volume,1
2505,nontraumatic cases,nontraumatic cases,1
9564,positive opinion,positive opinion,1
1575,significant immunity,significant immunity,1
1576,recent genetic analysis,recent genetic analysis,1
8789,3 little triangles,3 little triangles,1
7280,2017–18 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
1578,genetic segments,genetic segments,1
2501,randomized control trials,randomized control trials,1
2499,functional objective use,functional objective use,1
9574,splitvirus vaccine,splitvirus vaccine,1
8793,group iv viruses,group iv viruses,1
8761,uncapped mrna,transcript,1
4473,pegylated interferon alpha,group class proteins,1
1527,severe cases,severe cases,1
2573,benefits,benefits,1
5124,2019 iran outbreak,2019 iran outbreak,1
5123,11 deaths,11 deaths,1
9594,b strain,b strain,1
1538,experimental antiviral drug,experimental antiviral drug,1
2566,teratogenic effects,teratogenic effects,1
4458,drug users,drug users,1
2564,food drug administration category c,food drug administration category c,1
9590,standarddose vaccine,standarddose vaccine,1
9589,standard vaccine,standard vaccine,1
4461,intravenous drug use,intravenous drug use,1
2559,rare cases,rare cases,1
8743,insensitivity,insensitivity,1
2538,dizziness,dizziness,1
2555,gastrointestinal,gastrointestinal,1
5120,2019 morocco outbreak,2019 morocco outbreak,1
5119,30 cases,30 cases,1
1545,indiscriminate use,indiscriminate use,1
1546,antiviral medications,antiviral medications,1
1547,drugresistant strains,drugresistant strains,1
4467,specific vaccine,specific vaccine,1
5115,2019 malta outbreak,religious minority major religious group,1
8751,small rna viruses,structural class chemical compounds,1
4470,current established treatments,current established treatments,1
8753,genus aphthovirus,taxon,1
8754,picornaviridae family,taxon,1
4471,interferon alpha therapy,group class proteins,1
2542,rare severe adverse effects,rare severe adverse effects,1
8757,infection virus,infection virus,1
9588,greater immune response,greater immune response,1
7278,weakened immune systems,weakened immune systems,1
8795,rna genomes,structural class chemical compounds,1
6832,$1 billion drug manufacturers,$1 billion drug manufacturers,1
8821,5 end mayalsohave,5 end mayalsohave,1
1614,mechanical ventilation,mechanical ventilation,1
2465,levodopa effects,levodopa effects,1
8822,rna elements,structural class chemical compounds,1
2463,extrapyramidal effects,extrapyramidal effects,1
6848,genetic sequence,genetic sequence,1
8824,multiple rna elements,structural class chemical compounds,1
7262,placebocontrolled randomized clinical trials,placebocontrolled randomized clinical trials,1
1616,obesity respiratory disease,scientific journal hybrid open access journal academic journal allegedly,1
9526,rnacontaining viruses,rnacontaining viruses,1
1618,primary influenza pneumonia,infectious diseasecause death infectious disease,1
5071,similar strain,similar strain,1
4633,amazon,amazon,1
8831,rna replication,structural class chemical compounds,1
7264,medical institutions,medical institutions,1
2450,seasonal h3n2,subtype,1
1621,methicillinresistant strains,methicillinresistant strains,1
8833,rna synthesis,structural class chemical compounds,1
6852,classic symptoms,classic symptoms,1
5065,new jersey,new jersey,1
4527,viral envelope,viral envelope,1
7255,yearly vaccine,yearly vaccine,1
8840,rna structures,structural class chemical compounds,1
4534,hdag,hdag,1
9517,electrophysiology studies,electrophysiology studies,1
9516,antiviral assay,antiviral assay,1
6853,distributed computing,distributed computing,1
1633,confirmed infection,confirmed infection,1
6857,domesticated poultry,organisms known particular common,1
4536,animal viruses,taxon,1
5070,strain influenza a/ussr/90/77,infectious disease,1
5074,viral rna,structural class chemical compounds,1
8818,5 utr isimportantin,5 utr isimportantin,1
9530,respiratory synctial parainfluenza viruses,respiratory synctial parainfluenza viruses,1
2494,minimally conscious state,minimally conscious state,1
1584,mild cases,mild cases,1
1585,deadly waves,deadly waves,1
2493,vegetative state,vegetative state,1
8797,rna rna,structural class chemical compoundsstructural class chemical compounds,1
5094,501 people,501 people,1
8798,rna rna isunusualbecausernahasaproteinonthe5endthatisusedasaprimerfortranscriptionbyrnapolymerase.aprimerfortranscriptionby rna,structural class chemical compoundsstructural class chemical compoundsstructural class chemical compounds,1
6836,federal government goal,federal government goal,1
7276,59 months,59 months,1
7271,vaccine promotion,vaccine promotion,1
4510,36 strains,36 strains,1
5092,2017 maldives outbreak,2017 maldives outbreak,1
8808,5 cap,5 cap,1
9551,vaccines subunit,vaccines subunit,1
8809,virally encoded protein,virally encoded protein,1
6838,specialized chicken eggs,specialized chicken eggs,1
5089,31 974 cases,31 974 cases,1
1608,respiratory failure,respiratory failure,1
6844,genetic mechanisms,genetic mechanisms,1
8816,3 utr,3 utr,1
5079,genetic elements,genetic elements,1
6841,current vaccine research,current vaccine research,1
1603,seasonal influenza,infectious disease,1
2435,protein synthesis,protein synthesis,1
1602,disease pattern,disease pattern,1
2474,multiple control trials,multiple control trials,1
1601,clinical picture,clinical picture,1
5082,2012 india outbreak,dominion british empire sovereign state historical country,1
8810,mrna,transcript,1
5084,20 deaths,20 deaths,1
5087,2015 india outbreak,dominion british empire sovereign state historical country,1
8814,5 utr isusuallylongerbeingaround,5 utr isusuallylongerbeingaround,1
2280,antiviral drug,antiviral drug,1
2264,particular reaction,particular reaction,1
2276,medical applications,medical applications,1
4828,demographic characteristics,demographic characteristics,1
1989,h5n1 outbreak,subtype,1
1990,human transmission,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4826,remaining strains,remaining strains,1
1993,early outbreak,early outbreak,1
4824,asymptomatic cases,asymptomatic cases,1
4830,h5n1 attacks,subtype,1
6943,novartis vaccine,business multinational corporation,1
7032,respiratory infections,respiratory infections,1
4955,h5n1 genes,subtype,1
4822,poultry handlers,organisms known particular common,1
6939,2 clinical trials,2 clinical trials,1
1998,highly pathogenic h5n8 virus,highly pathogenic h5n8 virus,1
4821,h5n1 infection,subtype,1
9386,drug functions,drug functions,1
1983,ongoing outbreak,ongoing outbreak,1
9381,dna viruses,dna viruses,1
1979,seasonal strain,seasonal strain,1
1952,clinical specimens,clinical specimens,1
9241,sufficient efficacy,sufficient efficacy,1
1954,second case,second case,1
1956,clinical examination,clinical examination,1
4846,h2n2 strain,wikimedia disambiguation page,1
4950,human adaptation,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7018,fibrates,scholarly article review article,1
1964,infectious diseases society,infectious diseases society,1
9230,mohme,mohme,1
1970,american medical association,american medical association,1
4839,h5n1 influenza attacks,subtypeinfectious disease,1
1972,2009 h1n1 infection,virus,1
1974,seasonal strains,seasonal strains,1
4837,h5n1 attack,subtype,1
9223,new contract,new contract,1
7033,seasonal variation,seasonal variation,1
4848,n1 group,n1 group,1
2003,summer months,summer months,1
7038,13 studies,13 studies,1
2045,norway case,emoji regional indicator sequence,1
2046,highly pathogenic h5n8 strain,highly pathogenic h5n8 strain,1
9174,confirmed covid‑19,confirmed covid‑19,1
4795,h5n1 cases humans,subtypeinfectious disease france,1
2051,outdoor poultry,organisms known particular common,1
4967,human lives,organisms known particular common homo sapiens homo sapiens sapiens homo,1
2043,wild swans,wild swans,1
2052,pathogenic h5n8 avian influenza,infectious disease,1
2057,h5n8 avian influenza,infectious disease,1
2058,indian state,indian state,1
2059,kerala,state india start time 1 november 1956,1
4791,h5 surface proteins,group class chemical substances second-order class,1
6931,novartis s optaflu vaccine,business multinational corporation,1
9168,severe covid‑19 symptoms,severe covid‑19 symptoms,1
4794,premutated viruses,premutated viruses,1
7047,high lactoferrin whey protein,high lactoferrin whey protein,1
2034,highly pathogenic h5n8 strain ofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofthecountry bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
2030,highly pathogenic h5n8 type flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
9198,severe covid‑19,severe covid‑19,1
4959,human contagion,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4813,mild asymptomatic cases,mild asymptomatic cases,1
7041,rigorous clinical trials,rigorous clinical trials,1
4961,lethal humanadapted influenza,infectious disease,1
2018,official confirmed report,official confirmed report,1
9193,noninvasive ventilation,noninvasive ventilation,1
9191,compassionate use recommendations,compassionate use recommendations,1
9190,invasive mechanical ventilation,invasive mechanical ventilation,1
7044,vitro studies,vitro studies,1
6936,individual viral proteins,group class chemical substances second-order class,1
6935,subunit vaccine,subunit vaccine,1
6933,clinical studies,clinical studies,1
4804,known case,known case,1
2029,local official confirmed report,local official confirmed report,1
2004,wild birds,wild birds,1
2062,avian influenza outbreaks,infectious disease,1
4849,human form,organisms known particular common homo sapiens homo sapiens sapiens homo,1
1947,severe signs,severe signs,1
1859,state department,state department,1
1814,infection control,infection control,1
6985,protective immune response,protective immune response,1
9309,seven months,seven months,1
4895,h5n1 pandemic,subtype,1
9305,red blood cell breakdown,biogenic substance type,1
4905,eventual h5n1 pandemic,subtype,1
1812,2009 h1n1 outbreak,virus,1
6988,clade 2 h5n1 vaccine,subtype,1
9301,hantavirus infection,hantavirus infection,1
4891,lethal waves,lethal waves,1
1809,studies,studies,1
9298,viral hemorrhagic fevers,viral hemorrhagic fevers,1
9297,rsv infection,rsv infection,1
4894,human h5n1 infection,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,1
9321,respiratory syncytial virusrelated diseases,respiratory syncytial virusrelated diseases,1
4907,moderately severe strain,moderately severe strain,1
1815,u.s. government officials,u.s. government officials,1
4929,future pandemic strain,future pandemic strain,1
1820,worstcase scenario,worstcase scenario,1
1822,human services,organisms known particular common homo sapiens homo sapiens sapiens homo,1
1830,h1n1 outbreak,virus,1
9344,rna metabolism,structural class chemical compounds,1
9343,viral mrna,transcript,1
4918,ready transmission,ready transmission,1
4916,lethal avian strain lethality,lethal avian strain lethality,1
4915,lethal avian strain,lethal avian strain,1
1840,symptoms end,symptoms end,1
6975,against.the vaccine,against.the vaccine,1
9333,possible use,possible use,1
1817,young schoolage people,young schoolage people,1
9331,antiviral effect,antiviral effect,1
6961,sanofi vaccine,sanofi vaccine,1
9362,5 hydrogen,5 hydrogen,1
9244,compassionate use,compassionate use,1
4888,virulent transmissible human form,organisms known particular common homo sapiens homo sapiens sapiens homo,1
6951,h5n1 vaccine research,subtype,1
4947,certain strains,certain strains,1
1927,20 studies,20 studies,1
1928,mild benefits,mild benefits,1
1931,useful drug,useful drug,1
9256,government agency,government agency,1
4858,eventual pandemic strain,eventual pandemic strain,1
4860,current h5n1 influenza,subtypeinfectious disease,1
7008,scenario,scenario,1
9250,severe covid‐19 covid‐19,severe covid‐19 covid‐19,1
1942,border,border,1
4852,human h1n1,organisms known particular common homo sapiens homo sapiens sapiens homovirus,1
1944,nonlethal cases,nonlethal cases,1
9247,use requests,use requests,1
4949,avian adaptation,avian adaptation,1
7011,seasonal h1n1 strains,virus,1
4861,blood relatives,biogenic substance type,1
4862,familial genetic susceptibility,familial genetic susceptibility,1
4863,human infection,organisms known particular common homo sapiens homo sapiens sapiens homo,1
6991,viral m2 protein,viral m2 protein,1
4886,highly lethal second waves,highly lethal second waves,1
4883,certain genetic similarities,certain genetic similarities,1
4882,currently circulating h5n1 strains,subtype,1
1897,food products,food products,1
9366,natural products,natural products,1
9284,new guidance,new guidance,1
9282,countries disease,countries disease,1
9368,5 carbon,5 carbon,1
6947,new facility,new facility,1
3820,unknown effects,unknown effects,1
4867,needed immune function,needed immune function,1
7005,additional antiviral drugs,additional antiviral drugs,1
6946,trivalent vaccine,trivalent vaccine,1
4945,genetic properties,genetic properties,1
6953,h5n1 vaccine approval stockpiling,subtype,1
2278,medical applications known derivatives,medical applications known derivatives,1
4790,human cellular receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4788,laboratorygenerated h5n1,subtype,1
4694,waves,waves,1
4693,clinical symptoms,clinical symptoms,1
9037,new batch,new batch,1
4685,origin outbreak hong kong china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",1
6915,sometimesfatal infection,sometimesfatal infection,1
1719,seasonal vaccine,seasonal vaccine,1
2198,crystalline diamond,crystalline diamond,1
5000,nonbenzodiazepines,nonbenzodiazepines,1
4679,direct transmission,direct transmission,1
4676,divergent subtypes,divergent subtypes,1
7133,mild disinfectant,mild disinfectant,1
9022,9 12 months,9 12 months,1
4673,new subtypes,new subtypes,1
1717,2009 h1n1 vaccine,virus,1
4683,neuraminidase internal proteins,group class enzymesgroup class chemical substances second-order class,1
7114,cytokinerelated risks,cytokinerelated risks,1
7113,primary viral pneumonia,cause death infectious disease,1
7112,influenza strain,infectious disease,1
2169,diamond,diamond,1
7100,antiviral drugs ribavirin,chemical compound medication essential medicine 1 april 1990,1
2176,cell,cell,1
7102,cytopathic effects,cytopathic effects,1
2179,phase transition,phase transition,1
9422,drug interactions,drug interactions,1
9064,repurposed drug,repurposed drug,1
2184,cubic phase,cubic phase,1
9427,gastrointestinal central nervous adverse effects,gastrointestinal central nervous adverse effects,1
4708,new possible pandemic,new possible pandemic,1
2188,significant,significant,1
4989,emerging viral diseases,emerging viral diseases,1
1730,threatening new pandemic,threatening new pandemic,1
6916,vaccine ingredients,vaccine ingredients,1
2191,large single crystals,large single crystals,1
7135,stronger immune response,stronger immune response,1
7094,lethal infection,lethal infection,1
4668,known outbreak,known outbreak,1
5003,peptic ulcer disease,peptic ulcer disease,1
6892,cell cultures,cell cultures,1
5020,indistinguishable viruses,indistinguishable viruses,1
2263,friedel–crafts reaction,friedel–crafts reaction,1
6891,highly pathogenic influenza viruses,infectious disease,1
7157,vaccine effectiveness,vaccine effectiveness,1
8985,protective group,protective group,1
5016,reported h10n7 outbreak,reported h10n7 outbreak,1
5022,pond,pond,1
2269,difficult reaction,difficult reaction,1
1691,current h1n1 outbreak,virus,1
2271,nitrogensubstituted drug amantadine,chemical compound medication,1
7161,nearly people,nearly people,1
2274,nitroester,nitroester,1
4636,chronic disease,chronic disease,1
2268,nitration,nitration,1
4642,pará,federative unit brazil,1
7155,medical visits,medical visits,1
6896,protein sciences corporation,protein sciences corporation,1
4666,multiple subtypes,multiple subtypes,1
4665,genetic process,genetic process,1
4661,amazon region,amazon region,1
1711,vaccines,vaccines,1
6900,broadly protective vaccines,broadly protective vaccines,1
1704,state,state,1
2241,reaction products,reaction products,1
2242,reaction conditions,reaction conditions,1
9004,government agencies,government agencies,1
5011,bone diseases,bone diseases,1
6898,new pathways,new pathways,1
7143,medical experiments,medical experiments,1
8999,new line,new line,1
6897,clinical evaluation,clinical evaluation,1
7146,hospitalized severe cases,hospitalized severe cases,1
4667,clinical data,clinical data,1
7055,alternative influenza treatments,infectious disease,1
7092,control group,control group,1
7091,placebo,placebo,1
2092,human transmission confirmed,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4973,possible prepandemic vaccines,possible prepandemic vaccines,1
4773,humans.h5n1 vaccines,humans.h5n1 vaccines,1
2094,known human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8730,family picornaviridae,taxon,1
2096,humantohuman transmission,humantohuman transmission,1
9145,remdesivir group,chemical compound prodrug antiviral drug,1
7066,donated blood,biogenic substance type,1
4770,suspected human,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7068,newcastle disease,newcastle disease,1
7069,interferon therapies,group class proteins,1
9134,randomized controlled clinical trials,randomized controlled clinical trials,1
2108,diamond crystal,diamond crystal,1
7073,subsequent studies,subsequent studies,1
4974,human pandemic,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4971,vaccine development,vaccine development,1
4775,h5n1 prepandemic vaccines,subtype,1
7062,viral infection,viral infection,1
9164,drug baricitinib,chemical compound medication,1
4787,humancommunicable strain,humancommunicable strain,1
2070,poultry belt,organisms known particular common,1
4785,h5n1 clinical trials stage,subtype,1
9160,statistically significant differences,statistically significant differences,1
9159,10day remdesivir group,chemical compound prodrug antiviral drug,1
4969,human preparation,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7058,products,products,1
2079,highly pathogenic h5n8 bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
9154,fiveday remdesivir group,chemical compound prodrug antiviral drug,1
7061,cellular signalling factors,cellular signalling factors,1
9152,clinical status,clinical status,1
4779,prepandemic vaccine,prepandemic vaccine,1
9149,clinical improvement,clinical improvement,1
4777,emerging pandemic,emerging pandemic,1
7075,low concentrations,low concentrations,1
9421,fewer symptoms,fewer symptoms,1
7076,phase iii trials,phase iii trials,1
7077,initial trials,initial trials,1
4737,excess deaths,excess deaths,1
9097,directacting antiviral agent,directacting antiviral agent,1
7085,interferon manufacturers,group class proteins,1
4733,pandemic season,pandemic season,1
9092,growing rna chain,structural class chemical compounds,1
1746,outbreak cycle,outbreak cycle,1
9417,orally administered antiviral drug,orally administered antiviral drug,1
7086,interferon use,group class proteins,1
9419,similar drug amantadine,chemical compound medication,1
4983,available vaccines,available vaccines,1
9086,rnadependent rna polymerases,structural class chemical compounds,1
9085,viral rna production,structural class chemical compounds,1
9084,viral exoribonuclease,viral exoribonuclease,1
4725,large disruptions,large disruptions,1
7087,medical profession,medical profession,1
1748,real pandemic,real pandemic,1
4739,human fatality,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4979,human pandemic lethality,organisms known particular common homo sapiens homo sapiens sapiens homo,1
2118,reaction,reaction,1
9121,monoclonal antibody treatments,family protein complexes,1
4753,1968 pandemic,1968 pandemic,1
9117,promising antiviral activity,promising antiviral activity,1
4752,1957 pandemic,1957 pandemic,1
7081,interferon alfa2b medicine,group class proteins,1
4748,pandemic planning,pandemic planning,1
4747,southeast east asia,continent continental area surrounding islands,1
4975,human pandemic eventual emergence,organisms known particular common homo sapiens homo sapiens sapiens homo,1
9108,preclinical results,preclinical results,1
9411,drug entry,drug entry,1
4743,100 confirmed cases,100 confirmed cases,1
4742,confirmed cases,confirmed cases,1
4741,confirmed human deaths,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4977,veryeffective prepandemic vaccine,veryeffective prepandemic vaccine,1
4759,h5n1 infections,subtype,1
5431,cell cytoplasm,cell cytoplasm,1
2727,published clinical trials,published clinical trials,1
8726,large family,large family,1
8093,toxicity studies,toxicity studies,1
3448,respiratory distress,respiratory distress,1
3450,clinical signs,clinical signs,1
3451,severe pulmonary lesions,severe pulmonary lesions,1
8092,drive,drive,1
3457,southern state,southern state,1
3998,advanced liver disease,organ type,1
3444,clinical manifestations,clinical manifestations,1
7706,nonhuman animals,nonhuman animals,1
3992,active infection,active infection,1
8078,drug innovation ventures,drug innovation ventures,1
3468,poultry markets,organisms known particular common,1
7711,typical scenario,typical scenario,1
8075,sarscov2.the drug,sarscov2.the drug,1
8074,viral rna replication,structural class chemical compounds,1
7712,virusinfected cell,virusinfected cell,1
7708,foreign protein,foreign protein,1
7700,interferon alpha2b,group class proteins,1
3441,infected poultry,organisms known particular common,1
8098,preliminary human study,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3412,live poultry,organisms known particular common,1
7693,vitro,vitro,1
3415,fao avian influenza disease emergency situation update,infectious disease,1
3416,h5n1 pathogenicity,subtype,1
4017,sustained response,sustained response,1
3418,avian influenza disease situation,infectious disease,1
8110,rna dna viruses,structural class chemical compounds,1
4013,75%.prior 2012 sustained response,75%.prior 2012 sustained response,1
4009,rapid virological response,rapid virological response,1
8103,medical data,medical data,1
4007,detectable rna,structural class chemical compounds,1
3434,thailand zoo tiger outbreak,constitutional monarchy sovereign state country,1
8101,small numbers,small numbers,1
4006,absence,absence,1
3437,effort,effort,1
4005,sustained viral response,sustained viral response,1
3439,h5n1 virus infection,subtype,1
8072,antiviral action,antiviral action,1
3475,nucleoside analogue antiviral drug,nucleoside analogue antiviral drug,1
3986,blood donors,biogenic substance type,1
7714,virusinfected cell antiviral defenses,virusinfected cell antiviral defenses,1
7725,bacteria products,taxon,1
7726,viral glycoproteins,structural class chemical compounds,1
3515,preclinical efficacy,preclinical efficacy,1
3968,hcv rna,structural class chemical compounds,1
8037,emerge.several trials,emerge.several trials,1
8034,known strains,known strains,1
8031,looming h5n1 threat,subtype,1
8028,attenuated live viruses,attenuated live viruses,1
3959,contaminated blood,biogenic substance type,1
8026,h5n1 variants,subtype,1
8024,certain h5n1 variants,subtype,1
8023,flumist vaccine,brand,1
3535,nucleosidediphosphate kinase,nucleosidediphosphate kinase,1
8022,vaccine technology,academic discipline,1
8020,specific human h5n1 vaccine,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,1
8018,h5n1 advance preparation,subtype,1
3545,letter,letter,1
3973,mild nonspecific flulike symptoms,mild nonspecific flulike symptoms,1
4020,pegylated interferon ribavirin results,group class proteinschemical compound medication essential medicine 1 april 1990,1
3507,open letter,open letter,1
8054,antiviral immunosuppressive effects,antiviral immunosuppressive effects,1
3480,human patients,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3984,18 months,18 months,1
3483,cell culture,cell culture,1
7715,types interferon,group class proteins,1
8064,antiviral research,antiviral research,1
3486,lethal coronavirus disease,group class strains strain,1
7716,human interferons,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3489,veterinary use,veterinary use,1
3490,use research,use research,1
3491,approved treatments,approved treatments,1
7718,antiviral agents antiviral agents modulate functions,antiviral agents antiviral agents modulate functions,1
8058,foot mouth disease virus,foot mouth disease virus,1
3497,multiple trials,multiple trials,1
3498,field trials,field trials,1
8057,existing treatments,existing treatments,1
8056,modest benefits,modest benefits,1
8055,phase 2b human clinical trials,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7722,human tumors,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3953,3 hours,3 hours,1
7691,interferon alpha,group class proteins,1
3404,new regulation,new regulation,1
4072,1.7 million new infections,1.7 million new infections,1
3293,h5n1 influenza,subtypeinfectious disease,1
3294,genetic level,genetic level,1
3295,recent highly pathogenic emergent strain,recent highly pathogenic emergent strain,1
3297,h5n1 strain,subtype,1
3298,fastmutating highly pathogenic avian influenza virus,infectious disease,1
3301,recent highly pathogenic strain,recent highly pathogenic strain,1
3291,confirmed human fatality,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8196,viral nonstructural protein,viral nonstructural protein,1
8194,nonstructural protein,nonstructural protein,1
7648,human vaccines]. chickens,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,1
3306,h5n1 effects,subtype,1
3307,purposely mutated strain,purposely mutated strain,1
8192,improved treatments,improved treatments,1
8191,human trials,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8190,preclinical animal testing,taxon,1
7647,onlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueat human vaccines]. chickens],organisms known particular common homo sapiens homo sapiens sapiens homo,1
4073,numbers,numbers,1
7645,vaccine s99.99percentrelatedareweaker.chickensaresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].,vaccine s99.99percentrelatedareweaker.chickensaresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].,1
3288,human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3266,human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3267,current outbreak,current outbreak,1
3268,97 cases,97 cases,1
3269,53 deaths,53 deaths,1
3271,76 cases,76 cases,1
3272,37 deaths,37 deaths,1
8210,investigational new drug,investigational new drug,1
3276,4 cases,4 cases,1
3277,4 deaths,4 deaths,1
4079,infected people infection,infected people infection,1
8207,ns2 protein,ns2 protein,1
3280,widespread infection,widespread infection,1
3281,communityacquired infection,communityacquired infection,1
4078,people infection,people infection,1
4075,new infection rates,new infection rates,1
3286,avian influenza viruses,infectious disease,1
3287,human clinical specimens,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3313,stone,stone,1
8185,west nile virus,west nile virus,1
8183,related viruses,related viruses,1
3319,respiratory tract,respiratory tract,1
4044,new infections,new infections,1
7678,hairy cell leukemia,hairy cell leukemia,1
3371,david nabarro,david nabarro,1
8144,moscow government healthcare department,moscow government healthcare department,1
3373,avian human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,1
8142,moscow clinical research center,moscow clinical research center,1
8137,pegylated interferon alfa,group class proteins,1
4033,intravenous drug abuse,intravenous drug abuse,1
8132,sustained virologic response,sustained virologic response,1
3389,major outbreak,major outbreak,1
8127,antiviral activity,antiviral activity,1
8125,efficacy studies,efficacy studies,1
7689,galveston,galveston,1
7690,direct antiviral effect,direct antiviral effect,1
3400,poultry stall,organisms known particular common,1
4022,sustained responses,sustained responses,1
3403,local government,local government,1
3361,avian influenza experts,infectious disease,1
3405,live chickens,chicken gallus gallus domesticus common,1
8155,russian government,russian government,1
8157,clinical centers,clinical centers,1
8182,broad spectrum antiviral activity,broad spectrum antiviral activity,1
7649,human vaccines]. chickens forsixweeksbecausethat showlonghumanvaccines].chickenslivetill,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,1
7650,human vaccines]. chickens forsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].chickens said dr. john j. treanor,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,1
3324,large numbers,large numbers,1
7652,vaccine expert,vaccine expert,1
8174,oseltamivirresistant viruses,oseltamivirresistant viruses,1
7655,experimental vaccine,experimental vaccine,1
3330,virus infection,virus infection,1
8170,low fatality record,low fatality record,1
3339,highly pathogenic strain,highly pathogenic strain,1
3341,significant spread,significant spread,1
3344,turkeysh5n1 h5n1,subtype,1
7671,antiviral antineoplastic drug,chebi ontology term drug class,1
3348,highly pathogenic h5n1,subtype,1
3350,wild domestic birds,wild domestic birds,1
8158,russia.the drug,russia.the drug,1
3352,family,family,1
3355,major new outbreak,major new outbreak,1
3948,genus hepacivirus,genus hepacivirus,1
7742,welldefined cell signaling pathway,welldefined cell signaling pathway,1
8002,seasonal intranasal vaccine,seasonal intranasal vaccine,1
3722,6 months,6 months,1
3723,approved human h5n1 vaccines,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,1
7904,slowing disease progression,slowing disease progression,1
7795,interferon activity,group class proteins,1
3728,h5n1 influenza strain,subtypeinfectious disease,1
3730,results trials,results trials,1
7796,ifn response,ifn response,1
3720,vrc candidate vaccine,vrc candidate vaccine,1
3733,15mcg dose,15mcg dose,1
3866,pig,pig,1
3864,h5n1 viruses,subtype,1
3863,rna viruses,structural class chemical compounds,1
7893,definitive proof,definitive proof,1
3742,greatest promise,greatest promise,1
3860,internal viral protein,internal viral protein,1
3856,n1 protein,n1 protein,1
7900,interferon beta1a,group class proteins,1
3719,vrc vaccine pilot plant,vrc vaccine pilot plant,1
3873,matrix proteins,group class chemical substances second-order class,1
3874,surface proteins,group class chemical substances second-order class,1
3693,h5n1 vaccine developedbysanofipasteurinhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteurdnabasedvaccinescontainonlyportionsofanh5n1vaccinedevelopedby sanofi pasteur genetic material,subtype,1
3694,human cells,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3695,proteins,group class chemical substances second-order class,1
7919,interferon molecule,group class proteins,1
7788,protein deneddylation,protein deneddylation,1
3700,new vaccine technology,academic discipline,1
3701,effective vaccines,effective vaccines,1
7913,drug formulations,drug formulations,1
3878,rna segment,structural class chemical compounds,1
3706,dna vaccine approach,dna vaccine approach,1
3708,highly pathogenic viruses,highly pathogenic viruses,1
3709,deadly 1918 pandemic,deadly 1918 pandemic,1
3710,investigational vaccines,investigational vaccines,1
3711,promise,promise,1
3712,sars,sars,1
3713,west nile,west nile,1
3716,investigational vaccine,investigational vaccine,1
3749,inactivated vaccine,inactivated vaccine,1
7804,herpesvirus family,herpesvirus family,1
7885,large loss,large loss,1
3753,acceptable immune response,acceptable immune response,1
7822,doublestranded rna,structural class chemical compounds,1
3834,human type receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3833,low densities,low densities,1
3832,avian type receptors,avian type receptors,1
3797,attachment,attachment,1
7823,rnadependent protein kinases,rnadependent protein kinases,1
3800,hemagglutinin proteins,group class proteinsgroup class chemical substances second-order class,1
3827,human a/hk/212/03,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7827,protein production,protein production,1
7839,viral interference,viral interference,1
7828,interferon stimulated genes,group class proteins,1
7837,medical research,medical research,1
3824,human a/hk/212/03 a/hk/213/03 isolates,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7829,protein kinase r,protein kinase r,1
7831,antiviral activities,antiviral activities,1
3815,fatal case,fatal case,1
3817,human receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3782,5 genera,5 genera,1
3884,pa protein,pa protein,1
3781,orthomyxovirus family,orthomyxovirus family,1
3778,h5n1 genetic structure,subtype,1
7805,human cytomegalovirus,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,1
7881,human beta,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3758,prepandemic vaccines,prepandemic vaccines,1
3759,right dose,right dose,1
3760,dose interval,dose interval,1
7880,sufficient amounts,sufficient amounts,1
7809,e7 protein,e7 protein,1
7810,human papillomavirus,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7811,b18r protein,b18r protein,1
7874,interferon gene,group class proteins,1
7873,radiolabeled human beta,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7870,human beta interferon,organisms known particular common homo sapiens homo sapiens sapiens homogroup class proteins,1
7814,irf9,irf9,1
7868,interferon action gene,group class proteins,1
7867,somatic cell genetics,somatic cell genetics,1
3844,progeny viruses,progeny viruses,1
7864,specific antiviral effect,specific antiviral effect,1
7863,human amniotic cell cultures,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3691,dnabased vaccines,dnabased vaccines,1
7921,antiviral drug ribavirin,chemical compound medication essential medicine 1 april 1990,1
3688,hens eggs andthenadministeredas,hens eggs andthenadministeredas,1
3594,prototype strains,prototype strains,1
3595,new prototype strains,new prototype strains,1
7752,cell nucleus,cell nucleus,1
7980,live infection,live infection,1
3599,h5n1 vaccine,subtype,1
7978,certain chronic diseases,certain chronic diseases,1
3604,phase 1 clinical trials,phase 1 clinical trials,1
3605,h5n1 avian influenza vaccine candidate,subtypeinfectious disease,1
3606,h5n1 avian influenza vaccine candidate contract,subtypeinfectious disease,1
3924,hcv infection,hcv infection,1
3609,adjuvanted vaccines,adjuvanted vaccines,1
3610,strong immune responses,strong immune responses,1
3615,different h5n1 strain,subtype,1
3918,blood screening,biogenic substance type,1
7968,resulting viruses,resulting viruses,1
3620,chief medical officer,chief medical officer,1
7967,coming months,coming months,1
7983,people immune systems,people immune systems,1
3622,experimental h5n1 avian influenza vaccine,subtypeinfectious disease,1
3591,little use,little use,1
3588,candidate vaccines,candidate vaccines,1
8001,trivalent laiv vaccine,trivalent laiv vaccine,1
3563,clinical preclinical data,clinical preclinical data,1
7994,laiv vaccine rights,laiv vaccine rights,1
7992,laiv intranasal vaccine,laiv intranasal vaccine,1
3572,human oral use,organisms known particular common homo sapiens homo sapiens sapiens homo,1
3934,newer treatments,newer treatments,1
3575,potent antiviral effects,potent antiviral effects,1
3932,greater effects,greater effects,1
7988,aviron,aviron,1
3578,low variable absorption,low variable absorption,1
3580,blood levels,biogenic substance type,1
3581,viral diseases,viral diseases,1
3582,h5n1 clinical trials,subtype,1
3583,h5n1 vaccines,subtype,1
3930,earlier generation treatments,earlier generation treatments,1
3586,pharmacological effects,pharmacological effects,1
3587,current status h5n1 candidate vaccines,subtype,1
3590,2003 strain,2003 strain,1
3265,details,details,1
7966,genetic reassortment,genetic reassortment,1
3626,similar h5n1 vaccine,subtype,1
3663,adequate immune response,adequate immune response,1
7774,crk family,crk family,1
3665,volunteers,volunteers,1
7775,adaptor proteins,group class chemical substances second-order class,1
3667,wholevirus h5n1 avian influenza vaccine,subtypeinfectious disease,1
3670,acceptable response,acceptable response,1
7778,p38 mitogenactivated protein kinase,p38 mitogenactivated protein kinase,1
3673,inactivated strain,inactivated strain,1
3676,infectious diseases,infectious diseases,1
3677,avian influenza enters human trial,infectious diseaseorganisms known particular common homo sapiens homo sapiens sapiens homo,1
7782,cell proliferation,cell proliferation,1
3679,dna vaccine,dna vaccine,1
3680,h5n1 avian influenza infection,subtypeinfectious disease,1
3683,vaccine research center,vaccine research center,1
7784,ribosomal protein s6,ribosomal protein s6,1
7923,interferon treatment,group class proteins,1
3687,h5n1 vaccine developedbysanofipasteurinhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteurdnabasedvaccinescontainonlyportionsofanh5n1vaccinedevelopedby sanofi pasteur,subtype,1
7940,clinical evaluations,clinical evaluations,1
3917,injection drug use,injection drug use,1
3901,potential vaccine,potential vaccine,1
7947,attenuated vaccine,attenuated vaccine,1
3627,new study,new study,1
3628,immune response,immune response,1
7962,live attenuated vaccine,live attenuated vaccine,1
3915,dilated blood vessels,biogenic substance type,1
7959,20182019 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
3632,effective vaccine,effective vaccine,1
7956,50% cases,50% cases,1
3636,inactivated splitvirion strain,inactivated splitvirion strain,1
3912,liver disease,organ type,1
3639,low dose,low dose,1
3640,h5n1 avian influenza vaccine,subtypeinfectious disease,1
3910,initial infection,initial infection,1
3642,good immune response,good immune response,1
3643,human volunteers,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7952,20162017 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
3645,typical dose,typical dose,1
3648,strong immune response,strong immune response,1
3655,effective pandemic vaccine,effective pandemic vaccine,1
4450,simultaneous infection,simultaneous infection,1
7640,vaccine sonly85percentrelated,vaccine sonly85percentrelated,1
3261,h5n1 avian influenza,subtypeinfectious disease,1
4318,mothertochild transmission,mothertochild transmission,1
8547,h1n1 vaccines,virus,1
8546,september 2006.the vaccine,september 2006.the vaccine,1
7429,vaccine home visits,vaccine home visits,1
8537,weakened immune response,weakened immune response,1
4312,medical condition,medical condition,1
7430,group vaccinations,group vaccinations,1
8551,autoimmune disease,autoimmune disease,1
8533,h1n1 viruses,virus,1
8525,resistant h1n1,virus,1
2855,pegylated interferon,group class proteins,1
2856,directacting antiviral agents,directacting antiviral agents,1
2857,hcv viral rna replication,structural class chemical compounds,1
2858,protein translation,protein translation,1
8523,2007–08 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
2860,hcv viral transcription,hcv viral transcription,1
8527,2010–11 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
8552,upper airway respiratory infections,upper airway respiratory infections,1
2828,dose modifications,dose modifications,1
2820,cytochrome p450 cyp3a,gene,1
7407,polio,infectious disease sweden norway united states america france,1
2789,viral rnadependant rna polymerase,structural class chemical compoundsgroup class enzymes,1
8574,observational studies,observational studies,1
4334,rna,structural class chemical compounds,1
2796,hcv protein,hcv protein,1
8572,following effects,following effects,1
4333,hcv rna polymerase chain reaction,structural class chemical compoundsgroup class enzymes,1
7412,live attenuated virus,live attenuated virus,1
4331,viral load,viral load,1
2804,interferon,group class proteins,1
7413,australian government,australian government,1
7416,following people,following people,1
4328,blood testing,biogenic substance type,1
2809,specific effects,specific effects,1
8563,availability,availability,1
2818,concomitant use,concomitant use,1
4325,infected mother viral loads,infected mother viral loads,1
8522,surveillance studies,surveillance studies,1
2862,steady state,steady state,1
2863,human subjects,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8521,viral loads,viral loads,1
4273,low risks,low risks,1
2910,kidney disease,kidney disease,1
4270,sexual transmission,sexual transmission,1
2916,food drug administration,food drug administration,1
7468,significant human suffering,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7469,coming season,coming season,1
7470,2012–2013 northern hemisphere influenza season,infectious disease,1
8470,highrisk people,highrisk people,1
2925,antiviral medicine,antiviral medicine,1
7474,likely strains,likely strains,1
7475,2017–2018 northern hemisphere influenza season,infectious disease,1
8464,canine parvovirus infection,canine parvovirus infection,1
2932,severe itching,severe itching,1
7477,2018 southern hemisphere influenza season,infectious disease,1
8462,prequalified medicinal products,prequalified medicinal products,1
7478,2018–2019 northern hemisphere influenza season,infectious disease,1
8460,cipla drug,business enterprise,1
7463,australian vaccines,australian vaccines,1
7403,vulnerable people,vulnerable people,1
4277,anogenital mucosa,anogenital mucosa,1
4281,greater risks,greater risks,1
8520,antiviral resistance inability,antiviral resistance inability,1
2866,peak dose,peak dose,1
7440,2010–11 season,2010–11 season,1
8516,sporadic cases,sporadic cases,1
7442,previous season,previous season,1
2873,protein,protein,1
2875,dose strength,dose strength,1
8509,symptomatic disease,symptomatic disease,1
2878,oral dose,oral dose,1
8508,exposed people,exposed people,1
2880,iv dose,iv dose,1
2883,sale,sale,1
8504,drug labels,drug labels,1
8501,sufficient numbers,sufficient numbers,1
7450,staff absence,staff absence,1
2894,clinical candidate,clinical candidate,1
4284,condom use,condom use,1
8487,communityacquired pneumonia,cause death infectious disease,1
7479,2019 southern hemisphere influenza season,infectious disease,1
8582,gsk h1n1 vaccines,virus,1
2779,new macrocyclic inhibitors,new macrocyclic inhibitors,1
2648,medical uses,medical uses,1
2650,antiviral,antiviral,1
8683,cell differentiation,cell differentiation,1
8682,cell cycle control,cell cycle control,1
2655,dairy products,dairy products,1
4411,human immunodeficiency virus infection,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common,1
4410,immunosuppressed people,immunosuppressed people,1
2645,common effects,common effects,1
7341,highdose vaccine,highdose vaccine,1
7342,regulardose vaccine,regulardose vaccine,1
2662,21%,21%,1
7345,2016–2017 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
8671,tyk2 protein,tyk2 protein,1
8670,ligand,ligand,1
2669,host cell rna transcripts,structural class chemical compounds,1
7346,significant benefit,significant benefit,1
2660,single dose administration,single dose administration,1
2642,cap snatching,cap snatching,1
4419,preclinical testing,preclinical testing,1
8691,cell cycle arrest,cell cycle arrest,1
8724,related nonenveloped rna viruses,structural class chemical compounds,1
2592,medical literature,medical literature,1
8722,confirmed acute uncomplicated influenza infection,infectious disease,1
7309,virologically confirmed influenza,infectious disease,1
4441,antiviral compounds,antiviral compounds,1
7313,eighteen studies,eighteen studies,1
2609,additional studies,additional studies,1
8711,new viruses,new viruses,1
7316,vaccine uptake,vaccine uptake,1
2614,safe drug,safe drug,1
7318,reduced patient deaths,reduced patient deaths,1
7321,allcause deaths,allcause deaths,1
2621,experimental drug candidate,experimental drug candidate,1
2624,phase iii clinical trials,phase iii clinical trials,1
2630,medical use,medical use,1
2631,single dose,single dose,1
4426,human cell culture systems,organisms known particular common homo sapiens homo sapiens sapiens homo,1
2671,viral mrnas,viral mrnas,1
4400,vertical transmission,vertical transmission,1
2679,polycyclic family,polycyclic family,1
7353,randomized clinical trials,randomized clinical trials,1
2730,ribavirin use,chemical compound medication essential medicine 1 april 1990,1
7378,1.3 cases,1.3 cases,1
7379,severe symptoms,severe symptoms,1
8612,12 suspected cases,12 suspected cases,1
8611,12 confirmed cases,12 confirmed cases,1
8610,6 cases,6 cases,1
7383,live attenuated flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
4360,blood transfusions,biogenic substance type,1
4359,injection drug users,injection drug users,1
2752,compensated liver disease,organ type,1
7386,aso3adjuvanted vaccine,aso3adjuvanted vaccine,1
7387,aso3adjuvanted h1n1 vaccine,virus,1
2768,clinical development,clinical development,1
2769,human,organisms known particular common homo sapiens homo sapiens sapiens homo,1
7395,vaccine safety,vaccine safety,1
2776,human leukocyte elastase,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8586,multiple legal cases,multiple legal cases,1
8622,152 cases,152 cases,1
4343,disease severity,disease severity,1
1526,respiratory problems,respiratory problems,1
7365,severe health effects,severe health effects,1
8657,middle east respiratory syndrome,middle east respiratory syndrome,1
2688,compound numbers,compound numbers,1
4391,genetic factors,genetic factors,1
8653,sustained virological response,sustained virological response,1
8651,certain genetic variant alleles,certain genetic variant alleles,1
8649,significant differences,significant differences,1
8648,interferon lambda,group class proteins,1
8646,genetic polymorphisms,genetic polymorphisms,1
8644,host genetic factors,host genetic factors,1
7359,pregnant women chances,pregnant women chances,1
8638,alpha interferon family,group class proteins,1
8637,blood clots,biogenic substance type,1
2709,infecting influenza strain,infectious disease,1
8636,severe effects,severe effects,1
2711,polymerase protein,group class enzymes,1
2716,continuing research clinical concern,continuing research clinical concern,1
7364,allergic reaction,allergic reaction,1
2722,phase,phase,1
7480,2019–2020 northern hemisphere influenza season,infectious disease,1
7481,2020–2021 northern hemisphere influenza season,infectious disease,1
2942,rna polymerization,structural class chemical compounds,1
4138,preventive antiviral medication,preventive antiviral medication,1
3162,2012–2013 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
3163,majority,majority,1
8285,viral proteins neuraminidase,group class chemical substances second-order classgroup class enzymes,1
3169,cdc u.s. influenza season summary,infectious disease,1
4134,potential new treatments,potential new treatments,1
7594,universal vaccines,universal vaccines,1
4140,acute infection,acute infection,1
7595,tcell response,tcell response,1
3175,blood sugars,biogenic substance type,1
8280,cell membrane,cell membrane,1
7596,strong early tcell response,strong early tcell response,1
3178,elevated blood sugars,biogenic substance type,1
8277,rnadependent rna transcriptase,structural class chemical compounds,1
8276,future viruses,future viruses,1
3183,immune systems,immune systems,1
3174,healtheu portal eu response,healtheu portal eu response,1
4141,acute symptoms,acute symptoms,1
3154,clinical infectious diseases,clinical infectious diseases,1
8297,mammalian influenza viruses,infectious disease,1
4162,mild cognitive problems,mild cognitive problems,1
4159,detectable viral replication,detectable viral replication,1
8317,wild viruses,wild viruses,1
3123,vaccine formulations,vaccine formulations,1
3125,southern hemisphere,southern hemisphere,1
8313,inactivated live attenuated virions,inactivated live attenuated virions,1
4157,young people,young people,1
8311,low ph,low ph,1
4156,affected people,affected people,1
4154,acute phase,acute phase,1
3133,dominant strain,dominant strain,1
3135,standard antiviral drugs amantadine,chemical compound medication,1
3138,immune,immune,1
3139,risks,risks,1
3141,medical expenses,medical expenses,1
7583,annual seasonal vaccines,annual seasonal vaccines,1
3145,medical costs,medical costs,1
3185,lung disease,lung disease,1
7601,internal protein domains,internal protein domains,1
8271,cellular mrna,transcript,1
3190,acute respiratory distress syndrome,acute respiratory distress syndrome,1
7614,placebo group,placebo group,1
7618,clinical research,clinical research,1
7619,oral vaccine candidate,oral vaccine candidate,1
8239,ribonuclear proteins,group class chemical substances second-order class,1
7621,licensed injectable vaccine,licensed injectable vaccine,1
3234,broadspectrum antiviral effectiveness,broadspectrum antiviral effectiveness,1
8236,10 1.the viral envelope,10 1.the viral envelope,1
4101,clinical medical research,clinical medical research,1
4098,significant improvements,significant improvements,1
7628,poultry vaccines,organisms known particular common,1
7629,bits,bits,1
7631,human poultry vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common,1
8222,betainfluenzavirus,betainfluenzavirus,1
7633,strong immune reaction,strong immune reaction,1
7637,chicken vaccines,chicken vaccines,1
3258,h5n1 patients,subtype,1
3260,additional human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
8245,large glycoproteins,structural class chemical compounds,1
7575,universal vaccine,universal vaccine,1
3221,longer flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
8249,mature viral particles,mature viral particles,1
8269,new viral genome particles,scientific model natural environment,1
4124,insurance people,insurance people,1
3194,severe shortness,severe shortness,1
4123,insurance coverage,insurance coverage,1
7602,vaccine field,vaccine field,1
8265,newly synthesised viral proteins,group class chemical substances second-order class,1
3198,suppressed immune,suppressed immune,1
7603,vaccine adjuvants,vaccine adjuvants,1
7604,universal vaccines vaccines,universal vaccines vaccines,1
8260,rnadependent rna polymerase,structural class chemical compoundsgroup class enzymes,1
8259,accessory proteins,group class chemical substances second-order class,1
3207,inactivated viruses,inactivated viruses,1
7607,seven m001 trials,seven m001 trials,1
3209,live viruses,live viruses,1
8255,cell hemagglutinin glycoprotein,group class proteins,1
8254,detergents.flu viruses,detergents.flu viruses,1
8250,neuraminidase proteins,group class enzymesgroup class chemical substances second-order class,1
7610,3 study,3 study,1
3112,southern hemisphere winters,southern hemisphere winters,1
3105,paraguay,paraguay,1
3104,southern hemisphere countries,southern hemisphere countries,1
4235,shared intranasal drug use,shared intranasal drug use,1
8426,23–26 litres,23–26 litres,1
7500,viral growth,viral growth,1
2986,teratogenic embryotoxic effects,teratogenic embryotoxic effects,1
7501,embryonated hens eggs wasreportedby,embryonated hens eggs wasreportedby,1
2989,viral rnadependent rna polymerase,structural class chemical compoundsgroup class enzymes,1
4227,million intravenous drug users,million intravenous drug users,1
8418,especially h1n1 subtype,virus,1
8417,especially h1n1,virus,1
4225,drug use,drug use,1
4224,cryptogenic occult infection,cryptogenic occult infection,1
8414,15 studies,15 studies,1
2999,broadspectrum antiviral,broadspectrum antiviral,1
3000,fda phase ii phase iii clinical trials,fda phase ii phase iii clinical trials,1
8411,vast majority,vast majority,1
3005,unpublished phase iii trials,unpublished phase iii trials,1
4221,viral particles,viral particles,1
2978,viral infections,viral infections,1
4216,viral genome,scientific model natural environment,1
2972,pox viruses,pox viruses,1
2970,broad spectrum antiviral effects,broad spectrum antiviral effects,1
8454,oseltamivir low effectiveness,chemical compound neuraminidase inhibitor medication essential medicine,1
8453,routine seasonal influenza,infectious disease,1
7486,influenza season,infectious disease,1
8447,military use,military use,1
4247,potential blood donor,biogenic substance type,1
7488,2020 southern hemisphere influenza season,infectious disease,1
7489,2020 southern hemisphere influenza season influenza season,infectious diseaseinfectious disease,1
8441,h5n1 avian influenza epidemic,subtypeinfectious disease,1
4242,significant risks,significant risks,1
2960,experimental drug,experimental drug,1
8438,lower respiratory tract infections,lower respiratory tract infections,1
8437,randomised clinical trials,randomised clinical trials,1
7494,new vaccines,new vaccines,1
8435,doubleblinded randomized placebocontrolled clinical trials,doubleblinded randomized placebocontrolled clinical trials,1
2967,antiviral effects,antiviral effects,1
4239,blood products,biogenic substance type,1
2969,human clinical trials,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4238,blood transfusion,biogenic substance type,1
7639,h5n2 strain,h5n2 strain,1
8400,psychiatric effects,psychiatric effects,1
4212,occult infection,occult infection,1
7545,significantly enhanced immune response,significantly enhanced immune response,1
3077,viral rna synthesis,structural class chemical compounds,1
7546,2009 pandemic h1n1,virus,1
8349,dose adjustment,dose adjustment,1
8346,psychiatric symptoms,psychiatric symptoms,1
7558,20202021 influenza season,infectious disease,1
7559,2020–2021 influenza season,infectious disease,1
3089,hemisphere,hemisphere,1
7565,vaccine production,vaccine production,1
3091,season,season,1
8337,discretion,discretion,1
7568,70 known clinical trials,70 known clinical trials,1
7569,2009 h1n1,virus,1
8334,extant strains,extant strains,1
8333,genus,genus,1
8331,mild disease,mild disease,1
7570,initial vaccine lots,initial vaccine lots,1
7543,maligned 1976 vaccine,maligned 1976 vaccine,1
3017,rigorous studies,rigorous studies,1
8357,confirmed suspected influenza virus infection,infectious disease,1
3062,enteroviruses,enteroviruses,1
3023,guinea,guinea,1
4209,issues,issues,1
7520,recombinant proteins,group class chemical substances second-order class,1
8388,cardiac symptoms,cardiac symptoms,1
8382,22 adult people,22 adult people,1
4198,low platelet count,low platelet count,1
7529,vaccine coverage levels,vaccine coverage levels,1
3045,nipah virus infection,nipah virus infection,1
3046,aspects,aspects,1
3047,human disease,organisms known particular common homo sapiens homo sapiens sapiens homo,1
4194,small mediumsized blood vessels,biogenic substance type,1
8372,relevant clinical outcomes,relevant clinical outcomes,1
3051,lethal dose,lethal dose,1
3054,previous studies,previous studies,1
8368,new evidence,new evidence,1
6119,a/anhui/1/13 viruslike particle vaccine,a/anhui/1/13 viruslike particle vaccine,1
3061,severe disease,severe disease,1
8358,critically ill people,critically ill people,1
1525,pregnant post partum women,pregnant post partum women,1
3819,poultry receptors,organisms known particular common,1
5583,large amounts,large amounts,1
275,noteworthy murrain,noteworthy murrain,1
5951,mild upper respiratory symptoms,mild upper respiratory symptoms,1
5950,group,group,1
6223,18 positive cases,18 positive cases,1
6224,positive cases,positive cases,1
1026,government response,government response,1
284,pandemic strain,pandemic strain,1
1025,poultry,organisms known particular common,1
5942,19 deaths,19 deaths,1
1021,bird deaths,taxon,1
6589,large proportion,large proportion,1
5941,96 confirmed reports,96 confirmed reports,1
1018,initial reaction,initial reaction,1
1016,tamiflu vaccine,chemical compound neuraminidase inhibitor medication essential medicine,1
6228,additional laboratoryconfirmed cases,additional laboratoryconfirmed cases,1
5938,poultry production,organisms known particular common,1
10022,disease vectors,disease vectors,1
5937,surge,surge,1
10023,bodies,bodies,1
5936,winter months,winter months,1
10024,stronger immune,stronger immune,1
5935,144 cases,144 cases,1
5448,nasopharyngeal large rise,nasopharyngeal large rise,1
5932,avian populations,avian populations,1
5931,h7 viruses,h7 viruses,1
10003,successive waves,successive waves,1
5953,larger group,larger group,1
5954,2013 outbreak,2013 outbreak,1
272,previous medical historians data hasfound,previous medical historians data hasfound,1
10654,viral superinfections,viral superinfections,1
9966,egyptian government,egyptian government,1
10652,different strain,different strain,1
5973,low path,low path,1
5972,new territory,new territory,1
1067,official response,official response,1
6215,reported death,stock character psychopomp literary character,1
5414,diseases,diseases,1
6217,5 deaths,5 deaths,1
5964,h9n2 chicken viruses,h9n2 chicken viruses,1
5963,probably wild birds,probably wild birds,1
1055,chicken products,chicken products,1
998,poultry industry,organisms known particular common,1
1054,prices,prices,1
5419,respiratory mucosa,respiratory mucosa,1
5420,upper lower respiratory tract,upper lower respiratory tract,1
9985,gilead drug,gilead drug,1
5958,parent viruses,parent viruses,1
5424,infecting dose,infecting dose,1
5957,human beings,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5956,genetic characterisation,genetic characterisation,1
9991,medical tourism,medical tourism,1
6602,influenza infection,infectious disease,1
9993,increasing numbers,increasing numbers,1
6601,common symptoms,common symptoms,1
5955,h7n9 viruses,taxon,1
6607,coughs,coughs,1
993,infected people,infected people,1
992,typical seasonal influenza,infectious disease,1
303,repeated waves,repeated waves,1
323,new acquaintance,new acquaintance,1
10072,pandemic tuberculosis,notifiable disease valid place switzerland endemic disease,1
6242,xinhua chinese state media,xinhua chinese state media,1
10076,bells,bells,1
5488,large,large,1
5489,infected persons immune systems andwhether,infected persons immune systems andwhether,1
5913,low,low,1
929,trials,trials,1
6244,reported cases 2014,reported cases 2014,1
5493,known strain,known strain,1
927,vaccine manufacturers,vaccine manufacturers,1
6545,human vaccines,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5481,large fraction,large fraction,1
10579,longterm effects,longterm effects,1
6246,medical professional,medical professional,1
6248,reported cases 2015,reported cases 2015,1
919,vaccine aftermath,vaccine aftermath,1
918,new military recruits,new military recruits,1
916,destroyers,destroyers,1
6249,canadian visitor,canadian visitor,1
5503,panzootic outbreak,panzootic outbreak,1
910,680 deaths,680 deaths,1
334,varying waves,varying waves,1
5506,447 cases,447 cases,1
5507,significant effect,significant effect,1
6250,15 cases,15 cases,1
10578,additional adverse economic effects,additional adverse economic effects,1
10655,original infection,original infection,1
322,new sickness,new sickness,1
951,virus strain,virus strain,1
5452,clinical findings,clinical findings,1
985,vaccine trial,vaccine trial,1
10598,covid19 pandemic,covid19 pandemic,1
5927,outbreak report,outbreak report,1
6233,24 cases,24 cases,1
5463,highly pathogenic causative agent,highly pathogenic causative agent,1
10045,widely,widely,1
974,h3n2 strain,subtype,1
6238,ongoing humantohuman transmission,ongoing humantohuman transmission,1
5920,wild,wild,1
5919,low pathogenic strains,low pathogenic strains,1
5918,highly pathogenic strains,highly pathogenic strains,1
10066,comparable disease,comparable disease,1
966,h1n1 strain,virus,1
5471,455 people,455 people,1
5472,highly contagious strain,highly contagious strain,1
5473,airborne transmission,airborne transmission,1
5475,limited humantohuman transmission,limited humantohuman transmission,1
10060,deadliest diseases,deadliest diseases,1
956,history outbreak,history outbreak,1
319,food scarcity,food scarcity,1
10061,tuberculosis cases,notifiable disease valid place switzerland endemic disease,1
5477,asian strain,asian strain,1
5915,h7n3 chilean avian influenza viruses,infectious disease,1
5478,efficient humantohuman transmission,efficient humantohuman transmission,1
952,genetic analysis,genetic analysis,1
5470,861 confirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
903,outbreak areas,outbreak areas,1
5406,vaccine strains,vaccine strains,1
9962,indian activist group,indian activist group,1
5325,2004–2005 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
6191,52%,52%,1
1183,bernard matthews bin,bernard matthews bin,1
6013,visible disease,visible disease,1
9870,viral rna polymerase,structural class chemical compoundsgroup class enzymes,1
9871,3 hydroxyl group toactas,3 hydroxyl group toactas,1
5327,2005–2006 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
1178,viruses,viruses,1
5328,2005–2006 season,2005–2006 season,1
5329,2006–2007 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5330,vaccine composition,vaccine composition,1
6008,wild songbirds environment,wild songbirds environment,1
5334,2007–2008 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
1170,turkey products,sovereign state transcontinental country mediterranean country country social state regional power secular state,1
5336,2007–2008 northern hemisphere influenza season,infectious disease,1
5337,2008–2009 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5339,2008–2009 northern hemisphere influenza season,infectious disease,1
5340,2009–2010 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
10708,broadspectrum antiviral drug,broadspectrum antiviral drug,1
5341,2009–2010 season,2009–2010 season,1
9887,plasma protein,plasma protein,1
5342,2010–2011 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
6007,wild songbirds,wild songbirds,1
5343,2010–2011 season,2010–2011 season,1
5344,2011–2012 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
6669,known influenza virus subtypes,infectious disease,1
1187,contaminated poultry farming tools,organisms known particular common,1
9866,cell permeability,cell permeability,1
10716,new structural class,new structural class,1
165,people,people,1
6027,poultry vaccination,organisms known particular common,1
9837,previous treatments,previous treatments,1
6690,h1n1 virus strain,virus,1
9840,fewer effects,fewer effects,1
9842,injectable drug,injectable drug,1
9844,older drug combinations,older drug combinations,1
169,cases,cases,1
6184,24.08% response rate,24.08% response rate,1
5308,current commercial vaccines,current commercial vaccines,1
6683,influenza virus strain,infectious disease,1
1209,british poultry council,organisms known particular common,1
10705,laboratoryconfirmed case,laboratoryconfirmed case,1
10728,lethal influenza infection,infectious disease,1
1205,poultry products,organisms known particular common,1
6021,live bird markets,taxon,1
10721,viral genomic fragments,viral genomic fragments,1
1200,hungarian turkey products,sovereign state transcontinental country mediterranean country country social state regional power secular state,1
6675,eu response,eu response,1
1197,bernard matthews shipments,bernard matthews shipments,1
1196,bernard matthews bernard matthews,bernard matthews bernard matthews,1
9860,months posttreatment,months posttreatment,1
1193,bernard matthews,bernard matthews,1
10717,nonnucleoside antiviral drugs,nonnucleoside antiviral drugs,1
6673,potential influenza,infectious disease,1
6672,government preparations potential h5n1 pandemic (2003–2009),subtype,1
6022,human animal infections,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,1
5345,2011–2012 season,2011–2012 season,1
5346,northern hemisphere 2012–2013 season,northern hemisphere 2012–2013 season,1
5347,2014–2015 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5997,new england journal,nation uk cultural area country,1
6635,trivalent influenza vaccine,infectious disease,1
6202,international response,international response,1
5995,blood poisoning,biogenic substance type,1
1105,3 protection zone,3 protection zone,1
1104,h5n1 causation,subtype,1
6634,common human vaccine,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5386,respiratory tract secretions,respiratory tract secretions,1
6204,reported cases 2013,reported cases 2013,1
222,east,east,1
10676,whoconfirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5991,genetic modification work,genetic modification work,1
10683,wild water fowl,wild water fowl,1
5990,lethal human pandemic,organisms known particular common homo sapiens homo sapiens sapiens homo,1
6629,deadly avian strain,deadly avian strain,1
10668,documented case,documented case,1
10667,infected avian sources,infected avian sources,1
5396,upper respiratory tract,upper respiratory tract,1
1087,large cull,large cull,1
6625,mild illness,mild illness,1
5983,lot,lot,1
5981,thing sdifferentbetween 600 people,thing sdifferentbetween 600 people,1
1080,bernard matthews farms,bernard matthews farms,1
5402,subclinical infection,subclinical infection,1
5978,600 people,600 people,1
1077,h5n1 subtype,subtype,1
6206,confirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5977,genetic makeup,genetic makeup,1
10684,avian influenza cycle,infectious disease,1
5998,h7n9 virus infection,taxon,1
5348,northern hemisphere 2014–2015 season,northern hemisphere 2014–2015 season,1
5349,2015–2016 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5350,northern hemisphere 2015–2016 season,northern hemisphere 2015–2016 season,1
6664,trust.a letter,trust.a letter,1
10702,highly pathogenic h5n1 avian influenza,subtypeinfectious disease,1
6005,live poultry markets,organisms known particular common,1
5356,highly contagious respiratory disease,highly contagious respiratory disease,1
10700,widespread seasonal influenza vaccination,infectious disease,1
6655,human selfishness,organisms known particular common homo sapiens homo sapiens sapiens homo,1
6652,dead bodies,dead bodies,1
10696,pandemic period,pandemic period,1
6650,medical supplies,medical supplies,1
5383,route transmission,route transmission,1
5369,a/equine/2 strain,a/equine/2 strain,1
6199,current disease outbreak,current disease outbreak,1
6001,early infection,early infection,1
1120,mild respiratory illness evening,mild respiratory illness evening,1
10691,human human transmission,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common homo sapiens homo sapiens sapiens homo,1
6639,influenza b virus strain,infectious disease,1
6638,influenza virus subtypes,infectious disease,1
5379,1889 pandemic,1889 pandemic,1
1115,antiviral drugs,antiviral drugs,1
10687,resident water fowl,resident water fowl,1
5381,1889 1900 outbreak,1889 1900 outbreak,1
6636,viral strains,viral strains,1
10686,ai viruses,ai viruses,1
10695,new influenza virus subtypes,infectious disease,1
5512,potential avian influenza,infectious disease,1
899,response,response,1
5514,poultry sales,organisms known particular common,1
5659,contagious strains,contagious strains,1
10464,german samoa,german samoa,1
6428,genus betainfluenzavirus,genus betainfluenzavirus,1
5661,erasmus medical center,erasmus medical center,1
5662,rotterdam,rotterdam,1
6425,hemagglutinin protein,group class proteins,1
5814,wild swan,wild swan,1
10294,lethal strain,lethal strain,1
5813,h5n8 case,h5n8 case,1
466,lombardy,lombardy,1
10297,pathogenic viruses,pathogenic viruses,1
10298,dangerous strains,dangerous strains,1
10299,fatal cases,fatal cases,1
5669,respiratory droplets,respiratory droplets,1
5810,h5n8 outbreak,h5n8 outbreak,1
5672,highly pathogenic h5n2 variety,highly pathogenic h5n2 variety,1
659,eurasia,supercontinent,1
6416,viable progeny viruses,viable progeny viruses,1
6415,damaged viruses,damaged viruses,1
5678,poultry vaccine,organisms known particular common,1
10314,hair,hair,1
649,outbreak spread,outbreak spread,1
6319,ventilation,ventilation,1
6411,rna strands,structural class chemical compounds,1
472,dual outbreak,dual outbreak,1
5658,h5n1 transmission studies ferrets (2011),subtype,1
10466,22%,22%,1
10467,adult women,adult women,1
6433,matrix protein,matrix protein,1
5629,specific case,specific case,1
10247,chinese medical association circulation,chinese medical association circulation,1
10481,new caledonia,new caledonia,1
6445,virus family orthomyxoviridae,taxon,1
5632,highly pathogenic varieties,highly pathogenic varieties,1
5633,genetic clades,genetic clades,1
6444,genus gammainfluenzavirus,genus gammainfluenzavirus,1
10254,transmission mutation,transmission mutation,1
5637,significant disease,significant disease,1
10259,soldiers immune systems wereweakenedby,soldiers immune systems wereweakenedby,1
6305,eurasian avian lineage,eurasian avian lineage,1
5640,h5n1 caused acute disease,subtype,1
10453,indigenous people,indigenous people,1
10263,large factor,large factor,1
5641,severe neurological dysfunction,severe neurological dysfunction,1
5643,lethal influenza virus infection,infectious disease,1
699,edinburgh,capital scotland city college town lieutenancy area scotland big city,1
5644,wild aquatic birds,wild aquatic birds,1
10268,denial,denial,1
5646,earlier highly pathogenic genotypes,earlier highly pathogenic genotypes,1
448,large portion,large portion,1
10272,mild strain,mild strain,1
453,government officials,government officials,1
10278,deadlier strains,deadlier strains,1
6310,transmission chicken human,organisms known particular common homo sapiens homo sapiens sapiens homo,1
686,german empire,german empire,1
703,east coast,east coast,1
644,reported effects,reported effects,1
5687,highly pathogenic h5n2,highly pathogenic h5n2,1
641,great pandemic,great pandemic,1
5720,highly pathogenic avian influenza,infectious disease,1
5782,seven people,seven people,1
5781,poultry movement,organisms known particular common,1
5726,minor outbreak,minor outbreak,1
5779,philippines poultry outbreak,organisms known particular common,1
5728,lowpathogenic strain,lowpathogenic strain,1
10367,significant increase,significant increase,1
512,severe pain,severe pain,1
6379,lab strains,lab strains,1
573,highly contagious catarrhal fever,highly contagious catarrhal fever,1
5733,low pathogenic avian influenza,infectious disease,1
5776,new coronavirus pandemic,group class strains strain,1
6385,large proteins,group class chemical substances second-order class,1
567,severe bread shortage,severe bread shortage,1
565,food,food,1
6341,viral surface proteins,group class chemical substances second-order class,1
558,pregnant women,pregnant women,1
5743,montana,montana,1
5767,h5n6 avian influenza,infectious disease,1
525,blood,biogenic substance type,1
528,mary,mary,1
6361,human toll,organisms known particular common homo sapiens homo sapiens sapiens homo,1
10395,delayed response,delayed response,1
529,mary government,mary government,1
530,sufficient reinforcements,sufficient reinforcements,1
6348,virus family,virus family,1
10377,large percentage,large percentage,1
723,new zealand,new zealand,1
5785,dead animals,dead animals,1
595,pernicious symptoms,pernicious symptoms,1
479,graduate studies,graduate studies,1
5798,nervousness,nervousness,1
5797,usual symptoms,usual symptoms,1
5694,forage,forage,1
489,disease,disease,1
5697,low quality,low quality,1
6400,viral genomes,viral genomes,1
626,deaths,deaths,1
10332,transfected animals,transfected animals,1
10333,rapidly progressive respiratory failure,rapidly progressive respiratory failure,1
5794,virulent avian influenza,infectious disease,1
491,severe outbreak,severe outbreak,1
5716,h5n2 outbreak,h5n2 outbreak,1
5700,suspected low pathogenic h5n2 strain,suspected low pathogenic h5n2 strain,1
6396,viral proteins,group class chemical substances second-order class,1
10347,severe decline,severe decline,1
608,deadly disease,deadly disease,1
607,mass outbreak,mass outbreak,1
498,200 people,200 people,1
605,east europe,continental area surrounding islands continent geographic region,1
5788,highly pathogenic h1n1,virus,1
604,contagious seasonal pneumonias,contagious seasonal pneumonias,1
10350,mismanaged response,mismanaged response,1
5713,bingiriya,bingiriya,1
6388,target cell,target cell,1
504,severe headache,severe headache,1
6397,genetic material,genetic material,1
5831,wild duck,wild duck,1
6301,h9n2 viruses,h9n2 viruses,1
10242,comparatively mild flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
851,vaccine,vaccine,1
5546,genetic structure related subtypes,genetic structure related subtypes,1
10546,human behavioral changes,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5547,genus alphainfluenzavirus,genus alphainfluenzavirus,1
847,pneumonia,cause death infectious disease,1
368,treatments,treatments,1
6269,worldwide outbreak,worldwide outbreak,1
6270,protective immune responses,protective immune responses,1
10149,lima,capital city big city city millions inhabitants,1
6271,british medical journal,british medical journal,1
10542,biologically plausible values,biologically plausible values,1
6273,family cluster,family cluster,1
5883,h5n8 strain,h5n8 strain,1
838,novel strain,novel strain,1
836,avian influenza,infectious disease,1
6274,avian h7n9,taxon,1
5553,pb1,pb1,1
377,infection,infection,1
5876,official confirmed reports,official confirmed reports,1
5559,low pathogenic h5n1,subtype,1
825,global pandemic,global pandemic,1
5872,highly pathogenic h5n8 bird flu virus,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
823,primarily elderly people,primarily elderly people,1
5564,genetic recombination,genetic recombination,1
821,pneumonia heart attack,cause death infectious disease,1
385,worldwide highlycontagious respiratory disease,worldwide highlycontagious respiratory disease,1
837,human influenza viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,1
387,flulike symptoms,flulike symptoms,1
10140,government bonds,government bonds,1
859,preexisting heart lung disease,preexisting heart lung disease,1
10573,medical doctors,medical doctors,1
10107,flurelated deaths,flurelated deaths,1
10109,reported quarantines,reported quarantines,1
6251,h7n9 infection,taxon,1
887,origin outbreak china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",1
6254,460 human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,1
886,respiratory viruses,respiratory viruses,1
342,new spain,new spain,1
883,severe mortality impact,severe mortality impact,1
5521,crisis response,crisis response,1
5522,h5n1 s potential impact,subtype,1
6256,laboratoryconfirmed cases,laboratoryconfirmed cases,1
10548,human behavioral responses,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5523,nabarro,nabarro,1
6258,281 deaths,281 deaths,1
6263,h7n9 strains,taxon,1
10554,viral waves,viral waves,1
6265,pandemic influenza viruses,infectious disease,1
6266,viruses ability,viruses ability,1
5538,coronavirus pandemic,group class strains strain,1
360,medicine treatments,medicine treatments,1
6267,humantohuman infection,humantohuman infection,1
6515,seasonal epidemics,seasonal epidemics,1
861,economic effects,economic effects,1
10549,significant effects,significant effects,1
6514,known subtypes,known subtypes,1
5897,genetic test,genetic test,1
164,large volumes,large volumes,1
5566,previously uncontagious strain,previously uncontagious strain,1
6497,host cell receptors,host cell receptors,1
5596,future international response measures,future international response measures,1
412,localized outbreak,localized outbreak,1
5850,major poultry producers,organisms known particular common,1
6474,severe infections,severe infections,1
10508,differences,differences,1
6290,5 years,5 years,1
417,severe respiratory disease,severe respiratory disease,1
766,people alsothoughtthatfastingwouldstarve,people alsothoughtthatfastingwouldstarve,1
6469,coldlike symptoms,coldlike symptoms,1
6468,mild upper respiratory infections,mild upper respiratory infections,1
763,cheaper treatments,cheaper treatments,1
5845,poultry flocks,organisms known particular common,1
5594,significant numbers,significant numbers,1
10211,chinese medical association,chinese medical association,1
10215,austrian archives,austrian archives,1
10217,leading expert,leading expert,1
5611,avian respiratory tract,avian respiratory tract,1
10498,hospitalized women,hospitalized women,1
10497,thirteen studies,thirteen studies,1
6298,recent human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5618,infected poultry manure,organisms known particular common,1
433,sarajevo,sarajevo,1
734,reported case,reported case,1
6448,minor symptoms,minor symptoms,1
5626,differing pathogenic profiles,differing pathogenic profiles,1
728,northern hemisphere,northern hemisphere,1
421,ottoman empire east europe,continental area surrounding islands continent geographic region,1
5567,avian h5n1 varieties,subtype,1
778,subtypes,subtypes,1
10193,new disease,new disease,1
815,genetic comparisons,genetic comparisons,1
393,severe coughing,severe coughing,1
5569,limited use,limited use,1
10525,women,women,1
6283,efforts prevent spread disease,efforts prevent spread disease,1
397,case,case,1
811,human population,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5862,poultry market,organisms known particular common,1
810,strain,strain,1
6494,viral cellular membranes,viral cellular membranes,1
801,2002–2004 sars outbreak,2002–2004 sars outbreak,1
10180,january 1918 outbreak,january 1918 outbreak,1
10195,similar outbreak,similar outbreak,1
6485,family orthomyxoviridae,taxon,1
6289,h9n2 influenza strain,infectious disease,1
5584,new pandemic strain,new pandemic strain,1
5855,separate outbreak,separate outbreak,1
5854,avian products,avian products,1
10513,poorer people,poorer people,1
792,h1n1,virus,1
5586,food agriculture organization,food agriculture organization,1
789,1918 pandemic,1918 pandemic,1
6481,effective immune systems,effective immune systems,1
785,1889–1890 pandemic,1889–1890 pandemic,1
784,elderly people,elderly people,1
5591,avian influenza occurrences,infectious disease,1
5130,swine influenza virus strain,swine diseaseinfectious disease,1
5300,commercial siv vaccines,commercial siv vaccines,1
10639,second infection,second infection,1
10404,large extent,large extent,1
130,precipitous symptoms,precipitous symptoms,1
1306,labconfirmed deaths,labconfirmed deaths,1
6169,decade mighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwithchina sagricultureministryeffortsnowtoidentify h5n1 avian influenza virus,subtypeinfectious disease,1
5176,disease control prevention document,disease control prevention document,1
1430,crossreactive antibody reaction,family protein complexes,1
6045,new infection,new infection,1
6716,pandemic wave,pandemic wave,1
6769,54%,54%,1
6092,quick response,quick response,1
6134,different vaccine dosages,different vaccine dosages,1
1300,asymptomatic mild cases,asymptomatic mild cases,1
6133,phase ii trials,phase ii trials,1
134,3 days,3 days,1
1298,flu.some studies,flu.some studies,1
5264,viral genus influenzavirus,viral genus influenzavirus,1
1436,similar seasonal influenza viruses,infectious disease,1
5262,h3n2 viruses,subtype,1
1425,disease control,disease control,1
9674,nbk385156,nbk385156,1
10824,rational drug design,rational drug design,1
6167,poultry againsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwithchina sagricultureministryeffortsnowtoidentify h5n1 avian influenza virus,organisms known particular common namesubtypeinfectious disease,1
1412,clinical epidemiological backgrounds,clinical epidemiological backgrounds,1
9682,simprevir,simprevir,1
5256,farmed pig populations,farmed pig populations,1
9681,endstage kidney disease,endstage kidney disease,1
6719,pandemic severity,pandemic severity,1
6763,seasonal influenza vaccines,infectious disease,1
10763,peerreviewed studies,peerreviewed studies,1
5258,epidemic pandemic influenza preparedness,infectious disease,1
1311,strains,strains,1
6718,pandemic severity assessment framework,pandemic severity assessment framework,1
6086,immune phenomenon,immune phenomenon,1
1419,u.s. food drug administration,u.s. food drug administration,1
6765,weak immune response,weak immune response,1
129,adult sufferers,adult sufferers,1
6138,dosesparing strategy.in response,dosesparing strategy.in response,1
1422,existing vaccines,existing vaccines,1
6130,widespread transmission,widespread transmission,1
9663,postmarketing studies,postmarketing studies,1
5225,significant prerequisite,significant prerequisite,1
6097,effective vaccine response,effective vaccine response,1
6782,vaccine research,vaccine research,1
27,nearuniversal infection,nearuniversal infection,1
6103,h7n9 vaccine,taxon,1
5271,separate vaccines,separate vaccines,1
1457,fewer deaths,fewer deaths,1
1458,average flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
24,government,government,1
10755,hypersensitivity,biological process,1
10754,known overdose cases,known overdose cases,1
1462,usual flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5273,separate vaccines annual epidemics,separate vaccines annual epidemics,1
10751,darunavir,darunavir,1
5157,pandemic potential,pandemic potential,1
9787,ns5b protein,ns5b protein,1
5156,disease prevention,disease prevention,1
5154,230 people,230 people,1
6787,march 2005 plan,march 2005 plan,1
1453,swine influenza viruses,swine diseaseinfectious disease,1
1317,pneumonia acute respiratory distress syndrome,cause death infectious disease,1
10838,c4 hydroxyl group,c4 hydroxyl group,1
5267,influenza subtypes,infectious disease,1
9776,relatively low potency,relatively low potency,1
9777,low potency,low potency,1
1439,0.3% crossreactive antibody reaction,family protein complexes,1
36,middle east,middle east,1
5169,2001–02 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
5166,pig populations,pig populations,1
6099,existing seasonal vaccines,existing seasonal vaccines,1
6714,response planning activities,response planning activities,1
1291,new strain,new strain,1
1444,genetic sequences,genetic sequences,1
5266,internal proteins,group class chemical substances second-order class,1
9658,randomized doubleblind placebo controlled clinical trials,randomized doubleblind placebo controlled clinical trials,1
9657,clinical study,clinical study,1
6100,apdm09 vaccines,apdm09 vaccines,1
6101,vaccine efficacy,vaccine efficacy,1
31,east asia,continent continental area surrounding islands,1
6043,100 people,100 people,1
5162,reported cases,reported cases,1
10750,russian antiviral market,russian antiviral market,1
6721,pandemic response,pandemic response,1
9684,fetal deaths,fetal deaths,1
83,spanishimported diseases,spanishimported diseases,1
5236,entire respiratory tract,entire respiratory tract,1
98,sufferers,sufferers,1
5238,chronic pneumonia,cause death infectious disease,1
10784,poliovirus infection,taxon,1
5211,h9n2 candidate vaccines,h9n2 candidate vaccines,1
102,medicinal treatments,medicinal treatments,1
5235,severe pneumonia,cause death infectious disease,1
5209,pandemic preparedness,pandemic preparedness,1
9748,influenzalike symptoms,influenzalike symptoms,1
10781,mammalian cell cultures,mammalian cell cultures,1
5207,u.s. government,u.s. government,1
105,pectoral troches,pectoral troches,1
10779,vitro effectiveness,vitro effectiveness,1
10777,candidate drug,candidate drug,1
1380,confirmed diagnosis,activity,1
80,isle,isle,1
6748,influenza vaccine manufacturers,infectious disease,1
5214,h2n3 viruses,h2n3 viruses,1
6159,usfunded h7n9 vaccine,taxon,1
5228,pathogenic potential,pathogenic potential,1
93,common treatments,common treatments,1
6740,antiviral resistance,antiviral resistance,1
6741,possible pandemic,possible pandemic,1
9733,compared annual flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
9734,annual flu season deaths,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
9725,dr. david nabarro,dr. david nabarro,1
1362,heart disease,heart disease,1
6058,detected cases,detected cases,1
1363,weakened immune,weakened immune,1
97,symptoms,symptoms,1
10791,clinical testing,clinical testing,1
6745,population infection,population infection,1
1348,signs symptoms,signs symptoms,1
5232,human influenza infection,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,1
1369,paediatric deaths,paediatric deaths,1
5234,mild pneumonia,cause death infectious disease,1
10776,clinical application,clinical application,1
111,influenza viruses,infectious disease,1
5242,blood plasma levels,biogenic substance type,1
5206,deadly avian influenza virus subtypes,infectious disease,1
6147,new viral strain,new viral strain,1
6079,severe outcomes,severe outcomes,1
6144,synthetic genomics vaccines,branch biology genome omics academic discipline,1
9694,h5n1 pandemicthe social impact,subtype,1
5194,influenza outbreak,infectious disease,1
5192,pandemic varies,pandemic varies,1
1401,use,use,1
6053,widespread mild disease,widespread mild disease,1
5251,severe influenza infections,infectious disease,1
6052,new cases,new cases,1
1320,direct viral pneumonia,cause death infectious disease,1
5191,worldwide deaths,worldwide deaths,1
5190,preexisting human strain,organisms known particular common homo sapiens homo sapiens sapiens homo,1
5189,wild ducks,wild ducks,1
6760,usa h1n1 vaccine supply,virus,1
5253,larger outbreak,larger outbreak,1
6085,immune responses,immune responses,1
6756,h5n1 strains,subtype,1
1410,octors,octors,1
69,10 people,10 people,1
6726,limited humantohuman transmission influenza,infectious disease,1
5205,1957 strain,1957 strain,1
6752,large quantities,large quantities,1
9705,h5n1 threat,subtype,1
10801,small benefits,small benefits,1
6152,h7n9 avian influenza,taxoninfectious disease,1
1332,different cases,different cases,1
1331,genetic divergence,genetic divergence,1
1387,pandemic h1n1,virus,1
6728,public response measures,public response measures,1
9756,transporter protein,transporter protein,1
6150,rapid response,rapid response,1
5200,cap,cap,1
10773,humoral immune response,humoral immune response,1
10772,umifenovir exhibits modulatory effects,chemical compound,1
118,new strains,new strains,1
5247,human h2n2 infected animals,organisms known particular common homo sapiens homo sapiens sapiens homowikimedia disambiguation page,1
6073,poultry exposure,organisms known particular common,1
10770,specific antiviral action,specific antiviral action,1
9639,prevalent form,prevalent form,1
10788,rnadependent rna polymerase inhibitor,structural class chemical compoundsgroup class enzymes,1
9788,viral reproduction cycle,viral reproduction cycle,1
9800,sofosbuvir clinical development,chemical compound medication active ingredient essential medicine,1
9799,severe rash,severe rash,1
6122,matrix 1 protein,matrix 1 protein,1
1243,h5n1,subtype,1
6792,federal government,federal government,1
10746,clinical setting,clinical setting,1
1492,limited vaccine supplies,limited vaccine supplies,1
5136,g4 ea h1n1 viruses,virus,1
9797,6 12 months treatment,6 12 months treatment,1
5293,human swine avian lineages,organisms known particular common homo sapiens homo sapiens sapiens homoswine disease,1
6800,initial vaccine,initial vaccine,1
9801,warehouse people,warehouse people,1
6801,early use,early use,1
10747,drug brand,drug brand,1
10857,self reported investigator mediated pneumonia,cause death infectious disease,1
1491,dose,dose,1
5277,seasonal influenza viruses,infectious disease,1
6802,emerging pandemic.each state,emerging pandemic.each state,1
1490,new vaccine,new vaccine,1
9793,fixed dose combination drug sofosbuvir/ledipasvir,fixed dose combination drug sofosbuvir/ledipasvir,1
6699,787 confirmed cases,787 confirmed cases,1
9609,ribavirin active disease,chemical compound medication essential medicine 1 april 1990,1
1489,clinical trials,clinical trials,1
6030,new human h7n9 cases,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,1
10860,certain people,certain people,1
9803,fda availability,fda availability,1
158,outbreak,outbreak,1
1506,flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,1
6,medical historians,medical historians,1
6797,h5n1 vaccine production,subtype,1
153,1510 sudden symptoms,1510 sudden symptoms,1
6796,pilot vaccine lots,pilot vaccine lots,1
1500,effects,effects,1
6035,human seasonal influenza viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,1
5287,virus subtypes,virus subtypes,1
10856,middle ear infection,middle ear infection,1
151,months,months,1
5285,additional months,additional months,1
10858,prophylaxis trials,prophylaxis trials,1
10855,proof,proof,1
9622,sickle cell anemia,sickle cell anemia,1
9638,previous interferon therapy,group class proteins,1
9816,severe acute respiratory syndrome coronavirus,group class strains strain,1
6034,seasonal pattern,seasonal pattern,1
1247,highly pathogenic avian influenza virus,infectious disease,1
6794,u.s. vaccine production,u.s. vaccine production,1
6706,new recommendations,new recommendations,1
9808,sofosbuvi,sofosbuvi,1
10739,viral entry,viral entry,1
1246,birdadapted strain,birdadapted strain,1
1504,protective items,protective items,1
1505,clinical workers,clinical workers,1
9805,new drug,new drug,1
1274,eggs,eggs,1
9824,american association,american association,1
6111,medical sciences,medical sciences,1
9827,firstline treatments,firstline treatments,1
9825,liver diseases,organ type,1
19,pandemic,pandemic,1
6711,pandemic phases,pandemic phases,1
6040,h7n9 transmission,taxon,1
5151,predominant strain,predominant strain,1
6697,20 confirmed cases,20 confirmed cases,1
5296,bivalent siv vaccines,bivalent siv vaccines,1
9791,new drug application,new drug application,1
9636,adult people,adult people,1
1480,h1n1 vaccine,virus,1
1518,salicylate products,salicylate products,1
6709,response plans,response plans,1
1519,flutype symptoms,flutype symptoms,1
9607,active disease,active disease,1
9633,viral maturation,viral maturation,1
1521,medical attention,medical attention,1
1233,state benefits,state benefits,1
6698,3,3,1
1,acute respiratory disease,acute respiratory disease,1
1475,resident viruses,resident viruses,1
1485,vaccine priority,vaccine priority,1
1474,human viruses,organisms known particular common homo sapiens homo sapiens sapiens homo,1
9828,secondline treatments,secondline treatments,1
6109,food drug control,food drug control,1
10846,resources,resources,1
6336,siddique s,siddique s,2
8792,baltimore s viral classification asgroupivvirusesas,baltimore s viral classification asgroupivvirusesas,2
2600,parkinson s disease showed,parkinson s disease showed,2
4071,950 000 people,950 000 people,2
3816,flu virus s ability tobindto,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
2598,patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease amantadine],patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease amantadine],2
2597,parkinson s disease andgave,parkinson s disease andgave,2
2596,patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease],patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease],2
91,treatment,treatment,2
74,new world,new world,2
366,health,health,2
2589,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwithparkinson sdiseasefinished course,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwithparkinson sdiseasefinished course,2
2588,parkinson s disease symptoms worsenedafter,parkinson s disease symptoms worsenedafter,2
2587,woman withparkinson sdiseasealsoreportedthatawomanwith parkinson s disease symptoms],woman withparkinson sdiseasealsoreportedthatawomanwith parkinson s disease symptoms],2
5751,biological heat treatment,biological heat treatment,2
3729,country s national pharmaceutical institute,country s national pharmaceutical institute,2
913,million cases,million cases,2
10094,world war,world war,2
3349,entire world,entire world,2
4196,sjögren s syndrome,sjögren s syndrome,2
1705,private health providers,private health providers,2
5499,million treatment courses,million treatment courses,2
384,1557 pandemic s nature asaworldwidehighlycontagiousrespiratorydiseasewithfastonsetofflulikesymptomshasledmanyphysiciansfrommedicalhistorianslikecharlescreightontomodernepidemiologiststoconsider,1557 pandemic s nature asaworldwidehighlycontagiousrespiratorydiseasewithfastonsetofflulikesymptomshasledmanyphysiciansfrommedicalhistorianslikecharlescreightontomodernepidemiologiststoconsider,2
5873,22 700 birds,22 700 birds,2
588,spain s capital city,spain s capital city,2
4429,body s response,body s response,2
8387,oseltamivir s effect ontheheartisunclear:,chemical compound neuraminidase inhibitor medication essential medicine,2
5118,island s main state hospital overcrowdedwithin,island s main state hospital overcrowdedwithin,2
9696,million birds,million birds,2
6360,approximately 36 000 deaths,approximately 36 000 deaths,2
2610,schwab s team followed,schwab s team followed,2
841,world health organization,world health organization,2
1770,s handling,s handling,2
2604,parkinson s disease,parkinson s disease,2
5501,million courses,million courses,2
6810,canada followsthewho scategoriesbuthasexpanded s categories],varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,2
5127,4 000 people,4 000 people,2
9438,prichard s methods ofsynthesisofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsof synthesis,prichard s methods ofsynthesisofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsof synthesis,2
5722,41 000 birds,41 000 birds,2
2586,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafter woman,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafter woman,2
2583,woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease cogwheel rigidity],woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease cogwheel rigidity],2
9617,simeprevir s effectiveness,chemical compound medication essential medicine,2
2522,amantadine treatment,chemical compound medication,2
1744,s actions,s actions,2
8359,oseltamivir s riskbenefit ratio wasmovedfrom,chemical compound neuraminidase inhibitor medication essential medicine,2
5891,2 700 migratory birds,2 700 migratory birds,2
6262,world s leading experts onavianflureportedthatwhile,world s leading experts onavianflureportedthatwhile,2
893,people s republic,people s republic,2
561,city s residents,city s residents,2
4466,s dependence,s dependence,2
3002,2 000 patients,2 000 patients,2
5740,nation s largest egg producer],nation s largest egg producer],2
5525,150 million people,150 million people,2
5889,40 000 domestic birds,40 000 domestic birds,2
559,influenza s symptoms cameonsuddenlyandattacked,infectious disease,2
8410,influenza s neuraminidase enzyme cleaves,infectious diseasegroup class enzymes,2
5769,south korea bird flu alert,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
5516,international health officials,international health officials,2
8355,8 million prescriptions,8 million prescriptions,2
8405,cited published treatment trials,cited published treatment trials,2
6750,750 million doses,750 million doses,2
8356,world health organization use,world health organization use,2
8175,oseltamavir treatment,oseltamavir treatment,2
5902,7 million poultry,organisms known particular common,2
2533,lessens health care costs,lessens health care costs,2
9410,taribavirin s basic amidine group whichinhibits,chemical compound,2
5524,world health organization role,world health organization role,2
5737,43 million birds,43 million birds,2
7513,second world war,second world war,2
4463,20 million people,20 million people,2
2584,parkinson s disease cogwheel rigidity,parkinson s disease cogwheel rigidity,2
2511,treatment guidelines,treatment guidelines,2
10113,900 000 german soldiers,900 000 german soldiers,2
852,improved health care,improved health care,2
5729,25 000 turkeys,25 000 turkeys,2
2581,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenza infection,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenza infection,2
2580,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreported woman,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreported woman,2
2579,woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease],woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease],2
8362,oseltamivir s riskbenefit ratio wasmovedfromthecoretothecomplementarylistbasedonoseltamivir sriskbenefitratio lower costeffectiveness,chemical compound neuraminidase inhibitor medication essential medicine,2
2578,amantadine s effectiveness fortreating,chemical compound medication,2
87,medicine treatment,medicine treatment,2
6811,s categories,s categories,2
1542,oseltamivir treatment,chemical compound neuraminidase inhibitor medication essential medicine,2
6364,290 000–645 000 deaths,290 000–645 000 deaths,2
10141,12 000 deaths,12 000 deaths,2
5778,china s sichuan province.25 000 birds wereculledin,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
6754,32 million doses,32 million doses,2
9615,triple antiviral treatment regimen,triple antiviral treatment regimen,2
5513,200 million birds,200 million birds,2
9425,body s uptake,body s uptake,2
6753,canadian health authorities,canadian health authorities,2
357,pandemic s memorable effects,pandemic s memorable effects,2
10108,fewer 1 000 people,fewer 1 000 people,2
6519,human health,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7514,hen s eggs continuedtobeusedtoproducevirususedininfluenzavaccinesbutmanufacturersmadeimprovementsinthepurityofinfluenza,hen s eggs continuedtobeusedtoproducevirususedininfluenzavaccinesbutmanufacturersmadeimprovementsinthepurityofinfluenza,2
2585,woman withparkinson sdiseasealsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwith parkinson s disease],woman withparkinson sdiseasealsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwith parkinson s disease],2
589,flu thenenteredspain scapitalcitywheretheflurapidlyspreadto parts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
3252,140 million birds,140 million birds,2
6819,malaysian health ministry,malaysian health ministry,2
3192,close 100 000 asthmatics,close 100 000 asthmatics,2
9510,r s states,r s states,2
1583,firstever reported triplehybrid flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
3136,associated health complications,associated health complications,2
5802,270 000 ducks,270 000 ducks,2
8585,health service executive,health service executive,2
5830,china s ministry,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
10245,chinese population s previously acquired immunity,chinese population s previously acquired immunity,2
640,1 million people,1 million people,2
5688,660 000 birds,660 000 birds,2
5834,record 18.4 million birds,record 18.4 million birds,2
5800,8 000 turkeys,8 000 turkeys,2
7394,world health organization s global advisory committee,world health organization s global advisory committee,2
10239,chinese health officials,chinese health officials,2
5146,400 000 tests,400 000 tests,2
7393,world health organization s global advisory committee],world health organization s global advisory committee],2
5835,800 000 chickens,chicken gallus gallus domesticus common,2
4120,30 000 cad,30 000 cad,2
486,anonymous physician s descriptions,anonymous physician s descriptions,2
4119,antiviral treatment,antiviral treatment,2
6861,domestic birds,domestic birds,2
3202,body s ability tofightoff,body s ability tofightoff,2
635,army s hold,army s hold,2
3120,individual s risk ofgetting,individual s risk ofgetting,2
10440,25 39 million people,25 39 million people,2
7465,year s flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
7466,global influenza surveillance,infectious disease,2
5837,800 000 birds,800 000 birds,2
630,ottoman army s troops occupying,ottoman army s troops occupying,2
3142,world health organisation,world health organisation,2
10228,96 000 chinese laborers,96 000 chinese laborers,2
6108,china s national institute,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
2793,st. john s wort,st. john s wort,2
9640,liver s cyp3a4 enzymes mainlybreakdown,organ type,2
3157,approximately 60.8 million cases,approximately 60.8 million cases,2
6786,5–150 million people,5–150 million people,2
3155,estimated health burden,estimated health burden,2
5085,india s health ministry],dominion british empire sovereign state historical country,2
5086,india s health ministry declared,dominion british empire sovereign state historical country,2
5671,affected birds,affected birds,2
7861,john enders s lab,john enders s lab,2
9646,simeprevir s prescriber information,chemical compound medication essential medicine,2
5818,26 november 190 000 ducks,26 november 190 000 ducks,2
9647,simeprevir s prescriber information efficacy,chemical compound medication essential medicine,2
5088,indian health ministry,indian health ministry,2
6784,lead health official,lead health official,2
5651,birds death,stock character psychopomp literary character,2
3150,41 000 deaths,41 000 deaths,2
3149,200 000 hospitalizations,200 000 hospitalizations,2
8564,31 million people,31 million people,2
1456,10 000 deaths,10 000 deaths,2
1455,200 000 hospitalisations,200 000 hospitalisations,2
5825,5 000 turkeys,5 000 turkeys,2
5680,japan s health ministry saidin,sovereign state island nation country,2
7443,health professionals,health professionals,2
9518,r s enantiomers,r s enantiomers,2
5808,12 million poultry,organisms known particular common,2
8571,glaxosmithkline s patient information leaflet,public company,2
6107,china s national institute],"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
2797,world health organization s list,world health organization s list,2
10258,people s resistance,people s resistance,2
5149,30 000 swine,swine disease,2
4125,english national health service treatment rates,english national health service treatment rates,2
5839,3.5 million birds,3.5 million birds,2
3210,cancer treatment,constellation zodiacal constellation,2
9495,virus s protective shells,virus s protective shells,2
8457,india s court allowing,dominion british empire sovereign state historical country,2
5587,world organization,world organization,2
10,1357 s outbreak thefirsttobecalledinfluenzabut,1357 s outbreak thefirsttobecalledinfluenzabut,2
5853,140 000 birds,140 000 birds,2
51,1510 flu s springboard,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
6884,medimmune s live attenuated vaccine technology],business,2
52,europe s internationally traveled cities andflu shighlycontagiousnatureenabledeurope sinternationallytraveledcitiesand flu s highly contagious nature],continental area surrounding islands continent geographic regioninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
1682,national health service,national health service,2
1563,290 000–650 000 deaths,290 000–650 000 deaths,2
53,flu s highly contagious nature enabled europe s internationally traveled cities],influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzacontinental area surrounding islands continent geographic region,2
2676,polymerase s endonuclease activity mechanism isdistinctfrom,group class enzymes,2
2675,polymerase s endonuclease activity cleavage,group class enzymes,2
1562,3–5 million people,3–5 million people,2
2674,polymerase s endonuclease activity catalyzes polymerase s endonuclease activity cleavage],group class enzymesgroup class enzymes,2
5143,world health organization health emergencies program,world health organization health emergencies program,2
603,region s physicians oftendistinguishedtheregion sphysiciansfrom contagious seasonal pneumonias,region s physicians oftendistinguishedtheregion sphysiciansfrom contagious seasonal pneumonias,2
3251,nearly 1.2 million poultry,organisms known particular common,2
602,region s physicians oftendistinguished region s physicians],region s physicians oftendistinguished region s physicians],2
54,flu s highly contagious nature enabledeurope sinternationallytraveledcitiesandflu shighlycontagiousnaturespreadthrough european populations,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
601,flu symptoms couldbesointensethattheregion sphysiciansoftendistinguished region s physicians],influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
3750,company s proprietary formula induced,company s proprietary formula induced,2
5858,25 000 birds,25 000 birds,2
8216,treatment failure,treatment failure,2
6285,shanghai s health ministry orderedcullingof,city direct-controlled municipality national central city big city city millions inhabitants,2
5714,health ministry,health ministry,2
503,1557 flu s symptoms asfeaturing,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
6284,shanghai s health ministry],city direct-controlled municipality national central city big city city millions inhabitants,2
596,season s poor harvests,season s poor harvests,2
1404,loyola university health,loyola university health,2
9678,patient s liver function,organ type,2
5852,7 000 birds,7 000 birds,2
4099,improved antiviral treatment,improved antiviral treatment,2
10853,s need tobehospitalizedor,s need tobehospitalizedor,2
10221,europe s battlefields,continental area surrounding islands continent geographic region,2
10220,europe s battlefields],continental area surrounding islands continent geographic region,2
9562,abbott laboratoriesin s generic drugs business,abbott laboratoriesin s generic drugs business,2
755,medical treatment,medical treatment,2
756,standard treatment,standard treatment,2
8614,agency s committee,agency s committee,2
10850,glaxo s sales,glaxo s sales,2
3217,body s immune,body s immune,2
5842,striking domestic birds,striking domestic birds,2
9493,influenza s viral replication,infectious disease,2
5606,usgs national wildlife health center,usgs national wildlife health center,2
4373,prior treatment,prior treatment,2
6771,900 million doses,900 million doses,2
7372,million vaccinations,million vaccinations,2
5870,100 000 birds,100 000 birds,2
2720,combination s safety profile,combination s safety profile,2
1493,health officials,health officials,2
8632,body s immune response,body s immune response,2
10206,100 000 soldiers,100 000 soldiers,2
3110,south latitudes flu peaks,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
7879,y.h. tan s laboratory isolated,y.h. tan s laboratory isolated,2
3231,potential treatment,potential treatment,2
5707,5.7 million birds,5.7 million birds,2
6393,host s antibodies canbindandtrigger,family protein complexes,2
6874,world s ability tokeeph5n1containedlimiting,world s ability tokeeph5n1containedlimiting,2
5851,irvine s private limited],irvine s private limited],2
410,1557 pandemic s observers,1557 pandemic s observers,2
10823,biota s ongoing program todevelop,biota s ongoing program todevelop,2
6476,body s main source,body s main source,2
10346,russia s elite wasthat,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,2
6292,infection birds,infection birds,2
10488,brazil s amazon river delta hadnotreported,brazil s amazon river delta hadnotreported,2
2001,22 000 birds,22 000 birds,2
1028,253 000 birds,253 000 birds,2
6977,today s approval bythefdafollowsafebruary27recommendationbyan,today s approval bythefdafollowsafebruary27recommendationbyan,2
269,world,world,2
5279,global health officials,global health officials,2
4906,half million americans,half million americans,2
8089,drug s active ingredient weredeniedby,drug s active ingredient weredeniedby,2
8088,drug s active ingredient hadabandoned,drug s active ingredient hadabandoned,2
1310,250 000 500 000 people,250 000 500 000 people,2
6048,world health organization s assistant directorgeneral,world health organization s assistant directorgeneral,2
7172,million doses,million doses,2
1860,china s antiflu measures andwarned,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
7074,8.4 million units,8.4 million units,2
1937,u.s. world health organization,u.s. world health organization,2
6172,china s agriculture ministry defended china s agriculture ministry policy],"sovereign state socialist state secular state constitutional republic country ""peoples republic""sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
10703,prophylaxis treatment,prophylaxis treatment,2
4756,public health officials,public health officials,2
6047,world health organization s assistant directorgeneral],world health organization s assistant directorgeneral],2
9120,congolese health officials,congolese health officials,2
4754,official world health organization,official world health organization,2
9316,known treatment,known treatment,2
9902,12week treatment,12week treatment,2
1865,2 000 passengers,2 000 passengers,2
9314,combination s efficacy intreating,combination s efficacy intreating,2
2126,meerwein s ester,meerwein s ester,2
8077,university s drug innovation company,university s drug innovation company,2
3939,estimated 71 million people,estimated 71 million people,2
9979,gilead s patent,gilead s patent,2
1307,284 000 deaths,284 000 deaths,2
3940,health burden,health burden,2
5968,s assistant directorgeneral],s assistant directorgeneral],2
3449,antibiotic treatment,antibiotic treatment,2
4606,sureau s study provided,sureau s study provided,2
10002,world s population,world s population,2
9328,ribavirin treatment,chemical compound medication essential medicine 1 april 1990,2
1252,exotic birds,exotic birds,2
1180,government s cobra emergency committee indicatedthat,government s cobra emergency committee indicatedthat,2
3427,cambodian health ministry,cambodian health ministry,2
10016,pandemic s geographic origin,pandemic s geographic origin,2
4011,successful treatment,successful treatment,2
9813,previous treatment options,previous treatment options,2
10015,certainty thepandemic sgeographicoriginwithvaryingviewsasto pandemic s geographic origin],certainty thepandemic sgeographicoriginwithvaryingviewsasto pandemic s geographic origin],2
2082,63 700 birds,63 700 birds,2
10769,drug s actions aremoreeffectiveatpreventinginfectionsfromrnavirusesthan,drug s actions aremoreeffectiveatpreventinginfectionsfromrnavirusesthan,2
10742,umifenovir s efficacy hasmainlyoccurredinchinaandrussiaanditiswellknownin,chemical compound,2
4588,s region,s region,2
4778,6 000 health care workers,6 000 health care workers,2
5332,fda s vaccines,fda s vaccines,2
9240,agency s view,agency s view,2
9974,70 000 people,70 000 people,2
7064,14 000 subjects,14 000 subjects,2
5282,s global influenza surveillance network showed,infectious disease,2
6591,50–100 million people,50–100 million people,2
5944,outbreak s overall total was419including7in,outbreak s overall total was419including7in,2
9804,sofosbuvir s u.s. launch wasthefastestof,chemical compound medication active ingredient essential medicine,2
6592,million deaths,million deaths,2
1841,health safety executive,health safety executive,2
6173,china s agriculture ministry policy,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
10008,epidemic s effects,epidemic s effects,2
8021,medimmune s live,business,2
1029,587 000 eggs,587 000 eggs,2
5280,13 000 samples,13 000 samples,2
9133,agency s analysis,agency s analysis,2
9330,placebo treatment,placebo treatment,2
9132,covid‑19 treatment,covid‑19 treatment,2
5943,outbreak s overall total],outbreak s overall total],2
5969,s assistant directorgeneral,s assistant directorgeneral,2
9907,12 weeks combination treatment,12 weeks combination treatment,2
8069,treatment options,treatment options,2
8049,clinically useful drug treatment program,clinically useful drug treatment program,2
9946,gilead sciences s lawyers moved,gilead sciences s lawyers moved,2
8048,modern treatment regimens,modern treatment regimens,2
6993,symptomatic treatment,symptomatic treatment,2
1098,dead birds,dead birds,2
9927,treatment failures,treatment failures,2
10692,century s,century s,2
3547,nih s drug discovey arm,nih s drug discovey arm,2
3546,nih s drug discovey arm],nih s drug discovey arm],2
5388,person s hands,person s hands,2
9039,drug\ s poor predicted solubility,drug\ s poor predicted solubility,2
9264,health care providers,health care providers,2
4690,6 000 people,6 000 people,2
4724,60 000 estimated deaths,60 000 estimated deaths,2
4729,9 million doses,9 million doses,2
9265,607 000 vials,607 000 vials,2
5994,symptoms treatment,symptoms treatment,2
3961,country s geography,country s geography,2
1102,1 500 birds,1 500 birds,2
1903,9 million pigs,9 million pigs,2
9266,gilead s promised donation,gilead s promised donation,2
5269,estimated 36 000 people,estimated 36 000 people,2
9938,croatian health insurance fund,croatian health insurance fund,2
9072,updated world health organization treatment guidelines,updated world health organization treatment guidelines,2
9071,world health organization guideline,world health organization guideline,2
1108,159 000 turkeys,159 000 turkeys,2
4871,health care,health care,2
9062,private health insurance companies,private health insurance companies,2
10752,potential combination treatment,potential combination treatment,2
9934,10 000 courses,10 000 courses,2
3963,developed world,developed world,2
5286,s global influenza surveillance network],infectious disease,2
9923,health insurers,health insurers,2
1893,leading health agencies,leading health agencies,2
5970,health security,health security,2
1305,estimated 500 million people,estimated 500 million people,2
9970,gilead\ s leading performance,gilead\ s leading performance,2
1304,world population,world population,2
9968,world s 20 largest pharmaceutical countries,world s 20 largest pharmaceutical countries,2
9258,1.5 million vials,1.5 million vials,2
1302,500 million people,500 million people,2
246,king louis xii s national assembly,king louis xii s national assembly,2
3943,167 000 deaths,167 000 deaths,2
3488,gilead sciences s refusal tolicense,gilead sciences s refusal tolicense,2
5976,cdc s influenza division,infectious disease,2
1881,parisbased world organisation,parisbased world organisation,2
3944,326 000 deaths,326 000 deaths,2
9912,$84 000 price,$84 000 price,2
9260,500 000 courses,500 000 courses,2
9259,140 000 treatment courses,140 000 treatment courses,2
1275,poultry birds,organisms known particular common,2
9916,government health programs,government health programs,2
4736,34 000 100 000 people,34 000 100 000 people,2
240,king louis xii s royal court,king louis xii s royal court,2
4735,united states health authorities,united states health authorities,2
1130,company s attention,company s attention,2
9956,world s hcvinfected population andthat,world s hcvinfected population andthat,2
1296,eurasian pig flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
1888,world health organization designation,world health organization designation,2
6940,$600 million plant,$600 million plant,2
4664,million people,million people,2
9953,73 million people,73 million people,2
9292,drug s active ingredient,drug s active ingredient,2
4885,50 million 100 million people,50 million 100 million people,2
1882,animal health,taxon,2
9232,japan s ministry,sovereign state island nation country,2
3539,remdesivir s predominant metabolite circulatingin,chemical compound prodrug antiviral drug,2
9231,japan s ministry],sovereign state island nation country,2
2414,parkinson s disease hasinfoabout,parkinson s disease hasinfoabout,2
4029,16 000 people,16 000 people,2
2456,2011 world health organization virology report,2011 world health organization virology report,2
3390,china s health ministry hasconfirmed,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
6960,13 million doses,13 million doses,2
10044,play s popular musical number,play s popular musical number,2
943,70 000 116 000 people,70 000 116 000 people,2
4027,400 000 people,400 000 people,2
4815,s case count isclearlythemostauthoritative,s case count isclearlythemostauthoritative,2
9830,longer treatment durations,longer treatment durations,2
3366,6 000 migratory birds,6 000 migratory birds,2
4026,1.75 million people,1.75 million people,2
3395,country s 51st death,stock character psychopomp literary character,2
5317,estimated million people,estimated million people,2
4025,71 million people,71 million people,2
3374,5 150 million people,5 150 million people,2
9752,interferonfree treatment,interferonfree treatment,2
4045,western world,western world,2
8878,combination treatment,combination treatment,2
3402,2 700 birds,2 700 birds,2
112,asia s migratory water fowl,continent continental area surrounding islands,2
10599,115 million cases,115 million cases,2
9203,€63 million contract,€63 million contract,2
2042,south korea s agriculture ministry reportedthath5n8hadbeenfoundinwildswansinshanxiprovincewhilenorwaydetectednorwayfirstcaseofthehighlypathogenic,south korea s agriculture ministry reportedthath5n8hadbeenfoundinwildswansinshanxiprovincewhilenorwaydetectednorwayfirstcaseofthehighlypathogenic,2
4031,196 000 deaths,196 000 deaths,2
2041,south korea s agriculture ministry],south korea s agriculture ministry],2
5309,750 000 humans,infectious disease france,2
1237,159 000 culled turkeys,159 000 culled turkeys,2
2031,november 10southkorea sagricultureministrysaid south korea s agriculture ministry],november 10southkorea sagricultureministrysaid south korea s agriculture ministry],2
2032,south korea s agriculture ministry said south korea s agriculture ministry],south korea s agriculture ministry said south korea s agriculture ministry],2
2033,south korea s agriculture ministry saidsouthkorea sagricultureministryhadconfirmedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissued highly pathogenic h5n8 strain,south korea s agriculture ministry saidsouthkorea sagricultureministryhadconfirmedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissued highly pathogenic h5n8 strain,2
6686,estimated 1–4 million people,estimated 1–4 million people,2
9845,prior failed treatment,prior failed treatment,2
2429,m2 protein s function istoallow,m2 protein s function istoallow,2
159,guillaume baillou s description,guillaume baillou s description,2
10782,umifenovir s suppressive effect,chemical compound,2
9742,60 000 people,60 000 people,2
9181,alberta health services,alberta health services,2
7242,real world,real world,2
7680,behçet s disease,behçet s disease,2
9373,ribavirin s amide group canmake,chemical compound medication essential medicine 1 april 1990,2
6687,100 000 deaths,100 000 deaths,2
6945,50 million doses,50 million doses,2
949,approximately 700 000 deaths,approximately 700 000 deaths,2
2016,320 000 birds,320 000 birds,2
2069,437 000 birds,437 000 birds,2
3369,migratory birds,migratory birds,2
9179,150 000 vials,150 000 vials,2
7679,behçet s disease],behçet s disease],2
10600,2.56 million deaths,2.56 million deaths,2
5484,5 million 150 million people,5 million 150 million people,2
5476,infected birds,infected birds,2
1002,birds,birds,2
6177,china s agriculture ministry defendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwith china s agriculture ministry efforts],"sovereign state socialist state secular state constitutional republic country ""peoples republic""sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
7222,associated health benefits,associated health benefits,2
3619,novavax s senior vice president,novavax s senior vice president,2
2055,19 000 ducks,19 000 ducks,2
3410,local government s decision makes government s decision],local government s decision makes government s decision],2
3411,government s decision verydifficultfor,government s decision verydifficultfor,2
8907,postinfection treatment,postinfection treatment,2
9385,ribavirin s 2 deoxyribose analogue,chemical compound medication essential medicine 1 april 1990,2
6178,china s agriculture ministry efforts nowtoidentify,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",2
6015,world organisation,world organisation,2
9859,sofosbuvir/ribavirin/peginterferon combination treatment,sofosbuvir/ribavirin/peginterferon combination treatment,2
6962,6.5 million people,6.5 million people,2
3356,thailand s poultry industry,constitutional monarchy sovereign state countryorganisms known particular common,2
7695,10 000 fold reduction,10 000 fold reduction,2
3419,farmed birds,farmed birds,2
994,700 000 people,700 000 people,2
10609,newfoundland s leading cause,newfoundland s leading cause,2
2065,160 000 birds,160 000 birds,2
9206,500 000 remdesivir treatment courses,chemical compound prodrug antiviral drug,2
3618,novavax s senior vice president],novavax s senior vice president],2
3888,khurana s,khurana s,2
9382,ribavirin s effect,chemical compound medication essential medicine 1 april 1990,2
8154,120 million rubles,120 million rubles,2
3414,hk$50 000 months imprisonment,hk$50 000 months imprisonment,2
8153,700 million rubles,700 million rubles,2
1007,numerous birds,numerous birds,2
9229,20 000 150 000 ampoules,20 000 150 000 ampoules,2
1011,government s destruction,government s destruction,2
9352,national cancer institute s viruscancer program waswidelyconsideredafailureand,constellation zodiacal constellation,2
991,100 000 population,100 000 population,2
7586,challenges,challenges,3
7585,potential target,potential target,3
6350,negativesense,negativesense,3
7591,conserved domains,conserved domains,3
7592,projects,projects,3
6180,researcher neil seeman,researcher neil seeman,3
6351,h number,h number,3
6126,routine procedure,routine procedure,3
7817,—that bind,—that bind,3
7584,highly conserved m2 proton channel,highly conserved m2 proton channel,3
7735,activator,activator,3
7542,lingering doubts,lingering doubts,3
7821,ifn target cells,ifn target cells,3
7741,stat activation,stat activation,3
7532,president gerald ford,president gerald ford,3
6314,feathers,feathers,3
7541,potential swine,swine disease,3
7739,ii ifns,ii ifns,3
6183,internet users,internet users,3
7818,ifn cellular receptor,ifn cellular receptor,3
6317,especially escherichia coli infections,especially escherichia coli infections,3
7590,approach,approach,3
6316,secondary infections,secondary infections,3
7537,maximum military containment efforts,maximum military containment efforts,3
7538,single army base,single army base,3
7589,domains,domains,3
7737,transcription factors,transcription factors,3
7736,stats,stats,3
7756,collection,collection,3
7819,communication,communication,3
6200,minds,minds,3
7820,cytokine,cytokine,3
6315,trachea,trachea,3
7539,normal annual levels,normal annual levels,3
7757,known isgs,armed organization,3
7540,400 excess hospitalizations,400 excess hospitalizations,3
7588,target,target,3
6182,toronto,city single-tier municipality big city city millions inhabitants,3
7738,certain immune genes,certain immune genes,3
6318,bronchi,bronchi,3
7587,single antibodies,family protein complexes,3
6347,issue,issue,3
6346,better characterization studies,better characterization studies,3
7536,public relations problems,public relations problems,3
6181,university,university,3
6125,randomized observerblinded placebocontrolled clinical trial,randomized observerblinded placebocontrolled clinical trial,3
7535,delays,delays,3
6201,average chinese citizens,average chinese citizens,3
7740,ifn type,ifn type,3
7754,transcriptional complexes,transcriptional complexes,3
6124,284 adults,284 adults,3
6345,effective surveillance,effective surveillance,3
6330,distal head,distal head,3
7749,complex forms,complex forms,3
7761,stat homodimers,stat homodimers,3
7750,stat2,stat2,3
7574,active immunization,active immunization,3
6196,intense relevancy,intense relevancy,3
7564,novel technologies,novel technologies,3
7572,audenz,audenz,3
6329,ha protein,ha protein,3
6123,a/indonesia/5/05,a/indonesia/5/05,3
6328,multiple amino acid positions,multiple amino acid positions,3
7826,p25,p25,3
7561,rapid development,rapid development,3
6189,33%,33%,3
6337,idrees m,idrees m,3
7751,transcription factor,transcription factor,3
7563,short time frame,short time frame,3
6338,tong y,tong y,3
7760,isgs,armed organization,3
7571,following month,following month,3
6335,butt,butt,3
6192,ürümqi,ürümqi,3
6193,28%,28%,3
7759,curated online database,curated online database,3
6194,zhengzhou,zhengzhou,3
7567,low moderateincome countries,low moderateincome countries,3
6334,h9n2 genes,h9n2 genes,3
7830,jev,jev,3
7566,better realtime access,better realtime access,3
6175,poultry againsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainst earlier bird flu strain,organisms known particular common nametaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
6333,contribution,contribution,3
6332,multiple genotypes,multiple genotypes,3
6190,nanjing,nanjing,3
6121,recombinant baculovirus,recombinant baculovirus,3
6174,largescale vaccination,largescale vaccination,3
6331,ha trimer,ha trimer,3
6195,internet surveys,internet surveys,3
7557,fluzone highdose quadrivalent,fluzone highdose quadrivalent,3
7550,fluarix quadrivalent,fluarix quadrivalent,3
7576,supply,supply,3
6197,sense,sense,3
6186,contagion awareness,contagion awareness,3
6198,urgency,urgency,3
7544,2010 study,2010 study,3
6323,current prevalence,current prevalence,3
7580,subject,subject,3
6322,immunization failure,immunization failure,3
6342,continuous evolution,continuous evolution,3
7743,pathway,pathway,3
7581,promising approach,promising approach,3
6321,distinct antigenic groups,distinct antigenic groups,3
6344,favor,favor,3
6320,antigenicity,antigenicity,3
7582,broadly neutralizing antibodies,family protein complexes,3
6179,riwi corporation,riwi corporation,3
6185,20 hours,20 hours,3
7753,isgf3,isgf3,3
7744,jaks,jaks,3
7579,escape,escape,3
6187,38%,38%,3
6339,computational molecular analysis,computational molecular analysis,3
7748,ifnstimulated gene factor,ifnstimulated gene factor,3
7549,nasal mist,nasal mist,3
6188,hangzhou,hangzhou,3
7824,sigma,sigma,3
7747,stat1,gene,3
7577,error,error,3
7762,heterodimers form,heterodimers form,3
6120,insect cells,insect cells,3
7746,receptor engagement,receptor engagement,3
6327,antigenic areas,antigenic areas,3
7578,design,design,3
6326,different distribution,different distribution,3
7745,ifn receptors,ifn receptors,3
6325,h9 antigenic sites,h9 antigenic sites,3
6324,amino acids,amino acids,3
6340,phylogenetic characterization,phylogenetic characterization,3
7758,interferome,biological database,3
6245,31yearold thoracic surgeon,31yearold thoracic surgeon,3
6209,critical condition,critical condition,3
6313,dust,dust,3
6148,scientific community,scientific community,3
7781,p70s6,p70s6,3
6272,epidemiological investigations,epidemiological investigations,3
7696,quantity,quantity,3
6149,china transparency,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
7797,downstream signaling events,downstream signaling events,3
7694,texas medical branch,state united states,3
6166,vaccination ofpoultryagainsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationof poultry,organisms known particular common,3
6229,new patients,new patients,3
7783,phosphorylates,phosphorylates,3
6151,credit,credit,3
6230,85yearold man,85yearold man,3
7692,novel coronavirus,group class strains strain,3
6231,25yearold pregnant woman,25yearold pregnant woman,3
6165,gisaid,gisaid,3
6232,64yearold man,64yearold man,3
7646,chickens aresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetill,chicken gallus gallus domesticus common,3
7794,virus resistance interferons,virus resistance interferons,3
6234,laboratory,laboratory,3
6235,jiangsu,province china,3
6268,kawaoka,kawaoka,3
6153,china early openness,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
7793,lung cancer cells,constellation zodiacal constellation,3
7798,cytokine receptor,cytokine receptor,3
6154,reporting,reporting,3
7799,ifn production,ifn production,3
6146,novartis,business multinational corporation,3
7802,dengue,dengue,3
6282,unprotected exposure,unprotected exposure,3
6281,daughter,daughter,3
7641,useavaccinethat sonly85percentrelatedyou llget protection,useavaccinethat sonly85percentrelatedyou llget protection,3
7779,p38 map kinase,p38 map kinase,3
7801,japanese encephalitis virus,japanese encephalitis virus,3
6280,haemagglutination inhibition antibodies,family protein complexes,3
6279,fortythree close contacts,fortythree close contacts,3
6278,phylogenetic trees,phylogenetic trees,3
7699,77 moderate covid19 subjects,77 moderate covid19 subjects,3
7642,dr. cardona,dr. cardona,3
6227,chinese national health family planning commission,chinese national health family planning commission,3
7698,universities,universities,3
6142,gisaid initiative,gisaid initiative,3
6277,genome sequence,scientific model natural environment,3
7800,functions,functions,3
6143,j. craig venter institute,j. craig venter institute,3
6276,may. 60yearold man daughter,may. 60yearold man daughter,3
7643,single point mutation,single point mutation,3
7644,vaccine s99.99percentrelatedwon tprotect,vaccine s99.99percentrelatedwon tprotect,3
6275,may. 60yearold man,may. 60yearold man,3
7697,second study,second study,3
6145,inc.,inc.,3
7780,pi3k,pi3k,3
6141,china cdc,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
6236,600 close contacts,600 close contacts,3
7785,rigg,rigg,3
6160,chinese team,chinese team,3
7658,dinosaurs.\ researchers,dinosaurs.\ researchers,3
7659,nicholas savill,nicholas savill,3
7660,mathematical models,mathematical models,3
7661,95 percent,95 percent,3
7662,90 percent,90 percent,3
6161,usage,usage,3
7663,flock,flock,3
7677,cancers,cancers,3
7787,highly conserved multiprotein complex,highly conserved multiprotein complex,3
7791,nfκb,nfκb,3
7664,protection levels,protection levels,3
7670,natural immunity,natural immunity,3
7676,indications,indications,3
6162,j. craig venter institute data,j. craig venter institute data,3
6163,spirit,spirit,3
7675,alfa r.it,alfa r.it,3
6243,central henan,central henan,3
7672,recombinant form,recombinant form,3
7673,biogen,biogen,3
7674,scheringplough,scheringplough,3
7789,deubiquitination,deubiquitination,3
7790,phosphorylation,phosphorylation,3
7657,dr. david e. swayne,dr. david e. swayne,3
6237,760 close contacts,760 close contacts,3
7755,specific regulatory elements,specific regulatory elements,3
7786,csn5containing cop9 signalosome,csn5containing cop9 signalosome,3
6264,features,features,3
7688,university texas medical branch,state united states,3
6261,yoshihiro kawaoka,yoshihiro kawaoka,3
6260,international team,international team,3
6155,sharing,sharing,3
7687,peerreviewed scientific literature,peerreviewed scientific literature,3
6257,759 infections,759 infections,3
7686,malignant melanoma,rare disease,3
7685,mastocytosis,mastocytosis,3
7684,carcinoid tumor,carcinoid tumor,3
6156,spite,spite,3
6255,cumulative total,cumulative total,3
6157,initial worries,initial worries,3
7651,dr. john j. treanor,dr. john j. treanor,3
7683,follicular lymphoma,follicular lymphoma,3
7792,stat3,stat3,3
7682,multiple myeloma,multiple myeloma,3
6239,sevenyearold girl,sevenyearold girl,3
7653,rochester,rochester,3
7681,chronic myelogenous leukemia,chronic myelogenous leukemia,3
6253,5th epidemic,5th epidemic,3
6164,gisaid sharing mechanism,gisaid sharing mechanism,3
6252,reported cases late 2016 2017 (5th epidemic),reported cases late 2016 2017 (5th epidemic),3
6241,eastern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
7593,different antigens,different antigens,3
7777,stat5,protein family,3
6226,7.on april,7.on april,3
7729,membrane,membrane,3
7728,pattern recognition receptors,pattern recognition receptors,3
7727,bacterial flagella,bacterial flagella,3
6205,chp,chp,3
7724,microbes,microbes,3
6129,vaccine manufacturing,vaccine manufacturing,3
7768,isre gas elements,isre gas elements,3
6300,crucial role,crucial role,3
6207,anhui,province china,3
7723,induction interferons,induction interferons,3
6208,jiangsu province,province china,3
7721,beneficial action,beneficial action,3
6299,gene donor,gene donor,3
6210,suzhou,suzhou,3
6211,wuxi,wuxi,3
7605,sufficiently powerful enduring immune response,sufficiently powerful enduring immune response,3
7720,tumor growth,tumor growth,3
7813,ifnα activity,ifnα activity,3
7719,ifn,ifn,3
7769,gene induction,gene induction,3
6297,longterm vaccination programs,longterm vaccination programs,3
6131,nih,nih,3
7717,major types,major types,3
6302,wide host range,wide host range,3
6296,great economic loss,great economic loss,3
7815,poxviruses,poxviruses,3
7730,receptors,receptors,3
6312,air droplet,air droplet,3
6171,recent spread,recent spread,3
6309,a/duck/hong kong/y439/97,a/duck/hong kong/y439/97,3
6308,a/quail/hong kong/g1/97like,a/quail/hong kong/g1/97like,3
7597,better outcomes,better outcomes,3
6307,a/chicken/beijing/1/94like,a/chicken/beijing/1/94like,3
6306,distinct lineages,distinct lineages,3
7598,tcells,tcells,3
7763,dimers,dimers,3
7734,signal transducer,signal transducer,3
7599,epitopes,epitopes,3
7764,gene transcription,gene transcription,3
6170,chinese veterinary technicians,chinese veterinary technicians,3
7765,ifnactivated site elements,ifnactivated site elements,3
7766,gene promoters,gene promoters,3
7733,ifns,ifns,3
7600,developers,developers,3
7732,specific receptors,specific receptors,3
6203,travel,travel,3
7816,soluble ifn receptor,soluble ifn receptor,3
7731,downstream signaling,downstream signaling,3
7767,type ifns,type ifns,3
6304,breeding ground,breeding ground,3
6303,extensive gene reassortment,extensive gene reassortment,3
6140,unprecedented immediate release,unprecedented immediate release,3
6212,epidemiologic links,epidemiologic links,3
7770,type ifn,type ifn,3
6220,farmer,farmer,3
6221,huzhou,prefecture-level city big city city millions inhabitants,3
7707,usefulness,usefulness,3
6139,request,request,3
7625,primary course,primary course,3
7807,large t antigen,group class chemical substances,3
7626,boosters,boosters,3
7627,6–12 month intervals,6–12 month intervals,3
7705,ifnα,ifnα,3
7704,crossspecies nature,crossspecies nature,3
7632,mineral oil,mineral oil,3
7703,offlabel,offlabel,3
7702,inflammatory cytokine,inflammatory cytokine,3
7701,significant reduction,significant reduction,3
6222,death toll,stock character psychopomp literary character,3
6288,songjiang district,songjiang district,3
7634,abscesses,abscesses,3
7635,painful swollen fingers,painful swollen fingers,3
7636,thumbs,thumbs,3
7776,nuclear adaptor,nuclear adaptor,3
6287,huhuai wholesale agricultural products market,huhuai wholesale agricultural products market,3
6225,24 death case,stock character psychopomp literary character,3
6286,pigeon samples,pigeon samples,3
7773,signaling cascades,signaling cascades,3
7608,conclusion,conclusion,3
7624,vaccination schedules,vaccination schedules,3
7709,introna summary,introna summary,3
6213,h7n9 infections,taxon,3
7609,m001,m001,3
6295,chinese chickens,chicken gallus gallus domesticus common,3
6294,common subtype,common subtype,3
6214,close contacts,close contacts,3
6135,adjuvants,adjuvants,3
7611,12 400 participants,12 400 participants,3
6293,h9n2,h9n2,3
7612,data analysis,data analysis,3
6136,19 64 years,19 64 years,3
7613,statistical difference,statistical difference,3
7713,nearby cells,nearby cells,3
7808,polyomavirus,polyomavirus,3
6216,second man,second man,3
6291,latest occurring,latest occurring,3
7771,gas element,gas element,3
7620,similar immunity,similar immunity,3
6218,48yearold man,48yearold man,3
7772,jakstat pathway,jakstat pathway,3
6137,shanghai,city direct-controlled municipality national central city big city city millions inhabitants,3
6352,n number,n number,3
7710,product characteristics,product characteristics,3
7623,dry hacking cough,dry hacking cough,3
6219,52yearold woman,52yearold woman,3
7656,microgram,microgram,3
6808,current portal,current portal,3
6354,11 different known n antigens,11 different known n antigens,3
6653,great social disruption,great social disruption,3
6654,great deal,great deal,3
7084,emergency prevention,emergency prevention,3
7083,nasal drops,nasal drops,3
6656,trust,trust,3
7082,grippferon,grippferon,3
6657,illegal behavior,illegal behavior,3
6658,ignorance,ignorance,3
6659,horrific disconnect,horrific disconnect,3
6651,living,living,3
7080,interferonalpha actually reduced interferonalpha immune response,interferonalpha actually reduced interferonalpha immune response,3
6660,reassurances,reassurances,3
6661,reality,reality,3
6662,credibility,credibility,3
7078,oral dosing,oral dosing,3
6663,authority,authority,3
7072,256 units,256 units,3
7071,1969 study,1969 study,3
7070,high doses,high doses,3
7067,high dose,high dose,3
7079,elderly patients,elderly patients,3
7065,early studies leukocytes,early studies leukocytes,3
6649,hospital rooms,hospital rooms,3
6646,isolate a/fujian/411/2002,isolate a/fujian/411/2002,3
7107,cultured airway cells,cultured airway cells,3
7106,rantes production,rantes production,3
7105,equine influenzainfected canine kidney cells,equine influenzainfected canine kidney cells,3
7104,dna fragmentation,dna fragmentation,3
7103,influenzainfected macrophages,influenzainfected macrophages,3
6637,material,material,3
7101,nac,nac,3
7099,survival,survival,3
7098,body weight,body weight,3
6648,upheaval psychological damage,upheaval psychological damage,3
7097,kilogram,kilogram,3
7095,oral supplementation,oral supplementation,3
6640,following year,following year,3
7090,1.2 grams,1.2 grams,3
7089,randomized clinical trial,randomized clinical trial,3
7088,nacetylcysteine,nacetylcysteine,3
6642,variants subtypes influenzavirus,variants subtypes influenzavirus,3
6643,isolate,isolate,3
6644,lineage,lineage,3
6645,typical host,typical host,3
7096,gram,gram,3
7108,18%,18%,3
6665,u.s. army camp,u.s. army camp,3
7060,interferons,interferons,3
7037,metaanalysis,metaanalysis,3
7036,seasonality,seasonality,3
7035,vitamin d synthesis,vitamin d synthesis,3
7034,sunlight exposure,sunlight exposure,3
6692,unknown causation,unknown causation,3
6693,march–april,march–april,3
6694,24 april,24 april,3
6696,seven ill patients,seven ill patients,3
7031,anemia,anemia,3
7039,support,support,3
7030,zinc,zinc,3
7028,vitamin,vitamin,3
7027,vitamin d,vitamin d,3
6700,stages,stages,3
7025,micronutrient deficiencies,micronutrient deficiencies,3
6702,2009 revision,2009 revision,3
7024,ecuador,ecuador,3
6703,phase descriptions,phase descriptions,3
7023,immunodeficiency,organisms known particular common,3
6704,sixphase approach,sixphase approach,3
7029,folic acid,folic acid,3
6666,1921 book,1921 book,3
7040,adjunctive vitamin d therapy,adjunctive vitamin d therapy,3
7043,herbal alternative medicines,herbal alternative medicines,3
7059,shortcomings,shortcomings,3
7057,available data,available data,3
7056,compelling evidence,compelling evidence,3
6668,pandemic threat subtypes,pandemic threat subtypes,3
6671,strategies,strategies,3
6674,medicines,medicines,3
7054,quality,quality,3
7053,isatis indigotica,isatis indigotica,3
7052,isatis tinctoria,isatis tinctoria,3
7042,recent review,recent review,3
7051,astragalus membranaceus,astragalus membranaceus,3
7050,elenolic acid,elenolic acid,3
6677,wave nature,wave nature,3
7049,larix occidentalis arabinogalactans,larix occidentalis arabinogalactans,3
7048,panax quinquefolium,panax quinquefolium,3
6679,increasing lethality,increasing lethality,3
7046,dhea,chemical compound steroid,3
6681,spanish flu (1918–1920),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
6682,category 5 influenza,infectious disease,3
7045,possible benefit,possible benefit,3
6676,– health – eu portal,– health – eu portal,3
7109,elderberry,elderberry,3
7110,cytokines,cytokines,3
7111,imprudent,imprudent,3
7170,guillain–barré syndrome,guillain–barré syndrome,3
6605,unrelated gastroenteritis,unrelated gastroenteritis,3
6606,infected mammals,infected mammals,3
7169,increase,increase,3
7168,certain years,certain years,3
7167,tiredness,tiredness,3
7166,feelings,feelings,3
7165,temporary muscle pains,temporary muscle pains,3
7164,percent,percent,3
6604,different type,different type,3
6608,sneezes,sneezes,3
7163,certain health problems,certain health problems,3
6610,nasal secretions,nasal secretions,3
7162,high risk groups,high risk groups,3
6611,feces,biogenic substance type,3
6612,healthy individuals,healthy individuals,3
7160,yearly vaccination,yearly vaccination,3
6613,virusladen aerosol,virusladen aerosol,3
7159,vaccinating children,vaccinating children,3
6614,aforementioned bodily fluids,aforementioned bodily fluids,3
6609,droppings,droppings,3
6615,human body temperature,organisms known particular common homo sapiens homo sapiens sapiens homo,3
6603,muscle pains,muscle pains,3
7177,middle layer,middle layer,3
7195,manufacturing,manufacturing,3
6593,comets,comets,3
7193,public health organizations,public health organizations,3
7192,recommendations,recommendations,3
7191,15 45%,15 45%,3
6594,earthquakes,earthquakes,3
7190,myocardial infarction,myocardial infarction,3
6595,volcanoes,volcanoes,3
6596,cosmic dust,cosmic dust,3
7174,previous versions,previous versions,3
7188,healthy children,healthy children,3
7186,2012 metaanalysis,2012 metaanalysis,3
7185,protective antibodies,family protein complexes,3
7183,best way,best way,3
6597,setting,setting,3
6598,sun,sun,3
7181,u.s centers,u.s centers,3
6599,ground,ground,3
6600,blast,blast,3
7179,1930s,1930s,3
7187,hivpositive adults,hivpositive adults,3
7158,high quality research,high quality research,3
6616,low temperatures,low temperatures,3
6617,detergents,detergents,3
7131,epigallocatechin gallate,epigallocatechin gallate,3
7130,high levels,high levels,3
6630,great risk,great risk,3
7129,reduced risk,reduced risk,3
7128,high dietary intake,high dietary intake,3
7127,green tea,green tea,3
6632,highrisk humans,infectious disease france,3
7126,liter,liter,3
7125,1.2 milligrams,1.2 milligrams,3
7132,topical application,topical application,3
7124,ethanol extract,ethanol extract,3
7122,chinese medicinal herbs,chinese medicinal herbs,3
7121,extract,extract,3
7120,andrographis paniculata,andrographis paniculata,3
6633,industrialized countries,industrialized countries,3
7119,eleutherococcus senticosus,eleutherococcus senticosus,3
7118,mixture,mixture,3
7117,kan jang,kan jang,3
7116,antioxidant food supplement,antioxidant food supplement,3
7115,labels,labels,3
7123,rantes secretion,rantes secretion,3
6628,practice,practice,3
6627,important determinant,important determinant,3
7134,regular dietary intake,regular dietary intake,3
7154,high protection,high protection,3
7153,vaccines effectiveness,vaccines effectiveness,3
7152,new versions,new versions,3
7149,bovine colostrum,bovine colostrum,3
7148,37%,37%,3
6618,appearance,appearance,3
7145,procedural refinements,procedural refinements,3
7144,era,era,3
6620,epidemiological factors,epidemiological factors,3
7142,recovered patients,recovered patients,3
7141,plasma,plasma,3
7140,direct transfusion,direct transfusion,3
6621,wwi practice,wwi practice,3
6622,soldiers,soldiers,3
6623,severe influenza illness,infectious disease,3
6624,field hospitals,field hospitals,3
7139,alternative,alternative,3
7138,transfused antibodies,family protein complexes,3
7137,tcell function,tcell function,3
7136,enhancement,enhancement,3
6626,battlefield,battlefield,3
7022,common cause,common cause,3
7197,manufacturing process,manufacturing process,3
7021,malnutrition,malnutrition,3
7019,chloroquine,chemical compound medication essential medicine,3
6890,certain virulence genes,certain virulence genes,3
6889,anticipated epidemic strain,anticipated epidemic strain,3
6886,rapid generation,rapid generation,3
6885,reverse genetics,reverse genetics,3
6764,single injection,single injection,3
6883,flumist,brand,3
6881,phase 1 h5n1 study,subtype,3
6880,participants,participants,3
6766,large multicentre trial,large multicentre trial,3
6762,technical problems,technical problems,3
6876,extent,extent,3
6872,wild bird migration patterns,taxon,3
6768,provided protection,provided protection,3
6770,acceptable level,acceptable level,3
6868,pandemic mitigation funds,pandemic mitigation funds,3
6867,expenditures,expenditures,3
6866,dollars,dollars,3
6772,strength,strength,3
6773,15 μg,15 μg,3
6774,90 μg,90 μg,3
6767,90 µg h5,90 µg h5,3
6775,alum,structural class chemical compounds,3
6761,lessdeveloped countries,lessdeveloped countries,3
6895,recent niaidsupported phase ii clinical trial,recent niaidsupported phase ii clinical trial,3
6918,bacterium,bacterium,3
6917,harmful,harmful,3
6755,considerations,considerations,3
6914,e. coli bacteria,taxon,3
6913,success,success,3
6912,new jerseybased biotechnology company,new jerseybased biotechnology company,3
6911,vaxinnate,business,3
6910,peptides,peptides,3
6757,indonesia citizens,sovereign state archipelagic state constitutional republic island nation presidential régime country,3
6893,genetically engineering baculovirus,genetically engineering baculovirus,3
6758,assurances,assurances,3
6908,neugene therapeutics,neugene therapeutics,3
6907,key finding,key finding,3
6906,independent research laboratories,independent research laboratories,3
6759,10 percent,10 percent,3
6905,multiple strains.avi bio pharma inc. labs,multiple strains.avi bio pharma inc. labs,3
6904,morpholino oligomers,morpholino oligomers,3
6903,inhibition,inhibition,3
6902,multiple strains.avi bio pharma inc.,multiple strains.avi bio pharma inc.,3
6899,dnabased approaches,dnabased approaches,3
6909,morpholinos,morpholinos,3
6919,dowpharma,dowpharma,3
6776,as03,immunologic adjuvant,3
6859,domestic flock,domestic flock,3
6833,technology,academic discipline,3
6831,fiveyear contracts,fiveyear contracts,3
6830,current major flu research contracts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
6829,diagnostic tools,diagnostic tools,3
6828,therapies,therapies,3
6826,main goal,main goal,3
6825,genomics,branch biology genome omics academic discipline,3
6793,$100 million dhhs initiative,$100 million dhhs initiative,3
6823,molecular virology,molecular virology,3
6834,speedier mass production,speedier mass production,3
6821,malaysian population,malaysian population,3
6795,office,office,3
6798,critical pilot test,critical pilot test,3
6817,hazards,hazards,3
6816,growing concern,growing concern,3
6799,immunogenicity,immunogenicity,3
6815,document,document,3
6813,canadian public health agency,canadian public health agency,3
6805,professionally vetted search engine,professionally vetted search engine,3
6807,policies,policies,3
6820,place processes,place processes,3
6863,hope,hope,3
6835,$3.8 billion pandemic preparedness,$3.8 billion pandemic preparedness,3
6790,actions,actions,3
6777,as04,as04,3
6858,wild bird s lpai wouldmutatein,taxon,3
6778,mf59,immunologic adjuvant,3
6779,second problem,second problem,3
6855,global alliance,global alliance,3
6854,distributed research projects,distributed research projects,3
6780,circulating clades,circulating clades,3
6781,clade,clade,3
6851,infected monkeys,infected monkeys,3
6791,fforts,fforts,3
6850,kobasa et al,kobasa et al,3
6847,recent reconstruction,recent reconstruction,3
6846,local consumption,local consumption,3
6845,fort,fort,3
6843,fort riley,fort riley,3
6840,companies,companies,3
6839,speedy mass vaccinations,speedy mass vaccinations,3
6788,guidance,guidance,3
6837,american,american,3
6789,responsibilities,responsibilities,3
6783,clade 1 viruses,clade 1 viruses,3
6920,dow chemical,dow chemical,3
6921,different bacteria,taxon,3
6922,soil,soil,3
6992,classes,classes,3
6715,mitigation efforts,mitigation efforts,3
6990,acidic endonuclease inhibitors,acidic endonuclease inhibitors,3
6989,main classes,main classes,3
6987,hhs,hhs,3
6986,national stockpile,national stockpile,3
6984,103 healthy adults,103 healthy adults,3
6983,90microgram doses,90microgram doses,3
6982,2006 article,2006 article,3
6994,united states authority,united states authority,3
6717,post pandemic recovery activities,post pandemic recovery activities,3
6980,panel members,panel members,3
6979,fda advisory panel,fda advisory panel,3
6978,february 27 recommendation,february 27 recommendation,3
6720,adequate measure,adequate measure,3
6976,vietnamese patient,vietnamese patient,3
6974,strains antigen protects,group class chemical substances,3
6723,section,section,3
6973,15 micrograms,15 micrograms,3
6724,foreign relations panel,foreign relations panel,3
6981,reservations,reservations,3
6972,45 micrograms,45 micrograms,3
6995,certain drugs,certain drugs,3
6713,capacity development,capacity development,3
7017,statins,drug class group class molecular entities,3
6705,easy incorporation,easy incorporation,3
6707,approaches,approaches,3
7015,generic prescription medications,generic prescription medications,3
7014,offlabel uses drugs,offlabel uses drugs,3
7013,prescriptiononly medication,prescriptiononly medication,3
7012,overthecounter medication,overthecounter medication,3
7010,tamifluresistance mutation,tamifluresistance mutation,3
6708,existing national preparedness,existing national preparedness,3
6996,uninfected individuals,uninfected individuals,3
7007,performance,performance,3
7006,evaluation,evaluation,3
7004,stockpiles,stockpiles,3
7003,augmentation,augmentation,3
7002,urgent need,urgent need,3
7001,nature biotechnology,nature biotechnology,3
7000,june 2009 issue,june 2009 issue,3
6712,observable phenomena,observable phenomena,3
6998,bacterial antibiotic resistance,bacterial antibiotic resistance,3
6997,oseltamivir phosphate,chemical compound neuraminidase inhibitor medication essential medicine,3
6710,grouping,grouping,3
6970,piece,piece,3
6969,180 micrograms,180 micrograms,3
6725,animal problem,taxon,3
6738,groups,groups,3
6941,holly springs,holly springs,3
6739,adamantanes,adamantanes,3
6937,licensing,licensing,3
6934,optaflu,optaflu,3
6932,3 400 people,3 400 people,3
6742,commonly sought drug,commonly sought drug,3
6743,pill form,pill form,3
6744,initial stages,initial stages,3
6737,national surveys,national surveys,3
6930,27 eu countries,27 eu countries,3
6747,19 countries,19 countries,3
6928,pitfalls,pitfalls,3
6749,best scenario situation,best scenario situation,3
6927,production process,production process,3
6926,fda approval,fda approval,3
6751,welldeveloped plans,welldeveloped plans,3
6925,e. coli,e. coli,3
6924,higher volume,higher volume,3
6923,p. fluorescens,p. fluorescens,3
6929,chicken eggs.the committee,chicken eggs.the committee,3
6736,set,set,3
6944,annual output,annual output,3
6735,uk department,uk department,3
6968,informed consent,informed consent,3
6967,recipient,recipient,3
6966,april 17 2007 approval,april 17 2007 approval,3
6965,general ill feeling,general ill feeling,3
6964,injection site,injection site,3
6963,age groups,age groups,3
6727,following shortterm strategies,following shortterm strategies,3
6729,main ways,main ways,3
6730,good public health communication strategy,good public health communication strategy,3
6959,45 percent,45 percent,3
6958,better vaccines,better vaccines,3
6731,public concerns,public concerns,3
6957,interim measure,interim measure,3
6956,swiftwater,swiftwater,3
6955,sanofiaventis,sanofiaventis,3
6732,attitudes,attitudes,3
6952,problems,problems,3
6733,behaviour,behaviour,3
6949,marburg,location identifier q28791882 masculine plural 8 november 1919gregorian,3
6734,flu telephone survey template,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
6948,novartis cellbased vaccine production facility isin,business multinational corporation,3
7020,nutritional supplements herbal medicines,nutritional supplements herbal medicines,3
7198,announcement,announcement,3
6590,140 years,140 years,3
6588,large region,large region,3
6431,capsid virion,cellular component,3
6432,envelope,envelope,3
7424,patient reminders,patient reminders,3
7423,beliefs,beliefs,3
7422,chronic illness,chronic illness,3
7421,ethnicity,ethnicity,3
7420,gender,gender,3
7419,personal factors,personal factors,3
6434,nucleoprotein complex,group class proteins,3
6429,morphology,morphology,3
6435,polymerase complex,group class enzymes,3
6437,genome structure,scientific model natural environment,3
7417,risk groups,risk groups,3
6438,segments,segments,3
6439,linear negativesense,linear negativesense,3
6440,segment,segment,3
6441,separate nucleocapsid,separate nucleocapsid,3
6442,nucleocapsids,nucleocapsids,3
7411,sufficient antibodies,family protein complexes,3
7409,annual injection,annual injection,3
6436,500 surface projections,500 surface projections,3
7408,financial logistics burden,financial logistics burden,3
7425,leaflets,leaflets,3
7427,postcard reminders,postcard reminders,3
6413,expression,expression,3
7441,61.9%,61.9%,3
6414,essential gene,essential gene,3
7439,63.5%,63.5%,3
7438,united states healthcare workers,united states healthcare workers,3
6417,genomic segments,genomic segments,3
6418,undamaged copy,undamaged copy,3
6421,subtype list,subtype list,3
6422,following subtypes,following subtypes,3
7426,letters,letters,3
7437,2010 survey,2010 survey,3
6423,fi6 antibody,family protein complexes,3
7435,2009 pandemic low uptake,2009 pandemic low uptake,3
6424,fi6,fi6,3
7434,physician competition,physician competition,3
7433,physician reminders,physician reminders,3
7432,physician payment,physician payment,3
7431,free vaccinations,free vaccinations,3
6426,known antibody,family protein complexes,3
7428,client outreach programs,client outreach programs,3
7436,greece,greece,3
7444,direct patient contact,direct patient contact,3
7406,high herd immunity strategies,high herd immunity strategies,3
7400,secondary priority people,secondary priority people,3
7376,severe egg allergies,severe egg allergies,3
7375,egg allergies,egg allergies,3
6465,relatively short incubation period,relatively short incubation period,3
7374,eggbased techniques,eggbased techniques,3
6466,18–72 hours,18–72 hours,3
7373,egg allergy,egg allergy,3
7371,incidence,incidence,3
7370,guillain–barré,guillain–barré,3
7369,link,link,3
7377,anaphylaxis,anaphylaxis,3
7367,complication,complication,3
7362,soreness,soreness,3
6470,dry cough,dry cough,3
6471,rhinorrhea,rhinorrhea,3
6472,muscle pain,muscle pain,3
6473,achiness,achiness,3
7361,trivalent,trivalent,3
7360,successful fullterm pregnancy,physiological condition,3
7358,fluad tetra,fluad tetra,3
7357,fluad quadrivalent,fluad quadrivalent,3
7363,redness,redness,3
7401,chronic medical conditions,chronic medical conditions,3
6464,short durations,short durations,3
7380,nearly 800 children,nearly 800 children,3
6446,antigenic types,antigenic types,3
7399,age household contacts,age household contacts,3
7398,national advisory committee,national advisory committee,3
7397,moreexpensive singledose administration,moreexpensive singledose administration,3
7396,grounds,grounds,3
7392,mercurybased preservative,mercurybased preservative,3
7391,thiomersal,chemical compound excipient,3
7389,trigger,trigger,3
7388,hypocretin,hypocretin,3
6463,fomites,fomites,3
6450,amino acid composition,amino acid composition,3
6454,greater level,greater level,3
6456,single ancestor,single ancestor,3
7385,narcolepsy,narcolepsy,3
7384,increased incidence,increased incidence,3
6458,natural host,natural host,3
6460,animal reservoirs,taxon,3
6461,6 lineages,6 lineages,3
7382,zero systemic allergic reactions,zero systemic allergic reactions,3
7381,previous anaphylactic reactions,previous anaphylactic reactions,3
6451,divergence,divergence,3
6412,damage,damage,3
6410,radiation,radiation,3
7445,higher vaccination uptake,higher vaccination uptake,3
6369,smallest virions,smallest virions,3
6370,elliptical shape,elliptical shape,3
7506,jonas salk,jonas salk,3
7505,thomas francis,thomas francis,3
6371,length,length,3
6372,particle,particle,3
7504,growth,growth,3
6373,excess,excess,3
7503,vanderbilt university,vanderbilt university,3
7507,wilson smith,wilson smith,3
7502,ernest william goodpasture,ernest william goodpasture,3
6375,micrometers,micrometers,3
6376,filamentous virions,filamentous virions,3
6378,filaments,filaments,3
7499,success.in,success.in,3
7498,hint,hint,3
7497,new victims,new victims,3
7496,therapeutic measure,therapeutic measure,3
7495,serums,serums,3
6380,electron microscopy,electron microscopy,3
6374,tens,tens,3
6381,varied shapes,varied shapes,3
7508,macfarlane burnet,macfarlane burnet,3
7511,military,military,3
7530,needed.the eggbased technology,academic discipline,3
6355,h17n10,h17n10,3
6356,h18n11,h18n11,3
7527,physician visits,physician visits,3
6357,peruvian bat,peruvian bat,3
7526,influenzarelated respiratory illness,influenzarelated respiratory illness,3
7525,reductions,reductions,3
7524,cdc severe complications,cdc severe complications,3
7523,primary method,primary method,3
7510,1940s,1940s,3
6359,variants subtypes,variants subtypes,3
7518,systemic reactivity,systemic reactivity,3
7517,egg proteins,group class chemical substances second-order class,3
6362,total cost,total cost,3
7516,improved processes,improved processes,3
6363,toll,toll,3
7515,purity,purity,3
6365,previous estimates,previous estimates,3
6366,structure genetics,structure genetics,3
6368,80–120 nanometers,80–120 nanometers,3
7522,acceptance,acceptance,3
6382,virions,virions,3
6383,main types,main types,3
6384,central core,central core,3
7461,resident physicians,resident physicians,3
6405,negativesense rna,structural class chemical compounds,3
7460,adverse reactions,adverse reactions,3
6406,gene product,gene product,3
7459,reasons,reasons,3
7458,laboratory staff,laboratory staff,3
6407,multiplicity reactivation,multiplicity reactivation,3
7457,42%,42%,3
7456,nonclinical staff,nonclinical staff,3
7462,teaching hospital,teaching hospital,3
7455,34%,34%,3
7453,reasons healthcare workers decisions,reasons healthcare workers decisions,3
7452,reasons healthcare workers,reasons healthcare workers,3
7451,high service demand,high service demand,3
6408,inactivation,inactivation,3
7449,healthcare workers patients,healthcare workers patients,3
7448,main reason,main reason,3
7447,nurse practitioners,nurse practitioners,3
6409,uv radiation,uv radiation,3
7446,dentists,dentists,3
7454,public hospitals,public hospitals,3
6404,segmented pieces,segmented pieces,3
6403,single piece,single piece,3
7464,annual reformulation,annual reformulation,3
6386,outside,outside,3
6387,virion,virion,3
7493,ancient art,ancient art,3
7492,pharmacists,pharmacists,3
7490,origins development,origins development,3
7487,following,following,3
7484,quadrivalent formulation,quadrivalent formulation,3
7483,2020–2021,2020–2021,3
6389,abundant nonproductive attachment sites,abundant nonproductive attachment sites,3
7482,2019–2020,2019–2020,3
6390,progeny virions,progeny virions,3
6391,targets,targets,3
6392,antigen proteins,group class chemical substancesgroup class chemical substances second-order class,3
6394,16 subtypes,16 subtypes,3
6395,ha 9 subtypes,ha 9 subtypes,3
6398,organisms,organisms,3
6399,doublestranded dna,doublestranded dna,3
7473,contents,contents,3
7471,2nd bstrain,2nd bstrain,3
7467,h1n1 h3n2 typeb strains,virussubtype,3
6401,different singlestranded nucleic acid,different singlestranded nucleic acid,3
6475,infectious agent,infectious agent,3
7356,fluad quad,fluad quad,3
6478,young children,young children,3
7355,tentative evidence,tentative evidence,3
6554,david r. smith,david r. smith,3
6555,liesel schneider,liesel schneider,3
7261,rubbish,rubbish,3
6556,kathleen barton,kathleen barton,3
7259,cochrane collaboration reviews,cochrane collaboration reviews,3
6557,katlin mccuan,katlin mccuan,3
7258,tom jefferson,tom jefferson,3
7256,overall effectiveness,overall effectiveness,3
7254,future vaccination policy,future vaccination policy,3
7263,rubbish views,rubbish views,3
7253,yearly vaccinations,yearly vaccinations,3
7251,relevance,relevance,3
7249,reduction,reduction,3
7248,repeated vaccinations,repeated vaccinations,3
7247,slight mutation,slight mutation,3
6558,richard j. webby,richard j. webby,3
7245,good match,good match,3
6559,xiufeng wan,xiufeng wan,3
7240,antibody production,family protein complexes,3
6560,pathogenesis,biological process,3
7252,current recommendations,current recommendations,3
6562,public data,public data,3
6553,william b. epperson,william b. epperson,3
6551,alicia k. olivier,alicia k. olivier,3
6537,normal lung temperature,normal lung temperature,3
7281,cdc director,cdc director,3
6539,genetic changes,genetic changes,3
7279,possibly influenzalike illness,possibly influenzalike illness,3
6540,lower lung,lower lung,3
7277,chronic illnesses,chronic illnesses,3
7275,special attention,special attention,3
7274,vaccination campaigns,vaccination campaigns,3
7272,sales job,sales job,3
6552,suzanne genova,suzanne genova,3
7270,policy,policy,3
7269,disease research,disease research,3
7268,infectious,infectious,3
6547,inactivated influenzavirus d vaccine,inactivated influenzavirus d vaccine,3
7267,michael osterholm,michael osterholm,3
6548,partial protection,partial protection,3
6549,challenge experiments,challenge experiments,3
7266,anthony fauci,anthony fauci,3
6550,lucas ferguson,lucas ferguson,3
7265,key figures,key figures,3
6544,shift,shift,3
6563,david lipman,david lipman,3
6564,steven salzberg,steven salzberg,3
7239,high efficacy,high efficacy,3
7220,suitability,suitability,3
7219,2012 review,2012 review,3
7218,healthy working adults,healthy working adults,3
6580,genbank,sequence database data library,3
6581,international nihfunded searchable online database,international nihfunded searchable online database,3
6582,mid2008,mid2008,3
7214,complexities,complexities,3
7212,uncertainty,uncertainty,3
7211,economic evaluations,economic evaluations,3
6579,sequence data,sequence data,3
7210,key assumptions,key assumptions,3
6583,3000 isolates,3000 isolates,3
6584,affiliations,affiliations,3
6585,component,component,3
6586,agency,agency,3
7207,different groups,different groups,3
7205,costeffectiveness,costeffectiveness,3
6587,sequencing project home page,sequencing project home page,3
7202,nonhumans,nonhumans,3
7201,monovalent harvests,monovalent harvests,3
7208,different settings,different settings,3
7221,willingness,willingness,3
6578,research goals,research goals,3
7223,productivity gains,productivity gains,3
7238,observed reduction,observed reduction,3
7237,controlled conditions,controlled conditions,3
6565,consortium,consortium,3
7235,immunization series,immunization series,3
6566,proposal,proposal,3
6567,institute,institute,3
7234,immunological basis,immunological basis,3
7233,following objectives,following objectives,3
6568,genomic research,genomic research,3
6569,project,project,3
6570,handful,handful,3
6572,igsp,igsp,3
7229,researchers understanding ofwhatmakesonestrainmorelethalthananother,researchers understanding ofwhatmakesonestrainmorelethalthananother,3
7228,library,library,3
6573,new technology development,academic discipline,3
7227,basic research,basic research,3
6574,elodie ghedin,elodie ghedin,3
6575,tigr,tigr,3
6576,publication,publication,3
7226,molecular evolution,molecular evolution,3
7224,interventions,interventions,3
7282,85 percent,85 percent,3
6353,18 different known h antigens,18 different known h antigens,3
7283,preference,preference,3
6536,37°c,37°c,3
7336,nonpandemic year,nonpandemic year,3
7335,advanced age,advanced age,3
7334,frailty,frailty,3
7333,declining immunological function,declining immunological function,3
7332,steep decline,steep decline,3
7331,multiple reasons,multiple reasons,3
7328,case–control studies,case–control studies,3
7327,reviews,reviews,3
6498,new ha,new ha,3
6496,enzyme neuraminidase,group class enzymes,3
7326,highquality evidence,highquality evidence,3
7324,systematic reviews,systematic reviews,3
6499,type undergoes antigenic shift,type undergoes antigenic shift,3
7323,elderly,elderly,3
7322,comparison patients,comparison patients,3
6500,processes,processes,3
6503,diagnostic purposes,diagnostic purposes,3
6504,techniques,techniques,3
6505,color change,color change,3
6506,higher sensitivity,higher sensitivity,3
7325,randomized controlled case–control studies,randomized controlled case–control studies,3
7320,moderate evidence,moderate evidence,3
7337,influenzaassociated death,stock character psychopomp literary character,3
7338,younger person,younger person,3
7354,vaccinating healthcare workers,vaccinating healthcare workers,3
6479,underlying health problems,underlying health problems,3
6480,prior exposure,prior exposure,3
7352,conclusive evidence,conclusive evidence,3
7351,vulnerable population,vulnerable population,3
6483,highest preventable mortalities,highest preventable mortalities,3
7349,goal,goal,3
7348,immunization practices guidelines,immunization practices guidelines,3
7347,advisory committee,advisory committee,3
6495,enzyme esterase,enzyme esterase,3
6484,structure variation,structure variation,3
6487,antigens,antigens,3
7344,fluad,fluad,3
7343,65 years,65 years,3
6488,d.,d.,3
6490,np functions,np functions,3
6491,transcription,transcription,3
6492,glycoprotein,glycoprotein,3
7340,available evidence,available evidence,3
6493,hemagglutininesterase fusion,hemagglutininesterase fusion,3
6486,single stranded genomes,single stranded genomes,3
7319,2014 review,2014 review,3
7317,healthcare worker vaccination,healthcare worker vaccination,3
6507,hef,hef,3
6526,influenzavirus d,influenzavirus d,3
6527,serum samples,serum samples,3
7300,16%,16%,3
6528,hemagglutinationinhibiting antibodies,family protein complexes,3
6529,estimated occurrence,estimated occurrence,3
7299,unvaccinated adults,unvaccinated adults,3
7298,inflammatory bowel disease,inflammatory bowel disease,3
6530,1.3%,1.3%,3
7297,immunosuppressed pediatric patients,immunosuppressed pediatric patients,3
6524,situ esterase,situ esterase,3
7296,tertiary referral center,tertiary referral center,3
7294,healthy 5–18yearolds,healthy 5–18yearolds,3
7293,canadian national advisory committee,canadian national advisory committee,3
6533,lineages,lineages,3
6534,influenzavirus d natural host,influenzavirus d natural host,3
7292,afluria tetra,afluria tetra,3
7291,0.25 milliliters,0.25 milliliters,3
7289,afluria quadrivalent,afluria quadrivalent,3
7288,0.5 milliliters,0.5 milliliters,3
7286,age group,age group,3
7295,pediatric fluad,pediatric fluad,3
6523,o callaghan rj],o callaghan rj],3
6522,spence ha,spence ha,3
6521,wagaman pc,wagaman pc,3
7314,relationship,relationship,3
6508,hi test,hi test,3
7312,net benefit,net benefit,3
7311,2006 review,2006 review,3
7310,healthcare workers,healthcare workers,3
6509,esterase,esterase,3
6510,situ esterase assays,situ esterase assays,3
7308,moderate protection,moderate protection,3
7307,influenzarelated complications,influenzarelated complications,3
6511,quick inexpensive method,quick inexpensive method,3
7306,working days,working days,3
6513,animal reservoir,taxon,3
7305,modest decrease,modest decrease,3
7304,working adults,working adults,3
6516,drift,drift,3
6517,capability,capability,3
7303,1.1%,1.1%,3
7302,2.4%,2.4%,3
6518,significant concern,significant concern,3
7301,vaccinated adults,vaccinated adults,3
6520,vaccinations,vaccinations,3
7285,fluzone quadrivalent,fluzone quadrivalent,3
6999,overuse,overuse,3
8365,eml,eml,3
7833,precise mechanism,precise mechanism,3
9908,u.s. house democrats henry waxman,u.s. house democrats henry waxman,3
9906,list price,list price,3
9905,brand version,brand version,3
9904,91 developing countries,91 developing countries,3
9903,generic manufacturers,generic manufacturers,3
9901,media sources,media sources,3
9900,expired air recovery,expired air recovery,3
9899,2.5%,2.5%,3
9898,14%,14%,3
9897,single 400 mg oral dose,single 400 mg oral dose,3
9896,27 hours,27 hours,3
9895,0.4 hours,0.4 hours,3
9894,inactive metabolite,inactive metabolite,3
9893,subsequent repeated phosphorylation,subsequent repeated phosphorylation,3
9892,enzyme histidine triad nucleotidebinding protein,enzyme histidine triad nucleotidebinding protein,3
9891,phosphoramidate,phosphoramidate,3
9890,cathepsin,cathepsin,3
9875,2 deoxy2 αfluoroβcmethylcytidine],2 deoxy2 αfluoroβcmethylcytidine],3
9876,2 deoxy2 αfluoroβcmethylcytidine,2 deoxy2 αfluoroβcmethylcytidine,3
9877,chain terminator,chain terminator,3
9878,2 methyl group,2 methyl group,3
9879,steric clash,steric clash,3
9880,similar way,similar way,3
9909,frank pallone jr.,frank pallone jr.,3
9881,peak concentration,peak concentration,3
9883,initial dose,initial dose,3
9884,peak plasma concentration,peak plasma concentration,3
9885,gs331077,gs331077,3
9886,pharmacologically inactive nucleoside,pharmacologically inactive nucleoside,3
9888,61–65%,61–65%,3
9889,minimal binding,minimal binding,3
9882,oral administration,oral administration,3
9910,diana degette,diana degette,3
9911,gilead sciences inc.,gilead sciences inc.,3
9913,gilead sciences inc. ceo john martin,gilead sciences inc. ceo john martin,3
9937,croatia croatia cost,sovereign state unitary state mediterranean country countrysovereign state unitary state mediterranean country country,3
9939,negotiations,negotiations,3
9940,manufacturer,manufacturer,3
9941,successful outcome,successful outcome,3
9942,patent,patent,3
9943,controller general,controller general,3
9936,essential medications,essential medications,3
9944,exclusive rights,exclusive rights,3
9947,delhi high court,delhi high court,3
9948,appeal,appeal,3
9949,meantime,meantime,3
9950,agreement,agreement,3
9951,7%,7%,3
9952,indian firms,indian firms,3
9945,indian patent office,indian patent office,3
9874,similar nucleotide analogue,similar nucleotide analogue,3
9933,care excellence,care excellence,3
9931,nhs england,nation uk cultural area country,3
9914,discounts,discounts,3
9915,lowincome patients,lowincome patients,3
9917,insurers,insurers,3
9918,medicine cost,medicine cost,3
9919,specialty drugs,specialty drugs,3
9920,japan south korea,sovereign state island nation country,3
9932,22 operational delivery networks,22 operational delivery networks,3
9921,comparable western developed countries,comparable western developed countries,3
9924,national healthcare,national healthcare,3
9925,additional discounts,additional discounts,3
9926,rebates,rebates,3
9928,chf,chf,3
9929,24 pills,24 pills,3
9930,400 mg,400 mg,3
9922,germany negotiations,historical period germany historical country,3
9873,incoming ntp,incoming ntp,3
9872,nucleophile foranincomingntpasimilarnucleotideanalogue2 deoxy2 αfluoroβcmethylcytidineisproposedtoactasachainterminatorbecausethe2methylgroupofthenucleotideanaloguecausesastericclashwith incoming ntp,nucleophile foranincomingntpasimilarnucleotideanalogue2 deoxy2 αfluoroβcmethylcytidineisproposedtoactasachainterminatorbecausethe2methylgroupofthenucleotideanaloguecausesastericclashwith incoming ntp,3
9869,defective substrate,defective substrate,3
9792,hepc,hepc,3
9794,viral ns5a inhibitor,viral ns5a inhibitor,3
9795,breakthrough status,breakthrough status,3
9798,interferonbased regimen,interferonbased regimen,3
9802,anticipation,anticipation,3
9806,u.s. market,u.s. market,3
9790,scientist,scientist,3
9807,u.s. infected population,u.s. infected population,3
9810,considerable controversy,considerable controversy,3
9811,2017 range,2017 range,3
9814,low costs,low costs,3
9815,hill,hill,3
9817,tenofovir alafenamide,tenofovir alafenamide,3
9818,nucleotide reversetranscriptase inhibitor,nucleotide reversetranscriptase inhibitor,3
9809,controversies,controversies,3
9819,similar phosphoramidate prodrug technology,academic discipline,3
9789,michael sofia,michael sofia,3
9785,phosphorus,phosphorus,3
9768,darunavir/ritonavir,darunavir/ritonavir,3
9769,efavirenz,chemical compound medication alkyne essential medicine,3
9770,emtricitabine,chemical compound medication essential medicine,3
9771,methadone,group stereoisomers,3
9772,rilpivirine,chemical compound medication,3
9773,tacrolimus,chemical compound medication immunosuppressive drug polyketide,3
9786,negative charges,negative charges,3
9774,nucleoside analogs,nucleoside analogs,3
9779,phosphate groups,phosphate groups,3
9780,triphosphate,triphosphate,3
9781,protide approach,protide approach,3
9782,slow step,slow step,3
9783,phosphate group,phosphate group,3
9784,additional groups,additional groups,3
9778,enzymatic addition,enzymatic addition,3
9954,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthat gilead,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthat gilead,3
9820,sofosbuvir therapy,chemical compound medication active ingredient essential medicine,3
9822,nbk409960,nbk409960,3
9852,pregnancy outcomes,physiological condition,3
9853,pregnancy category x,physiological condition,3
9854,ribavirin fetus,chemical compound medication essential medicine 1 april 1990,3
9855,sofosbuvir/ribarivin combinations,sofosbuvir/ribarivin combinations,3
9856,pregnant females sofosbuvir/ribarivin combinations male sexual partners,pregnant females sofosbuvir/ribarivin combinations male sexual partners,3
9857,harmful fetal defects,harmful fetal defects,3
9851,adequate human data,organisms known particular common homo sapiens homo sapiens sapiens homo,3
9858,pregnancy test,physiological condition,3
9862,accidental pregnancy,physiological condition,3
9863,high barrier,high barrier,3
9864,protide type,protide type,3
9865,active phosphorylated nucleotide,active phosphorylated nucleotide,3
9867,active antiviral agent,active antiviral agent,3
9868,gs461203,gs461203,3
9861,fetal harm,fetal harm,3
9821,ifnl4 genotype,ifnl4 genotype,3
9850,pregnancy breastfeeding,physiological condition,3
9848,consideration,consideration,3
9823,initial hcv treatment,initial hcv treatment,3
9826,management,management,3
9829,close 100%,close 100%,3
9831,specific circumstances,specific circumstances,3
9832,genotype costeffectiveness–based perspective,genotype costeffectiveness–based perspective,3
9833,viral ns5a inhibitor ledipasvir,chemical compound carbocyclic compound heterocyclic compound essential medicine medication,3
9849,retreatment,retreatment,3
9834,2 3 hcv infections,2 3 hcv infections,3
9836,weightbased ribavirin,chemical compound medication essential medicine 1 april 1990,3
9838,sofosbuvirbased regimens,sofosbuvirbased regimens,3
9841,fourfold reduced duration,fourfold reduced duration,3
9843,key component,key component,3
9846,possible steps,possible steps,3
9847,initial treatment,initial treatment,3
9835,liver transplant patients,organ type,3
9955,generic licensing agreements,generic licensing agreements,3
9957,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthatgileadwouldsell brand version,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthatgileadwouldsell brand version,3
9958,approximately double party estimate,approximately double party estimate,3
10082,albert gitchell,albert gitchell,3
10083,army cook,army cook,3
10084,camp funston,camp funston,3
10085,haskell county,haskell county,3
10086,local doctor loring miner,local doctor loring miner,3
10087,522 men,522 men,3
10081,recording,recording,3
10088,camp,camp,3
10090,queens,queens,3
10091,new york,new york,3
10092,preventive measures,preventive measures,3
10093,march/april,march/april,3
10095,major training ground,major training ground,3
10096,american expeditionary forces,american expeditionary forces,3
10089,11 march,11 march,3
10097,army camps,army camps,3
10080,4 march,4 march,3
10078,spanish flu survivors,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
10055,similarities,similarities,3
10056,reconstruction,reconstruction,3
10058,significantly risk,significantly risk,3
10059,tuberculosis,notifiable disease valid place switzerland endemic disease,3
10062,scholars,scholars,3
10063,males life expectancy,males life expectancy,3
10079,wave early 1918,wave early 1918,3
10067,black death,stock character psychopomp literary character,3
10069,1300s,1300s,3
10070,comorbidities,comorbidities,3
10073,higher mortality rate,higher mortality rate,3
10074,life expectancy,life expectancy,3
10075,videoswe,videoswe,3
10077,1918 nih interviews,1918 nih interviews,3
10068,bubonic plague,bubonic plague,3
10054,nearsimultaneous outbreaks,nearsimultaneous outbreaks,3
10098,midwest,midwest,3
10100,great britain,great britain,3
10123,camp devens,camp devens,3
10124,u.s. military sites,u.s. military sites,3
10125,troop movements,troop movements,3
10126,central south america,central south america,3
10127,west africa,continent,3
10128,coast,coast,3
10122,boston navy yard,big city city united states,3
10129,rivers,rivers,3
10131,remote communities,remote communities,3
10132,south african native labour corps,south african native labour corps,3
10133,zambezi,zambezi,3
10134,ethiopia,ethiopia,3
10135,new york city,new york city,3
10136,new york city fatality,new york city fatality,3
10130,colonial railways,colonial railways,3
10099,western,western,3
10121,naval training,naval training,3
10119,american troops,american troops,3
10101,breslau,breslau,3
10102,odessa,port settlement big city city millions inhabitants amalgamated hromada city \u200b\u200bin ukraine,3
10103,signing,signing,3
10104,treaty,treaty,3
10105,brestlitovsk,brestlitovsk,3
10106,russian prisoners,russian prisoners,3
10120,french recruits,french recruits,3
10110,military operations,military operations,3
10112,half british forces,half british forces,3
10114,deadly second wave late 1918,deadly second wave late 1918,3
10115,boston,big city city united states,3
10116,freetown,city port settlement capital big city,3
10117,sierra leone,sierra leone,3
10118,brest,brest,3
10111,french troops,french troops,3
9767,ciclosporin,chemical compound medication essential medicine reactant reactant,3
10053,historians,historians,3
10051,news,news,3
9983,chris mcguigan team,chris mcguigan team,3
9984,cardiff university,cardiff university,3
9986,developing world countries,developing world countries,3
9987,court,court,3
9988,innovative step,innovative step,3
9989,prodrug design,prodrug design,3
9982,protide technology,academic discipline,3
9990,specific example,specific example,3
9995,chinese,chinese,3
9996,ns3/4a inhibitor,ns3/4a inhibitor,3
9997,fast track status,fast track status,3
9998,achillion,achillion,3
9999,pipeline update,pipeline update,3
10004,morale,morale,3
9992,high cost,high cost,3
10005,censors,censors,3
9981,known molecules,known molecules,3
9978,objection,objection,3
9959,minimum achievable cost,minimum achievable cost,3
9960,licenses,licenses,3
9961,leader,leader,3
9963,fierce marketing war,fierce marketing war,3
9964,highest incidence,highest incidence,3
9965,discounted price,discounted price,3
9980,european patent office,european patent office,3
9967,medicine indexrankedgileadfirstamongtheworld s20largestpharmaceuticalcountriesinthepricingmanufacturinganddistributioncategoryinboth2013and2014citing gilead,medicine indexrankedgileadfirstamongtheworld s20largestpharmaceuticalcountriesinthepricingmanufacturinganddistributioncategoryinboth2013and2014citing gilead,3
9971,equitable pricing,equitable pricing,3
9972,jennifer cohn,jennifer cohn,3
9973,algeria,emoji regional indicator sequence,3
9975,gilead partners,gilead partners,3
9976,middleincome countries,middleincome countries,3
9977,patent challenges,patent challenges,3
9969,pricing manufacturing distribution category,pricing manufacturing distribution category,3
10052,2000s,2000s,3
10006,early reports,early reports,3
10009,neutral spain,neutral spain,3
10035,purported origins,purported origins,3
10036,senegal,senegal,3
10037,senegal itwasnamedthebrazilianflu andinbrazilthegermanflu whileinpoland,senegal itwasnamedthebrazilianflu andinbrazilthegermanflu whileinpoland,3
10038,nickname,nickname,3
10039,naples soldier,naples soldier,3
10040,1916 operetta,1916 operetta,3
10034,alternative names,alternative names,3
10041,song,song,3
10043,librettists,librettists,3
10046,spanish flu],spanish flu],3
10047,epidemiology pathology,branch science,3
10048,legacy,legacy,3
10049,high morbidity mortality rates,high morbidity mortality rates,3
10050,public awareness,public awareness,3
10042,forgetting,forgetting,3
10007,newspapers,newspapers,3
10033,widelyspread stories,widelyspread stories,3
10031,disease geographic origin,disease geographic origin,3
10010,grave illness,grave illness,3
10011,king alfonso xiii,king alfonso xiii,3
10012,stories,stories,3
10013,false impression,false impression,3
10014,historical epidemiological data,historical epidemiological data,3
10017,varying views,varying views,3
10032,wartime censorship,wartime censorship,3
10018,higher survival rate,higher survival rate,3
10021,severe 6year climate anomaly,severe 6year climate anomaly,3
10025,2007 analysis,2007 analysis,3
10026,medical journals,medical journals,3
10028,recent war,recent war,3
10029,bacterial superinfection,bacterial superinfection,3
10030,somewhat prolonged death bed,stock character psychopomp literary character,3
10020,possible explanations,possible explanations,3
10137,philadelphia liberty loans parade,philadelphia liberty loans parade,3
9766,interaction,interaction,3
9764,hiv protease inhibitor tipranavir,organisms known particular common,3
9528,saint louis ecephalitis,saint louis ecephalitis,3
9527,arboviruses,arboviruses,3
9525,effective antiviral,effective antiviral,3
9524,channel pore,channel pore,3
9523,similar ability,similar ability,3
9522,similar binding affinity,similar binding affinity,3
9521,enantiomers,enantiomers,3
9520,acids,acids,3
9519,binding affinity,binding affinity,3
9515,senantiomer,senantiomer,3
9514,m2 channel pore,m2 channel pore,3
9513,stronger binding affinity,stronger binding affinity,3
9512,r enantiomer,r enantiomer,3
9509,racemic mixture,racemic mixture,3
9508,flumadine,flumadine,3
9507,rimantadine enantiomers interactions m2,chemical compound medication,3
9506,image,image,3
9486,db00478,db00478,3
9487,fch3207896,fch3207896,3
9488,mcule9027470290,mcule9027470290,3
9489,u.s. fda press release,u.s. fda press release,3
9491,m2 transmembrane channel,m2 transmembrane channel,3
9492,proton transport,proton transport,3
9529,sindbis,sindbis,3
9494,uncoating,uncoating,3
9499,virion m2 gene,virion m2 gene,3
9501,amino acid substitutions,amino acid substitutions,3
9502,certain locations,certain locations,3
9503,transmembrane region,transmembrane region,3
9504,m2,m2,3
9505,mutation s31n binding site,mutation s31n binding site,3
9498,ion channel,ion channel,3
9531,samatasvir,chemical compound,3
9532,good results,good results,3
9533,highly potent selective inhibitor,highly potent selective inhibitor,3
9557,middle eastern,middle eastern,3
9558,latin american markets,latin american markets,3
9559,sales revenue,sales revenue,3
9560,2009.in february,2009.in february,3
9561,mylan laboratories,pharmaceutical company multinational corporation business,3
9563,developed markets,developed markets,3
9556,eastern european,eastern european,3
9565,european union approval,european union approval,3
9567,plan,plan,3
9568,united states government,united states government,3
9569,construction costs,construction costs,3
9570,guaranteed vaccine purchases,guaranteed vaccine purchases,3
9572,fluzone,fluzone,3
9573,flublok,flublok,3
9566,mammalian cell line,mammalian cell line,3
9485,cs2380,cs2380,3
9555,solvay,solvay,3
9553,solvay pharmaceuticals $6.2 billion purchase,solvay pharmaceuticals $6.2 billion purchase,3
9535,fluzone/fluzone quadrivalent,fluzone/fluzone quadrivalent,3
9536,vaxigrip/vaxigriptetra,vaxigrip/vaxigriptetra,3
9537,influvac,influvac,3
9538,csl limited,csl limited,3
9540,csl subsidiary,csl subsidiary,3
9541,biocsl,biocsl,3
9554,acquisition,acquisition,3
9543,fluarix,fluarix,3
9546,mylan,pharmaceutical company multinational corporation business,3
9547,purified surface fragments,purified surface fragments,3
9548,latest recommendations,latest recommendations,3
9549,abbott laboratoriesin february,abbott laboratoriesin february,3
9550,abbott laboratoriesin,abbott laboratoriesin,3
9552,solvay pharmaceuticals,solvay pharmaceuticals,3
9544,flulaval,flulaval,3
9484,ccg236078,ccg236078,3
9483,bbv156986,bbv156986,3
9482,api0024288,api0024288,3
9430,200 mg/d,200 mg/d,3
9431,sodium borohydride,sodium borohydride,3
9432,racemic hydroxy acid,racemic hydroxy acid,3
9433,excess methyllithium,excess methyllithium,3
9434,methyl ketones,methyl ketones,3
9435,left,left,3
9429,sideeffects,sideeffects,3
9436,prichardpatent,prichardpatent,3
9439,synthesis ofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisof rimantadine,chemical compound medication,3
9440,rimantadine fromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisofrimantadinefrom corresponding ketone oxime,chemical compound medication,3
9441,corresponding ketone oxime,corresponding ketone oxime,3
9442,rimantadine fromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisofrimantadinefrom corresponding ketone oxime reduction,chemical compound medication,3
9443,synonyms,synonyms,3
9444,alphamethyl1adamantanemethylamine,alphamethyl1adamantanemethylamine,3
9437,new chemical compound u.s. patent,new chemical compound u.s. patent,3
9445,alphamethyladamantanemethylamine,alphamethyladamantanemethylamine,3
9428,approximately 6%,approximately 6%,3
9424,acetylsalicylic acid whiletakingrimantadineisknowntoreducethebody suptakeof rimantadine,chemical compound medication,3
9404,parent,parent,3
9405,j. t. witkowski,j. t. witkowski,3
9406,similar spectrum,similar spectrum,3
9407,useful properties,useful properties,3
9408,erythrocytetrapping,erythrocytetrapping,3
9409,property,property,3
9426,rimantadine isknowntoreducethebody suptakeofrimantadineby approximately 12%,chemical compound medication,3
9412,rbcs,rbcs,3
9414,increased concentration,increased concentration,3
9415,enzymes,enzymes,3
9416,amidine,amidine,3
9418,rimantadine rimantadine,chemical compound medicationchemical compound medication,3
9420,derivates,derivates,3
9423,acetylsalicylic acid,acetylsalicylic acid,3
9413,second property,second property,3
9575,chemical disruption,chemical disruption,3
9446,rimantadinum,rimantadinum,3
9448,rimantadina,rimantadina,3
9467,oprea1602732,oprea1602732,3
9468,schembl2619249,schembl2619249,3
9469,chembl1201272,chembl1201272,3
9471,ctk6a4437,ctk6a4437,3
9472,bcp12269,bcp12269,3
9473,hyb0338,hyb0338,3
9466,schembl2981,schembl2981,3
9474,zxan012619,zxan012619,3
9476,bbl013215,bbl013215,3
9477,mfcd00869344,mfcd00869344,3
9478,s1964,s1964,3
9479,stk177253,stk177253,3
9480,methylamine,methylamine,3
9481,akos000264537,akos000264537,3
9475,anw72018,anw72018,3
9447,remantadine,scholarly article,3
9465,maybridge1002066,maybridge1002066,3
9463,rimantidine,rimantidine,3
9449,1adamantan1ylethylamine,1adamantan1ylethylamine,3
9450,rimantadin,rimantadin,3
9451,chembl959,chembl959,3
9452,brn,brn,3
9453,riamantadine,riamantadine,3
9454,tricyclodecane1methanamine,tricyclodecane1methanamine,3
9464,rimantidin,rimantidin,3
9455,alphamethyl,alphamethyl,3
9457,tricyclo)decane1methanamine,tricyclo)decane1methanamine,3
9458,methyl rimant,methyl rimant,3
9459,enamine005755,enamine005755,3
9460,ncgc0015949102,ncgc0015949102,3
9461,rimant,rimant,3
9462,.alpha,.alpha,3
9456,ethyl]amine hydrochloride,ethyl]amine hydrochloride,3
9576,dosage storage,dosage storage,3
9577,intradermal injection,intradermal injection,3
9578,0.25 ml syringe,0.25 ml syringe,3
9707,trillions,trillions,3
9708,dollars worth,dollars worth,3
9709,stocks,stocks,3
9710,investors,investors,3
9711,assets,assets,3
9712,accordance,accordance,3
9706,valuations,valuations,3
9713,fears,fears,3
9715,political,political,3
9716,hhs secretary michael o. leavitt,hhs secretary michael o. leavitt,3
9717,alarmist,film,3
9718,social,social,3
9719,personal,personal,3
9720,web sites,web sites,3
9714,hopes,hopes,3
9721,cures,cures,3
9704,h5n1.according,h5n1.according,3
9701,donor nations,donor nations,3
9685,abortions,abortions,3
9686,negative pregnancy test,physiological condition,3
9687,effective birth control methods,effective birth control methods,3
9688,monthly pregnancy tests,physiological condition,3
9689,medication regimen,medication regimen,3
9690,ribavirin pregnancy registry,chemical compound medication essential medicine 1 april 1990physiological condition,3
9703,twoday international pledging conference,twoday international pledging conference,3
9691,gilead sciences emailed warnings,gilead sciences emailed warnings,3
9693,government preparation,government preparation,3
9695,billion dollars,billion dollars,3
9697,financial,financial,3
9698,2005 president george w. bush,2005 president george w. bush,3
9699,national strategy,national strategy,3
9700,danger,danger,3
9692,combinations aren trecommendedand product labels,combinations aren trecommendedand product labels,3
9683,patient populations,patient populations,3
9722,advertising space,advertising space,3
9724,intheknow,intheknow,3
9747,interferonfree ones,interferonfree ones,3
9749,3–6%,3–6%,3
9750,16–18%,16–18%,3
9751,neutropenia,abnormally low value absolute neutrophil count,3
9753,abnormally slow heartbeats,abnormally slow heartbeats,3
9754,substrate,substrate,3
9746,irritability,irritability,3
9755,pglycoprotein,pglycoprotein,3
9758,intestinal epithelium cells,intestinal epithelium cells,3
9759,gut,gut,3
9760,intestinal pglycoprotein,intestinal pglycoprotein,3
9761,absorption,absorption,3
9762,anticonvulsants,anticonvulsants,3
9763,antimycobacterials,antimycobacterials,3
9757,substances,substances,3
9723,personal fear,personal fear,3
9745,good safety profile,good safety profile,3
9743,30 weeks,30 weeks,3
9726,unanswered questions,unanswered questions,3
9727,evaluations,evaluations,3
9728,pop culture,pop culture,3
9729,barenaked ladies,barenaked ladies,3
9730,lines,lines,3
9731,drumstick,drumstick,3
9744,specific contraindications,specific contraindications,3
9732,tickin,tickin,3
9736,brand sovaldi,brand sovaldi,3
9737,ledipasvir,chemical compound carbocyclic compound heterocyclic compound essential medicine medication,3
9738,30 97%,30 97%,3
9739,abnormally slow heartbeat,abnormally slow heartbeat,3
9740,nucleotide analog family,nucleotide analog family,3
9741,works,works,3
9735,costs,costs,3
9765,sofosbuvir concentration,chemical compound medication active ingredient essential medicine,3
9680,moderate severe liver impairment,organ type,3
9677,appropriate dosing,appropriate dosing,3
9608,significant liver problems,organ type,3
9610,hcv protease inhibitor,hcv protease inhibitor,3
9611,medivir ab,medivir ab,3
9612,janssen pharmaceutica,janssen pharmaceutica,3
9613,simeprevir component,chemical compound medication essential medicine,3
9616,1 infected subjects,1 infected subjects,3
9605,sunlight,sunlight,3
9618,single therapy,single therapy,3
9620,rbv,rbv,3
9621,chc,chc,3
9623,rbv therapy,rbv therapy,3
9624,simeprevir pegifn combination therapy,chemical compound medication essential medicine,3
9625,men,men,3
9626,female partners,female partners,3
9619,pegifn,pegifn,3
9627,sensitivity,sensitivity,3
9604,typically 12 weeks,typically 12 weeks,3
9602,80s,80s,3
9580,0.5 ml syringe,0.5 ml syringe,3
9581,0.5 ml vial,0.5 ml vial,3
9582,5 ml vial,5 ml vial,3
9583,temperatures,temperatures,3
9584,8 °c,8 °c,3
9585,times strength,times strength,3
9603,90s,90s,3
9587,normal aging,normal aging,3
9593,vaxigriptetra,vaxigriptetra,3
9595,flublok/flublok quadrivalent,flublok/flublok quadrivalent,3
9597,recombinant virus technology,academic discipline,3
9599,setrobuvir,chemical compound,3
9600,anadys pharmaceuticals,anadys pharmaceuticals,3
9601,peginterferonalfa,peginterferonalfa,3
9592,vaxigrip,vaxigrip,3
9679,kidney function,kidney function,3
9628,rash,rash,3
9630,increased bilirubin,increased bilirubin,3
9661,presentation,presentation,3
9662,johnson,johnson,3
9664,racial ethnic minorities,racial ethnic minorities,3
9665,underrepresented populations,underrepresented populations,3
9666,simeprevir therapy,chemical compound medication essential medicine,3
9667,ifnl3 genotype,ifnl3 genotype,3
9660,fda fda,fda fda,3
9668,pratt vm,pratt vm,3
9670,rubinstein ws,rubinstein ws,3
9671,national center,national center,3
9672,biotechnology information,biotechnology information,3
9673,bookshelf id,bookshelf id,3
9675,dosing,dosing,3
9676,triple therapy,triple therapy,3
9669,mcleod hl,mcleod hl,3
9629,difficulty breathing,difficulty breathing,3
9659,chronic hcv gt1,chronic hcv gt1,3
9654,strong cyp3a4 inhibitors,strong cyp3a4 inhibitors,3
9632,ns3/4a protease inhibitor,ns3/4a protease inhibitor,3
9634,capsule,capsule,3
9637,hiv1 coinfection,hiv1 coinfection,3
9641,cyp2c19 enzymes,cyp2c19 enzymes,3
9642,cyp2c8 halflife,gene,3
9643,41 hours,41 hours,3
9655,strong cyp3a4 inducers,strong cyp3a4 inducers,3
9644,cyp2c8 peak effect,gene,3
9648,peginterferon alfa,peginterferon alfa,3
9649,ns3 q80k polymorphism,ns3 q80k polymorphism,3
9650,baseline,baseline,3
9651,q80k polymorphism,q80k polymorphism,3
9652,cyp3a4 substrate,cyp3a4 substrate,3
9653,simeprevir plasma concentration,chemical compound medication essential medicine,3
9645,pharmacogenomics,pharmacogenomics,3
10138,philadelphia,philadelphia,3
10139,28 september,28 september,3
10142,southwest–northeast diagonal,southwest–northeast diagonal,3
10608,social variability,social variability,3
10607,socioeconomic status,socioeconomic status,3
10606,nutritional deficiency,nutritional deficiency,3
10605,different results,different results,3
10604,social variation,social variation,3
10603,social behavior,social behavior,3
10602,major cause,major cause,3
10601,island newfoundland,island newfoundland,3
10597,lower percentage,lower percentage,3
10596,comparison pandemics,comparison pandemics,3
10595,fiction,fiction,3
10594,numerous works,numerous works,3
10593,fiction literature,fiction literature,3
10592,physiological condition,physiological condition,3
10591,elevated mortality risk,elevated mortality risk,3
10590,encephalitis lethargica,encephalitis lethargica,3
10589,birth cohorts,birth cohorts,3
10572,nursing,nursing,3
10574,nursing staff,nursing staff,3
10575,women patient care,women patient care,3
10576,2020 study,2020 study,3
10577,early extensive nonmedical measures,early extensive nonmedical measures,3
10580,2006 study,2006 study,3
10610,severe underlying condition,severe underlying condition,3
10581,political economy,political economy,3
10583,utero,utero,3
10584,reduced educational attainment increased rates,reduced educational attainment increased rates,3
10585,physical disability,physical disability,3
10586,lower income,lower income,3
10587,lower socioeconomic status,lower socioeconomic status,3
10588,higher transfer payments,higher transfer payments,3
10582,cohorts,cohorts,3
10612,diverse labor,diverse labor,3
10613,occupations,occupations,3
10614,day interaction,day interaction,3
10635,2 million men,2 million men,3
10636,wars,wars,3
10637,record,record,3
10638,transportation,transportation,3
10640,earlier,earlier,3
10641,different microbial agent,different microbial agent,3
10634,commonwealth war graves commission,commonwealth war graves commission,3
10642,exogenous endogenous origin,exogenous endogenous origin,3
10644,bacteriology,bacteriology,3
10645,overgrowth,overgrowth,3
10646,endogenous clostridium difficile,endogenous clostridium difficile,3
10647,broadspectrum antibiotic,broadspectrum antibiotic,3
10648,sepsis,sepsis,3
10649,pseudomonas aeruginosa,pseudomonas aeruginosa,3
10643,examples,examples,3
10571,increasing number,increasing number,3
10633,war scientists,war scientists,3
10630,soldier,soldier,3
10615,fishing,fishing,3
10616,major role,major role,3
10617,second waves,second waves,3
10618,wave men,wave men,3
10619,female population,female population,3
10620,certain regions,certain regions,3
10631,halifax,halifax,3
10621,bigger impact,bigger impact,3
10624,young men 20s,young men 20s,3
10625,enlistment,enlistment,3
10626,mobility,mobility,3
10627,biggest wave,biggest wave,3
10628,male troops,male troops,3
10629,halifax port,halifax port,3
10623,young men,young men,3
10570,historian nancy bristow,historian nancy bristow,3
10569,profit gains,profit gains,3
10568,healthcare industry,healthcare industry,3
10510,social classes,social classes,3
10511,oslo,capital big city city administrative centre,3
10512,apartment size,apartment size,3
10514,smaller apartments,smaller apartments,3
10515,social status,social status,3
10516,higher mortality,higher mortality,3
10509,major pattern,major pattern,3
10517,immigrant communities,immigrant communities,3
10519,recently arrived group,recently arrived group,3
10520,average americans,average americans,3
10521,disparities,disparities,3
10522,worse diets,worse diets,3
10523,crowded living conditions,crowded living conditions,3
10524,african americans,african americans,3
10518,italian americans,italian americans,3
10526,preexisting tuberculosis,notifiable disease valid place switzerland endemic disease,3
10507,extremes,extremes,3
10505,times higher mortality,times higher mortality,3
10485,main road,main road,3
10486,isolated island,isolated island,3
10487,marajó,marajó,3
10489,saint helena,saint helena,3
10490,patterns fatality,patterns fatality,3
10493,92%,92%,3
10506,times higher chance,times higher chance,3
10494,weak individuals,weak individuals,3
10499,71%,71%,3
10500,oddity,oddity,3
10501,geographic patterns,geographic patterns,3
10502,30 times higher death rates,stock character psychopomp literary character,3
10503,lower ones,lower ones,3
10504,great variation,great variation,3
10496,historian john m. barry,historian john m. barry,3
10650,immunocompromised patients,immunocompromised patients,3
10527,chances,chances,3
10529,poorer nutrition,poorer nutrition,3
10553,allied cause,allied cause,3
10555,central powers,central powers,3
10556,allied powers,allied powers,3
10557,2006 lancet study,2006 lancet study,3
10558,higher excess mortality rates,higher excess mortality rates,3
10559,kahn,kahn,3
10552,power,power,3
10560,oxford university computing services,oxford university computing services,3
10562,home computers,home computers,3
10563,theories,theories,3
10564,economic,economic,3
10565,entertainment service industries,entertainment service industries,3
10566,losses,losses,3
10567,revenue,revenue,3
10561,model,model,3
10528,indian women,indian women,3
10551,argument,argument,3
10547,factors modeling results,factors modeling results,3
10530,sick,sick,3
10531,et al,et al,3
10532,mechanistic modeling approach,mechanistic modeling approach,3
10533,underlie variability,underlie variability,3
10534,temporal patterns,temporal patterns,3
10535,sick correlation,sick correlation,3
10550,academic andrew pricesmith,academic andrew pricesmith,3
10536,morbidity,morbidity,3
10538,temporal variations,temporal variations,3
10540,best explanation,best explanation,3
10541,variation,variation,3
10543,simple epidemic model,simple epidemic model,3
10544,school opening,school opening,3
10545,temperature changes,temperature changes,3
10537,sick analysis,sick analysis,3
10651,definition,definition,3
10653,later point,later point,3
10656,recent metagenomic analyses,recent metagenomic analyses,3
10797,b.,b.,3
10798,otherwisehealthy individuals,otherwisehealthy individuals,3
10799,diagnostic uncertainty,diagnostic uncertainty,3
10800,financial cost,financial cost,3
10802,bronchospasms,bronchospasms,3
10803,breathing problems,breathing problems,3
10796,glaxo,glaxo,3
10804,initial approval,initial approval,3
10806,zanamivir package insert,chemical compound neuraminidase inhibitor medication,3
10807,precautionary information,precautionary information,3
10808,bronchospasm,bronchospasm,3
10809,neuraminidase protein,group class enzymes,3
10812,vivo,vivo,3
10813,symptom,symptom,3
10805,asthma chronic obstructive pulmonary disease,asthma chronic obstructive pulmonary disease,3
10814,1.5 days,1.5 days,3
10795,australian biotech firm biota holdings,australian biotech firm biota holdings,3
10793,vosevi,vosevi,3
10762,claims,claims,3
10764,арбидол,арбидол,3
10765,阿比朵尔.,阿比朵尔.,3
10766,biochemistry,biochemistry,3
10767,membrane fusion,membrane fusion,3
10768,virus target host cells,virus target host cells,3
10794,european committee,european committee,3
10774,interferonproduction,interferonproduction,3
10780,zaire ebolavirus,taxon,3
10785,mammalian cells,mammalian cells,3
10786,uprifosbuvir,uprifosbuvir,3
10787,valopicitabine,chemical compound,3
10789,vaniprevir,chemical compound,3
10792,brand vanihep,brand vanihep,3
10775,phagocytic function,phagocytic function,3
10761,tatyana golikova,tatyana golikova,3
10815,peter colman,peter colman,3
10817,australian csiro,australian csiro,3
10839,positively charged amino group,positively charged amino group,3
10840,salt bridge,salt bridge,3
10841,conserved glutamic acid,conserved glutamic acid,3
10842,glu,glu,3
10843,conserved pocket,conserved pocket,3
10844,basic guanidine functional group,basic guanidine functional group,3
10837,neuraminidase active site,group class enzymes,3
10845,small company,small company,3
10848,license agreement,license agreement,3
10849,7% royalty,7% royalty,3
10851,clear effect,clear effect,3
10852,affectstheriskofone sneedtobehospitalizedor risk,affectstheriskofone sneedtobehospitalizedor risk,3
10854,risk ofone sneedtobehospitalizedortheriskof death,stock character psychopomp literary character,3
10859,zanamivir resistance,chemical compound neuraminidase inhibitor medication,3
10847,zanamivir patent rights,chemical compound neuraminidase inhibitor medication,3
10816,joseph varghese,joseph varghese,3
10836,negatively charged zone,negatively charged zone,3
10834,residues,residues,3
10818,victorian college,victorian college,3
10819,pharmacy,pharmacy,3
10820,monash university,monash university,3
10821,australian biotechnology company,australian biotechnology company,3
10822,biota,biota,3
10825,zanamivir strategy,chemical compound neuraminidase inhibitor medication,3
10835,catalytic site canyon,catalytic site canyon,3
10826,computational chemistry techniques,computational chemistry techniques,3
10828,amino acid residues,amino acid residues,3
10829,catalytic site,catalytic site,3
10830,potent specific inhibitors,potent specific inhibitors,3
10831,grid software,grid software,3
10832,energetically favourable interactions,energetically favourable interactions,3
10833,functional groups,functional groups,3
10827,dana,dana,3
10484,iceland population,iceland population,3
10760,lobbying attempts,lobbying attempts,3
10758,arbidol,arbidol,3
10679,dealing outbreaks,dealing outbreaks,3
10680,local authorities,local authorities,3
10681,mass slaughter,mass slaughter,3
10682,united nations fao,united nations fao,3
10685,initial source,initial source,3
10688,particularly domestic ducks,particularly domestic ducks,3
10678,farming practices,farming practices,3
10690,domestic possibly resident bird populations,taxon,3
10694,interpandemic period,interpandemic period,3
10697,possible mutation,possible mutation,3
10698,humanized form,humanized form,3
10701,human incubation period,organisms known particular common homo sapiens homo sapiens sapiens homo,3
10704,international law,international law,3
10706,452 fatalities,452 fatalities,3
10693,phases,phases,3
10709,joint effort,joint effort,3
10677,poultry farming practices,organisms known particular common,3
10674,timm c. harder,timm c. harder,3
10657,colonization,colonization,3
10658,pathogens,pathogens,3
10659,rhinovirus species,taxon,3
10660,moraxella,moraxella,3
10661,parasitology,parasitology,3
10662,parasite,parasite,3
10675,ortrud werner,ortrud werner,3
10663,fasciola hepatica,fasciola hepatica,3
10665,tmc647055,tmc647055,3
10666,ns5b polymerase inhibitor,group class enzymes,3
10669,environmental survival,environmental survival,3
10670,temperature,temperature,3
10671,freezing,freezing,3
10672,northernmost areas,northernmost areas,3
10664,fasciola gigantica,fasciola gigantica,3
10759,russian media,russian media,3
10710,ural federal university,ural federal university,3
10712,ural center,ural center,3
10735,registration procedure,registration procedure,3
10736,republic,republic,3
10737,umifenovir,chemical compound,3
10738,pharmstandard,pharmstandard,3
10740,target cells,target cells,3
10741,status,status,3
10734,modern pharmaceutical enterprise llc plant medsintez,modern pharmaceutical enterprise llc plant medsintez,3
10743,russian tests,russian tests,3
10745,similar efficiency,similar efficiency,3
10748,highest sales volume,highest sales volume,3
10749,16 percent share,16 percent share,3
10753,sensitization,sensitization,3
10756,ld50,ld50,3
10757,4 g/kg,4 g/kg,3
10744,direct comparison,direct comparison,3
10711,russian academy,russian academy,3
10733,new active molecule,new active molecule,3
10731,registration certificate,registration certificate,3
10713,biopharma technologies,biopharma technologies,3
10714,medsintez pharmaceutical,medsintez pharmaceutical,3
10715,novel triazolotriazine core,novel triazolotriazine core,3
10718,main principle action,main principle action,3
10719,triazavirin,medication chemical compound,3
10720,viral ribonucleic acid,viral ribonucleic acid,3
10732,active substance,active substance,3
10722,synthetic analogue,synthetic analogue,3
10724,purine nucleosides,purine nucleosides,3
10725,antiinfluenza activity,antiinfluenza activity,3
10726,forestspring encephalitis virus,forestspring encephalitis virus,3
10727,potential application,potential application,3
10729,arvi,arvi,3
10730,sarscov2.in august,sarscov2.in august,3
10723,bases,bases,3
10483,effective quarantines,effective quarantines,3
10482,single death,stock character psychopomp literary character,3
10480,french colony,french colony,3
10255,close quarters,close quarters,3
10256,massive troop movements,massive troop movements,3
10257,probably increased transmission augmented mutation,probably increased transmission augmented mutation,3
10260,malnourishment,malnourishment,3
10261,combat chemical attacks,combat chemical attacks,3
10262,combat chemical attacks susceptibility,combat chemical attacks susceptibility,3
10253,original hosts,original hosts,3
10264,worldwide occurrence,worldwide occurrence,3
10266,civilian travelers,civilian travelers,3
10267,lies,lies,3
10269,circumstances,circumstances,3
10270,civilian life,civilian life,3
10271,natural selection,natural selection,3
10273,ill lives,ill lives,3
10265,modern transportation systems,modern transportation systems,3
10274,trenches,trenches,3
10252,detectable spread,detectable spread,3
10249,chinese southeast asian workers,chinese southeast asian workers,3
10229,british french lines,british french lines,3
10230,humphries,humphries,3
10231,memorial university ofnewfoundlandinst.john sbasedhumphriesofthememorialuniversityof newfoundland,memorial university ofnewfoundlandinst.john sbasedhumphriesofthememorialuniversityof newfoundland,3
10232,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandin st. john,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandin st. john,3
10233,st. john,st. john,3
10234,based humphries,based humphries,3
10251,chinese workers,chinese workers,3
10235,memorial university,memorial university,3
10237,newfoundland,newfoundland,3
10238,archival evidence,archival evidence,3
10240,tissue samples,tissue samples,3
10241,modern comparison,modern comparison,3
10243,lower rates,lower rates,3
10246,chinese southeast asian soldiers,chinese southeast asian soldiers,3
10236,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandinst.johnconclusionson newly unearthed records,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandinst.johnconclusionson newly unearthed records,3
10227,mobilization,mobilization,3
10275,crowded trains,crowded trains,3
10277,modern pandemics,modern pandemics,3
10303,mahogany spots,mahogany spots,3
10304,cheekbones,cheekbones,3
10305,black coloration,black coloration,3
10306,extremities,extremities,3
10307,limbs,limbs,3
10308,torso,torso,3
10301,1919 stanley cup finals,1919 stanley cup finals,3
10309,fluids,fluids,3
10311,nosebleeds,nosebleeds,3
10312,peculiar smell,peculiar smell,3
10313,teeth,teeth,3
10315,hearing,hearing,3
10316,smell,smell,3
10317,blurred vision,blurred vision,3
10310,spontaneous mouth,spontaneous mouth,3
10276,crowded field hospitals,crowded field hospitals,3
10300,player,player,3
10295,common occurrence,common occurrence,3
10279,social upheaval,social upheaval,3
10280,firstwave infections,firstwave infections,3
10281,copenhagen,copenhagen,3
10283,0.29%,0.29%,3
10284,lesslethal wave,lesslethal wave,3
10285,trenches – adults,trenches – adults,3
10296,tendency,tendency,3
10286,lethal second wave,lethal second wave,3
10288,explanation,explanation,3
10289,rapid decline,rapid decline,3
10290,john barry,john barry,3
10291,2004 book,2004 book,3
10292,epic story,epic story,3
10293,deadliest plague,deadliest plague,3
10287,4 597 people,4 597 people,3
10318,impaired color vision,impaired color vision,3
10226,historian mark humphries,historian mark humphries,3
10224,hannoun,hannoun,3
10162,fourth wave 1920,fourth wave 1920,3
10163,fourth wave,fourth wave,3
10164,isolated areas,isolated areas,3
10165,scandinavia,scandinavia,3
10166,south american islands,south american islands,3
10167,6 374 deaths,6 374 deaths,3
10161,tens thousands,tens thousands,3
10168,twice number,twice number,3
10170,milwaukee,milwaukee,3
10171,kansas city,state united states,3
10172,minneapolis,minneapolis,3
10173,late wave,late wave,3
10174,late peak,late peak,3
10175,january–april,january–april,3
10169,detroit,detroit,3
10176,potential origins,potential origins,3
10160,overall american mortality rates,overall american mortality rates,3
10158,nashville,nashville,3
10143,arkhangelsk,city/town big city,3
10144,russia intervention,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,3
10145,russian civil war,russian civil war,3
10146,celebrations,celebrations,3
10147,armistice,armistice,3
10148,11 november,11 november,3
10159,st. louis,st. louis,3
10150,nairobi,capital administrative territorial entity kenya big city city millions inhabitants,3
10152,lifting,lifting,3
10153,maritime quarantine,maritime quarantine,3
10154,initial wave,initial wave,3
10155,isolated outbreaks,isolated outbreaks,3
10156,los angeles,los angeles,3
10157,memphis,memphis,3
10151,wave 1919,wave 1919,3
10225,alternative hypotheses,alternative hypotheses,3
10177,geographic origin,geographic origin,3
10179,popular author john m. barry,popular author john m. barry,3
10202,ideal environment,ideal environment,3
10204,poison gas attacks,poison gas attacks,3
10205,casualties,casualties,3
10207,home,home,3
10208,piggery,piggery,3
10209,surrounding villages,surrounding villages,3
10201,etaples,etaples,3
10210,virologist john oxford team,virologist john oxford team,3
10213,possibly years,possibly years,3
10214,political scientist andrew pricesmith,political scientist andrew pricesmith,3
10216,claude hannoun,claude hannoun,3
10218,pasteur institute,pasteur institute,3
10222,allied soldiers,allied soldiers,3
10223,main disseminators,main disseminators,3
10212,european armies,european armies,3
10178,historian alfred w. crosby,historian alfred w. crosby,3
10200,overcrowded camp,overcrowded camp,3
10198,military pathologists,military pathologists,3
10181,2018 study,2018 study,3
10182,tissue slides,tissue slides,3
10183,medical reports,medical reports,3
10184,evolutionary biology professor michael worobey,evolutionary biology professor michael worobey,3
10185,phylogenetic analyses,phylogenetic analyses,3
10186,north american origin,north american origin,3
10199,early outbreaks,early outbreaks,3
10187,haemagglutinin glycoproteins,structural class chemical compounds,3
10189,étaples,commune france,3
10190,virologist john oxford,virologist john oxford,3
10191,virologist john oxford study,virologist john oxford study,3
10192,étaples camp,commune france,3
10196,army barracks,army barracks,3
10197,aldershot,aldershot,3
10188,major uk troop staging hospital camp,major uk troop staging hospital camp,3
9403,3carboxamidine derivative,3carboxamidine derivative,3
10319,observer,observer,3
10321,mucous membranes,mucous membranes,3
10423,information dissemination,information dissemination,3
10424,mass panic,mass panic,3
10425,misinformation,misinformation,3
10426,noxious gases,noxious gases,3
10427,mass graves,mass graves,3
10428,flanders fields,flanders fields,3
10422,kampo,traditional medicine,3
10429,winds,winds,3
10431,germans,germans,3
10432,aspirin,aspirin,3
10433,bayer,bayer,3
10434,poison gas,poison gas,3
10435,uboats,uboats,3
10436,onethird,onethird,3
10430,rumors,rumors,3
10437,early estimate,early estimate,3
10421,ayurveda,healing knowledge cure alternative medical treatment,3
10419,iodine,chemical element follows tellurium followed xenon,3
10405,new york city health commissioner,new york city health commissioner,3
10406,staggered shifts,staggered shifts,3
10407,subways,subways,3
10408,later study,later study,3
10409,wearing,wearing,3
10410,50 percent,50 percent,3
10420,traditional medicine,traditional medicine,3
10411,secondary bacterial infections,secondary bacterial infections,3
10413,varying degrees,varying degrees,3
10414,arsenics,arsenics,3
10415,digitalis,taxon,3
10416,strychnine,chemical compound flammable solid alkaloid heterocyclic compound neurotoxin,3
10417,epsom salts,epsom salts,3
10418,castor oil,castor oil,3
10412,random assortment,random assortment,3
10403,actual enforcement,actual enforcement,3
10439,1991 states,1991 states,3
10442,2018 reassessment,2018 reassessment,3
10463,western samoa,western samoa,3
10465,adult men,adult men,3
10468,governor john martin poyer,governor john martin poyer,3
10469,neighboring american samoa,neighboring american samoa,3
10470,blockade,blockade,3
10471,higher social classes,higher social classes,3
10462,fiji,fiji,3
10472,custom,custom,3
10474,chiefs,chiefs,3
10475,deathbeds,deathbeds,3
10476,community elders,community elders,3
10477,persian famine,persian famine,3
10478,lessaffected areas,lessaffected areas,3
10479,pacific,pacific,3
10473,oral tradition,oral tradition,3
10441,2005 estimate,2005 estimate,3
10461,nauru,nauru,3
10458,talune,talune,3
10443,american journal,american journal,3
10444,1 6 percent,1 6 percent,3
10445,devastated communities,devastated communities,3
10446,everyday life,everyday life,3
10447,stores,stores,3
10448,required customers,required customers,3
10460,tonga,tonga,3
10449,gravediggers,gravediggers,3
10451,bristol bay,bristol bay,3
10452,alaska,alaska,3
10454,40 percent,40 percent,3
10455,total population,total population,3
10456,villages,villages,3
10457,pacific island territories,pacific island territories,3
10450,coffins,coffins,3
10320,hemorrhage,hemorrhage,3
10401,antimask league,antimask league,3
10399,debates,debates,3
10342,common misdiagnosis,common misdiagnosis,3
10343,aftermath,aftermath,3
10344,october revolution,october revolution,3
10345,view,view,3
10348,assumption,assumption,3
10349,poor hygiene,poor hygiene,3
10341,deadly second wave,deadly second wave,3
10351,mass gatherings,mass gatherings,3
10353,spanish flu victims,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
10354,adverse climate conditions,adverse climate conditions,3
10355,extended periods,extended periods,3
10356,especially wwi troops,especially wwi troops,3
10357,incessant rains,incessant rains,3
10358,lowerthanaverage temperatures,lowerthanaverage temperatures,3
10352,role climate conditions,role climate conditions,3
10359,conflict,conflict,3
10340,bacillus,bacillus,3
10338,microscope,microscope,3
10322,intestine,intestine,3
10323,ears,ears,3
10324,petechial hemorrhages,petechial hemorrhages,3
10325,cytokine storms,cytokine storms,3
10326,common secondary infection,common secondary infection,3
10327,common upper respiratorytract bacteria,taxon,3
10339,haemophilus influenzae,haemophilus influenzae,3
10328,damaged bronchial tubes,damaged bronchial tubes,3
10330,modern analysis,modern analysis,3
10331,frozen victims,frozen victims,3
10334,strong immune reactions,strong immune reactions,3
10335,weaker immune reactions,weaker immune reactions,3
10336,middleaged adults,middleaged adults,3
10337,misdiagnosis,misdiagnosis,3
10329,massive hemorrhages,massive hemorrhages,3
10400,japan efficacy,sovereign state island nation country,3
10360,ultrahighresolution climate data,ultrahighresolution climate data,3
10362,harvard university,harvard university,3
10384,anzac troops,anzac troops,3
10385,extremely cold temperatures,extremely cold temperatures,3
10386,normally mediterranean climate,normally mediterranean climate,3
10387,anthropogenic increase,anthropogenic increase,3
10388,atmospheric dust,atmospheric dust,3
10389,incessant bombardment,incessant bombardment,3
10383,gallipoli campaign,gallipoli campaign,3
10390,nucleation,nucleation,3
10392,public health management,public health management,3
10393,systems,systems,3
10394,public health authorities,public health authorities,3
10396,maritime quarantines,maritime quarantines,3
10397,islands,islands,3
10398,american samoa,american samoa,3
10391,dust particles,dust particles,3
10361,highly detailed mortality records,highly detailed mortality records,3
10382,instrumental records,instrumental records,3
10380,cold marine air,cold marine air,3
10363,climate change institute,climate change institute,3
10364,maine,maine,3
10365,severe climate anomaly,severe climate anomaly,3
10366,environmental indicators,environmental indicators,3
10368,precipitation,precipitation,3
10370,concurrent increase,concurrent increase,3
10381,eyewitness accounts,eyewitness accounts,3
10371,explanations,explanations,3
10373,increased precipitation,increased precipitation,3
10374,ideal conditions,ideal conditions,3
10375,inclement weather,inclement weather,3
10376,pneumococcal comorbid infections,pneumococcal comorbid infections,3
10378,pandemic victims,pandemic victims,3
10379,sixyear climate anomaly,sixyear climate anomaly,3
10372,lower temperatures,lower temperatures,3
7832,single amino acid change,single amino acid change,3
9402,successful ribavirin derivative,chemical compound medication essential medicine 1 april 1990,3
9400,copegus ribasphere rebetol,copegus ribasphere rebetol,3
8396,aggravation,aggravation,3
8395,seizure,seizure,3
8394,abnormal heart rhythms,abnormal heart rhythms,3
8393,toxic epidermal necrolysis,toxic epidermal necrolysis,3
8392,rash allergic reactions,rash allergic reactions,3
8391,liver inflammation,organ type,3
8390,postmarketing reports,postmarketing reports,3
8389,arrhythmias,arrhythmias,3
8386,psychiatric events,psychiatric events,3
8385,kidney,kidney,3
8384,19 children,19 children,3
8383,oseltamivir experienced vomiting,chemical compound neuraminidase inhibitor medication essential medicine,3
8381,oseltamivir therapy,chemical compound neuraminidase inhibitor medication essential medicine,3
8380,common adverse drug reactions,common adverse drug reactions,3
8378,new information,new information,3
8376,pharmacological management,pharmacological management,3
8375,critically ill hospitalized patients,critically ill hospitalized patients,3
8351,essential medicines,essential medicines,3
8352,complementary status,complementary status,3
8353,generic version,generic version,3
8354,commonly prescribed medication,commonly prescribed medication,3
8360,core,core,3
8361,complementary list,complementary list,3
8397,haemorrhagic colitis,haemorrhagic colitis,3
8363,expert committee,expert committee,3
8366,inclusion,inclusion,3
8367,model list,model list,3
8370,earlier estimates,earlier estimates,3
8371,magnitude,magnitude,3
8373,listing,listing,3
8374,medicine use,medicine use,3
8364,deletion,deletion,3
8398,eu package inserts,eu package inserts,3
8399,warning,warning,3
8401,postmarketing surveillance,postmarketing surveillance,3
8429,6–10 hours,6–10 hours,3
8430,shikimic acid,shikimic acid,3
8431,starting point,starting point,3
8432,chinese star anise,chinese star anise,3
8433,30%,30%,3
8434,gilead sciences relevant patents,gilead sciences relevant patents,3
8428,active carboxylate metabolite,active carboxylate metabolite,3
8436,pooled analysis,pooled analysis,3
8440,hospital admissions,hospital admissions,3
8442,worldwide shortages,worldwide shortages,3
8443,high demand,high demand,3
8444,stockpiling,stockpiling,3
8445,president george w. bush,president george w. bush,3
8446,congress,congress,3
8439,antibiotic use,antibiotic use,3
8350,kidney problems,kidney problems,3
8427,1–3 hours,1–3 hours,3
8424,active form,active form,3
8402,frequency,frequency,3
8403,causative role,causative role,3
8404,doseresponse effect,doseresponse effect,3
8406,drugattributable adverse events,drugattributable adverse events,3
8407,pregnancy category c,physiological condition,3
8409,competitive inhibitor,competitive inhibitor,3
8425,firstpass,firstpass,3
8412,single amino acid residue substitutions,single amino acid residue substitutions,3
8415,pooled incidence rate,pooled incidence rate,3
8416,2.6%,2.6%,3
8419,substantial number,substantial number,3
8420,oseltamivir use,chemical compound neuraminidase inhibitor medication essential medicine,3
8421,severely immunocompromised patients,severely immunocompromised patients,3
8422,prolonged shedding,prolonged shedding,3
8413,2011 metaanalysis,2011 metaanalysis,3
8348,small number,small number,3
8347,seizures,seizures,3
8345,individual household levels,individual household levels,3
8273,vrna synthesis,vrna synthesis,3
8274,hostcell mrnas,hostcell mrnas,3
8275,negativesense vrnas,negativesense vrnas,3
8278,neuraminidase molecules,group class enzymes,3
8279,bulge,bulge,3
8281,membrane protrusion,membrane protrusion,3
8272,released nucleotides,released nucleotides,3
8282,sphere,sphere,3
8284,membrane coat,membrane coat,3
8286,sialic acid residues,sialic acid residues,3
8288,phylogeneticbased taxonomy,phylogeneticbased taxonomy,3
8291,generaassociated species,generaassociated species,3
8292,serotypes,serotypes,3
8293,orthomyxoviridae,taxon,3
8283,host phospholipid membrane,host phospholipid membrane,3
8294,following table,following table,3
8270,multiple actions,multiple actions,3
8267,cell surface,cell surface,3
8244,influenzavirus proteins,group class chemical substances second-order class,3
8246,lectin,lectin,3
8248,sugars,sugars,3
8251,key targets,key targets,3
8252,replication cycle,replication cycle,3
8253,contaminated surfaces,contaminated surfaces,3
8268,vrna,vrna,3
8256,sialic acid,sialic acid,3
8258,acidic endosome,acidic endosome,3
8261,complex,complex,3
8262,complementary positivesense crna,complementary positivesense crna,3
8263,crna,crna,3
8264,cytoplasm,cytoplasm,3
8266,golgi apparatus,golgi apparatus,3
8257,lung,lung,3
8448,defense secretary donald rumsfeld,defense secretary donald rumsfeld,3
8295,single species,single species,3
8298,100 days,100 days,3
8324,early age,early age,3
8325,lasting immunity,lasting immunity,3
8327,antigenic change,antigenic change,3
8328,limited host range,limited host range,3
8330,local epidemics,local epidemics,3
8335,main hosts,main hosts,3
8323,antigenic diversity,antigenic diversity,3
8336,clinicians,clinicians,3
8339,liquid,liquid,3
8340,criticisms,criticisms,3
8341,2014 cochrane review,2014 cochrane review,3
8342,metaanalyses,metaanalyses,3
8343,little evidence,little evidence,3
8344,high risk populations,high risk populations,3
8338,pill,pill,3
8296,viability disinfection,viability disinfection,3
8321,seal,seal,3
8318,n subtypes,n subtypes,3
8299,distilled water,distilled water,3
8300,200 days,200 days,3
8301,17 °c,17 °c,3
8302,manure,manure,3
8303,2 weeks,2 weeks,3
8304,cages,cages,3
8319,human pathogen,organisms known particular common homo sapiens homo sapiens sapiens homo,3
8305,bleach,bleach,3
8307,aldehydes,aldehydes,3
8308,133 °f,133 °f,3
8309,minimum,minimum,3
8310,60 minutes,60 minutes,3
8312,vaccination prophylaxis,vaccination prophylaxis,3
8316,antigenicities,antigenicities,3
8306,70% ethanol,70% ethanol,3
8449,past chairman,past chairman,3
8450,recused defense secretary donald rumsfeld,recused defense secretary donald rumsfeld,3
8451,government decisions,government decisions,3
8583,irish parliament,irish parliament,3
8584,td clare daly,td clare daly,3
8587,clack,clack,3
8588,clack job,clack job,3
8589,nurse,nurse,3
8590,swedish medical products agency,swedish medical products agency,3
8581,gsk,gsk,3
8591,finnish national institute,finnish national institute,3
8594,mpa,mpa,3
8595,thl,thl,3
8596,swedish finnish healthcare professionals,swedish finnish healthcare professionals,3
8597,suspected adverse drug reaction,suspected adverse drug reaction,3
8598,pandemrix vaccination,influenza vaccine,3
8599,reports concern children,reports concern children,3
8592,possible effect,possible effect,3
8600,consultation,consultation,3
8580,adverse event report data,adverse event report data,3
8578,1 incident,1 incident,3
8559,subsequent testing,subsequent testing,3
8560,twodose schedule,twodose schedule,3
8561,10 years,10 years,3
8562,immunocompromised adults,immunocompromised adults,3
8565,marketing authorisation,marketing authorisation,3
8566,gsk biologicals,gsk biologicals,3
8579,18 400 doses,18 400 doses,3
8567,renewal,renewal,3
8569,emea,emea,3
8570,chmp assessment report,chmp assessment report,3
8573,adverse outcomes,adverse outcomes,3
8575,514 times,514 times,3
8576,27 times,27 times,3
8577,adolescents,adolescents,3
8568,demand,demand,3
8558,21 days,21 days,3
8601,external experts,external experts,3
8603,reported reactions,reported reactions,3
8627,4fold increased risk,4fold increased risk,3
8629,use adjuvant,use adjuvant,3
8630,proprietary immunologic adjuvant,proprietary immunologic adjuvant,3
8631,potency,potency,3
8634,ribavirin cure rates,chemical compound medication essential medicine 1 april 1990,3
8635,24 92%,24 92%,3
8626,swedish registry based cohort study,swedish registry based cohort study,3
8639,breakdown,breakdown,3
8641,neovascular agerelated macular degeneration,neovascular agerelated macular degeneration,3
8642,improved visual acuity,improved visual acuity,3
8643,potential harm,potential harm,3
8647,human il28b gene,organisms known particular common homo sapiens homo sapiens sapiens homo,3
8652,il28b gene,il28b gene,3
8654,genetic variants,genetic variants,3
8640,alfa2a,alfa2a,3
8602,possible relationship,possible relationship,3
8625,mpa press release,mpa press release,3
8623,ninety percent,ninety percent,3
8604,eu member states,eu member states,3
8605,similar reports,similar reports,3
8606,pandemrix vaccinations,influenza vaccine,3
8607,recently vaccinated children,recently vaccinated children,3
8608,figure,figure,3
8609,expected average annual occurrence,expected average annual occurrence,3
8624,thadreceived pandemrix vaccination,influenza vaccine,3
8613,27 august,27 august,3
8616,finland,finland,3
8617,clear connection,clear connection,3
8618,pandemrix vaccination campaign,influenza vaccine,3
8619,narcolepsy epidemic,narcolepsy epidemic,3
8620,probability,probability,3
8621,developing narcolepsy,developing narcolepsy,3
8615,limited number,limited number,3
8243,13.5 kilobases,13.5 kilobases,3
8556,separate vials,separate vials,3
8554,active antigen,group class chemical substances,3
8477,plos,plos,3
8478,healthcare policymakers,healthcare policymakers,3
8479,nis,nis,3
8480,policymakers,policymakers,3
8482,aap,aap,3
8483,ema,ema,3
8476,cdc.a systematic review,cdc.a systematic review,3
8484,ema labeling,ema labeling,3
8486,intensive care units,intensive care units,3
8488,pcr testing,pcr testing,3
8489,2015 systematic review,2015 systematic review,3
8490,otitis media,otitis media,3
8491,18 hours,18 hours,3
8492,healthy people,healthy people,3
8485,cochrane study,cochrane study,3
8493,cdc states,cdc states,3
8475,infectious disease society,infectious disease society,3
8473,significant health problems,significant health problems,3
8452,cochrane review,cochrane review,3
8455,december 2008theindiandrugcompanyciplawonacaseinindia scourtsystemallowing indian drug company,december 2008theindiandrugcompanyciplawonacaseinindia scourtsystemallowing indian drug company,3
8456,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompany cipla,business enterprise,3
8458,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompanyciplatomanufacture cheaper generic version,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompanyciplatomanufacture cheaper generic version,3
8459,cheaper generic version,cheaper generic version,3
8461,antiflu,antiflu,3
8474,indigenous peoples,indigenous peoples,3
8463,hospitalization time,hospitalization time,3
8466,small intestine,small intestine,3
8467,gastrointestinal bacterial colonization,gastrointestinal bacterial colonization,3
8468,toxin production,toxin production,3
8469,– m2 inhibitors,– m2 inhibitors,3
8471,public health england,nation uk cultural area country,3
8472,pediatrics,pediatrics,3
8465,crypt cells,crypt cells,3
8555,dosage,dosage,3
8494,german clinical practice guideline,german clinical practice guideline,3
8496,2013 metaanalyses,2013 metaanalyses,3
8528,99.1%,99.1%,3
8529,99.8%,99.8%,3
8530,h3n,h3n,3
8531,european cdcs,european cdcs,3
8534,0%,0%,3
8535,3.3%,3.3%,3
8526,99.4%,99.4%,3
8536,18% resistance rate,18% resistance rate,3
8539,japanese investigators,japanese investigators,3
8541,1.7%,1.7%,3
8544,h274y n294s mutations,h274y n294s mutations,3
8545,pandemrix,influenza vaccine,3
8550,stanford university studies,stanford university studies,3
8553,constituents,constituents,3
8538,higher earlier dosing,higher earlier dosing,3
8495,german clinical practice guideline use,german clinical practice guideline use,3
8524,proportion,proportion,3
8518,community specimens,community specimens,3
8497,decreased risk,decreased risk,3
8498,0.5–1.0 day,0.5–1.0 day,3
8499,increased rates,increased rates,3
8500,vomiting.the 2014 cochrane review,vomiting.the 2014 cochrane review,3
8502,small benefit,small benefit,3
8503,harms,harms,3
8519,haematologic malignancies,haematologic malignancies,3
8505,widespread use,widespread use,3
8507,long term care facilities,long term care facilities,3
8510,systematic review,systematic review,3
8512,1 12%,1 12%,3
8513,healthy lowrisk persons,healthy lowrisk persons,3
8514,unvaccinated high risk persons,unvaccinated high risk persons,3
8517,immunosuppressed patients,immunosuppressed patients,3
8506,resistance development,resistance development,3
8655,natural clearance,natural clearance,3
8242,segmented negativesense rna,structural class chemical compounds,3
8240,helical symmetry,helical symmetry,3
7975,gelatin,mixture,3
7974,arginine,biological process,3
7973,sucrose,disaccharide chemical compound product reactant reactant reactant reactant reactant reactant cargo cargo cargo cargo cargo cargo reactant sucrose phosphorylase activity,3
7972,sucrose gradient,disaccharide chemical compound product reactant reactant reactant reactant reactant reactant cargo cargo cargo cargo cargo cargo reactant sucrose phosphorylase activity,3
7971,centrifuges,centrifuges,3
7970,refrigerated version,refrigerated version,3
7969,chick kidney cells,chick kidney cells,3
7965,body temperature,body temperature,3
7964,relatively cold temperatures,relatively cold temperatures,3
7961,acip,acip,3
7958,cdc advisory committee,cdc advisory committee,3
7957,younger children,younger children,3
7955,2018 review,2018 review,3
7954,poor effectiveness,poor effectiveness,3
7953,instead type,instead type,3
7951,medication uses,medication uses,3
7950,astrazeneca,astrazeneca,3
7933,1 april,1 april,3
7934,barda,barda,3
7935,estimated u$231m,estimated u$231m,3
7936,biota pharmaceuticals,biota pharmaceuticals,3
7937,wholly owned subsidiary,wholly owned subsidiary,3
7938,biota scientific management pty,biota scientific management pty,3
7976,acid,acid,3
7939,advanced development,advanced development,3
7942,laiv,laiv,3
7943,laiv effectiveness,laiv effectiveness,3
7944,recommendation,recommendation,3
7946,season.this recommendation,season.this recommendation,3
7948,intramuscular injection,intramuscular injection,3
7949,medimmune,business,3
7941,nasal spray,nasal spray,3
7981,small amounts,small amounts,3
7982,vaccinated person,vaccinated person,3
7984,hunein john maassab,hunein john maassab,3
8008,export,export,3
8009,serum institute,serum institute,3
8010,exclusive licenses,exclusive licenses,3
8011,bangladesh,bangladesh,3
8012,bhutan,bhutan,3
8013,nepal,nepal,3
8007,large domestic market,large domestic market,3
8014,government pharmaceutical organization,government pharmaceutical organization,3
8016,modifiability,modifiability,3
8017,light,light,3
8019,modifying flumist,brand,3
8025,broad protection,broad protection,3
8027,mouse ferret models,mouse ferret models,3
8029,2009 study,2009 study,3
8015,surface antigens,surface antigens,3
7932,laninamivir,chemical compound,3
8006,chinese market priorities,chinese market priorities,3
8004,prequalification,prequalification,3
7985,professor,professor,3
7986,michigan,michigan,3
7987,ann arbor,ann arbor,3
7989,mountain view,mountain view,3
7990,sponsorship,sponsorship,3
7991,fdaapproved lots,fdaapproved lots,3
8005,near future,near future,3
7993,quadrivalent version,quadrivalent version,3
7996,rights,rights,3
7997,private production,private production,3
7998,changchun bcht biotechnology,changchun bcht biotechnology,3
7999,public rights,public rights,3
8000,bcht plans,bcht plans,3
8003,candidates,candidates,3
7995,biodiem,biodiem,3
7931,nasal inhalation,nasal inhalation,3
7930,longacting neuraminidase inhibitor,group class enzymes,3
7929,influenzavirus b. laninamivir,chemical compound,3
7859,tissue homogenates,tissue homogenates,3
7860,monto ho,monto ho,3
7862,poliovirus,taxon,3
7865,1959 publication,1959 publication,3
7866,responsible factor viral inhibitory factor,responsible factor viral inhibitory factor,3
7869,purification,purification,3
7858,tissues,tissues,3
7871,y.h. tan,y.h. tan,3
7875,fibroblast cells,fibroblast cells,3
7876,coworkers,coworkers,3
7877,active site,active site,3
7878,tyrosine residues,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,3
7882,sugar composition,sugar composition,3
7883,nterminal analyses,nterminal analyses,3
7872,y.h. tan coworkers,y.h. tan coworkers,3
7884,unusually hydrophobic glycoprotein,unusually hydrophobic glycoprotein,3
7857,viral inhibitory factor,viral inhibitory factor,3
7855,japanese virologists,japanese virologists,3
7834,confers immunity,confers immunity,3
7835,alick isaacs,alick isaacs,3
7836,jean lindenmann,jean lindenmann,3
7838,alick isaacs jean lindenmann studies,alick isaacs jean lindenmann studies,3
7842,lindenmann,lindenmann,3
7844,chicken embryo chorioallantoic membranes,chicken embryo chorioallantoic membranes,3
7856,tokyo—,tokyo—,3
7846,isaacs lindenmann experiments,isaacs lindenmann experiments,3
7849,isaacs lindenmann results,isaacs lindenmann results,3
7850,observations,observations,3
7851,1957 publication,1957 publication,3
7852,efficient vaccine,efficient vaccine,3
7853,yasuichi nagano,yasuichi nagano,3
7854,yasuhiko kojima—,yasuhiko kojima—,3
7848,isaacs,isaacs,3
8030,early work,early work,3
7886,test tube,test tube,3
7888,vessel,vessel,3
7910,cutaneous tcell lymphoma,cutaneous tcell lymphoma,3
7911,recurrent melanomas,recurrent melanomas,3
7912,recombinant ifnα2b,recombinant ifnα2b,3
7914,different types,different types,3
7915,pegylated interferonalpha,pegylated interferonalpha,3
7916,formulation,formulation,3
7909,nodular lymphoma,nodular lymphoma,3
7917,interferonalpha2b,interferonalpha2b,3
7920,pegylated drugs,pegylated drugs,3
7924,interferoncontaining regimens,interferoncontaining regimens,3
7925,protease inhibitors,protease inhibitors,3
7926,boceprevir,medication group stereoisomers,3
7927,telaprevir,chemical compound medication,3
7928,neuraminidase inhibitor,group class enzymes,3
7918,polyethylene glycol,polyethylene glycol,3
7887,tube,tube,3
7908,chronic myeloid leukemia,chronic myeloid leukemia,3
7906,hematological malignancy,hematological malignancy,3
7889,chemical verification,chemical verification,3
7890,sidney pestka,sidney pestka,3
7891,alan waldman,alan waldman,3
7892,early 1980s,early 1980s,3
7894,gene cloning,gene cloning,3
7895,related genes,related genes,3
7907,lymphomas,lymphomas,3
7896,ii ifn gene,ii ifn gene,3
7898,mass cultivation,mass cultivation,3
7899,recombinant mammalian cells,recombinant mammalian cells,3
7901,autoimmune disorder,autoimmune disorder,3
7902,attacks,attacks,3
7903,relapsingremitting multiple sclerosis,relapsingremitting multiple sclerosis,3
7905,secondary progressive multiple sclerosis,secondary progressive multiple sclerosis,3
7897,recombinant dna technology,academic discipline,3
8032,cdc team,cdc team,3
8033,kanta subbarao,kanta subbarao,3
8035,base,base,3
8165,longlasting antiinfluenza virus activity,longlasting antiinfluenza virus activity,3
8166,longlasting activity,longlasting activity,3
8167,recent years,recent years,3
8168,early treatment,early treatment,3
8169,statistical reports,statistical reports,3
8171,symptomatic illness,symptomatic illness,3
8164,activation,activation,3
8172,universal implementation,universal implementation,3
8176,abnormal behaviors,abnormal behaviors,3
8177,extension,extension,3
8178,hallucinations,hallucinations,3
8180,nitd008,chemical compound,3
8181,flavivirus infections,flavivirus infections,3
8193,covid19 patients,covid19 patients,3
8173,nais,nais,3
8195,p70,p70,3
8163,b. peramivir,scholarly article review article,3
8161,yaroslavl,yaroslavl,3
8140,i.g. bakulin,i.g. bakulin,3
8141,hepatology,hepatology,3
8143,chief gastroenterologist,chief gastroenterologist,3
8145,regulatory approval,regulatory approval,3
8146,major milestone,major milestone,3
8147,rpharm,rpharm,3
8162,neuraminidase enzyme,group class enzymes,3
8148,license,license,3
8150,federal target program development,federal target program development,3
8151,pharmaceutical medical industry,pharmaceutical medical industry,3
8152,russian federation,russian federation,3
8156,scheringplough research institute,scheringplough research institute,3
8159,pharmaceutical factory,pharmaceutical factory,3
8160,russian city,russian city,3
8149,texas liver institute,state united statesorgan type,3
8139,narlaprevir pharmacokinetics,chemical compound,3
8197,70 kda cleavage product,70 kda cleavage product,3
8200,cterminal thirds,cterminal thirds,3
8224,gammainfluenzavirus,gammainfluenzavirus,3
8225,quaranjavirus,taxon,3
8226,genera,genera,3
8227,isaviruses,isaviruses,3
8228,salmon,salmon,3
8229,thogotoviruses,thogotoviruses,3
8223,deltainfluenzavirus,deltainfluenzavirus,3
8230,influenzavirus virion,influenzavirus virion,3
8232,approximately 500 distinct spikelike surface projections,approximately 500 distinct spikelike surface projections,3
8233,varying surface densities,varying surface densities,3
8234,major glycoprotein,major glycoprotein,3
8235,clusters,clusters,3
8237,lipid bilayer membrane,lipid bilayer membrane,3
8238,glycoprotein spikes,glycoprotein spikes,3
8231,spherical filamentous forms,spherical filamentous forms,3
8199,serine protease,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
8221,alphainfluenzavirus,alphainfluenzavirus,3
8219,negativesense rna viruses,structural class chemical compounds,3
8201,helicase,helicase,3
8202,nucleoside triphosphatase,nucleoside triphosphatase,3
8203,180 aminoacids,180 aminoacids,3
8204,ns3,ns3,3
8205,additional role,additional role,3
8206,cofactor domains,cofactor domains,3
8220,seven genera,seven genera,3
8208,telaprevir drugs,chemical compound medication,3
8212,ns5a inhibitor,ns5a inhibitor,3
8213,multiple functions,multiple functions,3
8214,viral life cycle,viral life cycle,3
8215,interferonresistance,interferonresistance,3
8217,achillion pharmaceuticals,achillion pharmaceuticals,3
8218,ns5a inhibitors,ns5a inhibitors,3
8209,odalasvir,chemical compound,3
8241,pieces,pieces,3
8138,narlaprevir safety profile,chemical compound,3
8135,treatmentexperienced patients,treatmentexperienced patients,3
8065,tickborne encephalitis virus,tickborne encephalitis virus,3
8067,mk608 mk608,mk608 mk608,3
8068,continuing lack,continuing lack,3
8070,synthetic nucleoside derivative n4hydroxycytidine,synthetic nucleoside derivative n4hydroxycytidine,3
8071,molnupiravir,chemical compound,3
8073,errors,errors,3
8063,promising results,promising results,3
8076,emory university,emory university,3
8080,miamibased company ridgeback biotherapeutics,miamibased company ridgeback biotherapeutics,3
8081,safety controversy,safety controversy,3
8082,whistleblower complaint,whistleblower complaint,3
8083,rick bright,rick bright,3
8084,similar drugs,similar drugs,3
8085,mutagenic properties,mutagenic properties,3
8079,emory,emory,3
8086,previous company,previous company,3
8062,merck,merck,3
8060,phase 2 clinical trial,phase 2 clinical trial,3
8038,laivs,laivs,3
8039,virusspecific ctls,virusspecific ctls,3
8040,mucosal serum antibodies,family protein complexes,3
8041,broad crossprotection,broad crossprotection,3
8043,mediated immunity,mediated immunity,3
8044,viruses.in september,viruses.in september,3
8061,viralclear pharmaceuticals,viralclear pharmaceuticals,3
8045,following populations,following populations,3
8047,deoxycytidine analog,deoxycytidine analog,3
8050,enzyme inosine monophosphate dehydrogenase,enzyme inosine monophosphate dehydrogenase,3
8051,nucleotide bases,nucleotide bases,3
8052,guanine,chemical compound,3
8053,dna,dna,3
8059,merimepodib,chemical compound,3
8046,mericitabine,chemical compound,3
8136,dual therapy,dual therapy,3
8087,pharmasset,business,3
8091,ceo,ceo,3
8118,narlaprevir,chemical compound,3
8119,oral ns3 serine protease inhibitor,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
8120,infected host cells,infected host cells,3
8121,reversible covalent binding,reversible covalent binding,3
8122,human proteases,organisms known particular common homo sapiens homo sapiens sapiens homo,3
8123,overexpression,overexpression,3
8116,russian tableted medication,russian tableted medication,3
8124,malignancies,malignancies,3
8128,dual combination,dual combination,3
8129,narlaprevir activity,chemical compound,3
8130,hcv mutations,hcv mutations,3
8131,largescale phase iii multicenter pioneer study,largescale phase iii multicenter pioneer study,3
8133,89%,89%,3
8134,treatmentnaïve,treatmentnaïve,3
8126,narlaprevir safety,chemical compound,3
8090,george painter,george painter,3
8115,arlansa,arlansa,3
8112,heterocyclic biguanidine,heterocyclic biguanidine,3
8094,regulators,regulators,3
8095,safety studies,safety studies,3
8096,ridgeback biotherapeutics,ridgeback biotherapeutics,3
8097,future safety studies,future safety studies,3
8099,tolerability,tolerability,3
8100,healthy volunteers,healthy volunteers,3
8113,ns3/4a serine protease,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
8102,hospitalized nonhospitalized patients,hospitalized nonhospitalized patients,3
8105,stage 2/3 trial,stage 2/3 trial,3
8106,hospitalized patients,hospitalized patients,3
8107,december 3rd,december 3rd,3
8108,moroxydine,chemical compound,3
8109,potential applications,potential applications,3
8111,structurally moroxydine,chemical compound,3
8104,late stage trials,late stage trials,3
8659,melanoma melanoma,rare diseaserare disease,3
8660,melanoma,rare disease,3
8661,liver problems,organ type,3
9162,mortality rates,mortality rates,3
9161,recovery rates,recovery rates,3
9158,subject s moderate covid‑19 symptoms improvingweresimilarforthosein,subject s moderate covid‑19 symptoms improvingweresimilarforthosein,3
9157,separate randomized openlabel multicenter clinical trial,separate randomized openlabel multicenter clinical trial,3
9156,care,care,3
9155,standard,standard,3
9153,subject s covid‑19 symptoms improvingwerestatisticallysignificantlyhigherin,subject s covid‑19 symptoms improvingwerestatisticallysignificantlyhigherin,3
9151,hospitalized adult participants,hospitalized adult participants,3
9150,second randomized openlabel multicenter clinical trial,second randomized openlabel multicenter clinical trial,3
9148,odds,odds,3
9147,statistically significant difference,statistically significant difference,3
9146,15 days,15 days,3
9144,10 days,10 days,3
9143,ongoing medical care,ongoing medical care,3
9142,1 062 hospitalized participants,1 062 hospitalized participants,3
9141,29 days,29 days,3
9140,randomized doubleblind placebocontrolled clinical trial,randomized doubleblind placebocontrolled clinical trial,3
9123,regneb3,regneb3,3
9124,veterinary uses,veterinary uses,3
9125,feline coronavirus,group class strains strain,3
9126,websites,websites,3
9127,social media,social media,3
9128,unregulated black market substance,unregulated black market substance,3
9163,remdesivir/baricitinib,remdesivir/baricitinib,3
9129,main circulating metabolite,main circulating metabolite,3
9131,direct administration,direct administration,3
9135,mildtosevere covid‑19,mildtosevere covid‑19,3
9136,revised eua,revised eua,3
9137,hospitalized participants,hospitalized participants,3
9138,226 sites,226 sites,3
9139,17 countries,17 countries,3
9130,similar potency,similar potency,3
9165,eua,eua,3
9166,eli lilly,eli lilly,3
9167,remdesivir/interferon beta1a,remdesivir/interferon beta1a,3
9192,hospitalized individuals,hospitalized individuals,3
9194,highflow oxygen devices,highflow oxygen devices,3
9195,ecmo,ecmo,3
9196,niaidactt study,niaidactt study,3
9197,beneficial effect,beneficial effect,3
9199,fiveday treatment course,fiveday treatment course,3
9189,gilead sciences international,gilead sciences international,3
9200,additional days,additional days,3
9202,conditional marketing authorization,conditional marketing authorization,3
9204,early august,early august,3
9205,joint procurement framework contract,joint procurement framework contract,3
9207,37 european countries,37 european countries,3
9208,27 european union member states,27 european union member states,3
9209,albania,albania,3
9201,3 july,3 july,3
9122,mab114,monoclonal antibody,3
9188,orphan designation,orphan designation,3
9186,covid‑19 patients,covid‑19 patients,3
9169,sufficient supply,sufficient supply,3
9170,australia national stockpile,continent,3
9171,requests,requests,3
9172,additional doses,additional doses,3
9173,sap,sap,3
9175,19 june,19 june,3
9187,condition,condition,3
9176,22 september,22 september,3
9178,deal,deal,3
9180,8 october,8 october,3
9182,formulary review,formulary review,3
9183,midnovember,midnovember,3
9184,czech republic,czech republic,3
9185,17 march,17 march,3
9177,public services,public services,3
9119,kivu ebola epidemic,infectious disease,3
9118,west african ebola virus epidemic,infectious disease,3
9116,gilead sciences compound library,gilead sciences compound library,3
9053,23 june,23 june,3
9054,emergency marketing approval,emergency marketing approval,3
9055,generic remdesivir,chemical compound prodrug antiviral drug,3
9056,gilead sciences licensees,gilead sciences licensees,3
9057,hetero drugs,hetero drugs,3
9058,pricing,pricing,3
9052,covid‑19 emergency,covid‑19 emergency,3
9059,29 june,29 june,3
9061,vial,vial,3
9063,expected course,expected course,3
9065,important effect,important effect,3
9066,little effect,little effect,3
9067,hospital stay,hospital stay,3
9068,high price,high price,3
9060,price,price,3
9069,funds,funds,3
9051,royalties,royalties,3
9049,agreements,agreements,3
9033,powder form,powder form,3
9034,gilead sciences filling plant,gilead sciences filling plant,3
9035,la verne,la verne,3
9036,filling plant,filling plant,3
9038,fresh raw materials,fresh raw materials,3
9040,poor stability,poor stability,3
9050,licensees,licensees,3
9041,ligand pharmaceuticals,ligand pharmaceuticals,3
9043,excipient,excipient,3
9044,captisol annual manufacturing capacity,captisol annual manufacturing capacity,3
9045,500 metric tons,500 metric tons,3
9046,nonexclusive voluntary licenses,nonexclusive voluntary licenses,3
9047,generic drug companies,generic drug companies,3
9048,127 countries,127 countries,3
9042,captisol,captisol,3
9210,bosnia,bosnia,3
9070,covid‑19.in november,covid‑19.in november,3
9074,esterases,esterases,3
9099,rapid extracellular conversion,rapid extracellular conversion,3
9100,nucleoside gs441524,nucleoside gs441524,3
9101,active nucleotide triphosphate,active nucleotide triphosphate,3
9102,activated nucleotide triphosphate form,activated nucleotide triphosphate form,3
9103,intracellular levels,intracellular levels,3
9104,pbmc,pbmc,3
9098,delayed chain terminator,delayed chain terminator,3
9106,partial resistance,partial resistance,3
9110,rhesus monkeys,rhesus monkeys,3
9111,travis warren,travis warren,3
9112,usamriid principal investigator,usamriid principal investigator,3
9113,continuing collaboration,continuing collaboration,3
9114,usamriid,usamriid,3
9115,initial screening,initial screening,3
9107,united states army medical research institute,united states army medical research institute,3
9073,protide,protide,3
9096,additional nucleotides,additional nucleotides,3
9094,sarscov2 arrest,sarscov2 arrest,3
9075,active metabolite triphosphate,active metabolite triphosphate,3
9076,nucleosidephosphate kinases,nucleosidephosphate kinases,3
9077,bioactivation,bioactivation,3
9078,substantial,substantial,3
9079,major metabolite,major metabolite,3
9080,metabolite remaining hours,metabolite remaining hours,3
9095,incorporation,incorporation,3
9081,adenosine nucleoside triphosphate analog,adenosine nucleoside triphosphate analog,3
9083,evades,evades,3
9088,irreversible chain termination,irreversible chain termination,3
9089,chain terminators,chain terminators,3
9090,immediately subsequent nucleotide,immediately subsequent nucleotide,3
9091,additional bases,additional bases,3
9093,merscov,merscov,3
9082,remdesivir interferes,chemical compound prodrug antiviral drug,3
9211,herzegovina,herzegovina,3
9212,iceland,iceland,3
9213,kosovo,kosovo,3
9338,zidovudine,chemical compound medication essential medicine carcinogen,3
9339,didanosine,didanosine,3
9340,mitochondrial toxicity,mitochondrial toxicity,3
9341,mechanisms action,mechanisms action,3
9342,guanosine,"""purine ribonucleoside 5-triphosphate"" product participant cargo reactant",3
9345,direct indirect mechanisms,direct indirect mechanisms,3
9337,birth defects,birth defects,3
9346,ribavirin mechanism,chemical compound medication essential medicine 1 april 1990,3
9348,joseph t. witkovski,joseph t. witkovski,3
9349,roland k. robins,roland k. robins,3
9350,undue toxicity,undue toxicity,3
9351,cancer chemotherapies,constellation zodiacal constellation,3
9353,ribosyl purine analogue,ribosyl purine analogue,3
9354,incomplete purine 6membered ring,incomplete purine 6membered ring,3
9347,international chemical nuclear corporation,international chemical nuclear corporation,3
9355,structural resemblance,structural resemblance,3
9336,sex,sex,3
9334,especially acute myeloid leukemia,especially acute myeloid leukemia,3
9311,generic medication,generic medication,3
9312,oral form,oral form,3
9313,pediatric population,pediatric population,3
9317,crimeancongo hemorrhagic fever,crimeancongo hemorrhagic fever,3
9318,venezuelan hemorrhagic fever,venezuelan hemorrhagic fever,3
9319,vivo activity,vivo activity,3
9335,fda black box warnings,fda black box warnings,3
9320,aerosol form,aerosol form,3
9323,experimental data,experimental data,3
9324,useful activity,useful activity,3
9325,canine distemper,canine distemper,3
9327,small study,small study,3
9329,herpes outbreaks,herpes outbreaks,3
9332,acyclovir,acyclovir,3
9322,weak.this,weak.this,3
9310,safest effective medicines,safest effective medicines,3
9356,replacement,replacement,3
9358,triazole,triazole,3
9383,mystery,mystery,3
9384,complete inactivity,complete inactivity,3
9387,rna nucleoside mimic,structural class chemical compounds,3
9388,dna nucleoside mimic,dna nucleoside mimic,3
9389,ribavirin 5 monophosphateinhibits cellular inosine monophosphate dehydrogenase,chemical compound medication essential medicine 1 april 1990,3
9390,cellular inosine monophosphate dehydrogenase,cellular inosine monophosphate dehydrogenase,3
9380,hypermutation,hypermutation,3
9391,intracellular pools,intracellular pools,3
9393,cited paper,cited paper,3
9395,inn,inn,3
9396,usan,usan,3
9397,tribavirin,tribavirin,3
9398,brand names,brand names,3
9399,generic forms,generic forms,3
9392,gtp,gtp,3
9357,2 nitrogen,2 nitrogen,3
9379,rnadependent replication,rnadependent replication,3
9377,uracil,uracil,3
9359,carbon,carbon,3
9360,great effect,great effect,3
9361,imidazole riboside derivatives,imidazole riboside derivatives,3
9363,halide,halide,3
9364,larger substituent,larger substituent,3
9365,smaller activity,smaller activity,3
9378,cytosine,chemical compound,3
9367,imidazole riboside structure,imidazole riboside structure,3
9370,pyrazofurin,scholarly article,3
9371,unacceptable toxicity,unacceptable toxicity,3
9372,amino group results,amino group results,3
9374,native nucleoside drug resemble adenosine,native nucleoside drug resemble adenosine,3
9375,base analog,base analog,3
9376,adenine,adenine,3
9369,oh results,oh results,3
9032,100 kilograms,100 kilograms,3
9308,effective birth control,effective birth control,3
9306,allergic reactions,allergic reactions,3
9237,news conference,news conference,3
9238,lópezgatell,lópezgatell,3
9239,cofepris,cofepris,3
9242,20 march,20 march,3
9243,united states president donald trump,united states president donald trump,3
9245,fda commissioner stephen hahn,fda commissioner stephen hahn,3
9236,23 october,23 october,3
9246,press conference,press conference,3
9249,agent,agent,3
9251,oxygen saturation,oxygen saturation,3
9252,room air,room air,3
9253,extracorporeal membrane oxygenation,extracorporeal membrane oxygenation,3
9254,heart–lung bypass machine,heart–lung bypass machine,3
9255,authorized distributors,authorized distributors,3
9248,23 march,23 march,3
9257,state local government authorities,state local government authorities,3
9235,emergency authorization,emergency authorization,3
9233,labour,labour,3
9214,montenegro,montenegro,3
9215,north macedonia,north macedonia,3
9216,serbia,serbia,3
9217,treatment course,treatment course,3
9218,13 october,13 october,3
9219,reuters,news agency,3
9234,fasttracked process,fasttracked process,3
9220,2 070 euros,2 070 euros,3
9222,contract,contract,3
9224,participating country,participating country,3
9225,orders,orders,3
9226,barakat,barakat,3
9227,productions,productions,3
9228,remdesivir ampoules,chemical compound prodrug antiviral drug,3
9221,total value,total value,3
9307,pregnancy results,physiological condition,3
9261,2020.the initial distribution,2020.the initial distribution,3
9263,frustration,frustration,3
9287,amerisourcebergen,business enterprise,3
9288,sole distributor,sole distributor,3
9289,veklury,veklury,3
9290,face,face,3
9291,emerging sales,emerging sales,3
9293,compounders,compounders,3
9286,domestic demand,domestic demand,3
9294,ribavirin],ribavirin],3
9296,\ tribavirin,\ tribavirin,3
9299,lassa fever,lassa fever,3
9300,crimean–congo hemorrhagic fever,crimean–congo hemorrhagic fever,3
9302,ebola marburg infections,infectious diseaselocation identifier q28791882 masculine plural 8 november 1919gregorian,3
9303,headache nausea,headache nausea,3
9304,irritable mood,irritable mood,3
9295,ribavirin \ alsoknownas,chemical compound medication essential medicine 1 april 1990,3
9262,seemingly capricious decisionmaking,seemingly capricious decisionmaking,3
9285,remdesivir allocation,chemical compound prodrug antiviral drug,3
9281,suspected laboratoryconfirmed covid‑19,suspected laboratoryconfirmed covid‑19,3
9267,american patients,american patients,3
9268,highest caseloads,highest caseloads,3
9269,distribution rounds,distribution rounds,3
9270,florida,florida,3
9271,initial distribution,initial distribution,3
9272,wrong hospitals,wrong hospitals,3
9283,fact sheet,fact sheet,3
9273,needed refrigeration,needed refrigeration,3
9275,discussion,discussion,3
9276,allocation,allocation,3
9277,approximately 70 countries,approximately 70 countries,3
9278,implications,implications,3
9279,current needs,current needs,3
9280,28 august,28 august,3
9274,announcements,announcements,3
9031,gilead sciences entire stock,gilead sciences entire stock,3
9030,alberta,alberta,3
9029,edmonton,edmonton,3
8775,gastric acid,gastric acid,3
8776,icosahedral capsid,cellular component,3
8777,60 protomers,60 protomers,3
8778,tightly packed icosahedral structure,tightly packed icosahedral structure,3
8779,4 polypeptides,4 polypeptides,3
8780,vp,vp,3
8774,acidic conditions,acidic conditions,3
8781,vp2 vp4 polypeptides,vp2 vp4 polypeptides,3
8783,vp0,vp0,3
8784,different capsid components,cellular component,3
8785,icosahedral,icosahedral,3
8786,triangulation number,triangulation number,3
8787,icosahedral structure,icosahedral structure,3
8788,60 triangles,60 triangles,3
8782,protomer,protomer,3
8790,subunit,subunit,3
8773,lower temperature,lower temperature,3
8771,rhinoviruses,rhinoviruses,3
8749,small unit,small unit,3
8750,measurement,measurement,3
8752,prototypic member,prototypic member,3
8755,plaque assay,plaque assay,3
8756,culture,culture,3
8758,molecular building blocks,molecular building blocks,3
8772,33 °c,33 °c,3
8759,polyprotein synthesis,polyprotein synthesis,3
8762,poliovirus infected cells,taxon,3
8763,poliovirus clone,taxon,3
8764,infectious dna clone,infectious dna clone,3
8767,mengovirus,mengovirus,3
8769,enteric tract,enteric tract,3
8770,primarily nose,primarily nose,3
8760,internal ribosome entry sites,internal ribosome entry sites,3
8748,pico,pico,3
8791,corner,corner,3
8796,viral particle,viral particle,3
8826,cis acting replication element,cis acting replication element,3
8827,stemloopstructure,stemloopstructure,3
8828,cre,cre,3
8830,3’ end elements,3’ end elements,3
8832,poly tract,poly tract,3
8834,important element,important element,3
8825,negative plus strand rna synthesis,structural class chemical compounds,3
8835,positive—strand synthesis,positive—strand synthesis,3
8837,secondary structural elements,secondary structural elements,3
8838,poliovirus translation initiation,taxon,3
8839,internal ribosome entry site,internal ribosome entry site,3
8841,cap independent initiation,cap independent initiation,3
8842,messenger,messenger,3
8843,viral particle binds,viral particle binds,3
8836,ncr,ncr,3
8794,single stranded positive sense,single stranded positive sense,3
8823,genomic rnas,genomic rnas,3
8819,translation andthe3in negative strand synthesis,translation andthe3in negative strand synthesis,3
8799,vpg,wikimedia disambiguation page,3
8800,tyrosine residue,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,3
8801,3’ end,3’ end,3
8802,tyrosine,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,3
8803,–oh source,–oh source,3
8804,5’ end,5’ end,3
8820,negative strand synthesis,negative strand synthesis,3
8805,rna.the genome,scientific model natural environment,3
8807,mammalian mrna picornaviruses,transcript,3
8811,poly tail,poly tail,3
8812,untranslated region,untranslated region,3
8813,ends,ends,3
8815,500–1200 nucleotides,500–1200 nucleotides,3
8817,30–650,30–650,3
8806,nonsegmented positivesense,nonsegmented positivesense,3
8844,cell surface receptors,cell surface receptors,3
8747,ribonucleic acid,ribonucleic acid,3
8744,coxsackievirus,coxsackievirus,3
8685,multifunctional immunoregulatory cytokine,multifunctional immunoregulatory cytokine,3
8686,t helper cells,t helper cells,3
8687,type 2 helper t cells,type 2 helper t cells,3
8688,stimulation,stimulation,3
8689,b cells,b cells,3
8690,foreign antigen,group class chemical substances,3
8684,apoptosis,biological process,3
8692,u266 daudi rhek1 cell lines,u266 daudi rhek1 cell lines,3
8694,previous study,previous study,3
8696,cleavage,cleavage,3
8697,caspase3,caspase3,3
8698,important role,important role,3
8699,initiation,initiation,3
8700,apoptotic cascade,apoptotic cascade,3
8693,caspases,caspases,3
8701,mitochondrial membrane potential,mitochondrial membrane potential,3
8681,interferon stimulate transcription factor3,group class proteins,3
8679,interferon transcription factor,group class proteins,3
8662,irregular heartbeat,irregular heartbeat,3
8664,major mechanisms,major mechanisms,3
8665,peginterferon alpha2b,peginterferon alpha2b,3
8666,jakstat signaling pathway,jakstat signaling pathway,3
8667,basic mechanism,basic mechanism,3
8668,peginterferon alpha2b receptor,peginterferon alpha2b receptor,3
8680,p48,p48,3
8669,interferonalpha receptor,interferonalpha receptor,3
8673,ifnar2,ifnar2,3
8674,basic mechanism signal transduction,basic mechanism signal transduction,3
8675,jak,jak,3
8676,tyk2,tyk2,3
8677,phosphorylated stats,phosphorylated stats,3
8678,receptor heterodimer,receptor heterodimer,3
8672,ifnar1,gene,3
8746,rhinovirus,taxon,3
8703,mitochondria,mitochondria,3
8705,upstream activators,upstream activators,3
8728,meningitis,meningitis,3
8729,paralysis,paralysis,3
8731,order picornavirales,order picornavirales,3
8732,riboviria,riboviria,3
8733,110 species,110 species,3
8734,47 genera,47 genera,3
8727,poliomyelitis,poliomyelitis,3
8735,notable examples,notable examples,3
8737,aphthovirus,taxon,3
8738,cardiovirus,taxon,3
8739,hepatovirus,taxon,3
8740,picornavirus,taxon,3
8741,dual etymology,dual etymology,3
8742,acronym,acronym,3
8736,genera enterovirus,taxon,3
8704,followup research,followup research,3
8725,vertebrates,vertebrates,3
8721,alleviation,alleviation,3
8706,apoptotic pathway,apoptotic pathway,3
8707,brand,brand,3
8708,later report,later report,3
8709,transitionstate analogue inhibitor,transitionstate analogue inhibitor,3
8710,influenza neuraminidase,infectious diseasegroup class enzymes,3
8712,intravenous administration,intravenous administration,3
8723,picornaviruses,picornaviruses,3
8713,ii,ii,3
8715,19 december,19 december,3
8716,rapiacta,rapiacta,3
8717,peramiflu,peramiflu,3
8718,intravenous option,intravenous option,3
8719,intramuscular peramivir phase ii study,scholarly article review article,3
8720,primary endpoint,primary endpoint,3
8714,limited phase iii trial data,limited phase iii trial data,3
9401,taribavirin,chemical compound,3
8845,serotype,serotype,3
8847,cd155,cd155,3
8973,−108 °f,−108 °f,3
8974,intermediate c.,intermediate c.,3
8976,solution,solution,3
8978,weakly acidic aqueous solution,weakly acidic aqueous solution,3
8979,1: 1 anomers,1: 1 anomers,3
8980,trimethylsilyl cyanide,trimethylsilyl cyanide,3
8972,−78 °c,−78 °c,3
8981,10 minutes,10 minutes,3
8983,additional hour,additional hour,3
8984,aqueous sodium hydrogen carbonate,aqueous sodium hydrogen carbonate,3
8986,benzyl,benzyl,3
8987,boron,boron,3
8988,−20 °c,−20 °c,3
8989,potassium carbonate,potassium carbonate,3
8982,trimethylsilyl triflate,trimethylsilyl triflate,3
8990,methanol,methanol,3
8970,nbutyllithium,nbutyllithium,3
8967,triazin4amine,triazin4amine,3
8952,multiple steps,multiple steps,3
8953,ribose derivatives,ribose derivatives,3
8954,right,right,3
8955,synthesis routes,synthesis routes,3
8956,chun,chun,3
8957,coauthors,coauthors,3
8969,excess trimethylsilyl chloride,excess trimethylsilyl chloride,3
8958,lalanine,lalanine,3
8960,triethylamine,triethylamine,3
8961,dichloromethane,dichloromethane,3
8962,triple benzylprotected ribose,triple benzylprotected ribose,3
8963,dimethyl sulfoxide,dimethyl sulfoxide,3
8964,acetic anhydride,acetic anhydride,3
8966,pyrrolo,pyrrolo,3
8959,phenyl,phenyl,3
8951,intracellular metabolic activation,intracellular metabolic activation,3
8991,reversedphase hplc,reversedphase hplc,3
8993,trimethyl phosphate,trimethyl phosphate,3
9014,indication,indication,3
9015,entire population,entire population,3
9016,1,1,3
9017,continued access,continued access,3
9018,pediatric patient population,pediatric patient population,3
9019,70 raw materials,70 raw materials,3
9013,authorizations deployment,authorizations deployment,3
9020,reagents,reagents,3
9023,raw materials,raw materials,3
9024,contract manufacturers,contract manufacturers,3
9025,production time,production time,3
9026,remdesivir production,chemical compound prodrug antiviral drug,3
9027,glasslined steel chemical reactors,glasslined steel chemical reactors,3
9028,gilead sciences manufacturing plant,gilead sciences manufacturing plant,3
9021,ingredients,ingredients,3
8992,optically pure compound,optically pure compound,3
9012,filoviruses,filoviruses,3
9010,patents,patents,3
8994,diastereomer mixture,diastereomer mixture,3
8995,pure remdesivir,chemical compound prodrug antiviral drug,3
8996,chiral resolution methods,chiral resolution methods,3
8997,rsv,rsv,3
8998,czech news agency,czech news agency,3
9000,direction,direction,3
9011,9 april,9 april,3
9001,scientist tomáš cihlář,scientist tomáš cihlář,3
9003,pneumoviruses,pneumoviruses,3
9005,academic institutions,academic institutions,3
9006,mid2010s,mid2010s,3
9007,mintz levin law firm,mintz levin law firm,3
9008,patent applications,patent applications,3
9009,united states patent trademark office,united states patent trademark office,3
9002,multiple filoviruses,multiple filoviruses,3
8846,poliovirus receptor,taxon,3
8950,antagonistic effect,antagonistic effect,3
8947,remdesivir chloroquine phosphate,chemical compound prodrug antiviral drugchemical compound medication essential medicine,3
8875,radalbuvir,carboxylic acid chemical compound,3
8876,ravidasvir,ravidasvir,3
8877,investigational ns5a inhibitor,investigational ns5a inhibitor,3
8880,mixing,mixing,3
8882,different individuals,different individuals,3
8883,different processes,different processes,3
8873,fusion inhibitor,fusion inhibitor,3
8884,assortment,assortment,3
8886,chromosomal crossover,chromosomal crossover,3
8888,particular reassortment occurs,particular reassortment occurs,3
8889,distinct segments,distinct segments,3
8891,minichromosomes,minichromosomes,3
8892,copy,copy,3
8893,uv irradiation,uv irradiation,3
8885,chromosomes,chromosomes,3
8894,genome segments,scientific model natural environment,3
8872,presatovir,presatovir,3
8869,animal pathogen,taxon,3
8848,special receptor,special receptor,3
8849,primate species,primate species,3
8850,transgenic mice,transgenic mice,3
8851,cd155 receptor,cd155 receptor,3
8852,laboratories cell surface,laboratories cell surface,3
8853,conformational change,conformational change,3
8871,pimodivir,group stereoisomers,3
8855,myristic acid,myristic acid,3
8861,minus,minus,3
8862,picornavirus replication,taxon,3
8863,uridylylation,uridylylation,3
8865,vpg primer mechanism,wikimedia disambiguation page,3
8866,additional virus groups,additional virus groups,3
8867,supergroup,supergroup,3
8856,pore,pore,3
8948,hydroxychloroquine sulfate,chemical compound medication essential medicine,3
8897,bionyt,magazine,3
8899,hhmi.org,hhmi.org,3
8927,low potassium,low potassium,3
8929,thrombocytes,thrombocytes,3
8930,elevated bilirubin,elevated bilirubin,3
8933,elevated transaminase levels,elevated transaminase levels,3
8934,infusion site reactions,infusion site reactions,3
8935,electrocardiogram abnormalities,electrocardiogram abnormalities,3
8925,organ impairment,organ impairment,3
8936,infusion‐related reactions,infusion‐related reactions,3
8940,cyp2c8,gene,3
8941,blood plasma concentrations,biogenic substance type,3
8943,rifampicin,rifampicin,3
8944,phenobarbital,phenobarbital,3
8945,hydroxychloroquine,chemical compound medication essential medicine,3
8946,coadministration,coadministration,3
8937,shivering,shivering,3
8898,animation,animation,3
8922,baricitinib,chemical compound medication,3
8920,40 kilograms,40 kilograms,3
8901,covid‑19,covid‑19,3
8902,50 countries,50 countries,3
8903,updated guidelines,updated guidelines,3
8904,conditional recommendation,conditional recommendation,3
8905,covid19.remdesivir,covid19.remdesivir,3
8908,covid19.the common effect,covid19.the common effect,3
8921,supplemental oxygen,supplemental oxygen,3
8912,international nonproprietary,international nonproprietary,3
8914,gs5734,gs5734,3
8915,therapeutics,therapeutics,3
8916,solidarity trial,solidarity trial,3
8917,new data,new data,3
8918,revision,revision,3
8919,authorization,authorization,3
8913,development code,development code,3
6118,manufacture,manufacture,3
0,summary,summary,3
6116,april 3.on,april 3.on,3
1987,subsequent cullings,subsequent cullings,3
1988,millions,millions,3
1991,russian authorities,russian authorities,3
1992,poultry farm workers,organisms known particular common,3
1994,saudi arabia,saudi arabia,3
1995,early outbreak saudi arabia,early outbreak saudi arabia,3
1986,wild bird populations,taxon,3
1996,4 february,4 february,3
1999,poultry farm,organisms known particular common,3
2000,central sudair region,central sudair region,3
2002,h5n8 spreads russia central asia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917juliancontinent continental area surrounding islands,3
2005,western russia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,3
2006,kazakhstan,sovereign state unitary state landlocked country transcontinental country country,3
2007,waterbirds,waterbirds,3
1997,saudi arabian government,saudi arabian government,3
2008,northern western europe,continental area surrounding islands continent geographic region,3
1985,poultry farms,organisms known particular common,3
1982,cdc illness,cdc illness,3
1960,texas children s hospital inhoustontexaswasofatoddlerfrommexicocitywhowasvisitingfamilyinbrownsvilletexasbeforebeingairliftedto,state united states,3
1961,houston,houston,3
1962,texas,state united states,3
1963,texas children shospitalinhoustontexaswasof toddler,state united states,3
1965,america,america,3
1966,total number,total number,3
1984,h5n8,h5n8,3
1967,followup,followup,3
1969,journal,journal,3
1973,perceived severity,perceived severity,3
1975,1.5%,1.5%,3
1977,30 days,30 days,3
1978,3.7%,3.7%,3
1980,3.1%,3.1%,3
1968,wisconsin study,wisconsin study,3
1958,28 march,28 march,3
2009,international spread late 2020 early 2021,international spread late 2020 early 2021,3
2011,netherlands,netherlands,3
2039,south korea,south korea,3
2040,central west ofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestof country bird flu warning,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
2044,shanxi province,shanxi province,3
2047,wild geese,wild geese,3
2048,sandnes municipality,sandnes municipality,3
2049,norwegian food safety authority,norwegian food safety authority,3
2038,central west,central west,3
2050,regional ban,regional ban,3
2054,north jeolla province,north jeolla province,3
2056,2021 outbreaks,2021 outbreaks,3
2060,early january,early january,3
2061,late december,late december,3
2063,unknown subtypes,unknown subtypes,3
2064,states,states,3
2053,jeongeup,city south korea big city,3
2010,agriculture minister carola schouten,agriculture minister carola schouten,3
2037,wild birds inthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsin central west,wild birds inthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsin central west,3
2028,toyama prefecture,toyama prefecture,3
2012,countermeasure,countermeasure,3
2013,late october,late october,3
2014,chicken farms,chicken farms,3
2015,duck farm,duck farm,3
2017,countermeasures,countermeasures,3
2019,fisheries,fisheries,3
2036,samples fromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfrom wild birds,samples fromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfrom wild birds,3
2020,multiple dead chickens,chicken gallus gallus domesticus common,3
2022,shikoku island,shikoku island,3
2023,kyushu island,kyushu island,3
2024,kanto region,kanto region,3
2025,western honshu,western honshu,3
2026,awaji island,awaji island,3
2027,gifu prefecture,gifu prefecture,3
2021,49 places poultry farms,organisms known particular common,3
2066,barwala,barwala,3
1957,30 march,30 march,3
1953,14 april,14 april,3
1887,widespread media use,widespread media use,3
1889,u.s. hogs,u.s. hogs,3
1890,hogs,hogs,3
1891,northern ireland,emoji regional indicator sequence éire (irish),3
1892,argentina,argentina,3
1894,united states secretary,united states secretary,3
1886,canadian pork council,canadian pork council,3
1895,agriculture,agriculture,3
1898,azerbaijan,sovereign state start time 30 august 1991 18 october 1991 landlocked country administrative territorial entity,3
1899,ban,ban,3
1900,animal husbandry products,taxon,3
1901,entire americas,entire americas,3
1902,examination,examination,3
1904,slaughter,slaughter,3
1896,properly cooked pork,properly cooked pork,3
1905,29 april,29 april,3
1885,american meat institute,american meat institute,3
1883,industry groups,industry groups,3
1863,240 guests,240 guests,3
1864,cruise ship,cruise ship,3
1867,egyptian muslims,egyptian muslims,3
1868,annual pilgrimage,annual pilgrimage,3
1869,mecca return,tourist attraction city millions inhabitants,3
1870,47 airline passengers,47 airline passengers,3
1884,u.s. national pork board,u.s. national pork board,3
1871,hotel,hotel,3
1873,prescreening outbound passengers,prescreening outbound passengers,3
1874,pigs food safety,pigs food safety,3
1876,rise,rise,3
1877,common,common,3
1879,term,term,3
1880,mass media,mass media,3
1872,midjune india,dominion british empire sovereign state historical country,3
1955,nearby imperial county,nearby imperial county,3
1906,medications,medications,3
1908,nausea,nausea,3
1933,paucity,paucity,3
1934,good data,good data,3
1935,u.s. children,u.s. children,3
1936,18 march,18 march,3
1938,outbreak mexico city,state mexico,3
1939,flights,flights,3
1932,duration,duration,3
1940,trade,trade,3
1943,hundreds,hundreds,3
1945,midst,midst,3
1946,silent epidemic,silent epidemic,3
1949,skewed initial estimate,skewed initial estimate,3
1950,san diego county,san diego county,3
1951,california,state united states start time 9 september 1850gregorian,3
1941,calls,calls,3
1907,lightheadedness,lightheadedness,3
1930,role,role,3
1926,previous findings,previous findings,3
1909,trouble breathing,trouble breathing,3
1910,selfinjury,selfinjury,3
1911,online sources,online sources,3
1912,half drugs,half drugs,3
1913,online pharmacies,online pharmacies,3
1914,physical address,physical address,3
1929,finding,finding,3
1915,resistance,resistance,3
1918,99.6%,99.6%,3
1921,antivirals effectiveness questioned healthy adults,chebi ontology term,3
1922,8 december,8 december,3
1923,cochrane collaboration,cochrane collaboration,3
1924,medical evidence,medical evidence,3
1925,bmj,scientific journal open-access journal medical journal,3
1916,314 samples,314 samples,3
1862,entire hotel,entire hotel,3
2067,panchkula,panchkula,3
2071,middecember,middecember,3
2171,1.112 å.at ambient conditions,1.112 å.at ambient conditions,3
2172,adamantane crystallizes,chemical compound,3
2173,facecentered cubic structure,facecentered cubic structure,3
2174,orientationally disordered adamantane molecules,chemical compound,3
2175,ordered primitive tetragonal phase,ordered primitive tetragonal phase,3
2177,208 k,208 k,3
2170,carbon–hydrogen distances,carbon–hydrogen distances,3
2178,0.5 gpa,0.5 gpa,3
2181,anomaly,anomaly,3
2182,heat capacity,heat capacity,3
2183,properties,properties,3
2185,density,density,3
2186,1.08 1.18 g/cm3,1.08 1.18 g/cm3,3
2187,entropy changes,entropy changes,3
2180,order,order,3
2189,hardness,hardness,3
2168,1.54 å,1.54 å,3
2166,td symmetry,td symmetry,3
2152,dry etching masks,dry etching masks,3
2153,polymer formulations,polymer formulations,3
2154,adamantane analogues,chemical compound,3
2155,molecules,molecules,3
2156,ions,ions,3
2157,adamantanelike cage structures,adamantanelike cage structures,3
2167,carbon–carbon bond lengths,carbon–carbon bond lengths,3
2158,tetramine,tetramine,3
2160,silaadamantane,silaadamantane,3
2161,naturally occurring organoarsenic analogue,naturally occurring organoarsenic analogue,3
2162,new caledonian marine sponge,new caledonian marine sponge,3
2163,structure,structure,3
2164,electron diffraction,electron diffraction,3
2165,xray crystallography,xray crystallography,3
2159,extreme toxicity,extreme toxicity,3
2151,unfunctionalized hydrocarbon,unfunctionalized hydrocarbon,3
2190,elastic constants,elastic constants,3
2193,principal value,principal value,3
2213,high molecular symmetry,high molecular symmetry,3
2214,optical activity,optical activity,3
2215,different substituents,different substituents,3
2216,nodal carbon sites,nodal carbon sites,3
2217,hydrogen bromine methyl carboxyl group,hydrogen bromine methyl carboxyl group,3
2218,values,values,3
2212,simplicity,simplicity,3
2219,specific rotation,specific rotation,3
2221,adamantane cation,chemical compound,3
2222,1fluoroadamantane,1fluoroadamantane,3
2223,sbf5,sbf5,3
2224,dication,dication,3
2225,solutions,solutions,3
2226,superacids,superacids,3
2220,adamantane cations,chemical compound,3
2192,ultrasonic echo technique,ultrasonic echo technique,3
2211,37.85 ppm,37.85 ppm,3
2209,13c nmr chemical shifts,13c nmr chemical shifts,3
2194,elasticity tensor,elasticity tensor,3
2195,c11,c11,3
2196,6.17 gpa,6.17 gpa,3
2197,corresponding values,corresponding values,3
2199,1123 gpa,1123 gpa,3
2200,arrangement,arrangement,3
2210,1.756 ppm,1.756 ppm,3
2201,covalent lattice,covalent lattice,3
2203,adamantane crystals,chemical compound,3
2204,spectroscopy,spectroscopy,3
2205,spectrum,spectrum,3
2206,poorly resolved signals,poorly resolved signals,3
2207,sites,sites,3
2208,1h,1h,3
2202,weak van der waals forces,weak van der waals forces,3
2068,raipur rani,raipur rani,3
2150,applications,applications,3
2148,iupac,learned society publisher,3
2093,20 february,20 february,3
2095,7 farm workers,7 farm workers,3
2097,adamantane,chemical compound,3
2098,organic compound,organic compound,3
2099,formula c10h16,formula c10h16,3
2100,adamantane molecules,chemical compound,3
2091,chiba prefecture,chiba prefecture,3
2101,fusion,fusion,3
2103,stable isomer,stable isomer,3
2104,c10h16,c10h16,3
2105,spatial arrangement,spatial arrangement,3
2106,carbon atoms,carbon atoms,3
2107,molecule,molecule,3
2109,similarity,similarity,3
2102,cyclohexane rings,cyclohexane rings,3
2110,greek adamantinos,greek adamantinos,3
2090,narita,narita,3
2088,edible ducks,edible ducks,3
2072,8 january,8 january,3
2073,9 january,9 january,3
2074,seven states,seven states,3
2075,namibia,emoji regional indicator sequence,3
2076,transit,transit,3
2077,european countries,european countries,3
2089,yokoshibahikari,municipality japan town japan,3
2078,iraq,emoji regional indicator sequence,3
2081,samsara,religious concept,3
2083,68 800strong flock,68 800strong flock,3
2084,forestry,forestry,3
2085,fishers,fishers,3
2086,h5n8 type birdflu,h5n8 type birdflu,3
2087,weaken bodies condition,weaken bodies condition,3
2080,city,city,3
2149,uses,uses,3
2111,camphorlike odor,camphorlike odor,3
2113,history synthesis,history synthesis,3
2134,water,water,3
2135,nonpolar organic solvents,nonpolar organic solvents,3
2136,unusually high melting point,unusually high melting point,3
2137,hydrocarbon,hydrocarbon,3
2138,270 °c,270 °c,3
2139,melting point,melting point,3
2133,physical properties,physical properties,3
2140,hydrocarbons,hydrocarbons,3
2142,camphene,analytical technique toxaphene,3
2143,room temperature,room temperature,3
2144,water vapor,water vapor,3
2145,nomenclature,nomenclature,3
2146,rules,rules,3
2147,systematic nomenclature,systematic nomenclature,3
2141,molecular weight,molecular weight,3
2112,simplest diamondoid,simplest diamondoid,3
2132,petroleum,petroleum,3
2130,cyclohexanone,chemical compound class ii combustible liquid,3
2114,h. decker,h. decker,3
2115,existence,existence,3
2116,attempted laboratory synthesis,attempted laboratory synthesis,3
2117,german chemist hans meerwein,german chemist hans meerwein,3
2119,formaldehyde,organic compound flammable gas occupational carcinogen aldehydes chemical compound carcinogen,3
2120,diethyl malonate,diethyl malonate,3
2131,natural occurrence,natural occurrence,3
2121,piperidine,chemical compound piperidine,3
2123,synthesis,synthesis,3
2124,adamantane adamantane derivatives,chemical compoundchemical compound,3
2125,d. bottger,d. bottger,3
2127,derivative,derivative,3
2128,phloroglucinol,chemical compound benzenetriol medication,3
2129,derivatives,derivatives,3
2122,compound,compound,3
2227,stability,stability,3
1861,travellers,travellers,3
1857,teachers,teachers,3
1617,strongest risk factors,strongest risk factors,3
1619,lung injury,lung injury,3
1620,staphylococcus aureus,staphylococcus aureus,3
1622,important cause,important cause,3
1623,streptococcus,streptococcus,3
1624,second important cause,second important cause,3
1615,previously unhealthy individuals,previously unhealthy individuals,3
1625,primary,primary,3
1627,risk factors,risk factors,3
1628,hospitalisation,hospitalisation,3
1629,poor outcome,poor outcome,3
1631,631 patients,631 patients,3
1632,55 hospitals,55 hospitals,3
1634,13%,13%,3
1626,united kingdom investigation,united kingdom investigation,3
1635,high dependency,high dependency,3
1613,immediate respiratory support,immediate respiratory support,3
1611,intensive care unit,intensive care unit,3
1593,throat,throat,3
1594,nose throat lungs,nose throat lungs,3
1595,subsequent pandemics,subsequent pandemics,3
1596,fewer fatalities,fewer fatalities,3
1597,development,development,3
1598,antibiotic medicines,antibiotic medicines,3
1612,admission,admission,3
1599,external links,external links,3
1604,certain underlying medical conditions,certain underlying medical conditions,3
1605,increased risk,increased risk,3
1606,symptom onset,symptom onset,3
1607,deterioration,deterioration,3
1609,24 hours,24 hours,3
1610,immediate admission,immediate admission,3
1600,curlie,curlie,3
1592,common bacteria,taxon,3
1636,5%,5%,3
1638,45%,45%,3
1662,transmissions,transmissions,3
1665,ferrets,ferrets,3
1666,household cats,household cats,3
1667,dog,dog,3
1668,cheetah,cheetah,3
1669,public health response,public health response,3
1661,past pandemics,past pandemics,3
1670,27 april,27 april,3
1672,europeans,europeans,3
1673,nonessential travel,nonessential travel,3
1675,6,6,3
1676,public health agency,public health agency,3
1677,canada,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,3
1678,canada national microbiology laboratory,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,3
1671,european union health commissioner,european union health commissioner,3
1637,36%,36%,3
1659,transmissibility,transmissibility,3
1657,2009 novel,2009 novel,3
1639,underlying condition,underlying condition,3
1640,mainly asthma,mainly asthma,3
1641,documented chest xrays,documented chest xrays,3
1642,29%,29%,3
1643,evidence,evidence,3
1644,bacterial coinfection,bacterial coinfection,3
1658,december 2009 study,december 2009 study,3
1645,multivariate analyses,multivariate analyses,3
1647,pulmonary conditions,pulmonary conditions,3
1648,chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,3
1651,raised creactive protein,raised creactive protein,3
1652,h1n1associated myocarditis,h1n1associated myocarditis,3
1655,person,person,3
1656,basic reproduction number,basic reproduction number,3
1646,physicianrecorded obesity,scientific journal hybrid open access journal academic journal allegedly,3
1681,u.k.,u.k.,3
1591,victims,victims,3
1589,lining,lining,3
1513,adequate liquid intake,adequate liquid intake,3
1514,thecounter,thecounter,3
1515,paracetamol,chemical compound medication essential medicine,3
1516,thecounter pain medications,thecounter pain medications,3
1517,ibuprofen,ibuprofen,3
1520,fever medication,fever medication,3
1512,methods,methods,3
1522,ones,ones,3
1524,antivirals,chebi ontology term,3
1528,h1n1caused illness,h1n1caused illness,3
1529,bacterial infection,bacterial infection,3
1530,48 hours,48 hours,3
1531,start,start,3
1532,outcomes,outcomes,3
1523,preexisting underlying medical conditions,preexisting underlying medical conditions,3
1533,hospitalised patients,hospitalised patients,3
1509,immunization practices,immunization practices,3
1507,cdc s advisory committee],cdc s advisory committee],3
1483,priority groups,priority groups,3
1484,nhs,nhs,3
1486,households,households,3
1487,compromised immunity,compromised immunity,3
1488,injections,injections,3
1494,officials,officials,3
1508,cdc s advisory committee,cdc s advisory committee,3
1495,businesses,businesses,3
1497,possible school closures,possible school closures,3
1498,multiple employee absences,multiple employee absences,3
1499,surges,surges,3
1501,potentially widespread outbreaks,potentially widespread outbreaks,3
1502,disaster response organizations,disaster response organizations,3
1503,direct relief,direct relief,3
1496,contingency plans,contingency plans,3
1590,bronchial tubes,bronchial tubes,3
1534,oseltamivir,chemical compound neuraminidase inhibitor medication essential medicine,3
1536,substitute,substitute,3
1567,industrialised countries,industrialised countries,3
1568,highrisk populations,highrisk populations,3
1569,infants,infants,3
1570,annual epidemics,annual epidemics,3
1571,global pandemics,global pandemics,3
1572,20th century,20th century,3
1566,data,data,3
1573,spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
1577,threequarters,threequarters,3
1580,north american swine flu strains,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
1581,factory farm,factory farm,3
1582,north carolina,north carolina,3
1586,autumn,autumn,3
1587,great majority,great majority,3
1574,major genetic changes,major genetic changes,3
1535,zanamivir,chemical compound neuraminidase inhibitor medication,3
1565,influenzarelated illnesses,influenzarelated illnesses,3
1561,severe illness,severe illness,3
1537,peramivir,scholarly article review article,3
1539,available methods,available methods,3
1540,shortages,shortages,3
1541,drugs,drugs,3
1548,fight,fight,3
1549,addition,addition,3
1564,41 400 people,41 400 people,3
1550,british report,british report,3
1553,medication,medication,3
1554,epidemiology,branch science,3
1555,scientific journals,scientific journals,3
1557,comparisons pandemics epidemics,comparisons pandemics epidemics,3
1559,5–15%,5–15%,3
1560,global population,global population,3
1551,course,course,3
1858,teachers hotel rooms,teachers hotel rooms,3
1683,website,website,3
1687,burden,burden,3
1795,visitors,visitors,3
1796,u.s. airlines,u.s. airlines,3
1797,major changes,major changes,3
1798,continued standing practices,continued standing practices,3
1799,passengers,passengers,3
1800,masks,masks,3
1794,restricting,restricting,3
1801,airline crews,airline crews,3
1803,singapore airlines,emoji regional indicator sequence,3
1804,china eastern airlines,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
1805,china southern airlines,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
1806,cathay pacific,cathay pacific,3
1807,aeromexico,airline,3
1808,measures,measures,3
1802,nonu.s. airlines,nonu.s. airlines,3
1811,airports,airports,3
1793,closing borders,closing borders,3
1791,containment,containment,3
1777,bmj feature,scientific journal open-access journal medical journal,3
1778,editorial,editorial,3
1779,readers,readers,3
1780,impression,impression,3
1781,decision,decision,3
1782,desire,desire,3
1792,effect,effect,3
1783,profits,profits,3
1785,line,line,3
1786,decisions,decisions,3
1787,pandemic alert,pandemic alert,3
1788,clearly defined virological epidemiological criteria,clearly defined virological epidemiological criteria,3
1789,travel precautions,travel precautions,3
1790,7,7,3
1784,pharmaceutical industry,pharmaceutical industry,3
1776,question,question,3
1813,effective method,effective method,3
1819,workplace,workplace,3
1843,face masks,face masks,3
1844,respirators,respirators,3
1845,nonhealth care settings,nonhealth care settings,3
1846,workplaces,workplaces,3
1847,public places,public places,3
1848,exceptions,exceptions,3
1842,general guidance,general guidance,3
1849,disagreement,disagreement,3
1851,quarantine,quarantine,3
1852,fear,fear,3
1853,quarantines,quarantines,3
1854,foreign visitors,foreign visitors,3
1855,contact,contact,3
1856,21 u.s. students,21 u.s. students,3
1850,value,value,3
1818,24 years,24 years,3
1839,seven days,seven days,3
1837,ill family member,ill family member,3
1821,u.s. department,u.s. department,3
1823,centers,centers,3
1824,department,department,3
1825,homeland security,homeland security,3
1826,updated guidance,updated guidance,3
1827,video,video,3
1838,persons,persons,3
1828,employers,employers,3
1831,employers objectives,employers objectives,3
1832,staff,staff,3
1833,40%,40%,3
1834,workforce,workforce,3
1835,peak,peak,3
1836,healthy adults,healthy adults,3
1829,plans,plans,3
1685,authorisation number,authorisation number,3
1775,directorgeneral,directorgeneral,3
1773,fiona godlee,fiona godlee,3
1712,19 november,19 november,3
1713,doses,doses,3
1714,16 countries,16 countries,3
1715,2009 review,2009 review,3
1716,u.s. national institutes,u.s. national institutes,3
1718,safety profile,safety profile,3
1710,usual federal requirements,usual federal requirements,3
1720,accusations conflict,accusations conflict,3
1722,wodarg,wodarg,3
1723,false pandemic flu campaign,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
1724,greatest medicine scandals,greatest medicine scandals,3
1725,century,century,3
1726,false pandemic campaign,false pandemic campaign,3
1727,mexico city,state mexico,3
1721,wolfgang wodarg,wolfgang wodarg,3
1729,beginning,beginning,3
1709,waivers,waivers,3
1707,u.s. president obama,u.s. president obama,3
1688,general practitioners,general practitioners,3
1689,u.s. officials,u.s. officials,3
1692,steps,steps,3
1693,similar crisis,similar crisis,3
1694,u.s. governmental agencies,u.s. governmental agencies,3
1695,summer lull,summer lull,3
1708,national emergency,national emergency,3
1696,stock,stock,3
1698,gaps,gaps,3
1699,public health safety net,public health safety net,3
1700,early autumn,early autumn,3
1701,preparations,preparations,3
1703,coordination,coordination,3
1706,24 october,24 october,3
1697,united states response,united states response,3
1774,margaret chan,margaret chan,3
1731,little scientific evidence,little scientific evidence,3
1733,big pharmaceutical companies,big pharmaceutical companies,3
1756,preparation,preparation,3
1757,12 april,12 april,3
1758,12 april 2010keijifukudathewho stopinfluenzaexpertstatedthatthesystemleadingtothedeclarationofapandemicledtoconfusionabouth1n1circulatingaroundtheworldand keiji fukuda,12 april 2010keijifukudathewho stopinfluenzaexpertstatedthatthesystemleadingtothedeclarationofapandemicledtoconfusionabouth1n1circulatingaroundtheworldand keiji fukuda,3
1759,keiji fukuda,keiji fukuda,3
1761,declaration,declaration,3
1762,confusion,confusion,3
1755,preliminary report,preliminary report,3
1763,failure,failure,3
1765,uncertainties,uncertainties,3
1767,directorgeneral margaret chan,directorgeneral margaret chan,3
1768,29 flu experts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
1769,organization,organization,3
1771,frank critical transparent credible independent review,frank critical transparent credible independent review,3
1772,performance.in june,performance.in june,3
1764,regard,regard,3
1732,cooperation,cooperation,3
1753,influence,influence,3
1751,council,council,3
1734,redefined pandemics,redefined pandemics,3
1735,statement scientists,statement scientists,3
1736,statement,statement,3
1737,enormous,enormous,3
1738,existing definition,existing definition,3
1739,borders,borders,3
1752,enquiry,enquiry,3
1740,independent advice,independent advice,3
1742,outside interests,outside interests,3
1743,review,review,3
1745,spokeswoman fadela chaib,spokeswoman fadela chaib,3
1747,chance,chance,3
1749,description,description,3
1750,fake,fake,3
1741,interference,interference,3
1482,initial doses,initial doses,3
2228,phenomenon,phenomenon,3
2230,pair,pair,3
2719,daclatasvir,scholarly article review article,3
2721,liver function,organ type,3
2723,asunaprevir/daclatasvir/beclabuvir,asunaprevir/daclatasvir/beclabuvir,3
2724,hiv,organisms known particular common,3
2725,hcv,hcv,3
2726,recent metaanalysis,recent metaanalysis,3
2718,postmarketing trial,postmarketing trial,3
2728,high response rates,high response rates,3
2731,prior interferonbased therapy,prior interferonbased therapy,3
2732,restriction,restriction,3
2733,noncirrhotic patients,noncirrhotic patients,3
2734,il28b genotype,il28b genotype,3
2735,resistanceassociated variants,resistanceassociated variants,3
2736,bulevirtide,medication synthetic peptide,3
2729,hcv genotype 1infected patients,hcv genotype 1infected patients,3
2737,brand hepcludex,brand hepcludex,3
2717,beclabuvir,chemical compound,3
2714,i38m,i38m,3
2698,covid19,covid19,3
2699,published evidence,published evidence,3
2700,8 april,8 april,3
2701,available forms,available forms,3
2702,tablet form,tablet form,3
2703,granules,granules,3
2715,i38f mutations,i38f mutations,3
2704,2.2%,2.2%,3
2706,phase ii trial,phase ii trial,3
2707,10%,10%,3
2708,phase iii trial,phase iii trial,3
2710,variants,variants,3
2712,substitutions,substitutions,3
2713,isoleucine38 specifically i38t,isoleucine38 specifically i38t,3
2705,baloxavir recipients,baloxavir recipients,3
2697,shionogi research reporting,pharmaceutical company,3
2739,raised levels,raised levels,3
2741,injection,injection,3
2771,ns3/4a protease,ns3/4a protease,3
2772,hcv genotype 1a,hcv genotype 1a,3
2773,good selectivity,good selectivity,3
2774,representative serine,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
2775,cysteine proteases,cysteine proteases,3
2778,ciluprevir scaffold,chemical compound,3
2770,potent competitive reversible inhibitor,potent competitive reversible inhibitor,3
2780,cmx521,chemical compound,3
2782,norovirus,taxon,3
2783,related viral diarrheas,related viral diarrheas,3
2784,rotovirus,scholarly article,3
2785,sapoviruses,sapoviruses,3
2786,astroviruses,astroviruses,3
2787,adenoviruses,adenoviruses,3
2781,chimerix,chimerix,3
2740,bile salts,bile salts,3
2767,ns3/4a,ns3/4a,3
2765,research code,research code,3
2742,receptor,receptor,3
2745,liver cells,organ type,3
2746,entry,entry,3
2747,cells,cells,3
2748,ability,ability,3
2749,hdv,hdv,3
2766,biln,biln,3
2750,european union,european union,3
2753,pharmacology,pharmacology,3
2754,sodium/bile acid cotransporter,sodium/bile acid cotransporter,3
2755,hepatocytes,hepatocytes,3
2759,ntcp,ntcp,3
2762,ciluprevir,chemical compound,3
2764,boehringer ingelheim,boehringer ingelheim,3
2751,hdvrna positive adult patients,hdvrna positive adult patients,3
2788,nucleoside analogue,nucleoside analogue,3
2696,names,names,3
2694,japanese pharmaceutical company,japanese pharmaceutical company,3
2619,adverse effect,adverse effect,3
2620,asunaprevir,chemical compound carbocyclic compound heterocyclic compound,3
2623,bristolmyers squibb,bristolmyers squibb,3
2625,inhibitor,inhibitor,3
2627,baloxavir marboxil,baloxavir marboxil,3
2628,brand xofluza,brand xofluza,3
2618,adamas pharma,adamas pharma,3
2632,mouth,mouth,3
2634,resistant mutants,resistant mutants,3
2635,prodrug strategy,prodrug strategy,3
2636,baloxavir marboxil metabolism,baloxavir marboxil metabolism,3
2637,active agent,active agent,3
2638,baloxavir acid,baloxavir acid,3
2639,bxa,bxa,3
2633,selection,selection,3
2640,enzyme inhibitor,enzyme inhibitor,3
2617,ldopa anticholinergic drugs,ldopa anticholinergic drugs,3
2615,long periods,long periods,3
2593,manufacturer data,manufacturer data,3
2594,researchers lookedatagroupoftenpatientswithparkinson sdiseaseandgave group,researchers lookedatagroupoftenpatientswithparkinson sdiseaseandgave group,3
2595,group oftenpatientswithparkinson sdiseaseandgaveagroupof patients,group oftenpatientswithparkinson sdiseaseandgaveagroupof patients,3
2599,seven patients,seven patients,3
2601,clinical trial,clinical trial,3
2602,1969 trial,1969 trial,3
2616,monotherapy,monotherapy,3
2603,163 patients,163 patients,3
2606,subjective objective reduction,subjective objective reduction,3
2607,maximum daily dose,maximum daily dose,3
2608,200 mg,200 mg,3
2611,greater lengths,greater lengths,3
2612,different combinations,different combinations,3
2613,neurological drugs,neurological drugs,3
2605,66%,66%,3
2695,switzerlandbased roche ag,switzerlandbased roche ag,3
2641,influenza virus capdependent endonuclease activity,infectious disease,3
2644,process,process,3
2678,substituted pyridone derivative,substituted pyridone derivative,3
2680,chemical synthesis,chemical synthesis,3
2681,ways,ways,3
2682,shionogi,pharmaceutical company,3
2683,co.,co.,3
2684,shionogi reports,pharmaceutical company,3
2677,chemistry,chemistry,3
2685,japanese patent literature,japanese patent literature,3
2687,possible industrial synthetic routes,possible industrial synthetic routes,3
2689,bxm,bxm,3
2690,publications,publications,3
2691,patent literature,patent literature,3
2692,market,market,3
2693,shionogi co.,pharmaceutical company,3
2686,insight,insight,3
2643,virus polymerase complex,group class enzymes,3
2673,host premrnasattheir5,host premrnasattheir5,3
2670,polymerasecatalyzed synthesis,polymerasecatalyzed synthesis,3
2646,bronchitis,bronchitis,3
2647,sinusitis,sinusitis,3
2651,updated indication,updated indication,3
2654,postexposure prevention,postexposure prevention,3
2656,calciumfortified beverages,calciumfortified beverages,3
2657,laxatives,laxatives,3
2672,host,host,3
2658,antacids,antacids,3
2661,adverse events,adverse events,3
2663,mechanism action,mechanism action,3
2665,specifically enzyme inhibitor,specifically enzyme inhibitor,3
2666,activities,activities,3
2667,baloxavir,baloxavir,3
2668,short capped primers,short capped primers,3
2659,oral supplements,oral supplements,3
2591,instances,instances,3
2791,cirrhosis,cirrhosis,3
2794,rifampin,rifampin,3
2915,inhibitor class,inhibitor class,3
2917,ombitasvir/paritaprevir/ritonavir,medication chemical substance mixture essential medicine,3
2919,following hcv subtypes,following hcv subtypes,3
2920,genotype 1a,genotype 1a,3
2921,genotype,genotype,3
2922,unknown subtype,unknown subtype,3
2914,dasabuvir,scholarly article,3
2923,1 mixed infection,1 mixed infection,3
2927,copackaged dasabuvir,scholarly article,3
2929,1a,1a,3
2930,following criteria,following criteria,3
2931,viekira pak,viekira pak,3
2933,insomnia,insomnia,3
2934,subjects,subjects,3
2924,compensated cirrhosis,compensated cirrhosis,3
2935,increases,increases,3
2913,ethinylestradiol,ethinylestradiol,3
2911,harm,harm,3
2896,multiple hcv genotypes,multiple hcv genotypes,3
2897,(gt1b,(gt1b,3
2898,ic50,ic50,3
2899,danaoprevir,danaoprevir,3
6117,novavax,novavax,3
2901,roche,roche,3
2912,birth control pills,birth control pills,3
2902,commercialization,commercialization,3
2904,tradename,tradename,3
2905,combinations,combinations,3
2906,cure,cure,3
2907,90%,90%,3
2908,trouble,trouble,3
2909,liver failure,organ type,3
2903,ascletis,ascletis,3
2895,favorable potency profile,favorable potency profile,3
2936,liver enzymes,organ type,3
2938,alt,alt,3
2959,deleobuvir,chemical compound,3
2963,interferonfree regimens,interferonfree regimens,3
2964,eicar,eicar,3
2965,enzyme imp dehydrogenase,enzyme imp dehydrogenase,3
2966,nucleoside derivative,nucleoside derivative,3
2968,leukemia,leukemia,3
2958,28 days,28 days,3
2971,activity,activity,3
2979,fujifilm,fujifilm,3
2980,zhejiang hisun pharmaceutical co.,zhejiang hisun pharmaceutical co.,3
2981,generic drug,generic drug,3
2982,zhejiang hisun pharmaceutical co. ofchinatoproduceanantiviralmedicationusedtotreatinfluenzainjapaninthepeople srepublicof china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
2983,favipiravir,chemical compound medication,3
2985,baby,baby,3
2975,reovirus,reovirus,3
2937,ast,ast,3
2957,monthly package,monthly package,3
2955,meal,meal,3
2939,greater times upper limit,greater times upper limit,3
2940,dasabuvir works,scholarly article,3
2941,ns5b palm polymerase,group class enzymes,3
2943,replication,replication,3
2944,polymerase,group class enzymes,3
2945,new cells,new cells,3
2956,combination pack,combination pack,3
2946,u.s. fda,u.s. fda,3
2948,ombitasvirparitaprevirritonavir,ombitasvirparitaprevirritonavir,3
2950,administration storage,administration storage,3
2951,tablets,tablets,3
2952,ritonavir,chemical compound medication heterocyclic compound essential medicine,3
2953,morning,morning,3
2954,dasabuvir tablet,scholarly article,3
2947,regimen,regimen,3
2792,sofusbivir,sofusbivir,3
2893,fluoroisoindole tertbutyl carbamate moieties,fluoroisoindole tertbutyl carbamate moieties,3
2891,orally available 15membered macrocyclic peptidomimetic inhibitor,orally available 15membered macrocyclic peptidomimetic inhibitor,3
2825,inhibitors,inhibitors,3
2826,enzyme,enzyme,3
2827,daclatasvir levels,scholarly article review article,3
2829,cyp3a,gene,3
2830,pgp,pgp,3
2831,nonnucleoside reverse transcriptase inhibitors,nonnucleoside reverse transcriptase inhibitors,3
2824,cyp3a pglycoprotein substrate,gene,3
2832,induction,induction,3
2834,ketoconazole,pair enantiomers medication heterocyclic compound azole,3
2835,required dosage adjustments,required dosage adjustments,3
2836,immunosuppressants,immunosuppressants,3
2837,narcotic analgesics,chebi ontology term,3
2838,antidepressants,antidepressants,3
2839,sedatives,sedatives,3
2833,antifungals,antifungals,3
2840,cardiovascular agents,cardiovascular agents,3
2823,phenytoin,chemical compound medication essential medicine carcinogen,3
2821,decreased therapeutic effect,decreased therapeutic effect,3
2795,carbamazepine,chemical compound medication essential medicine,3
2798,brand daklinza,brand daklinza,3
2799,bristol myers squibb,bristol myers squibb,3
2800,bms,bms,3
2802,sofosbuvir,chemical compound medication active ingredient essential medicine,3
2803,ribavirin,chemical compound medication essential medicine 1 april 1990,3
2822,inducers,inducers,3
2806,breastmilk,breastmilk,3
2808,single agent,single agent,3
2810,sofusbivir triple therapy,sofusbivir triple therapy,3
2811,sofusbivir/ribavirin,sofusbivir/ribavirin,3
2812,common adverse events,common adverse events,3
2815,european medicines agency,european medicines agency,3
2819,strong inducers,strong inducers,3
2807,bradycardia,medical finding,3
2892,ns3/4a hcv protease,ns3/4a hcv protease,3
2841,amiodarone,chemical compound medication essential medicine,3
2844,daklinza,daklinza,3
2872,pgp substrate,pgp substrate,3
2874,99%,99%,3
2876,volume,volume,3
2877,distribution,distribution,3
2879,60 mg,60 mg,3
2881,100 μg,100 μg,3
2871,liver enzyme cyp3a4,organ type,3
2882,economics,economics,3
2885,different countries,different countries,3
2886,economic development,economic development,3
2887,generics manufacturers,generics manufacturers,3
2888,developing world,developing world,3
2889,twelveweek course,twelveweek course,3
2890,danoprevir,chemical compound,3
2884,different prices,different prices,3
2842,slowing,slowing,3
2870,67%,67%,3
2868,oral tablet,oral tablet,3
2845,precursor,precursor,3
2846,phenotypic screening,phenotypic screening,3
2847,gt1b replicon,gt1b replicon,3
2848,huh7 cells,cell line cancer cell line,3
2850,huh7,cell line cancer cell line,3
2851,counterscreen,counterscreen,3
2869,bioavailability,bioavailability,3
2852,specificity,specificity,3
2854,combination regimens,combination regimens,3
2859,ns5a,ns5a,3
2861,translation,translation,3
2864,4 days,4 days,3
2865,oncedaily 60 mg oral administration,oncedaily 60 mg oral administration,3
2867,administration,administration,3
2853,society culture,society culture,3
2229,fourcenter twoelectron bond,fourcenter twoelectron bond,3
2590,published case report,published case report,3
2577,investigations,investigations,3
2338,fda,fda,3
2339,extended release formulation,extended release formulation,3
2340,levodopainduced dyskinesia,levodopainduced dyskinesia,3
2341,offlabel uses,offlabel uses,3
2342,improvement,improvement,3
2343,multiple sclerosis,multiple sclerosis,3
2337,amantadine resistance,chemical compound medication,3
2345,functional recovery,functional recovery,3
2347,brain injury,brain injury,3
2348,chemical structure,chemical structure,3
2349,adamantane backbone,chemical compound,3
2350,amino group,amino group,3
2351,methyne positions,methyne positions,3
2352,similar biological properties,similar biological properties,3
2346,arousal,arousal,3
2353,m2 proton channel,m2 proton channel,3
2336,high level,high level,3
2334,a. epidemic resistance frequency,a. epidemic resistance frequency,3
2316,nanotechnology,branch science,3
2317,example,example,3
2318,adamantane solid allow incorporation,chemical compound,3
2319,guest molecules,guest molecules,3
2320,human body,organisms known particular common homo sapiens homo sapiens sapiens homo,3
2321,matrix,matrix,3
2335,early 2000s,early 2000s,3
2322,nicotinic antagonist,nicotinic antagonist,3
2324,noncompetitive nmda antagonist,noncompetitive nmda antagonist,3
2326,antagonism,antagonism,3
2327,influenzavirus m2 proton channel,influenzavirus m2 proton channel,3
2328,endosomal escape,endosomal escape,3
2331,approval,approval,3
2332,prophylaxis,prophylaxis,3
2323,dopamine agonist,chemical compound medication neurotransmitter,3
2315,homologues,homologues,3
2354,pharmacokinetics,pharmacokinetics,3
2356,dyskinesia,dyskinesia,3
2379,enhanced cns depressant effects,enhanced cns depressant effects,3
2380,antidopaminergic drugs,antidopaminergic drugs,3
2381,metoclopramide,chemical compound medication essential medicine,3
2382,typical antipsychotics,typical antipsychotics,3
2383,dopaminergic mechanisms,dopaminergic mechanisms,3
2384,contraindications,contraindications,3
2377,anticholinergic drugs,anticholinergic drugs,3
2387,enlarged prostate,enlarged prostate,3
2391,efficacy,efficacy,3
2394,veterinary misuse,veterinary misuse,3
2395,chinese poultry farmers,organisms known particular common,3
2396,western countries,western countries,3
2397,international livestock regulations,international livestock regulations,3
2398,estimated 2.6 billion doses,estimated 2.6 billion doses,3
2388,glaucoma,glaucoma,3
2355,parkinsonian syndromes,parkinsonian syndromes,3
2376,additional cns stimulants,additional cns stimulants,3
2374,cns effects,cns effects,3
2357,plasma concentrations,plasma concentrations,3
2358,amantadine increase,chemical compound medication,3
2359,greater risk,greater risk,3
2360,toxicity,toxicity,3
2361,halflife elimination,halflife elimination,3
2363,hemodialysis,hemodialysis,3
2375,caution,caution,3
2364,small extent,small extent,3
2366,urine,urine,3
2367,renal excretion,renal excretion,3
2370,interactions,interactions,3
2371,central nervous,central nervous,3
2372,dopaminergic anticholinergic properties,dopaminergic anticholinergic properties,3
2373,mechanisms,mechanisms,3
2365,acetylation,acetylation,3
2399,southeast asia,continent continental area surrounding islands,3
2314,prospects,prospects,3
2312,coatings,coatings,3
2251,formic acid,formic acid,3
2252,carboxylating agent,carboxylating agent,3
2253,carbon tetrachloride,carbon tetrachloride,3
2254,solvent,solvent,3
2255,oxidation,oxidation,3
2256,hydrolysis,hydrolysis,3
2250,carboxylation,carboxylation,3
2257,aqueous solution,aqueous solution,3
2259,ozonation,scholarly article review article,3
2260,alcohol,alcohol,3
2261,benzene,chemical compound class ib flammable liquid occupational carcinogen male reproductive toxicant developmental toxicant carcinogen,3
2262,lewis acids,lewis acids,3
2265,anisole proceeds,anisole proceeds,3
2266,normal conditions,normal conditions,3
2258,acetone,chemical compound excipient polar aprotic solvent class ib flammable liquid mutagen ketone oxygenated hydrocarbons organic compound ketone bodies reactant product product product acetone carboxylase activity,3
2267,catalyst,catalyst,3
2249,gaseous fluorine,gaseous fluorine,3
2247,formation,formation,3
2231,electrons,electrons,3
2232,bridgehead atoms,bridgehead atoms,3
2233,reactions,reactions,3
2234,3coordinated carbon sites,3coordinated carbon sites,3
2235,concentrated sulfuric acid,concentrated sulfuric acid,3
2236,bromination,bromination,3
2248,fluorinated nucleophiles,fluorinated nucleophiles,3
2237,brominating agents,brominating agents,3
2239,composition,composition,3
2240,ratio,ratio,3
2243,especially presence,especially presence,3
2244,catalysts,catalysts,3
2245,fluorination,fluorination,3
2246,initial compounds,initial compounds,3
2238,molecular bromine,molecular bromine,3
2313,touchscreens,touchscreens,3
2270,moderate yields,moderate yields,3
2273,bromide,bromide,3
2298,synthetic cannabinoid designer drugs,synthetic cannabinoid designer drugs,3
2299,ab001,ab001,3
2300,sdb001,sdb001,3
2301,spacecraft fuel,spacecraft fuel,3
2302,attractive candidate,attractive candidate,3
2303,fuel,fuel,3
2297,key structural subunit,key structural subunit,3
2304,hall thrusters,hall thrusters,3
2306,heavy pressure tank,heavy pressure tank,3
2307,potential technological applications,potential technological applications,3
2308,working fluid,working fluid,3
2309,hydraulic systems,hydraulic systems,3
2310,adamantanebased polymers,adamantanebased polymers,3
2311,application,application,3
2305,solid form,solid form,3
2272,bromine nitric acid,bromine nitric acid,3
2296,designer drugs,designer drugs,3
2293,drug resistance,drug resistance,3
2275,acetamide,acetamide,3
2277,pure adamantane,chemical compound,3
2279,adamantane derivative,chemical compound,3
2281,adamantane derivatives,chemical compound,3
2282,adapalene,chemical compound medication carboxylic acid,3
2283,carmantadine,chemical compound,3
2294,amantadine,chemical compound medication,3
2284,chlodantane,chlodantane,3
2286,memantine,chemical compound medication,3
2287,rimantadine,chemical compound medication,3
2288,saxagliptin,medication group stereoisomers,3
2289,tromantadine,chemical compound,3
2290,vildagliptin,medication heterocyclic compound group stereoisomers,3
2291,polymers,polymers,3
2285,dopamantine,chemical compound,3
2582,woman,woman,3
2401,choice,choice,3
2404,surface,surface,3
2517,neurons,neurons,3
2518,physiatrists,physiatrists,3
2519,impairments,impairments,3
2521,improved functional recovery,improved functional recovery,3
2523,initial brain injury,initial brain injury,3
2524,insufficient evidence,insufficient evidence,3
2516,capacity,capacity,3
2525,functional gains,functional gains,3
2527,direct dopamine stimulation,chemical compound medication neurotransmitter,3
2528,stimulants,stimulants,3
2529,norepinephrine pathway,chemical compound medication neurotransmitter,3
2530,longterm outcomes,longterm outcomes,3
2531,amantadineinduced acceleration,amantadineinduced acceleration,3
2532,disability,disability,3
2526,dopamine norepinephrine pathways,chemical compound medication neurotransmitterchemical compound medication neurotransmitter,3
2534,psychosocial stressors,psychosocial stressors,3
2515,neuroplasticity,neuroplasticity,3
2513,neuroplasticity overall functional recovery patients brain injury,neuroplasticity overall functional recovery patients brain injury,3
2495,emergence,emergence,3
2496,mcs,mcs,3
2497,consistent demonstration,consistent demonstration,3
2498,interactive communication,interactive communication,3
2500,traumatic brain injury patients,traumatic brain injury patients,3
2502,time period,time period,3
2514,timelimited window,timelimited window,3
2503,injury,injury,3
2506,doc,doc,3
2507,subarachnoid hemorrhage,subarachnoid hemorrhage,3
2508,cerebral hemorrhage,cerebral hemorrhage,3
2509,american academy,american academy,3
2510,neurology,neurology,3
2512,prolonged doc,prolonged doc,3
2504,significantly improved consciousness,significantly improved consciousness,3
2492,coma,coma,3
2535,neurological,neurological,3
2537,light headedness,light headedness,3
2560,skin rashes,skin rashes,3
2561,stevens–johnson syndrome,stevens–johnson syndrome,3
2562,livedo reticularis,livedo reticularis,3
2563,pregnancy lactation,physiological condition,3
2565,pregnancy,physiological condition,3
2567,animal reproduction studies,taxon,3
2558,skin,skin,3
2568,breast milk,breast milk,3
2570,excretion,excretion,3
2571,amantadine therapy,chemical compound medication,3
2572,infant exposure,infant exposure,3
2574,breastfeeding,breastfeeding,3
2575,mother,mother,3
2576,incidental finding,incidental finding,3
2569,breast milk production,breast milk production,3
2536,drowsiness,drowsiness,3
2557,constipation,constipation,3
2554,peripheral edema,peripheral edema,3
2539,combination,combination,3
2540,agents,agents,3
2541,excessive alcohol usage,excessive alcohol usage,3
2543,neuroleptic malignant syndrome,neuroleptic malignant syndrome,3
2544,depression,depression,3
2545,convulsions,convulsions,3
2556,dry mouth,dry mouth,3
2546,psychosis,psychosis,3
2548,inhibited actions,inhibited actions,3
2549,control,control,3
2550,compulsions,compulsions,3
2551,cardiovascular,cardiovascular,3
2552,orthostatic hypotension,orthostatic hypotension,3
2553,syncope,syncope,3
2547,suicidal ideation,suicidal ideation,3
2403,viral neuraminidase enzyme,group class enzymes,3
2491,consciousness,consciousness,3
2489,awareness patients disorders consciousness,awareness patients disorders consciousness,3
2426,nerve endings,nerve endings,3
2427,anticholinergic,anticholinergic,3
2428,similar pharmaceutical memantine,chemical compound medication,3
2432,extracellular space,extracellular space,3
2433,m2 channel,m2 channel,3
2434,impaired replication,impaired replication,3
2425,norepinephrine,chemical compound medication neurotransmitter,3
2436,exocytosis,exocytosis,3
2438,mechanistically identical fashion,mechanistically identical fashion,3
2439,barrel,barrel,3
2440,tetrameric m2 channel,tetrameric m2 channel,3
2441,pore function,pore function,3
2442,drug class,drug class,3
2443,consequence,consequence,3
2437,function,function,3
2444,mutations,mutations,3
2424,dopamine,chemical compound medication neurotransmitter,3
2422,brain,brain,3
2406,increasing incidence,increasing incidence,3
2407,oseltamivir resistance,chemical compound neuraminidase inhibitor medication essential medicine,3
2409,new antiinfluenza therapies,new antiinfluenza therapies,3
2410,recall,recall,3
2411,dingo chip twists,dingo chip twists,3
2412,potential,potential,3
2423,release,release,3
2413,u.s. national library,u.s. national library,3
2416,antiparkinsonian effect,antiparkinsonian effect,3
2417,weak antagonist,weak antagonist,3
2418,nmdatype glutamate receptor,structural class chemical compounds,3
2419,dopamine release,chemical compound medication neurotransmitter,3
2420,dopamine reuptake,chemical compound medication neurotransmitter,3
2421,monoamine,monoamine,3
2415,mechanism,mechanism,3
2490,disorders,disorders,3
2445,porelining amino acid residues,porelining amino acid residues,3
2447,usual way,usual way,3
2475,improvements,improvements,3
2476,subjective objective ratings,subjective objective ratings,3
2477,final conclusion,final conclusion,3
2478,effectiveness,effectiveness,3
2479,consensus guidelines,consensus guidelines,3
2480,german multiple sclerosis society,german multiple sclerosis society,3
2473,amantadineinduced improvement,amantadineinduced improvement,3
2481,2006 state,2006 state,3
2483,subjective fatigue,symptom,3
2484,problem solving,problem solving,3
2485,memory,memory,3
2486,concentration,concentration,3
2487,gmss guidelines,gmss guidelines,3
2488,msrelated fatigue,symptom,3
2482,moderate improvement,moderate improvement,3
2446,channel,channel,3
2472,2012 cochrane review,2012 cochrane review,3
2470,overall evidence,overall evidence,3
2449,100%,100%,3
2452,cdc guidelines,cdc guidelines,3
2453,neuraminidase inhibitors,group class enzymes,3
2455,cdc cdc,cdc cdc,3
2457,current guidelines,current guidelines,3
2458,m2 inhibitors,m2 inhibitors,3
2471,ms,ms,3
2460,laboratory testing,laboratory testing,3
2462,m2 resistance testing,m2 resistance testing,3
2464,combination therapy,combination therapy,3
2466,fatigue multiple sclerosis,symptom,3
2467,modafinil,chemical compound medication,3
2468,commonly medications,commonly medications,3
2469,2007 cochrane literature review,2007 cochrane literature review,3
2461,priority,priority,3
1481,short supply,short supply,3
1479,exchange,exchange,3
1478,twoway street,twoway street,3
468,members,members,3
469,padua,comune italy big city city college town capital,3
470,german medical historian justus hecker,german medical historian justus hecker,3
471,young population,young population,3
473,spring,spring,3
474,new illness,new illness,3
467,catarrh,catarrh,3
475,extreme cough,extreme cough,3
477,late summer,late summer,3
478,swiss plateaus,swiss plateaus,3
480,swiss physician felix plater,swiss physician felix plater,3
481,severe fits,severe fits,3
482,candidate,candidate,3
483,doctorate,doctorate,3
476,citizens,citizens,3
484,kingdom france,kingdom france,3
465,northern italy,northern italy,3
463,complications,complications,3
447,economy,economy,3
449,sicilian senate,sicilian senate,3
450,advisory capacity,advisory capacity,3
451,collaboration,collaboration,3
452,healthcare,healthcare,3
454,contagious catarrhal fevers,contagious catarrhal fevers,3
464,bernardo,bernardo,3
455,early detection,early detection,3
457,naples,naples,3
458,lower,lower,3
459,italian peninsula,italian peninsula,3
460,coastline,coastline,3
461,entire city,entire city,3
462,individuals,individuals,3
456,epidemic control,epidemic control,3
446,sicilian social life,sicilian social life,3
485,french physician medical historian lazare rivière,french physician medical historian lazare rivière,3
490,french,french,3
516,paris law court,paris law court,3
517,judiciary meetings,judiciary meetings,3
518,spread,spread,3
519,medical historian charlesjacques saillant,medical historian charlesjacques saillant,3
520,kingdoms england scotland,nation uk cultural area countrynation uk nation,3
521,british isles,british isles,3
515,paris judiciary,paris judiciary,3
522,contemporary writer,contemporary writer,3
524,18th century physician thomas short,18th century physician thomas short,3
526,unsound viscera,unsound viscera,3
527,army,army,3
531,earl,earl,3
532,rutland,rutland,3
533,calais,calais,3
523,wriothesley,wriothesley,3
488,languedoc region,languedoc region,3
514,sufferers noses ranlike,sufferers noses ranlike,3
511,french lawyer étienne pasquier,french lawyer étienne pasquier,3
492,nîmes,nîmes,3
493,headaches,headaches,3
494,intense coughing,intense coughing,3
495,fourth day,fourth day,3
499,toulouse,commune france follows tolosa big city,3
500,italian physician francisco vallerioli,italian physician francisco vallerioli,3
513,12 15hour fever,12 15hour fever,3
501,françois valleriola,françois valleriola,3
505,shortness,shortness,3
506,breath,breath,3
507,chills,chills,3
508,expulsion,expulsion,3
509,phlegm,phlegm,3
510,7 14 days,7 14 days,3
502,witness,witness,3
534,impending french assault,impending french assault,3
445,palermo,comune italy city big city,3
443,continental europe,continental area surrounding islands continent geographic region,3
376,gentle bleeding,gentle bleeding,3
378,medical techniques,medical techniques,3
379,urbino,comune italy city,3
380,diet,diet,3
381,good governance,good governance,3
382,common ways,common ways,3
375,sealed earth,sealed earth,3
386,fast onset,fast onset,3
390,ingrassia,ingrassia,3
391,dodoens,dodoens,3
392,mercado,mercado,3
394,short period,short period,3
395,death,stock character psychopomp literary character,3
396,days,days,3
388,contemporary physicians,contemporary physicians,3
398,weather,weather,3
374,mulberries,mulberries,3
372,rose water,rose water,3
354,access point,access point,3
355,red sea,red sea,3
356,shipping routes,shipping routes,3
358,ottoman army,ottoman army,3
359,1559 wave,1559 wave,3
361,time,time,3
373,quinces,quinces,3
362,theory,theory,3
364,cosmos,cosmos,3
365,climate,climate,3
367,entire communities,entire communities,3
369,excess humors physicians,excess humors physicians,3
370,illness,illness,3
371,dr. thomas short,dr. thomas short,3
363,humorism,theory,3
444,sicily italian states holy roman empire,autonomous region special statute cultural region region italy,3
399,mass poisoning,mass poisoning,3
401,reoccurring pattern,reoccurring pattern,3
428,balkans,balkans,3
429,bulgaria,bulgaria,3
430,unrestricted access,unrestricted access,3
431,athens,athens,3
432,sofia,sofia,3
434,sail,sail,3
427,ottoman empire territory,ottoman empire territory,3
435,capital,capital,3
437,tripoli,tripoli,3
438,habesh,habesh,3
439,land,land,3
440,poland,poland,3
441,grand duchy,grand duchy,3
442,lithuania,lithuania,3
436,recently conquered north african territories,recently conquered north african territories,3
400,observers,observers,3
426,infected travelers,infected travelers,3
424,constantinople,constantinople,3
403,greater research,greater research,3
404,19th century,19th century,3
405,scarlet fever,scarlet fever,3
406,diphtheria,diphtheria,3
407,striking features,striking features,3
408,rashes,rashes,3
425,asia minor,continent continental area surrounding islands,3
409,pseudomembranes,pseudomembranes,3
413,illnesses,illnesses,3
414,early stages,early stages,3
418,ages,ages,3
419,widespread infections,widespread infections,3
420,mortalities,mortalities,3
423,trade shipping routes,trade shipping routes,3
411,recognized whooping cough epidemic,recognized whooping cough epidemic,3
353,continent,continent,3
535,january,january,3
537,guise,guise,3
657,sea,sea,3
658,region,region,3
660,central asian city,central asian city,3
661,bukhara,city local administrative unit nuts big city,3
662,transsiberian railway,transsiberian railway,3
663,samarkand,samarkand,3
656,transatlantic travel,transatlantic travel,3
664,tomsk,tomsk,3
666,transcaspian,transcaspian,3
667,krasnovodsk,krasnovodsk,3
668,volga trade routes,volga trade routes,3
669,november,november,3
670,saint petersburg,saint petersburg,3
671,moscow,moscow,3
665,westernmost station,westernmost station,3
672,kiev,capital city special status 1991 city/town city millions inhabitants,3
655,railroads,railroads,3
653,russian empire,russian empire,3
631,massawa,city port settlement,3
632,ottomans,ottomans,3
633,medri bahri,medri bahri,3
634,conquest,conquest,3
636,territory,territory,3
637,epidemic ottoman soldiers,epidemic ottoman soldiers,3
654,202 887,202 887,3
642,deadliest pandemics,deadliest pandemics,3
645,december,december,3
646,recurrences,recurrences,3
647,march,march,3
648,winter,winter,3
650,modern transport infrastructure,modern transport infrastructure,3
652,19 largest european countries,19 largest european countries,3
643,history,history,3
629,battle,battle,3
673,lake baikal region,lake baikal region,3
675,sakhalin,island time discovery invention 1808 1928,3
696,london,london,3
697,birmingham,association football club,3
698,glasgow,city big city lieutenancy area scotland,3
700,dublin,capital big city administrative city republic ireland,3
701,american soil,american soil,3
702,18 december,18 december,3
695,ajaccio,commune france ajaccio seen west (english),3
704,chicago,chicago,3
706,thomas smith,thomas smith,3
707,massachusetts,massachusetts,3
708,25 december,25 december,3
709,san francisco,san francisco,3
710,month,month,3
711,total death toll,stock character psychopomp literary character,3
705,kansas,state united states,3
674,siberia,geographic region russia,3
694,lyon,commune france big city,3
692,grenoble,commune france big city,3
676,end,end,3
677,st. petersburg,st. petersburg,3
678,baltic shipping trade,baltic shipping trade,3
679,vaxholm,urban area sweden,3
680,early november,early november,3
681,stockholm,capital sweden start time 1436 big city hanseatic city port settlement,3
693,toulon,commune france big city,3
682,sweden,sovereign state start time 6 june 1523 country unitary state countries bordering baltic sea,3
684,norway,emoji regional indicator sequence,3
685,denmark,denmark,3
687,posen,posen,3
688,vienna,federal capital statutory city austria metropolis city millions inhabitants enclave city-state municipality austria,3
689,rome,rome,3
690,17 december,17 december,3
683,60%,60%,3
536,duke,duke,3
628,portuguese attaché,portuguese attaché,3
625,severe wave,severe wave,3
556,place,place,3
557,9th 14th day,9th 14th day,3
560,thousands,thousands,3
562,hunger,hunger,3
563,higher death toll,stock character psychopomp literary character,3
564,authorities,authorities,3
555,tight convulsive cough,tight convulsive cough,3
566,needy,needy,3
569,flemish physician rembert dodoens,flemish physician rembert dodoens,3
570,dry hot summer,dry hot summer,3
571,cold winter,cold winter,3
572,chroniclers,chroniclers,3
574,madrid,municipality spain city big city city millions inhabitants capital,3
575,mantua carpentaria,mantua carpentaria,3
568,low countries,low countries,3
576,roughness,roughness,3
554,complaint,complaint,3
552,patients,patients,3
538,underprotected city,underprotected city,3
539,habsburg netherlands,habsburg netherlands,3
540,october,october,3
541,dutch historian petrus forestus,dutch historian petrus forestus,3
542,alkmaar,municipality netherlands start time 1 january 1812gregorian,3
543,span,span,3
553,paroxysm,paroxysm,3
544,slight fever,slight fever,3
546,dutch historian petrus forestus great malignancy,dutch historian petrus forestus great malignancy,3
547,degrees,degrees,3
548,sudden fits,sudden fits,3
549,suffocation,suffocation,3
550,pain,pain,3
551,chest,chest,3
545,common catarrh,common catarrh,3
627,emperor gelawdewos,emperor gelawdewos,3
577,jaws,jaws,3
579,breast,breast,3
611,valencia,valencia,3
612,granada,granada,3
613,pathological records,pathological records,3
614,true plague,true plague,3
615,area,area,3
616,abyssinian empire habesh eyalet,abyssinian empire habesh eyalet,3
610,plagues,plagues,3
617,war,war,3
619,habesh eyalet,habesh eyalet,3
620,aid,aid,3
621,emperor,emperor,3
622,team,team,3
623,andrés oviedo,andrés oviedo,3
624,events,events,3
618,ottoman expansion,ottoman expansion,3
578,small cough,small cough,3
609,pestilencia,pestilencia,3
599,severity,severity,3
580,weight,weight,3
581,stomach,stomach,3
582,sweat,sweat,3
583,nose,nose,3
584,pleurisy,pleurisy,3
585,fatal peripneumony,fatal peripneumony,3
606,sixteenth century spaniards,sixteenth century spaniards,3
586,risk,risk,3
591,spanish mainland,spanish mainland,3
592,country,country,3
593,luis mercado,luis mercado,3
594,double tertian type,double tertian type,3
597,spanish population,spanish population,3
598,negligent medical care,negligent medical care,3
590,parts,parts,3
712,mexico,state mexico,3
352,northern eastern parts,northern eastern parts,3
349,newly established trade routes,newly established trade routes,3
131,contemporaries,contemporaries,3
132,tommasino bianchi,tommasino bianchi,3
133,high fever,high fever,3
135,headache,headache,3
136,prostration,prostration,3
137,loss,loss,3
128,whooping cough,whooping cough,3
138,sleep,sleep,3
140,delirium,disease,3
141,cough,cough,3
142,5th,5th,3
143,10th days,10th days,3
144,lung congestion,lung congestion,3
145,slow recovery,slow recovery,3
139,appetite,appetite,3
146,second week,second week,3
127,suggestions,suggestions,3
125,1510 coqueluche,1510 coqueluche,3
104,oily lintus,oily lintus,3
106,decoctions,decoctions,3
108,justus hecker,justus hecker,3
109,john parkin,john parkin,3
113,massive migrations,massive migrations,3
114,water sources,water sources,3
126,modern epidemiologists,modern epidemiologists,3
115,humans,infectious disease france,3
117,antigenic shift,antigenic shift,3
120,little immunity,little immunity,3
121,european chroniclers,european chroniclers,3
122,chronicled biological evidence,chronicled biological evidence,3
123,europeeurope,europeeurope,3
124,debunking suggestions whooping cough,debunking suggestions whooping cough,3
116,infections,infections,3
103,bole armoniac,bole armoniac,3
147,adults,adults,3
149,weeks,weeks,3
175,southern france,southern france,3
176,merchant ships,merchant ships,3
177,central europe,continental area surrounding islands continent geographic region,3
178,alps,alps,3
179,switzerland,emoji regional indicator sequence,3
180,holy roman empire,holy roman empire,3
174,italy,italy,3
181,mellingen chronicler anton tegenfeld,mellingen chronicler anton tegenfeld,3
184,respiratory illness,respiratory illness,3
185,canton,canton,3
186,aargua,aargua,3
187,june,june,3
188,population,population,3
189,fatigue,symptom,3
183,germanspeaking europeans,germanspeaking europeans,3
148,pertussis,pertussis,3
173,mediterranean coasts,mediterranean coasts,3
171,arrival,arrival,3
150,period,period,3
152,experts,experts,3
154,explosive spread,explosive spread,3
155,timelines,timelines,3
156,sickness,sickness,3
157,recovery,recovery,3
172,infected merchant ships,infected merchant ships,3
160,paris,paris,3
162,jerusalem,city big city capital city council,3
163,mecca,tourist attraction city millions inhabitants,3
166,egypt,emoji regional indicator sequence,3
167,ottoman empire,ottoman empire,3
168,sicily italian kingdoms,autonomous region special statute cultural region region italy,3
170,july,july,3
161,cities,cities,3
190,german physician achilles gasser,german physician achilles gasser,3
101,short,short,3
99,hoods,hoods,3
29,1%,1%,3
32,possibly china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
33,gregor horst,gregor horst,3
34,operum medicorum tombus primus,operum medicorum tombus primus,3
35,trade routes,trade routes,3
37,german medical writer justus hecker,german medical writer justus hecker,3
26,society,society,3
38,historical nature,historical nature,3
40,recent pandemics,recent pandemics,3
41,africa,continent,3
42,,,3
45,continents,continents,3
46,mediterranean,mediterranean,3
47,malta,religious minority major religious group,3
39,influenzas,influenzas,3
48,british medical historian thomas short,british medical historian thomas short,3
25,church,church,3
22,early modern europe,continental area surrounding islands continent geographic region,3
2,asia,continent continental area surrounding islands,3
3,north africa,continent,3
4,europe,continental area surrounding islands continent geographic region,3
7,epidemiologists,epidemiologists,3
8,influenzalike illnesses,influenzalike illnesses,3
9,charlemagne,charlemagne,3
23,significant disruption,significant disruption,3
12,communication advances,communication advances,3
15,coqueluche,coqueluche,3
16,coccolucio,coccolucio,3
17,france,france,3
18,sicily,autonomous region special statute cultural region region italy,3
20,variations,variations,3
21,popular names,popular names,3
13,printing press,printing press,3
100,light sensitivity,light sensitivity,3
49,island,island,3
55,royal courts,royal courts,3
77,ships,ships,3
78,atlantic,atlantic,3
81,santo domingo,santo domingo,3
82,1493.amerindian populations sharp decline,1493.amerindian populations sharp decline,3
84,1490s,1490s,3
85,early 1500s,early 1500s,3
76,fleets,fleets,3
86,smallpox,eradicated disease start time 1980,3
89,shoulders,shoulders,3
90,form,form,3
92,paré,paré,3
94,bloodletting,treatment,3
95,purgation,purgation,3
96,supraorbital pain vision problems,supraorbital pain vision problems,3
88,head,head,3
50,melite,melite,3
75,spain,spain,3
72,americas,americas,3
56,church services,church services,3
57,social life,social life,3
58,turin professor francisco vallerioli,turin professor francisco vallerioli,3
59,constriction,constriction,3
60,breathing,breathing,3
61,hoarseness,hoarseness,3
73,records,records,3
62,voice,voice,3
64,lungs,lungs,3
65,physicians,physicians,3
66,valleriola,valleriola,3
67,children,children,3
68,lawyer francesco muralto,lawyer francesco muralto,3
70,day,day,3
63,cooked humor,cooked humor,3
350,spanish colonies,spanish colonies,3
191,deadly epidemic,deadly epidemic,3
193,mankind,mankind,3
293,populations,populations,3
294,greatest intensity,greatest intensity,3
295,governments,governments,3
296,possibly time,possibly time,3
297,bureaucratic organization,bureaucratic organization,3
298,epidemic responses,epidemic responses,3
292,modern physicians,modern physicians,3
299,miscarriages,miscarriages,3
301,higher burial rates,higher burial rates,3
302,economic turmoil,economic turmoil,3
304,garotillo,garotillo,3
305,established trade pilgrimage routes,established trade pilgrimage routes,3
306,flulike illness,flulike illness,3
307,portuguese goa,portuguese goa,3
300,english names,english names,3
308,1557 parts,1557 parts,3
291,catarrhal fevers,catarrhal fevers,3
289,charles creighton,charles creighton,3
273,reports,reports,3
274,gastrodynia,gastrodynia,3
276,cattle,organisms known particular common bos taurus bos primigenius taurus bos taurus taurus bos primigenius indicus bos indicus,3
277,ireland,emoji regional indicator sequence éire (irish),3
278,spain portugal,sovereign state start time 1415 country,3
279,iberian peninsula,iberian peninsula,3
290,descriptions,descriptions,3
280,highly interconnected trade pilgrimage routes,highly interconnected trade pilgrimage routes,3
282,italian kingdoms,italian kingdoms,3
283,spanish cities,spanish cities,3
285,eventually americas,eventually americas,3
286,intense occasionally lethal symptoms,intense occasionally lethal symptoms,3
287,thomas short,thomas short,3
288,lazare rivière,lazare rivière,3
281,portugal,sovereign state start time 1415 country,3
271,past influenza pandemics,infectious disease,3
309,outbreaks,outbreaks,3
311,typhus,typhus,3
333,air,air,3
335,years,years,3
336,european death rates,stock character psychopomp literary character,3
337,highest levels,highest levels,3
338,spanish portuguese empires,spanish portuguese empires,3
339,sailors,sailors,3
332,dryness,dryness,3
340,central america,central america,3
343,year,year,3
344,south atlantic states,south atlantic states,3
345,gulf area,gulf area,3
346,southwest,southwest,3
347,native american cherokee,native american cherokee,3
348,wave,wave,3
341,spanish ships,spanish ships,3
310,plague,plague,3
331,damp weather,damp weather,3
329,stars,stars,3
312,measles,infectious disease france,3
313,mediterranean sea,mediterranean sea,3
314,advantage,advantage,3
315,trade pilgrimage routes,trade pilgrimage routes,3
316,death rates,stock character psychopomp literary character,3
317,conditions,conditions,3
330,vapors,vapors,3
318,communities,communities,3
321,fevers,fevers,3
324,scotland,nation uk nation,3
325,rest,rest,3
326,entire populations,entire populations,3
327,mass outbreaks,mass outbreaks,3
328,contemporary scholars,contemporary scholars,3
320,epidemics,epidemics,3
192,holy roman empire upper kingdoms,holy roman empire upper kingdoms,3
270,epidemiological study,epidemiological study,3
267,foreign account,foreign account,3
212,kingdom,kingdom,3
213,ports,ports,3
214,marseille,association football club,3
215,nice,commune france big city,3
216,international crowds,international crowds,3
217,shipyards,shipyards,3
211,infected sailors,infected sailors,3
218,merchants,merchants,3
220,travelers,travelers,3
221,south,south,3
224,western mediterranean,western mediterranean,3
225,cephalie catarrhal,cephalie catarrhal,3
226,french physicians,french physicians,3
227,historian françois eudes mézeray,historian françois eudes mézeray,3
219,pilgrims,pilgrims,3
228,etymology,etymology,3
210,england,nation uk cultural area country,3
208,baltic states,baltic states,3
194,mira,mira,3
195,epidemia mortales,epidemia mortales,3
196,urbes,urbes,3
197,v ad summum,v ad summum,3
198,paucissimis ad gorcum,paucissimis ad gorcum,3
199,24 august,24 august,3
209,west,west,3
200,margaret,margaret,3
202,royal assembly,royal assembly,3
203,austria father,sovereign state start time 12 november 1918gregorian republic rechtsstaat landlocked country country state,3
204,holy roman emperor maximilian,holy roman emperor maximilian,3
205,louis xii,louis xii,3
206,king,king,3
207,northern europe,continental area surrounding islands continent geographic region,3
201,austria,sovereign state start time 12 november 1918gregorian republic rechtsstaat landlocked country country state,3
268,fernel,fernel,3
229,coqueluchons,coqueluchons,3
231,rheumatic affliction,rheumatic affliction,3
252,physician,physician,3
253,henry iii,henry iii,3
255,1510 epidemic,1510 epidemic,3
256,fever,fever,3
257,heaviness,heaviness,3
258,coughing,coughing,3
251,jean fernel,jean fernel,3
259,1000 parisians,1000 parisians,3
261,1510 peste,1510 peste,3
262,judicial proceedings,judicial proceedings,3
263,colleges,colleges,3
264,countries,countries,3
265,england ireland,nation uk cultural area countryemoji regional indicator sequence éire (irish),3
266,british medical historian charles creighton,british medical historian charles creighton,3
260,height,height,3
230,french surgeon ambroise paré,french surgeon ambroise paré,3
250,intensity,intensity,3
248,prelates,prelates,3
232,heart,heart,3
233,august,august,3
234,tours,tours,3
235,summer,summer,3
236,entire country,entire country,3
237,september,september,3
249,university professors,university professors,3
238,french poet,french poet,3
241,epidemic,epidemic,3
242,entire kingdom,entire kingdom,3
243,towns,towns,3
244,countryside.coqueluche,countryside.coqueluche,3
245,hospitals,hospitals,3
247,bishops,bishops,3
239,historian jean bouchet,historian jean bouchet,3
713,buenos aires,buenos aires,3
714,2 february,2 february,3
715,south africa,continent,3
1213,domestic sales,domestic sales,3
1214,supermarket sales,supermarket sales,3
1215,onset,onset,3
1216,shoppers,shoppers,3
1217,alternatives,alternatives,3
1218,biggest ongoing surveys,biggest ongoing surveys,3
1212,level,level,3
1219,consumer confidence,consumer confidence,3
1221,respected trusted brand,respected trusted brand,3
1222,company,company,3
1223,130 workers,130 workers,3
1224,drop,drop,3
1225,product sales,product sales,3
1226,transport,transport,3
1220,13 february,13 february,3
1227,general workers union thencalledfor,general workers union thencalledfor,3
1211,9%,9%,3
1208,bans,bans,3
1189,product,product,3
1190,bernard matthews owned subsidiary,bernard matthews owned subsidiary,3
1191,allegations,allegations,3
1192,coverup,coverup,3
1194,14 february,14 february,3
1195,information,information,3
1210,exports,exports,3
1198,uk,uk,3
1201,plausible cause,plausible cause,3
1202,consequences,consequences,3
1203,lengthening list,lengthening list,3
1204,importation,importation,3
1206,russia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,3
1207,spokesman,spokesman,3
1199,17 february,17 february,3
1188,feed,feed,3
1228,workers,workers,3
1230,hardship monies,hardship monies,3
1256,dead whooper swan,dead whooper swan,3
1257,cellardyke,village,3
1258,corresponding incidence,corresponding incidence,3
1259,southeastern hungary,sovereign state country,3
1260,25 january,25 january,3
1261,thirteen districts,thirteen districts,3
1255,essex,essex,3
1262,birbhum,district india,3
1264,murshidabad,municipality west bengal,3
1265,burdwan,municipality west bengal big city,3
1266,hooghly,hooghly,3
1267,cooch behar,cooch behar,3
1268,malda,malda,3
1269,bankura,municipality west bengal big city,3
1263,nadia,nadia,3
1229,general workers union general workers union paidout,general workers union general workers union paidout,3
1254,privately owned quarantine facility,privately owned quarantine facility,3
1251,recent outbreaks uk rest eu,recent outbreaks uk rest eu,3
1231,union funds,union funds,3
1232,union members,union members,3
1234,laidoff workers,laidoff workers,3
1235,row,row,3
1236,1 march,1 march,3
1238,hens,hens,3
1253,south america,south america,3
1239,toms,toms,3
1241,event,event,3
1242,actual compensation,actual compensation,3
1244,subtype,subtype,3
1245,animal species,taxon,3
1248,type,type,3
1249,causative agent,causative agent,3
1240,payout,payout,3
1270,purulia,municipality west bengal,3
1186,middle man,middle man,3
1184,possibility,possibility,3
1128,biosecurity failings,type security,3
1129,holton plant,holton plant,3
1131,gulls,gulls,3
1132,turkey waste,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
1133,roosts,roosts,3
1134,turkeyhouse,turkeyhouse,3
1127,series,series,3
1135,holes,holes,3
1137,rodents,rodents,3
1138,defra minister jeff rooker,defra minister jeff rooker,3
1139,lords,lords,3
1140,22 february,22 february,3
1141,exclusively bernard matthews holton problem,exclusively bernard matthews holton problem,3
1142,hungarian connection,hungarian connection,3
1136,turkey houses,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
1143,8 february,8 february,3
1126,highly critical report,highly critical report,3
1124,permission,permission,3
1106,10 surveillance zone,10 surveillance zone,3
1107,restricted zone,restricted zone,3
1109,evening,evening,3
1110,5 february,5 february,3
1111,criticism,criticism,3
1112,nearby farmers,nearby farmers,3
1125,production,production,3
1113,action,action,3
1116,vet,vet,3
1117,vet fromthesitewasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfrom site,vet fromthesitewasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfrom site,3
1118,site,site,3
1119,hospital,hospital,3
1121,6 february,6 february,3
1123,12 february,12 february,3
1114,320 workers,320 workers,3
1185,gallfoods,gallfoods,3
1144,semiprocessed turkey meat,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
1146,david miliband,david miliband,3
1165,9 february,9 february,3
1166,hungarian authorities,hungarian authorities,3
1167,investigation,investigation,3
1168,connection,connection,3
1169,suffolk hungarian outbreaks,suffolk hungarian outbreaks,3
1171,directions,directions,3
1164,britain,britain,3
1172,eu regulations,eu regulations,3
1174,hungary link,sovereign state country,3
1175,european commission,european commission,3
1177,99.96%,99.96%,3
1179,leak,leak,3
1181,investigator,investigator,3
1182,gallfoods delivery wrapper,gallfoods delivery wrapper,3
1173,transport ban,transport ban,3
1145,hungary,sovereign state country,3
1163,human consumption,organisms known particular common homo sapiens homo sapiens sapiens homo,3
1161,biosecurity,type security,3
1147,house,house,3
1148,commons,commons,3
1149,hungarian connection.bernard matthews,hungarian connection.bernard matthews,3
1150,38 tons,38 tons,3
1151,partly processed turkey meat,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
1152,weekly basis,weekly basis,3
1162,meat,meat,3
1153,hungarian connection.bernard matthews saga foods company,hungarian connection.bernard matthews saga foods company,3
1155,processing plant,processing plant,3
1156,recent hungarian h5n1 outbreak,subtype,3
1157,company director,company director,3
1158,revelation,revelation,3
1159,whitehall,whitehall,3
1160,concern,concern,3
1154,sárvár,town hungary,3
1103,3 february,3 february,3
1271,howrah,municipal corporation west bengal city millions inhabitants,3
1273,chickens,chicken gallus gallus domesticus common,3
1402,ridts,ridts,3
1403,researcher paul schreckenberger,researcher paul schreckenberger,3
1405,rapid tests,rapid tests,3
1406,dangerous public health risk,dangerous public health risk,3
1407,nikki shindo,nikki shindo,3
1408,regret,regret,3
1400,u.s. cdc,u.s. cdc,3
1409,h1n1 test results,virus,3
1413,new test,new test,3
1414,pdm realtime rtpcr panel,pdm realtime rtpcr panel,3
1415,molecular biology technique,molecular biology technique,3
1417,previous realtime rtpcr diagnostic test,previous realtime rtpcr diagnostic test,3
1418,emergency use authorization,emergency use authorization,3
1420,tests results,tests results,3
1411,laboratory confirmation,laboratory confirmation,3
1421,hours,hours,3
1399,ridt false negatives,ridt false negatives,3
1396,30 minutes,30 minutes,3
1377,277 children,277 children,3
1379,diagnosis,activity,3
1382,testing,testing,3
1383,nasopharyngeal nasal oropharyngeal tissue swab,nasopharyngeal nasal oropharyngeal tissue swab,3
1384,patient,patient,3
1385,realtime rtpcr,realtime rtpcr,3
1397,2–4 hours,2–4 hours,3
1386,recommended test,recommended test,3
1390,test results,test results,3
1391,recommended course,recommended course,3
1392,mere diagnosis,activity,3
1393,widely available tests,widely available tests,3
1394,rapid influenza diagnostic tests,infectious disease,3
1395,results,results,3
1389,test,test,3
1376,26 april,26 april,3
1423,little protection,little protection,3
1426,prevention,prevention,3
1450,north american swine influenza,swine diseaseinfectious disease,3
1451,north american avian influenza,infectious disease,3
1454,americans,americans,3
1459,1 100 children,1 100 children,3
1460,7 500 adults,7 500 adults,3
1461,figures,figures,3
1448,genes,genes,3
1463,discovery,discovery,3
1467,report,report,3
1468,reassortment,reassortment,3
1470,nancy cox,nancy cox,3
1472,particular paper,particular paper,3
1476,new variants,new variants,3
1477,situation,situation,3
1465,hybrid,hybrid,3
1424,u.s. centers,u.s. centers,3
1447,nature,nature,3
1445,isolates,isolates,3
1427,preexisting immunity,preexisting immunity,3
1428,degree,degree,3
1429,immunity,immunity,3
1431,6–9%,6–9%,3
1432,older adults,older adults,3
1433,findings,findings,3
1446,gisaid database,gisaid database,3
1434,partial immunity,partial immunity,3
1437,november 2009 study,november 2009 study,3
1438,rural unvaccinated population,rural unvaccinated population,3
1440,previous vaccinations,previous vaccinations,3
1441,exposure,exposure,3
1442,older u.s. population,older u.s. population,3
1443,analyses,analyses,3
1435,previous exposure,previous exposure,3
1272,west midnapore,west midnapore,3
1375,especially high risk,especially high risk,3
1373,developmental delays,developmental delays,3
1313,60 years,60 years,3
1314,unusual characteristic feature,unusual characteristic feature,3
1315,previously healthy people,previously healthy people,3
1316,small percentage,small percentage,3
1318,increased breathing difficulty,increased breathing difficulty,3
1319,initial onset,initial onset,3
1308,followup study,followup study,3
1321,secondary bacterial pneumonia,cause death infectious disease,3
1323,child,child,3
1324,relapse,relapse,3
1325,bacterial pneumonia,cause death infectious disease,3
1326,controversy,controversy,3
1327,wide assortment,wide assortment,3
1328,terms,terms,3
1322,warning sign,warning sign,3
1329,journalists,journalists,3
1303,higher proportion,higher proportion,3
1299,actual number,actual number,3
1276,imposition,imposition,3
1277,disinfection programme,disinfection programme,3
1278,blanket ban,blanket ban,3
1279,causes,causes,3
1280,immediate causes,immediate causes,3
1281,high poultry density,organisms known particular common,3
1301,lower value,lower value,3
1282,moist cold climate,moist cold climate,3
1284,highest population density,highest population density,3
1285,high risk,high risk,3
1287,districts,districts,3
1290,pandemics,pandemics,3
1292,previous triple reassortment,previous triple reassortment,3
1293,bird,taxon,3
1283,quick spread,quick spread,3
1374,nerve muscle problems,nerve muscle problems,3
1330,academics,academics,3
1334,pigs,pigs,3
1355,neurological problems,neurological problems,3
1356,higher risk,higher risk,3
1357,neurodevelopmental conditions,neurodevelopmental conditions,3
1358,underlying medical conditions,underlying medical conditions,3
1359,asthma,asthma,3
1360,diabetes,diabetes,3
1354,vomiting,vomiting,3
1361,obesity,scientific journal hybrid open access journal academic journal allegedly,3
1365,u.s.,u.s.,3
1366,cdc.in september,cdc.in september,3
1367,8 august,8 august,3
1368,36 reports,36 reports,3
1371,state local health authorities,state local health authorities,3
1372,muscular dystrophy,muscular dystrophy,3
1364,hospitalizations,hospitalizations,3
1333,research,research,3
1353,diarrhea,diarrhea,3
1351,sore throat,sore throat,3
1335,need,need,3
1336,agricultural surveillance,agricultural surveillance,3
1337,future outbreaks,future outbreaks,3
1338,u.s. agricultural officials,u.s. agricultural officials,3
1339,way,way,3
1340,popular assumption,popular assumption,3
1352,runny nose,runny nose,3
1342,factory farms,factory farms,3
1344,mount sinai school,mount sinai school,3
1345,medicine,medicine,3
1346,small region,small region,3
1347,central mexico,state mexico,3
1349,muscle,muscle,3
1350,joint pain,joint pain,3
1343,subsequent report,subsequent report,3
1101,surrey,ceremonial county england,3
1100,weybridge,town,3
1099,veterinary laboratories agency,veterinary laboratories agency,3
835,recombination,recombination,3
839,minimal immunity,minimal immunity,3
843,0.2%,0.2%,3
844,study,study,3
845,cfr,cfr,3
846,approximately 0.67%,approximately 0.67%,3
833,virology,virology,3
848,presence,presence,3
853,invention,invention,3
854,antibiotics,scientific journal academic journal 2012,3
855,opportunistic bacterial infections,opportunistic bacterial infections,3
857,schools,schools,3
858,school closures,school closures,3
860,estimates,estimates,3
849,secondary bacterial infection,secondary bacterial infection,3
862,dow jones industrial average,dow jones industrial average,3
832,origin,origin,3
830,h3n2,subtype,3
808,authors,authors,3
809,introduction,introduction,3
812,lone simonsen,lone simonsen,3
813,anders gorm pedersen,anders gorm pedersen,3
814,calculation,calculation,3
816,different strains,different strains,3
831,hong kong,hong kong,3
817,oc43,oc43,3
820,underlying conditions,underlying conditions,3
822,physical stress,physical stress,3
826,h2n2,wikimedia disambiguation page,3
827,guizhou,province china,3
828,southern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
829,number,number,3
818,anders gorm pedersen research,anders gorm pedersen research,3
807,bovine coronavirus,group class strains strain,3
863,15%,15%,3
865,second half,second half,3
888,neighbouring province,neighbouring province,3
889,yunnan,yunnan,3
890,late february,late february,3
891,early march,early march,3
892,middle,middle,3
894,member,member,3
885,chile,chile,3
895,united states cdc,united states cdc,3
897,second wave,second wave,3
898,rural areas,rural areas,3
900,chinese government,chinese government,3
901,chinese national influenza center,infectious disease,3
902,manual,manual,3
904,17 april,17 april,3
896,february 1957.in,february 1957.in,3
864,dow jones industrial average value,dow jones industrial average value,3
882,cécile,cécile,3
880,mark a.,mark a.,3
866,united kingdom,united kingdom,3
867,sickness benefit,sickness benefit,3
868,factories,factories,3
869,mines,mines,3
870,readings,readings,3
871,chowell,chowell,3
881,viboud,viboud,3
872,gerardo,gerardo,3
874,lone,lone,3
875,fuentes,fuentes,3
876,rodrigo,rodrigo,3
877,flores,flores,3
878,jose,jose,3
879,miller,miller,3
873,simonsen,simonsen,3
905,times,times,3
806,betacoronavirus 1 species,betacoronavirus 1 species,3
803,human animal coronaviruses,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,3
738,resurgence,resurgence,3
739,66 fatalities,66 fatalities,3
740,contagious quick action,contagious quick action,3
741,pervasiveness,pervasiveness,3
742,climates,climates,3
743,terrains,terrains,3
737,4%,4%,3
744,pathology,pathology,3
746,carbolic smoke ball company – case,carbolic smoke ball company – case,3
747,english contract law,english contract law,3
748,advertisement,advertisement,3
750,reading,reading,3
751,bäumler,bäumler,3
752,christian,christian,3
745,patterns,patterns,3
753,ueber,ueber,3
736,hold,hold,3
732,12 january,12 january,3
716,india,dominion british empire sovereign state historical country,3
717,durban,city port settlement big city,3
718,february,february,3
719,singapore,emoji regional indicator sequence,3
720,indonesia,sovereign state archipelagic state constitutional republic island nation presidential régime country,3
721,japan,sovereign state island nation country,3
733,median time,median time,3
722,australia,continent,3
725,china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
726,original starting point,original starting point,3
727,central asia,continent continental area surrounding islands,3
729,1 december,1 december,3
730,united states,united states,3
731,week,week,3
724,april,april,3
804,comparison,comparison,3
757,quinine,chemical compound medication essential medicine,3
759,small doses,small doses,3
782,antibodies,family protein complexes,3
783,sera,sera,3
787,1898–1900 epidemic,1898–1900 epidemic,3
788,subtype h3,subtype h3,3
790,subtype h1,subtype h1,3
791,confirmation,confirmation,3
781,seroarcheology—the detection,seroarcheology—the detection,3
793,cause,cause,3
796,reanalysis,reanalysis,3
797,seroarcheological data,seroarcheological data,3
798,h3,h3,3
799,likely cause,likely cause,3
800,coronavirus,group class strains strain,3
802,virologists,virologists,3
795,exhumed corpses,exhumed corpses,3
758,phenazone,chemical compound medication,3
780,work,work,3
777,researchers,researchers,3
760,strychnine larger ones,chemical compound flammable solid alkaloid heterocyclic compound neurotoxin,3
761,whiskey,whiskey,3
762,brandy,brandy,3
764,salt,salt,3
765,warm water,warm water,3
767,belief,belief,3
779,1918 epidemics,1918 epidemics,3
768,body,body,3
770,fact,fact,3
771,doctors,doctors,3
772,miasma theory,miasma theory,3
773,infectious spread,infectious spread,3
774,public health,public health,3
775,result,result,3
769,heat,heat,3
907,hong kong residents,hong kong residents,3
909,midmay,midmay,3
911,extensive outbreak,extensive outbreak,3
1041,similar restrictions,similar restrictions,3
1042,pharmaceutical companies,pharmaceutical companies,3
1043,cipla,business enterprise,3
1044,antiflu medication,antiflu medication,3
1045,indian army,indian army,3
1046,alert,alert,3
1040,kashmir,kashmir,3
1047,evacuation operations,evacuation operations,3
1049,grievances locals,grievances locals,3
1050,main source,main source,3
1051,nawapur,nawapur,3
1052,compensation,compensation,3
1053,economic impact,economic impact,3
1056,steep rise,steep rise,3
1048,drugdistribution measures,drugdistribution measures,3
1057,mutton,mutton,3
1039,jammu,jammu,3
1037,state governments,state governments,3
1017,indian population,indian population,3
1019,19 february,19 february,3
1020,villagers,villagers,3
1022,maharashtra state animal husbandry ministry authorities,state indiataxon,3
1023,spot,spot,3
1024,lab analysis,lab analysis,3
1038,tamil nadu,tamil nadu,3
1027,culling operations,culling operations,3
1031,blood samples,biogenic substance type,3
1032,150 persons,150 persons,3
1033,national institute,national institute,3
1034,analysis,analysis,3
1035,movement,movement,3
1036,passenger trains,passenger trains,3
1030,observation,observation,3
1015,overreaction,overreaction,3
1058,fish,fish,3
1060,rupees,rupees,3
1083,instance,instance,3
1084,h5n1subtype,h5n1subtype,3
1085,range,range,3
1086,precautions,precautions,3
1088,turkeys,turkeys,3
1089,segregation zones,segregation zones,3
1082,suffolk,suffolk,3
1090,plant,plant,3
1092,tuesday,tuesday,3
1093,55 turkey poults,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
1094,1 february,1 february,3
1095,defra,defra,3
1096,farm,farm,3
1097,tests,tests,3
1091,initial signs,initial signs,3
1059,hundreds millions,hundreds millions,3
1081,holton,holton,3
1078,30 january,30 january,3
1061,airlines,airlines,3
1062,air india,dominion british empire sovereign state historical country,3
1063,jet airways,jet airways,3
1064,indian airlines,indian airlines,3
1065,kingfisher airlines,kingfisher airlines,3
1066,chicken,chicken,3
1079,2007 bernard matthews h5n1 outbreak affected poultry,subtypeorganisms known particular common,3
1068,state central governments,state central governments,3
1070,supplies,supplies,3
1071,tamiflu,chemical compound neuraminidase inhibitor medication essential medicine,3
1072,worry,worry,3
1074,west bengal,west bengal,3
1075,2007 bernard matthews h5n1 outbreak,subtype,3
1076,occurrence,occurrence,3
1069,centre,centre,3
1014,incident,incident,3
1013,unnecessary panic,unnecessary panic,3
1012,media,media,3
937,microbiologist maurice hilleman s vaccine isbelievedtohavesaved,microbiologist maurice hilleman s vaccine isbelievedtohavesaved,3
938,hundreds thousands,hundreds thousands,3
939,lives,lives,3
940,u.s. death toll,stock character psychopomp literary character,3
942,cdc,cdc,3
945,soviet union,soviet union,3
936,vaccine rapid deployment,vaccine rapid deployment,3
946,northern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
948,age,age,3
953,unusual characteristics,unusual characteristics,3
954,public,public,3
955,laboratory accident,laboratory accident,3
957,liaoning,province china,3
958,jilin,province china,3
947,younger 25 26 years,younger 25 26 years,3
959,tianjin,direct-controlled municipality port settlement national central city big city city millions inhabitants,3
935,limited quantities,limited quantities,3
933,29 july,29 july,3
912,taiwan,island disputed territory,3
914,late june,late june,3
915,navy personnel,navy personnel,3
917,newport naval station,newport naval station,3
920,microbiologist maurice hilleman,microbiologist maurice hilleman,3
921,pictures,pictures,3
934,wales,wales,3
922,new york times,new york times,3
924,navy doctor,navy doctor,3
925,public health service,public health service,3
928,12,12,3
930,fort ord,fort ord,3
931,26 july,26 july,3
932,lowry air force base,lowry air force base,3
923,samples,samples,3
960,chinese researchers,chinese researchers,3
961,students,students,3
962,areas,areas,3
987,certain reanalysis,certain reanalysis,3
988,1977 reemergent lineage,1977 reemergent lineage,3
989,detection,detection,3
995,list,list,3
997,functioning,functioning,3
999,navapur,human settlement,3
986,hand,hand,3
1000,area main source,area main source,3
1003,village,village,3
1004,nandurbar district,nandurbar district,3
1005,maharashtra,state india,3
1008,residents,residents,3
1009,reason,reason,3
1010,residents main source,residents main source,3
1001,income,income,3
984,soviet scientists,soviet scientists,3
983,biological weapon,biological weapon,3
982,deliberate release,deliberate release,3
963,mainland china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
964,british hong kong,british hong kong,3
965,following months,following months,3
967,high school,high school,3
968,cheyenne,cheyenne,3
970,70%,70%,3
971,solely students,solely students,3
972,military bases,military bases,3
973,u.s,u.s,3
976,reappearance,reappearance,3
977,1950s,1950s,3
978,younger population,younger population,3
979,scientists,scientists,3
980,laboratory leak,laboratory leak,3
981,origin theories,origin theories,3
2987,actions actions,actions actions,3
2988,selective inhibition,selective inhibition,3
2900,array biopharma,array biopharma,3
2991,favipiravir active form,chemical compound medication,3
4942,evolutionary adaptation,evolutionary adaptation,3
4941,humantype receptor,humantype receptor,3
4940,haemagglutinin molecule,haemagglutinin molecule,3
4939,haemagglutinin gene,haemagglutinin gene,3
4938,highvirulence alleles,highvirulence alleles,3
4937,different genes,different genes,3
4936,independent virulence factors,independent virulence factors,3
4935,intervention measures,intervention measures,3
4934,category 5 pandemic,category 5 pandemic,3
4933,higher pandemic severity index level,higher pandemic severity index level,3
4928,herd immunity,herd immunity,3
4927,reliable prediction,reliable prediction,3
4926,far lower 12% lethality rate,far lower 12% lethality rate,3
4925,basis,basis,3
4943,haemagglutinin,haemagglutinin,3
4923,prepandemic virulence,prepandemic virulence,3
4921,accurate projection,accurate projection,3
4920,current lethality,current lethality,3
4919,initial outbreaks,initial outbreaks,3
4917,adaptations,adaptations,3
4914,early projections,early projections,3
4913,1900s,1900s,3
4909,accurate guess,accurate guess,3
4904,speculation,speculation,3
4903,things,things,3
4902,planning,planning,3
4901,levels,levels,3
4900,organizations,organizations,3
4899,planning reports,planning reports,3
4898,proinflammatory cytokines,proinflammatory cytokines,3
4922,initial lethality,initial lethality,3
4897,significantly higher levels,significantly higher levels,3
4944,simultaneous change,simultaneous change,3
4951,additional virulence factor,additional virulence factor,3
4998,pyrazolopyrimidines,pyrazolopyrimidines,3
4997,gabaaagonizing imidazopyridines,gabaaagonizing imidazopyridines,3
4996,benzodiazepines,benzodiazepines,3
4995,chemical substructure,chemical substructure,3
4994,class,class,3
4993,heterocycle,heterocycle,3
4992,nitrogen,nitrogen,3
4991,imidazopyridine,structural class chemical compounds,3
4990,mers,mers,3
4988,potentially useful activity,potentially useful activity,3
4987,reasonable effectiveness,reasonable effectiveness,3
4986,ns5b rna polymerase inhibitor,structural class chemical compoundsgroup class enzymes,3
4985,idx184,idx184,3
4984,increasing vaccine manufacturing capacity,increasing vaccine manufacturing capacity,3
4946,exceptionally high virulence,exceptionally high virulence,3
4982,examples research,examples research,3
4978,sufficient herd immunity,sufficient herd immunity,3
4976,nonevent,nonevent,3
4972,production facilities,production facilities,3
4970,reverse dna techniques,reverse dna techniques,3
4968,passage,passage,3
4966,ultimate outcome,ultimate outcome,3
4964,genetic lethality potential,genetic lethality potential,3
4963,probable lethality,probable lethality,3
4962,scientific advances,scientific advances,3
4960,greater lesser likelihood,greater lesser likelihood,3
4958,rapid slow evolution,rapid slow evolution,3
4957,likelihood,likelihood,3
4956,areas research,areas research,3
4954,virulence factors,virulence factors,3
4980,secretary,secretary,3
4896,mouse study,mouse study,3
4893,date,date,3
4892,over50% case fatality ratio,over50% case fatality ratio,3
4819,overlooked genuine cases,overlooked genuine cases,3
4818,problem,problem,3
4817,unknown number,unknown number,3
4816,unavoidable limitations,unavoidable limitations,3
4814,national governments,national governments,3
4812,global extent,global extent,3
4811,press reports,press reports,3
4810,account,account,3
4809,official tally,official tally,3
4808,fatality ratio,fatality ratio,3
4807,existing prepandemic global case fatality ratio,existing prepandemic global case fatality ratio,3
4803,18 humans,infectious disease france,3
4802,little attention,little attention,3
4801,moderate number,moderate number,3
4820,occasional reports,occasional reports,3
4800,guangdong,province china,3
4798,countryspecific information,countryspecific information,3
4797,mortality incidence,mortality incidence,3
4796,graphic exhibiting total cases,graphic exhibiting total cases,3
4793,mutants,mutants,3
4792,mouse antibodies,family protein complexes,3
4789,substantially greater affinity,substantially greater affinity,3
4786,efforts,efforts,3
4784,technologies,technologies,3
4782,general public,general public,3
4781,preemptive vaccination,preemptive vaccination,3
4780,widespread vaccinations,widespread vaccinations,3
4776,quantities,quantities,3
4774,difficulties,difficulties,3
4772,key point,key point,3
4799,h5n1 killed chickens,subtypechicken gallus gallus domesticus common,3
4823,largest number,largest number,3
4825,relatively benign korean strain,relatively benign korean strain,3
4829,patient ages,patient ages,3
4890,10% 20%,10% 20%,3
4887,1918 spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
4881,grim backdrop,grim backdrop,3
4880,prepandemic case fatality ratio,prepandemic case fatality ratio,3
4879,possible ranges,possible ranges,3
4878,advance,advance,3
4875,unrelated maladies survival chances,unrelated maladies survival chances,3
4874,accustomed care,accustomed care,3
4873,unrelated maladies,unrelated maladies,3
4872,medical care,medical care,3
4870,poorer chances,poorer chances,3
4869,aids,endemic disease location west africa benin rep syndrome,3
4868,familial genetics,familial genetics,3
4866,impairment,impairment,3
4865,significant familial pattern,significant familial pattern,3
4864,harvard school,harvard school,3
4859,human victims,organisms known particular common homo sapiens homo sapiens sapiens homo,3
4831,preadults,preadults,3
4832,older victims,older victims,3
4833,milder attacks,milder attacks,3
4834,frequent development,frequent development,3
4835,cytokine storm,cytokine storm,3
4836,50 years,50 years,3
4999,cyclopyrrones,cyclopyrrones,3
4838,agefatality curve,agefatality curve,3
4844,additional factor,additional factor,3
4847,opportunity,opportunity,3
4851,inoculation,inoculation,3
4854,flumist inoculation,brand,3
4856,factor,factor,3
4857,attempt,attempt,3
4841,opposite,opposite,3
4771,earlier later instances,earlier later instances,3
5001,anxiolytics,anxiolytics,3
5004,gerd,gerd,3
5170,latvia,sovereign state republic countries bordering baltic sea country,3
5168,6 cities,6 cities,3
5165,h1n2,subtype,3
5164,alarm,alarm,3
5163,smithsonian magazine,smithsonian magazine,3
5161,close contact,close contact,3
5160,important intervention,important intervention,3
5159,ecdc,ecdc,3
5158,variant,variant,3
5155,european centre,european centre,3
5153,20.5%,20.5%,3
5152,chinese ministry,chinese ministry,3
5150,nasal swabs,nasal swabs,3
5148,g4 variant,g4 variant,3
5171,oman,emoji regional indicator sequence,3
5147,early identification,early identification,3
5142,executive director,executive director,3
5141,implemented.michael ryan,implemented.michael ryan,3
5139,close monitoring,close monitoring,3
5138,ea,ea,3
5137,essential hallmarks,essential hallmarks,3
5135,sciences,sciences,3
5134,national academy,national academy,3
5133,proceedings,proceedings,3
5132,2020 peerreviewed paper,2020 peerreviewed paper,3
5131,variant genotype,variant genotype,3
5126,56 fatalities,56 fatalities,3
5125,iran,iran,3
5122,confirmed fatalities,confirmed fatalities,3
5121,morocco,morocco,3
5144,chinese cdc,chinese cdc,3
5117,midjanuary,midjanuary,3
5172,malaysia,emoji regional indicator sequence,3
5174,references,references,3
5227,big concern,big concern,3
5226,particular humans,infectious disease france,3
5224,mammalian receptor,mammalian receptor,3
5222,adaptation,adaptation,3
5221,transmits,transmits,3
5220,prior adaptation,prior adaptation,3
5219,certain mammals,certain mammals,3
5218,diseased pigs,diseased pigs,3
5216,national institutes,national institutes,3
5215,overview,overview,3
5213,h2n3 coat,h2n3 coat,3
5212,h2n3,h2n3,3
5210,lessons,lessons,3
5208,vials,vials,3
5173,earliest documented outbreak,earliest documented outbreak,3
5204,cincinnati,big city city united states county seat,3
5202,unidentified samples,unidentified samples,3
5201,accuracy,accuracy,3
5199,american pathologists,american pathologists,3
5198,college,college,3
5196,approximately 3 700 test kits,approximately 3 700 test kits,3
5195,test kits,test kits,3
5188,coastal cities,coastal cities,3
5187,n2 neuraminidase genes,group class enzymes,3
5186,h2 hemagglutinin,group class proteins,3
5183,1960s,1960s,3
5182,early coronaviruses,early coronaviruses,3
5181,speculations,speculations,3
5180,detailed records,detailed records,3
5175,public domain material,public domain material,3
5203,private contractor meridian bioscience,private contractor meridian bioscience,3
5116,european union member state,european union member state,3
5114,lahore,city big city city millions inhabitants administrative territorial entity,3
5113,gujranwala,city big city city millions inhabitants,3
5046,physical changes,physical changes,3
5045,hormonal changes,hormonal changes,3
5044,developing complications,developing complications,3
5041,diameter,diameter,3
5040,size,size,3
5039,small fraction,small fraction,3
5038,host cells,host cells,3
5037,glycoside hydrolase enzyme,glycoside hydrolase enzyme,3
5034,metabolic synergy,metabolic synergy,3
5033,n,n,3
5032,h,h,3
5031,orthomyxovirus,orthomyxovirus,3
5029,known outbreaks,known outbreaks,3
5026,local harbour seal population,local harbour seal population,3
5048,growing fetus,growing fetus,3
5025,wadden sea area,wadden sea area,3
5021,healthy mallards,healthy mallards,3
5019,31%,31%,3
5018,turkey farms,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
5017,minnesota,minnesota,3
5015,ismaillia,ismaillia,3
5014,oneyearold infants,oneyearold infants,3
5013,wikimedia commons,wikimedia commons,3
5012,imidazopyridines,imidazopyridines,3
5010,bone,bone,3
5009,antimigraine drugs,antimigraine drugs,3
5008,analgesics,chebi ontology term,3
5007,nsaids,nsaids,3
5006,antiinflammatories,antiinflammatories,3
5005,gastroprokinetic agents,gastroprokinetic agents,3
5024,harbour seals,harbour seals,3
5049,center,center,3
5050,fever recover,fever recover,3
5053,prescription,prescription,3
5112,multan,city big city city millions inhabitants,3
5109,international assistance,international assistance,3
5108,help,help,3
5107,official request,official request,3
5106,sports,sports,3
5104,27 july,27 july,3
5103,late july,late july,3
5101,saudi monarch,saudi monarch,3
5100,trip,trip,3
5099,saudi arabian embassy,saudi arabian embassy,3
5098,entire atoll,entire atoll,3
5097,widespread rumors,widespread rumors,3
5096,holidays,holidays,3
5095,education,education,3
5093,maldives,maldives,3
5091,midmarch,midmarch,3
5090,1 895 people,1 895 people,3
5054,1 october,1 october,3
5058,1918–1919 spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
5062,severe respiratory illness,severe respiratory illness,3
5063,13 soldiers,13 soldiers,3
5064,fort dix,fort dix,3
5066,19 january,19 january,3
5002,hypnotics,hypnotics,3
5067,retrospective serologic testing,retrospective serologic testing,3
5072,substantial immunity,substantial immunity,3
5073,striking similarity,striking similarity,3
5076,approximately year,approximately year,3
5077,2009 a(h1n1) pandemic,2009 a(h1n1) pandemic,3
5081,unusually mongrelised mix,unusually mongrelised mix,3
5083,300 infections,300 infections,3
5068,230 soldiers,230 soldiers,3
5230,cynomolgus macaques,cynomolgus macaques,3
4769,solid number,solid number,3
4767,spokeswoman,spokeswoman,3
2990,prodrug,prodrug,3
4519,exception,exception,3
4518,9.5x10×10−3 1.2x10×10−3 substitutions/site/year,9.5x10×10−3 1.2x10×10−3 substitutions/site/year,3
4516,3.18 x 10×10−3 substitutions,3.18 x 10×10−3 substitutions,3
4514,1.07×10−3 substitutions,1.07×10−3 substitutions,3
4512,early 1950s,early 1950s,3
4511,recent common ancestor,recent common ancestor,3
4509,african origin,african origin,3
4508,phylogenetic studies,phylogenetic studies,3
4507,8 genotypes,8 genotypes,3
4506,okinawa islands,okinawa islands,3
4505,genomes,genomes,3
4504,genotype iii,genotype iii,3
4503,yakutia,republic russia,3
4521,hdvspecific cd8+ t cells,hdvspecific cd8+ t cells,3
4502,genotype ii,genotype ii,3
4500,entire genome genus,scientific model natural environment,3
4499,entire genome,scientific model natural environment,3
4498,complete viral particle,complete viral particle,3
4497,pathogen,pathogen,3
4496,structural,structural,3
4495,subsequent experiments,subsequent experiments,3
4492,nuclear antigen,group class chemical substances,3
4491,improved measures,improved measures,3
4488,globe,globe,3
4486,major medical scourge,major medical scourge,3
4485,packaging,packaging,3
4484,hbsag,hbsag,3
4483,b. bulevirtide,medication synthetic peptide,3
4479,committee,committee,3
4501,deltavirus,deltavirus,3
4478,therapy,therapy,3
4522,related species,related species,3
4525,small spherical virus,small spherical virus,3
4563,nterminals,nterminals,3
4562,smallhdag,smallhdag,3
4561,27kda largehdag,27kda largehdag,3
4560,forms,forms,3
4559,viroids,viroids,3
4558,significant difference,significant difference,3
4557,delta antigens,delta antigens,3
4556,hdv replication,hdv replication,3
4555,iii,iii,3
4551,hdv genome,scientific model natural environment,3
4550,signal,signal,3
4549,nucleus,nucleus,3
4548,nucleocapsid,nucleocapsid,3
4547,hepatocyte,hepatocyte,3
4524,structure genome,scientific model natural environment,3
4546,receptorbinding site,receptorbinding site,3
4544,mutagenesis,mutagenesis,3
4542,nterminal domain,nterminal domain,3
4541,hdv receptor,hdv receptor,3
4540,ntcp bile transporter,ntcp bile transporter,3
4539,life cycle,life cycle,3
4538,partially doublestranded rodlike hdv structure,partially doublestranded rodlike hdv structure,3
4537,nucleotide sequence,nucleotide sequence,3
4535,coiledcoil region,coiledcoil region,3
4533,central region,central region,3
4531,200 molecules,200 molecules,3
4530,ribonucleoprotein particle,ribonucleoprotein particle,3
4529,kinds,kinds,3
4528,host phospholipids,host phospholipids,3
4526,36 nm diameter,36 nm diameter,3
4545,9–15,9–15,3
4477,late relapse,late relapse,3
4476,%,%,3
4475,efficiency,efficiency,3
4415,barrier,barrier,3
4414,unusually rapid progression,unusually rapid progression,3
4413,hypogammaglobulinemia,hypogammaglobulinemia,3
4412,recipients,recipients,3
4409,immunosuppressed,immunosuppressed,3
4408,subsequent pregnancy,physiological condition,3
4407,nipples,nipples,3
4406,procedures,procedures,3
4405,membrane rupture,membrane rupture,3
4403,factors,factors,3
4402,leading cause,leading cause,3
4401,developed countries transmission,developed countries transmission,3
4399,higher rates,higher rates,3
4398,spontaneous clearance,spontaneous clearance,3
4416,lack,lack,3
4397,3–5%,3–5%,3
4394,1–8%,1–8%,3
4392,children pregnancy,physiological condition,3
4390,develop chronic infection,develop chronic infection,3
4389,15–45%,15–45%,3
4388,spontaneous resolution,spontaneous resolution,3
4387,alternative therapy,alternative therapy,3
4386,silver,silver,3
4385,ginseng,ginseng,3
4384,alternative therapies proponents,alternative therapies proponents,3
4383,alternative therapies,alternative therapies,3
4382,alternative medicine,alternative medicine,3
4381,unclear evidence,unclear evidence,3
4380,2013 review,2013 review,3
4379,recurrence,recurrence,3
4395,0.05–5%,0.05–5%,3
4417,suitable animal model,taxon,3
4418,moderate success,moderate success,3
4420,mammalian systems,mammalian systems,3
4474,benefit,benefit,3
4472,latest evidence,latest evidence,3
4469,rare instances,rare instances,3
4462,immediate mediterranean region,immediate mediterranean region,3
4460,developed countries,developed countries,3
4459,clotting factor concentrates,clotting factor concentrates,3
4455,routes,routes,3
4454,genome,scientific model natural environment,3
4451,hbv,hbv,3
4448,virusoid,virusoid,3
4447,viroid,viroid,3
4446,small spherical enveloped particle,small spherical enveloped particle,3
4443,susceptibility,susceptibility,3
4442,inbred mice,inbred mice,3
4440,3d architectural design,3d architectural design,3
4439,opportunities,opportunities,3
4438,humanized mice,humanized mice,3
4421,mouse,mouse,3
4422,poorer communities,poorer communities,3
4423,available living,available living,3
4424,ethical concerns,ethical concerns,3
4425,regulatory restrictions,regulatory restrictions,3
4427,questions,questions,3
4564,19 amino acids,19 amino acids,3
4428,questions accuracy,questions accuracy,3
4432,mammalian models,mammalian models,3
4433,liver tissues,organ type,3
4434,technique,technique,3
4435,xenotransplantation,xenotransplantation,3
4436,chimeric mice,chimeric mice,3
4437,engineering process,engineering process,3
4430,aspect,aspect,3
4768,probably half dozen,probably half dozen,3
4565,cterminal,cterminal,3
4568,reading frame,reading frame,3
4707,handling,handling,3
4706,little improvement,little improvement,3
4704,lethality,lethality,3
4703,extensive outbreaks,extensive outbreaks,3
4702,outbreaks areas,outbreaks areas,3
4699,retrospective analysis,retrospective analysis,3
4698,cultural revolution,cultural revolution,3
4697,reported data,reported data,3
4696,june–december,june–december,3
4695,july–september,july–september,3
4692,maximum intensity,maximum intensity,3
4691,square kilometre,square kilometre,3
4689,population density,population density,3
4688,unconfirmed possibility,unconfirmed possibility,3
4709,northern australia,continent,3
4687,13 july,13 july,3
4684,fewer casualties,fewer casualties,3
4682,accumulated antibodies,family protein complexes,3
4681,internal genes,internal genes,3
4678,similar coinfection,similar coinfection,3
4677,hosts,hosts,3
4672,queen mary hospital,queen mary hospital,3
4671,late 19th century,late 19th century,3
4670,h3n1 infections,h3n1 infections,3
4669,serologic evidence,serologic evidence,3
4662,hong kong flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
4658,74%,74%,3
4656,asymptomatic hbv carriers,asymptomatic hbv carriers,3
4655,24%,24%,3
4653,epidemiological survey,epidemiological survey,3
4686,recorded instance,recorded instance,3
4652,1987 boca acre study,1987 boca acre study,3
4710,troops,troops,3
4713,mao tsetung,mao tsetung,3
4766,maria cheng,maria cheng,3
4765,atlanta,atlanta,3
4764,united states centers,united states centers,3
4763,director,director,3
4762,dr. julie l. gerberding,dr. julie l. gerberding,3
4761,human transmissions,organisms known particular common homo sapiens homo sapiens sapiens homo,3
4760,estimate,estimate,3
4757,ontario,ontario,3
4755,approximately 60%,approximately 60%,3
4751,0.6%,0.6%,3
4750,23%,23%,3
4749,casefatality rates,casefatality rates,3
4745,pandemic threat,pandemic threat,3
4744,10% human fatality ratio,organisms known particular common homo sapiens homo sapiens sapiens homo,3
4711,vietnam war,war proxy war,3
4734,smoldering pattern,smoldering pattern,3
4730,key role,key role,3
4728,maurice hilleman team,maurice hilleman team,3
4727,american microbiologist maurice hilleman,american microbiologist maurice hilleman,3
4726,absenteeism,absenteeism,3
4723,total,total,3
4722,undertakers,undertakers,3
4721,garbage collectors,garbage collectors,3
4720,west germany,historical period germany historical country,3
4719,subway tunnels,subway tunnels,3
4718,corpses,corpses,3
4717,excessive number,excessive number,3
4716,berlin,berlin,3
4715,scientific medical journals,scientific medical journals,3
4714,public health warnings virus descriptions,public health warnings virus descriptions,3
4731,circulation,circulation,3
4651,macrophages,macrophages,3
4650,inflammatory cells,inflammatory cells,3
4649,infiltration,infiltration,3
4602,antigenic loop,antigenic loop,3
4601,camille sureau,camille sureau,3
4600,georges abou jaoudé,georges abou jaoudé,3
4599,cellular receptor,cellular receptor,3
4598,mediator,mediator,3
4596,nterminal pres1 domain,nterminal pres1 domain,3
4595,infectivity,infectivity,3
4594,determinant,determinant,3
4593,virallike particles,virallike particles,3
4592,ribonucleoprotein,ribonucleoprotein,3
4591,hdv antigen proteins,group class chemical substancesgroup class chemical substances second-order class,3
4590,subviral particles,subviral particles,3
4589,genome main function,scientific model natural environment,3
4586,hdv envelope protein,hdv envelope protein,3
4603,hdv envelope proteins,group class chemical substances second-order class,3
4585,antigenic loop infectivity,antigenic loop infectivity,3
4583,balance,balance,3
4582,virus’ life cycle,virus’ life cycle,3
4580,assembly,assembly,3
4579,later stages,later stages,3
4578,contrast,contrast,3
4577,hdagl,hdagl,3
4576,hdags,hdags,3
4575,roles,roles,3
4574,90% identical sequences,90% identical sequences,3
4573,largehdag,largehdag,3
4572,ugg,ugg,3
4571,stop,stop,3
4570,cellular enzyme adenosine,cellular enzyme adenosine,3
4569,codon,codon,3
4584,virion assembly,virion assembly,3
4604,virion surface,virion surface,3
4605,jaoudé,jaoudé,3
4607,important factor,important factor,3
4648,particular type,particular type,3
4647,steatosis,steatosis,3
4646,liver tissue,organ type,3
4645,extensive destruction,extensive destruction,3
4644,infected patients,infected patients,3
4643,collaborators,collaborators,3
4641,belém,municipality brazil capital big city city millions inhabitants,3
4640,instituto evandro chagas,instituto evandro chagas,3
4639,gilberta bensabath,gilberta bensabath,3
4638,hbv association,hbv association,3
4637,main discovery,main discovery,3
4635,survivors,survivors,3
4634,39 patients,39 patients,3
4632,boca acre,boca acre,3
4631,males,males,3
4630,young adults,young adults,3
4628,hemorrhagic coma,hemorrhagic coma,3
4608,hdv entry,hdv entry,3
4610,lábrea fever,municipality brazil,3
4612,lábrea,municipality brazil,3
4615,acre,acre,3
4616,amazonas,amazonas,3
4617,rondônia,federative unit brazil,3
4567,isoforms,isoforms,3
4618,colombia,sovereign state republic secular state country,3
4620,coinfection,coinfection,3
4621,superinfection,superinfection,3
4623,sudden onset,sudden onset,3
4624,anorexia,anorexia,3
4625,hematemesis,hematemesis,3
4627,agitation,agitation,3
4619,peru,sovereign state republic country,3
4378,graft,graft,3
5231,surrogate model,surrogate model,3
5240,significantly higher titers,significantly higher titers,3
5829,symposium,symposium,3
5828,december official delegations,december official delegations,3
5827,rural,rural,3
5826,writing,writing,3
5824,combined death,stock character psychopomp literary character,3
5823,louth,louth,3
5822,tetney,tetney,3
5821,16 december,16 december,3
5820,december 2016,december 2016,3
5819,israel,israel,3
5817,zoo,zoo,3
5816,november 2016,november 2016,3
5815,seven additional european countries,seven additional european countries,3
5812,27 october,27 october,3
5832,turkey farm,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
5811,october 2016,october 2016,3
5807,duck chicken farms,duck chicken farms,3
5806,18 january,18 january,3
5805,breeding ducks,breeding ducks,3
5804,2014,2014,3
5803,lab,lab,3
5801,28 020 chickens,chicken gallus gallus domesticus common,3
5799,close proximity,close proximity,3
5796,farms,farms,3
5795,1983,1983,3
5793,cleavage site,cleavage site,3
5792,conserved amino acids,conserved amino acids,3
5791,importance,importance,3
5790,kawaoka y,kawaoka y,3
5789,walker ja,walker ja,3
5809,2016–17,2016–17,3
5787,75 percent,75 percent,3
5833,lincolnshire,lincolnshire,3
5838,nigeria,nigeria,3
5884,migratory species,migratory species,3
5882,kantō region,kantō region,3
5881,15 places,15 places,3
5880,16 places,16 places,3
5879,25 february,25 february,3
5878,5 november,5 november,3
5877,49 chicken poultry farms,organisms known particular common,3
5875,22 october,22 october,3
5874,october–december,october–december,3
5871,12 locations,12 locations,3
5869,cull,cull,3
5868,mazahmiya,mazahmiya,3
5867,dharma,dharma,3
5866,alquaiyat,alquaiyat,3
5836,january 2017,january 2017,3
5865,alkharj,alkharj,3
5863,riyadh,riyadh,3
5861,20 december,20 december,3
5860,december 2017,december 2017,3
5859,south african poultry association,organisms known particular common,3
5857,mpumalanga,mpumalanga,3
5856,standerton,standerton,3
5849,zimbabwe,republic sovereign state landlocked country country,3
5848,harare,capital city big city city millions inhabitants,3
5847,june 2017,june 2017,3
5846,16 march,16 march,3
5844,restrictions,restrictions,3
5843,february 2017,february 2017,3
5841,uganda,uganda,3
5840,slovenia,slovenia,3
5864,alahsa,alahsa,3
5786,intravenous pathogenicity index,intravenous pathogenicity index,3
5784,h5n8 virus,h5n8 virus,3
5780,7 mile zone,7 mile zone,3
5732,affected flock slaughter,affected flock slaughter,3
5731,routine testing,routine testing,3
5730,west virginia,west virginia,3
5727,affected flock,affected flock,3
5725,pennsylvania,pennsylvania,3
5723,accentuated virulence,accentuated virulence,3
5721,south african commercial ostrich industry,south african commercial ostrich industry,3
5719,south africa ostriches,continent,3
5718,destruction,destruction,3
5717,single farm,single farm,3
5715,50006000 chicken,50006000 chicken,3
5712,sri lanka outbreak,sri lanka outbreak,3
5711,sri lanka,sri lanka,3
5710,documented occurrence,documented occurrence,3
5734,chicken turkey farming operations,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
5709,h5n2 outbreaks,h5n2 outbreaks,3
5706,a/ chicken /ibaraki/1/2005,a/ chicken /ibaraki/1/2005,3
5705,saitama prefecture,saitama prefecture,3
5704,chicken farm,chicken farm,3
5703,40 chicken farms,40 chicken farms,3
5702,antih5 antibody,family protein complexes,3
5699,quarantine officials,quarantine officials,3
5698,korea,korea,3
5696,dispersion,dispersion,3
5695,forage wasn tthermallydisinfectedbefore dispersion,forage wasn tthermallydisinfectedbefore dispersion,3
5693,factory,factory,3
5692,chickens combs,chicken gallus gallus domesticus common,3
5691,owners,owners,3
5690,central federal district,central federal district,3
5689,kostroma oblast,kostroma oblast,3
5708,ibaraki,ibaraki,3
5735,midwestern region,midwestern region,3
5736,30,30,3
5738,15 states,15 states,3
5777,1 840 2 497 birds,1 840 2 497 birds,3
5775,2020,2020,3
5774,pampanga,pampanga,3
5772,australian test,australian test,3
5771,2017,2017,3
5770,highest level,highest level,3
5768,bird droppings,taxon,3
5766,2016,2016,3
5765,h5n6,h5n6,3
5764,haiti,sovereign state island nation country,3
5763,central northern southern parts,central northern southern parts,3
5762,locations,locations,3
5760,northern province,northern province,3
5759,moca,moca,3
5758,dominican department,dominican department,3
5757,visible sign,visible sign,3
5756,2 hens,2 hens,3
5739,iowa,state united states,3
5741,duck,duck,3
5742,fergus county,fergus county,3
5744,commercial turkey farm,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
5745,abbottsford,abbottsford,3
5746,british columbia,british columbia,3
5885,himachal pradesh,himachal pradesh,3
5747,36 sites,36 sites,3
5749,st. catharines,st. catharines,3
5750,cfia,cfia,3
5752,compost,compost,3
5753,infected premises,infected premises,3
5754,dominican republic,dominican republic,3
5755,15 roosters,15 roosters,3
5748,precautionary measure,precautionary measure,3
5686,russian ministry,russian ministry,3
5886,rajasthan,rajasthan,3
5888,kerala officials,state india start time 1 november 1956,3
6065,male,male,3
6064,possible reasons,possible reasons,3
6063,twothirds,twothirds,3
6062,h7n9infected patients,h7n9infected patients,3
6061,older males,older males,3
6060,unusual prevalence,unusual prevalence,3
6059,age/gender distribution,age/gender distribution,3
6057,city hospitals,city hospitals,3
6055,surveillance artifact,surveillance artifact,3
6054,true distribution,true distribution,3
6051,early,early,3
6049,security,security,3
6046,fifth,fifth,3
6042,widespread bird migratory patterns,taxon,3
6066,female relationship,female relationship,3
6041,colder weather,colder weather,3
6038,limited humantohuman spread,limited humantohuman spread,3
6037,previous experience,previous experience,3
6036,past,past,3
6033,possibly combination,possibly combination,3
6032,seasons,seasons,3
6031,chinese authorities,chinese authorities,3
6029,potential channel,potential channel,3
6028,control option,control option,3
6026,assessment,assessment,3
6025,april 30 report,april 30 report,3
6024,veterinary services,veterinary services,3
6023,overall level,overall level,3
6020,contaminated environment,contaminated environment,3
6019,markets,markets,3
6039,fall,fall,3
6018,hypothesis,hypothesis,3
6067,median age,median age,3
6069,female ratio,female ratio,3
6115,infected patient,infected patient,3
6114,throat swab,throat swab,3
6113,widespread vaccination,widespread vaccination,3
6112,chinese national influenza center director shu yuelong,infectious disease,3
6110,chinese academy,chinese academy,3
6106,chinese center,chinese center,3
6105,hong kong university,hong kong university,3
6104,zhejiang university,zhejiang university,3
6102,65 years.on,65 years.on,3
6096,global public health community,global public health community,3
6095,additional vaccine manufacturing capacity,additional vaccine manufacturing capacity,3
6094,adequate supplies,adequate supplies,3
6093,great difficulty,great difficulty,3
6091,related nonidentical variants,related nonidentical variants,3
6068,584 years,584 years,3
6090,uptake,uptake,3
6088,crossreactive antibodies,family protein complexes,3
6087,dengue fever,dengue fever,3
6083,lifetime exposure,lifetime exposure,3
6082,older chinese men,older chinese men,3
6081,british columbia centre,british columbia centre,3
6080,danuta m. skowronski,danuta m. skowronski,3
6078,possible greater biological susceptibility,possible greater biological susceptibility,3
6077,elderly men,elderly men,3
6076,greater exposure,greater exposure,3
6075,age distribution,age distribution,3
6074,common risk factor,common risk factor,3
6072,yuzo arima colleagues,yuzo arima colleagues,3
6071,yuzo arima,yuzo arima,3
6070,3.6:1.dr,3.6:1.dr,3
6089,complexes,complexes,3
6017,advice,advice,3
6016,oie experts,oie experts,3
6014,director general,director general,3
5939,chinese new year feasts,chinese new year feasts,3
5934,closing,closing,3
5929,h7n9,taxon,3
5926,jager cm,jager cm,3
5925,koopmans m,koopmans m,3
5924,meijer,meijer,3
5923,du ry van beest holle m,du ry van beest holle m,3
5922,unusual zoonotic potential,unusual zoonotic potential,3
5921,laboratory studies,laboratory studies,3
5917,h7n7,h7n7,3
5916,h7n4,h7n4,3
5914,high pathogenicity,high pathogenicity,3
5912,comparative pathobiology,comparative pathobiology,3
5911,sources,sources,3
5940,spike,spike,3
5910,h7n3,h7n3,3
5908,h5,h5,3
5907,mind,mind,3
5906,h7n2,h7n2,3
5904,february 17th,february 17th,3
5903,japan ground selfdefense force,sovereign state island nation country,3
5901,larger nationwide trend,larger nationwide trend,3
5900,5400 ducks,5400 ducks,3
5899,21 january,21 january,3
5898,regional official,regional official,3
5895,dead edible ducks,dead edible ducks,3
5894,state animal husbandry officials,taxon,3
5893,lake area,lake area,3
5892,barheaded geese,barheaded geese,3
5890,kuttanad region,kuttanad region,3
5909,research update,research update,3
5945,unofficial number,unofficial number,3
5947,h7n9 identifies,taxon,3
5948,h7 subtype,h7 subtype,3
6012,virush5n1,virush5n1,3
6011,great concern,great concern,3
6010,dissemination,dissemination,3
6009,intermediate hosts,intermediate hosts,3
6006,route,route,3
6004,pigeons,pigeons,3
6003,chinese scientists,chinese scientists,3
6002,75%,75%,3
6000,multiorgan failure,multiorgan failure,3
5999,approximately 20%,approximately 20%,3
5996,organ failure,organ failure,3
5993,high security laboratories,high security laboratories,3
5992,highly transmissible deadly forms,highly transmissible deadly forms,3
5989,mutant forms,mutant forms,3
5988,purely human.in august,purely human.in august,3
5987,middle ground,middle ground,3
5986,stillhasawaystogobeforeitbecomeslikeahumanvirusbutthefactisit ssomewherein middle ground,stillhasawaystogobeforeitbecomeslikeahumanvirusbutthefactisit ssomewherein middle ground,3
5949,n9 subtype,n9 subtype,3
5952,subgroup,subgroup,3
5959,sequences,sequences,3
5960,zhejiang province,zhejiang province,3
5961,origins,origins,3
5962,ha origin,ha origin,3
5887,madhya pradesh,madhya pradesh,3
5965,east asian flyway,east asian flyway,3
5967,migration,migration,3
5971,toronto interview,city single-tier municipality big city city millions inhabitants,3
5974,simplydon tknow,simplydon tknow,3
5975,deputy director,deputy director,3
5979,past 10 years,past 10 years,3
5980,thing,thing,3
5966,european lineages,european lineages,3
5237,pathologic changes,pathologic changes,3
5685,h5n2 antibody titers,family protein complexes,3
5683,35 chicken farms,35 chicken farms,3
5426,underlying epithelial cells,underlying epithelial cells,3
5425,mucosal layer,mucosal layer,3
5423,mucus,mucus,3
5422,mucopolysaccharides,mucopolysaccharides,3
5421,glycoproteins,structural class chemical compounds,3
5418,embeds,embeds,3
5416,pathophysiology,pathophysiology,3
5415,long incubation periods,long incubation periods,3
5413,appropriate control measures,appropriate control measures,3
5412,infected horses,infected horses,3
5411,7 days,7 days,3
5410,typically 1–3 days,typically 1–3 days,3
5409,horse,horse,3
5408,incubation period,incubation period,3
5427,binding,binding,3
5407,field,field,3
5404,vaccinated horses,vaccinated horses,3
5401,proper biosecurity procedures,type security,3
5400,tack,tack,3
5399,horse equipment,horse equipment,3
5398,pets,pets,3
5397,different surfaces,different surfaces,3
5395,epithelial cells,epithelial cells,3
5393,disinfectants,disinfectants,3
5392,desiccation,desiccation,3
5390,inanimate objects,inanimate objects,3
5389,clothing,clothing,3
5387,direct contact,direct contact,3
5385,ultimate source,ultimate source,3
5384,different routes,different routes,3
5405,mismatch,mismatch,3
5382,certainty,certainty,3
5428,hemagglutinin spike,group class proteins,3
5430,endocytosis,endocytosis,3
5464,hpai,hpai,3
5462,important concept,important concept,3
5461,period infectivity,period infectivity,3
5460,stiffness,stiffness,3
5459,muscle soreness,muscle soreness,3
5458,tachycardia,medical finding,3
5457,tachypnea,medical finding,3
5456,nasal conjunctival mucosa,nasal conjunctival mucosa,3
5455,submandibular lymph nodes,submandibular lymph nodes,3
5454,epiphora,epiphora,3
5453,serous light mucoid nasal discharge,serous light mucoid nasal discharge,3
5451,2 serum,2 serum,3
5450,equine1,equine1,3
5449,antibody titer,family protein complexes,3
5429,nacetylneuraminic acid receptor,nacetylneuraminic acid receptor,3
5447,isolation,isolation,3
5444,drippy’ nose,drippy’ nose,3
5443,102.5 105.0 f frequent dry cough,102.5 105.0 f frequent dry cough,3
5442,limb edema,limb edema,3
5441,encephalitic signs,encephalitic signs,3
5440,skeletal cardiac muscle,skeletal cardiac muscle,3
5439,basement membrane,basement membrane,3
5438,focal erosion,focal erosion,3
5437,desquamation,desquamation,3
5436,necrosis,necrosis,3
5435,edema,edema,3
5434,hyperemia,hyperemia,3
5433,trachea bronchial tree,trachea bronchial tree,3
5432,new virions,new virions,3
10861,2013 genes,2013 genes,3
5445,discharge,discharge,3
5380,h2n2 subtype,wikimedia disambiguation page,3
5378,identification,identification,3
5377,possible cause,possible cause,3
5298,strong serologic crossreactions,strong serologic crossreactions,3
5297,97 recent h3n2 isolates,subtype,3
5295,swine farms,swine disease,3
5294,present vaccination strategies,present vaccination strategies,3
5292,triple reassortants,triple reassortants,3
5290,h3n2 subtypes,subtype,3
5289,late august,late august,3
5284,h3n2 virusthatwerecollectedacrosssixcontinentsfrom2002to2007bythewho sglobalinfluenzasurveillancenetworkshowedthenewlyemergingstrainsofh3n2appearedin east southeast asian countries,subtype,3
5283,newly emerging strains,newly emerging strains,3
5278,overlapping epidemics,overlapping epidemics,3
5276,b. measured resistance,b. measured resistance,3
5275,past years,past years,3
5274,clear seasonality,clear seasonality,3
5272,northern southern hemispheres,northern southern hemispheres,3
5299,antiserum,antiserum,3
5265,h3n2 coat,subtype,3
5260,isolatefujian flustrains,isolatefujian flustrains,3
5259,h3n1,h3n1,3
5257,integral,integral,3
5255,surveillance efforts,surveillance efforts,3
5254,nonimmune partially immune population,nonimmune partially immune population,3
5252,threat,threat,3
5250,potential marker,potential marker,3
5249,increased il6 levels,increased il6 levels,3
5248,previously published notion,previously published notion,3
5246,interferongamma,interferongamma,3
5245,chemotactic protein1,chemotactic protein1,3
5244,monocyte,monocyte,3
5243,interleukin,group class proteins,3
5241,nasal oral swabs,nasal oral swabs,3
5263,classification,classification,3
5301,protective ability,protective ability,3
5303,closeness,closeness,3
5304,match,match,3
5375,quarter,quarter,3
5374,1997 study,1997 study,3
5373,europeanlike lineage,europeanlike lineage,3
5372,americanlike lineage,americanlike lineage,3
5371,families,families,3
5370,late 1980s,late 1980s,3
5368,widespread epidemics,widespread epidemics,3
5367,0.8 amino acid substitutions,0.8 amino acid substitutions,3
5366,single lineage,single lineage,3
5364,massive outbreaks,massive outbreaks,3
5363,north south america,north south america,3
5362,miami,miami,3
5361,present day lineages,present day lineages,3
5360,zebras,zebras,3
5359,mules,mules,3
5358,donkeys,donkeys,3
5357,related animals,related animals,3
5307,nonreactive h3n2 siv variants,subtype,3
5311,91%,91%,3
5312,graphic,graphic,3
5313,h3n2 mutations,subtype,3
5314,207 isolates,207 isolates,3
5316,hong kong flu (1968–1969),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
5465,tens millions,tens millions,3
5318,estimated 500 000 hong kong residents,estimated 500 000 hong kong residents,3
5326,2004–05 trivalent,2004–05 trivalent,3
5331,15 february,15 february,3
5333,related biological products advisory committee,related biological products advisory committee,3
5351,h3n8,h3n8,3
5352,horses,horses,3
5353,main cause,main cause,3
5323,h3n2 subtype,subtype,3
5684,ibaraki prefectural government,ibaraki prefectural government,3
5466,culling,culling,3
5468,fao,fao,3
5624,fertilizer dust,fertilizer dust,3
5623,surfaces,surfaces,3
5622,diseasespreading hosts,diseasespreading hosts,3
5621,migrating waterfowl,migrating waterfowl,3
5620,turn,turn,3
5619,fertilizer,fertilizer,3
5617,movements,movements,3
5616,domestic poultry,organisms known particular common,3
5615,usual route,usual route,3
5614,sneezing,sneezing,3
5613,oxygen,oxygen,3
5612,alveoli,alveoli,3
5610,galactose receptors,galactose receptors,3
5609,variant forms,variant forms,3
5625,virulence,virulence,3
5608,potential global spread,potential global spread,3
5604,animal,taxon,3
5603,detailed mutually coordinated onsite surveillance,detailed mutually coordinated onsite surveillance,3
5602,animal populations,taxon,3
5601,federal government.together steps,federal government.together steps,3
5600,agencies,agencies,3
5599,departments,departments,3
5598,white house,white house,3
5597,behalf,behalf,3
5595,containment measures,containment measures,3
5593,global efforts,global efforts,3
5592,international partners,international partners,3
5590,transparency,transparency,3
5589,greater monitoring,greater monitoring,3
5588,88 foreign governments,88 foreign governments,3
5607,contagiousness,contagiousness,3
5585,international organizations,international organizations,3
5627,specific known genetic variation,specific known genetic variation,3
5631,dozens,dozens,3
5682,257 workers,257 workers,3
5681,ibaraki prefecture,ibaraki prefecture,3
5679,h5n2 humans,infectious disease france,3
5677,inactivated h5n2,inactivated h5n2,3
5676,falcon,falcon,3
5675,humantohuman spread,humantohuman spread,3
5674,conjunctivitis,conjunctivitis,3
5673,ostrich chicks,ostrich chicks,3
5670,h5n2,h5n2,3
5668,aerosols,aerosols,3
5667,uninfected ones,uninfected ones,3
5666,infected ferrets,infected ferrets,3
5665,noses,noses,3
5660,ron fouchier,ron fouchier,3
5630,antigenic drift,antigenic drift,3
5657,arctic temperatures,arctic temperatures,3
5655,6 days,6 days,3
5654,0 °c,0 °c,3
5653,bodily fluids,bodily fluids,3
5652,transmission host range,transmission host range,3
5650,longer periods,longer periods,3
5649,genotype pathogenicity,genotype pathogenicity,3
5648,bird populations,taxon,3
5647,clades,clades,3
5645,1961.genotype z,1961.genotype z,3
5642,ducks,ducks,3
5639,bird population,taxon,3
5638,new isolates,new isolates,3
5635,z,z,3
5634,specific isolates,specific isolates,3
5656,37 °c,37 °c,3
5582,rapid production,rapid production,3
5581,facilities,facilities,3
5580,vaccine manufacturing companies,vaccine manufacturing companies,3
5530,inappropriate focus,inappropriate focus,3
5529,underestimations,underestimations,3
5527,international herald tribune,international herald tribune,3
5526,interview,interview,3
5520,chief,chief,3
5519,united nations,united nations,3
5517,unknown questions,unknown questions,3
5511,u.s. dollars,u.s. dollars,3
5510,billions,billions,3
5509,especially financial political social personal responses,especially financial political social personal responses,3
5508,human society,organisms known particular common homo sapiens homo sapiens sapiens homo,3
5505,entire domestic poultry population,organisms known particular common,3
5504,killing,killing,3
5502,hassan albushra,hassan albushra,3
5531,intervention,intervention,3
5500,disposal,disposal,3
5497,roche ag,roche ag,3
5496,focus,focus,3
5495,highly effective treatment,highly effective treatment,3
5494,flocks,flocks,3
5492,genetics,genetics,3
5490,infected persons,infected persons,3
5486,progression,progression,3
5485,key events,key events,3
5483,adequate resources,adequate resources,3
5482,american scientist,american scientist,3
5480,edge,edge,3
5479,worldrenowned virologist robert g. webster,worldrenowned virologist robert g. webster,3
5474,concerns,concerns,3
5469,imperfect disease surveillance systems,imperfect disease surveillance systems,3
5498,stockpile,stockpile,3
5532,shuangqing district,shuangqing district,3
5533,shaoyang city,shaoyang city,3
5534,hunan,hunan,3
5579,preparedness,preparedness,3
5577,georgetown university,georgetown university,3
5576,biohazardous threats emerging diseases graduate program,biohazardous threats emerging diseases graduate program,3
5575,codirector,codirector,3
5574,daniel r. lucey,daniel r. lucey,3
5572,best protection,best protection,3
5570,crossprotection,crossprotection,3
5568,continual mutation,continual mutation,3
5565,segment reassortment,segment reassortment,3
5563,segmentation,segmentation,3
5561,noticeable signs,noticeable signs,3
5560,minor sickness,minor sickness,3
5558,ns,ns,3
5557,mp,mp,3
5556,na,na,3
5555,np,np,3
5554,pa,pa,3
5535,hubei province,hubei province,3
5536,wuhan,sub-province-level division big city city millions inhabitants human settlement,3
5537,epicenter,epicenter,3
5539,mild—decrease,mild—decrease,3
5540,egg production,egg production,3
5541,nasal discharge,nasal discharge,3
5467,global hpai situation,global hpai situation,3
5542,noticeable sign,noticeable sign,3
5544,actual hpai example,actual hpai example,3
5545,a/chicken/nakornpatom/thailand/cuk2/04,a/chicken/nakornpatom/thailand/cuk2/04,3
5549,segmented genome,scientific model natural environment,3
5550,negative sense,negative sense,3
5551,singlestrands,singlestrands,3
5552,pb2,pb2,3
5543,sudden death,stock character psychopomp literary character,3
4377,common reason,common reason,3
4520,slave trade,slave trade,3
4375,elbasvir/grazoprevir,combination drug,3
3558,art,art,3
3557,preclinical data,preclinical data,3
3556,human oral bioavailability,organisms known particular common homo sapiens homo sapiens sapiens homo,3
3555,prediction,prediction,3
3554,cynomolgus nonhuman primates,cynomolgus nonhuman primates,3
3553,oral bioavailability,oral bioavailability,3
3552,multiple preclinical species,multiple preclinical species,3
3551,pk,pk,3
3550,experiments,experiments,3
3549,ind,ind,3
3548,ncats,ncats,3
3544,advantages,advantages,3
3543,utility,utility,3
3542,dephosphorylation,biological process,3
3541,rapid hydrolysis,rapid hydrolysis,3
3540,serum,serum,3
3538,prodrug remdesivir,chemical compound prodrug antiviral drug,3
3523,sales,sales,3
3524,research purposes,research purposes,3
3525,patent infringements,patent infringements,3
3526,supreme court decision,supreme court decision,3
3527,fda regulations,fda regulations,3
3528,chemicals,chemicals,3
3559,science,science,3
3529,chemicals manufacture,chemicals manufacture,3
3531,pharmacodynamics,pharmacodynamics,3
3532,gs441524 nucleoside,gs441524 nucleoside,3
3533,nucleoside kinases,nucleoside kinases,3
3534,structurally similar ribavirin,chemical compound medication essential medicine 1 april 1990,3
3536,active nucleotide triphosphate form,active nucleotide triphosphate form,3
3537,nucleoside,nucleoside,3
3530,fda cgmp certified conditions,fda cgmp certified conditions,3
3560,modeling data,modeling data,3
3561,multiple species,multiple species,3
3562,reference,reference,3
3597,cidrap article novavax,cidrap article novavax,3
3598,good preliminary phase 1 findings,good preliminary phase 1 findings,3
3600,oct,oct,3
3601,pharmaceutical company,pharmaceutical company,3
3602,rockville,rockville,3
3603,md.,md.,3
3596,subclades,subclades,3
3607,biomedical advanced research development authority,biomedical advanced research development authority,3
3611,hemagglutination inhibition,hemagglutination inhibition,3
3612,82% seroconversion,82% seroconversion,3
3613,seroprotection,seroprotection,3
3614,signs,signs,3
3616,gregory glenn,gregory glenn,3
3617,md,md,3
3608,42 days,42 days,3
3522,medchemexpress,scholarly article erratum,3
3593,manufacturers,manufacturers,3
3589,protection,protection,3
3564,nucleoside analogues,nucleoside analogues,3
3565,high point,high point,3
3566,nonhuman primates,nonhuman primates,3
3567,bit half molecular weight,bit half molecular weight,3
3568,active metabolite,active metabolite,3
3569,50%,50%,3
3592,h5n1 prototype seed strain,subtype,3
3570,2 hours,2 hours,3
3573,gs6620,gs6620,3
3574,nucleotide analogue,nucleotide analogue,3
3576,early testing,early testing,3
3577,oral dosage form,oral dosage form,3
3579,intestines,intestines,3
3584,immunization,immunization,3
3571,longer half life,longer half life,3
3621,testing.cidrap article sanofi,testing.cidrap article sanofi,3
3521,selleckchem,selleckchem,3
3519,suppliers,suppliers,3
3470,sumatra,island,3
3469,java,multi-paradigm programming language jvm language programming language,3
3467,500 stray cats,500 stray cats,3
3466,surabaya,city indonesia big city city millions inhabitants,3
3465,airlangga university,airlangga university,3
3464,chairul anwar nidom,chairul anwar nidom,3
3463,january 24 2007,january 24 2007,3
3462,literature,literature,3
3461,august 2006 cdc eid journal,august 2006 cdc eid journal,3
3460,august 2006,august 2006,3
3459,living cats,living cats,3
3458,styria,state austria,3
3456,agriculture official,agriculture official,3
3455,hans seitinger,hans seitinger,3
3454,march 6 2006,march 6 2006,3
3453,dead cat,dead cat,3
3452,february 28 2006,february 28 2006,3
3429,october 2004,october 2004,3
3430,domestic cats,domestic cats,3
3431,leopards,leopards,3
3432,tigers,tigers,3
3433,high lethality,high lethality,3
3435,140 tigers,140 tigers,3
3471,resulting illness,resulting illness,3
3436,sick tigers,sick tigers,3
3440,ingestion,ingestion,3
3442,infected cats,infected cats,3
3443,initial oie report,initial oie report,3
3445,11 october,11 october,3
3446,weakness,psychopathological symptom symptom,3
3447,lethargy,lethargy,3
3438,reservoir,reservoir,3
3472,20%,20%,3
3473,original cat populations,original cat populations,3
3474,gs441524,gs441524,3
3503,hepatotoxicity,hepatotoxicity,3
3504,oral delivery,oral delivery,3
3505,public health advocacy group,public health advocacy group,3
3506,public citizen,public citizen,3
3508,dhhs,dhhs,3
3509,gilead,gilead,3
3502,lower kidney,lower kidney,3
3510,covid19covid19,covid19covid19,3
3512,longer intellectual property lifespan,longer intellectual property lifespan,3
3513,direct efficacy,direct efficacy,3
3514,deuterium modified version,deuterium modified version,3
3516,wuhan institute,sub-province-level division big city city millions inhabitants human settlement,3
3517,research chemical,research chemical,3
3518,high purity,high purity,3
3511,financial motives,financial motives,3
3520,medkoo,specialty,3
3501,ease,ease,3
3499,sarscov2,sarscov2,3
3476,gilead sciences,gilead sciences,3
3477,main plasma metabolite,main plasma metabolite,3
3478,antiviral prodrug remdesivir,chemical compound prodrug antiviral drug,3
3479,halflife,halflife,3
3481,remdesivir,chemical compound prodrug antiviral drug,3
3482,feline infectious peritonitis,feline infectious peritonitis,3
3500,specific advantages,specific advantages,3
3484,effective treatment,effective treatment,3
3487,official fda approval,official fda approval,3
3492,black market,black market,3
3493,pet owners,pet owners,3
3494,affected cats,affected cats,3
3495,gilead sciences efficacy,gilead sciences efficacy,3
3496,purpose,purpose,3
3485,fip,fip,3
3623,adjuvant,adjuvant,3
3624,modestly better performance,modestly better performance,3
3625,lower dose,lower dose,3
3796,hemagglutinin forms spikes,group class proteins,3
3795,antigenic glycoprotein,antigenic glycoprotein,3
3794,hemagglutinin,group class proteins,3
3793,ha codes,ha codes,3
3792,surface antigen encoding gene segments,group class chemical substances,3
3791,surface encoding gene segments,surface encoding gene segments,3
3790,biological organisms,biological organisms,3
3789,microscopic parasite,microscopic parasite,3
3787,context,context,3
3786,thogotovirus,taxon,3
3785,isavirus,monotypic taxon taxon,3
3780,terminology,terminology,3
3779,molecular structure,molecular structure,3
3777,children february 2007,children february 2007,3
3774,expected completion,expected completion,3
3773,h5 healthy adults november 2006,h5 healthy adults november 2006,3
3772,h5 elderly august 2006,h5 elderly august 2006,3
3755,fourths,fourths,3
3756,adjuvanted 3.8microgram subjects,adjuvanted 3.8microgram subjects,3
3757,clade 1 vietnam virus,war proxy war,3
4376,surgery,medical specialty academic discipline,3
3762,puzzle,puzzle,3
3763,primed immunity,primed immunity,3
3798,efficient transfer,efficient transfer,3
3764,regulatory authorities,regulatory authorities,3
3766,public discussion,public discussion,3
3767,safety data,safety data,3
3768,revaccination january 2006,revaccination january 2006,3
3769,study completion,study completion,3
3770,a/h5n1 adult february 2006,a/h5n1 adult february 2006,3
3771,h5 booster doses june 2006,h5 booster doses june 2006,3
3765,answers,answers,3
3801,genetic factor,genetic factor,3
3802,ha bind alpha,ha bind alpha,3
3803,26 sialic acid receptors,26 sialic acid receptors,3
3831,recent research,recent research,3
3835,places,places,3
3836,gene,gene,3
3837,host range restriction,host range restriction,3
3838,pathogenicity,pathogenicity,3
3839,receptor specificity,receptor specificity,3
3830,closely related a/gs,closely related a/gs,3
3841,na codes,na codes,3
3843,antigenic glycoprotein enzyme,antigenic glycoprotein enzyme,3
3845,infected cells,infected cells,3
3846,relenza,relenza,3
3848,n2,n2,3
3849,n9,n9,3
3850,n1 form,n1 form,3
3842,neuraminidase,group class enzymes,3
3754,adjuvanted 3.8microgram doses,adjuvanted 3.8microgram doses,3
3829,unique amino acid substitution,unique amino acid substitution,3
3826,avian receptor binding,avian receptor binding,3
3804,types,types,3
3805,sialic acid receptors,sialic acid receptors,3
3806,mutation,mutation,3
3807,substitution,substitution,3
3808,sample,sample,3
3809,amino acid,amino acid,3
3828,a/hk/213/03 isolates,a/hk/213/03 isolates,3
3810,haemoagglutinin receptor protein,haemoagglutinin receptor protein,3
3813,father,father,3
3814,son,son,3
3821,positions,positions,3
3822,receptor binding pocket,receptor binding pocket,3
3823,ha,ha,3
3825,signature,signature,3
3812,23 sialic acid receptors,23 sialic acid receptors,3
3752,1.9 mcg.the glaxosmithklinebacked team,1.9 mcg.the glaxosmithklinebacked team,3
3751,euaccepted levels,euaccepted levels,3
3748,press release,press release,3
3657,bbc radio,television station,3
3658,agence francepresse,agence francepresse,3
3660,jennifer armstrong,jennifer armstrong,3
3661,gsk spokeswoman,gsk spokeswoman,3
3662,lancet,lancet,3
3664,78%,78%,3
3656,big breakthrough,big breakthrough,3
3666,10microgram doses,10microgram doses,3
3669,european union s requirement,european union s requirement,3
3671,sinovac biotech,sinovac biotech,3
3672,beijing,capital city direct-controlled municipality national central city big city city millions inhabitants,3
3674,vietnam/1194/2004.national institute,vietnam/1194/2004.national institute,3
3675,allergy,allergy,3
3678,2007the human trial,organisms known particular common homo sapiens homo sapiens sapiens homo,3
3668,aluminum,aluminum,3
3681,volunteer,volunteer,3
3654,position,position,3
3652,antigen,group class chemical substances,3
3629,30 micrograms,30 micrograms,3
3630,accompanying commentary,accompanying commentary,3
3631,obstacles,obstacles,3
3633,sanofi pasteur,sanofi pasteur,3
3634,subsidiary,subsidiary,3
3635,francebased sanofi aventis,francebased sanofi aventis,3
3653,meaning,meaning,3
3637,vietnam/1194/2004.cidrap article glaxo,vietnam/1194/2004.cidrap article glaxo,3
3641,glaxosmithkline,public company,3
3644,80%,80%,3
3647,15 mcg,15 mcg,3
3649,gsk chief executive officer j.p. garnier,gsk chief executive officer j.p. garnier,3
3650,news release,news release,3
3651,given,given,3
3638,vietnam/1194/2004.cidrap article glaxo h5n1 vaccine,subtype,3
3428,sunday,sunday,3
3682,bethesda,bethesda,3
3685,infectious material,infectious material,3
3726,hungarian prime minister ferenc gyurcsány,hungarian prime minister ferenc gyurcsány,3
3727,omninvest,omninvest,3
3731,early results,early results,3
3732,poor immunogenicity,poor immunogenicity,3
3734,30mcg doses,30mcg doses,3
3735,unacceptable results,unacceptable results,3
3725,manufacturer sanofi pasteur,manufacturer sanofi pasteur,3
3736,2006 trial,2006 trial,3
3738,acceptable levels,acceptable levels,3
3741,high dose level.adjuvanted vaccines,high dose level.adjuvanted vaccines,3
3743,grave supplydemand imbalance,grave supplydemand imbalance,3
3745,glaxosmithkline formula,public company,3
3746,trial,trial,3
3747,twodose regimen,twodose regimen,3
3737,90 mcg,90 mcg,3
3684,nih institutes,nih institutes,3
3721,research bench,research bench,3
3717,2 months,2 months,3
3689,weakened killed form,weakened killed form,3
3690,sanofi pasteur inhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteur,sanofi pasteur inhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteur,3
3692,portions,portions,3
3696,vrc director gary nabel,vrc director gary nabel,3
3697,m.d.,m.d.,3
3698,ph.d.,ph.d.,3
3718,1 year,1 year,3
3699,vrc,vrc,3
3703,supply manufacturing capacity,supply manufacturing capacity,3
3704,dr. nabel,dr. nabel,3
3705,colleagues,colleagues,3
3707,animal models,taxon,3
3714,45 volunteers,45 volunteers,3
3715,placebo injections,placebo injections,3
3702,reliability,reliability,3
3426,joint statement,joint statement,3
3425,southwestern kampong speu province,southwestern kampong speu province,3
3424,10yearold girl,10yearold girl,3
3132,free service,free service,3
3131,employee,employee,3
3130,small cost,small cost,3
3128,large companies employees,large companies employees,3
3127,large companies,large companies,3
3126,growing number,growing number,3
3124,northern,northern,3
3122,different times,different times,3
3121,flu seasonandcanloweranindividual sriskofgettingthefluby half,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
3118,early spring,early spring,3
3117,humid subtropical climate,humid subtropical climate,3
3116,variability,variability,3
3115,subtropics,geographic region,3
3114,tropics,tropics,3
3111,junejuly,junejuly,3
3109,south latitudes,south latitudes,3
3108,tropical climate,tropical climate,3
3085,strategic reasons,strategic reasons,3
3086,annually recurring time period,annually recurring time period,3
3087,prevalence,prevalence,3
3088,cold half,cold half,3
3092,location,location,3
3094,influenzavirus,influenzavirus,3
3134,measured resistance,measured resistance,3
3097,main infective agents,main infective agents,3
3099,cooler temperature,cooler temperature,3
3101,higher incidence,higher incidence,3
3102,manifestations,manifestations,3
3103,timing,timing,3
3106,brazil,brazil,3
3107,complex seasonality component,complex seasonality component,3
3098,periods,periods,3
3137,medical conditions,medical conditions,3
3140,cost,cost,3
3144,2007 study,2007 study,3
3179,environment,environment,3
3180,bacteria,taxon,3
3182,hospitalization,hospitalization,3
3184,common cold,common cold,3
3186,lifethreatening complications,lifethreatening complications,3
3187,common cold viruses,common cold viruses,3
3177,wide range,wide range,3
3188,pneumonias,pneumonias,3
3191,related complications,related complications,3
3193,emergency room,emergency room,3
3195,asthmatics,asthmatics,3
3197,cancer,constellation zodiacal constellation,3
3199,cancer patients,constellation zodiacal constellation,3
3200,radiation therapy,radiation therapy,3
3189,acute bronchitis,acute bronchitis,3
3084,m423 investigation,m423 investigation,3
3176,diabetics,diabetics,3
3172,graphs,graphs,3
3146,earnings,earnings,3
3147,life,life,3
3148,total economic burden,total economic burden,3
3153,article,article,3
3158,274 304 hospitalizations,274 304 hospitalizations,3
3159,12 469 deaths,12 469 deaths,3
3173,extensive text,extensive text,3
3160,ph1n1,ph1n1,3
3164,high rates,high rates,3
3165,influenzalike illness,influenzalike illness,3
3167,source,source,3
3168,particularly heavy prevalence,particularly heavy prevalence,3
3170,weekly updates,weekly updates,3
3171,dozen charts,dozen charts,3
3161,notable occurrences,notable occurrences,3
3083,filibuvir monotherapy,chemical compound,3
3082,m423,m423,3
3081,filibuvirresistant mutations,filibuvirresistant mutations,3
3015,emergency,emergency,3
3016,limited evidence,limited evidence,3
3018,conclusions,conclusions,3
3019,ebola,infectious disease,3
3020,mouse models,mouse models,3
3022,guéckédou,guéckédou,3
3014,production condition,production condition,3
3024,preliminary results,preliminary results,3
3026,retroviruses,retroviruses,3
3027,opportunistic infections,opportunistic infections,3
3028,decrease,decrease,3
3029,lowtomoderate levels,lowtomoderate levels,3
3030,trial design,trial design,3
3031,historical controls,historical controls,3
3025,conference,conference,3
3032,nipah,nipah,3
3013,welfare,welfare,3
3011,ministry,ministry,3
2992,primary human airway cells,organisms known particular common homo sapiens homo sapiens sapiens homo,3
2993,doubt,doubt,3
2994,favipiravir efficacy,chemical compound medication,3
2995,legal status,legal status,3
2996,defense,defense,3
2997,partnership,partnership,3
3012,labor,labor,3
2998,medivector inc.,medivector inc.,3
3003,accelerated clearance,accelerated clearance,3
3004,6 14 hours,6 14 hours,3
3006,usa,usa,3
3007,current antivirals,chebi ontology term,3
3008,toyama chemical,toyama chemical,3
3010,animal experiments,taxon,3
3001,safety,safety,3
3201,potent immunosuppressive medications,potent immunosuppressive medications,3
3035,malaysiasingapore,malaysiasingapore,3
3037,philippines,philippines,3
3064,limited efficacy,limited efficacy,3
3066,animal studies,taxon,3
3067,rabies,infectious disease switzerland disease,3
3068,tautomerism,tautomerism,3
3069,possible tautomerism,possible tautomerism,3
3070,enollike form,enollike form,3
3060,control cases,control cases,3
3071,ketolike form,ketolike form,3
3073,pfizer,pfizer,3
3075,noncatalytic thumb ii allosteric pocket,noncatalytic thumb ii allosteric pocket,3
3076,ns5b viral polymerase,group class enzymes,3
3078,potent selective inhibitor,potent selective inhibitor,3
3079,0.019 μm,0.019 μm,3
3080,genotype 1 polymerases,genotype 1 polymerases,3
3072,ns5b inhibitor,ns5b inhibitor,3
3036,slaughterhouses,slaughterhouses,3
3059,lethal niv challenge,lethal niv challenge,3
3057,100% survival,100% survival,3
3038,bangladesh outbreaks,bangladesh outbreaks,3
3039,consumption,consumption,3
3040,raw date palm sap,raw date palm sap,3
3041,saliva,mixture body fluids,3
3042,fruit bats,fruit bats,3
3043,scientific reports,scientific reports,3
3058,obvious morbidity,obvious morbidity,3
3044,syrian hamster model,syrian hamster model,3
3049,encephalitis,encephalitis,3
3050,hamsters,hamsters,3
3052,104 pfu nivm,104 pfu nivm,3
3053,intraperitoneal,intraperitoneal,3
3055,peroral route,peroral route,3
3056,14 days,14 days,3
3048,widespread vasculitis,widespread vasculitis,3
3851,small segment,small segment,3
3205,lung cancer patients,constellation zodiacal constellation,3
3208,nasal spray vaccines,nasal spray vaccines,3
3365,unprecedented dieoff,unprecedented dieoff,3
3364,2005,2005,3
3362,strategy,strategy,3
3360,point,point,3
3359,especially ducks,especially ducks,3
3358,waterfowl,waterfowl,3
3357,regions,regions,3
3354,2004,2004,3
3353,fujian province,fujian province,3
3351,2003,2003,3
3347,z genotype,z genotype,3
3346,evolution,evolution,3
3343,great economic losses,great economic losses,3
3342,numerous farms,numerous farms,3
3338,1959–1997,1959–1997,3
3337,seroconversion,seroconversion,3
3336,calf,calf,3
3318,cats,cats,3
3320,novel route,novel route,3
3322,mammals,mammals,3
3323,onethousandth,onethousandth,3
3325,felines,felines,3
3326,carnivores,carnivores,3
3367,qinghai lake,qinghai lake,3
3327,dogs,dogs,3
3329,seals,seals,3
3331,dr. osterhaus,dr. osterhaus,3
3332,apparent symptoms.h5n1,apparent symptoms.h5n1,3
3333,asymptomatic shedding,asymptomatic shedding,3
3334,infected calves,infected calves,3
3335,subsequent seroconversion,subsequent seroconversion,3
3328,foxes,foxes,3
3368,central china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",3
3370,mongolia,sovereign state landlocked country country,3
3372,newly appointed senior united nations coordinator,newly appointed senior united nations coordinator,3
3396,25yearold female,25yearold female,3
3397,sennoris district,sennoris district,3
3398,fayum governorate,fayum governorate,3
3401,sham shui po,sham shui po,3
3406,8pm,8pm,3
3407,chairman,chairman,3
3394,northern vietnam,war proxy war,3
3408,chairman ofthehongkongpoultrywholesalersassociationsaidthelocalgovernment sdecisionmakesthegovernment sdecisionverydifficultfor hong kong poultry wholesalers association,organisms known particular common,3
3413,fine,fine,3
3417,endemic areas,endemic areas,3
3420,check,check,3
3421,23yearold woman,23yearold woman,3
3422,thanh hóa,thanh hóa,3
3423,—the standard mammalian model,—the standard mammalian model,3
3409,hong kong poultry wholesalers association,organisms known particular common,3
3317,indoors,indoors,3
3393,school teacher,school teacher,3
3391,22yearold man,22yearold man,3
3375,turkey,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
3376,romania,sovereign state start time 10 1877julian country,3
3377,croatia,sovereign state unitary state mediterranean country country,3
3378,kuwait,city capital big city,3
3379,2006,2006,3
3380,asian countries,asian countries,3
3392,central hunan province,central hunan province,3
3381,wild migratory bird populations,taxon,3
3383,decades,decades,3
3384,2007,2007,3
3385,nations,nations,3
3386,pakistan,sovereign state country,3
3387,afghanistan,emoji regional indicator sequence,3
3388,myanmar,sovereign state country,3
3382,multiple continents,multiple continents,3
3316,stray dog,stray dog,3
3315,bbc,television station,3
3314,germany,historical period germany historical country,3
3233,human trial,organisms known particular common homo sapiens homo sapiens sapiens homo,3
3236,bunyaviruses,bunyaviruses,3
3237,arenaviruses,arenaviruses,3
3238,paramyxoviruses,paramyxoviruses,3
3239,coronaviruses,coronaviruses,3
3240,flaviviruses,flaviviruses,3
3232,deadly filovirus infections,deadly filovirus infections,3
3241,phleboviruses,phleboviruses,3
3243,monkeys,monkeys,3
3244,bcx4430 galidesivir,chemical compound,3
3245,mouse model,mouse model,3
3246,june 10th,june 10th,3
3247,viremia,viremia,3
3248,provinces,provinces,3
3242,ebola marburg viruses,infectious diseaselocation identifier q28791882 masculine plural 8 november 1919gregorian,3
3249,vietnam,war proxy war,3
3230,niaid,niaid,3
3228,biocryst pharmaceuticals,biocryst pharmaceuticals,3
3211,chemotherapy,chemotherapy,3
3212,lymphatic form,lymphatic form,3
3213,cancer doctor,constellation zodiacal constellation,3
3214,cancer suspect,constellation zodiacal constellation,3
3215,hiv/aids,endemic disease location west africa benin rep syndrome,3
3216,variety,variety,3
3229,funding,funding,3
3218,viral bacterial fungal protozoa disorders,viral bacterial fungal protozoa disorders,3
3220,aggressive antibiotic therapy,aggressive antibiotic therapy,3
3222,vaccination,vaccination,3
3224,galidesivir,chemical compound,3
3225,adenosine analog,adenosine analog,3
3226,bcx4430,bcx4430,3
3227,immucillina,immucillina,3
3219,flurelated complications,flurelated complications,3
3206,nasal spray vaccine,nasal spray vaccine,3
3250,forced killing,forced killing,3
3254,province,province,3
3290,jakarta,city capital province indonesia big city city millions inhabitants human settlement,3
3292,global spread,global spread,3
3296,hitherto unprecedented global spread,hitherto unprecedented global spread,3
3299,multiple bird species,taxon,3
3300,timeline,timeline,3
3302,mammals general,mammals general,3
3289,greater frequency,greater frequency,3
3303,laboratories,laboratories,3
3305,mice,mice,3
3308,notable international policy debate,notable international policy debate,3
3309,openness,openness,3
3310,scientific research,scientific research,3
3311,bioterrorism,bioterrorism,3
3312,civet cats,civet cats,3
3304,species,species,3
3253,surveillance,surveillance,3
3285,extensive experience,extensive experience,3
3283,institutes,institutes,3
3255,thailand,constitutional monarchy sovereign state country,3
3256,isolated cases,isolated cases,3
3257,caregivers,caregivers,3
3259,official confirmation,official confirmation,3
3262,hung yen,hung yen,3
3263,ha tay provinces,ha tay provinces,3
3284,hong kong sar,hong kong sar,3
3264,2 april,2 april,3
3273,severely affected country,severely affected country,3
3274,17 cases,17 cases,3
3275,12 deaths,12 deaths,3
3278,international experts,international experts,3
3279,suggestive evidence,suggestive evidence,3
3282,team members,team members,3
3270,cambodia,sovereign state start time 9 november 1953 country constitutional monarchy,3
3852,hollow pocket,hollow pocket,3
3761,lasts,lasts,3
4135,better understanding,better understanding,3
4172,10–30%,10–30%,3
4171,25%,25%,3
4170,cirrhosis cases,cirrhosis cases,3
4169,27%,27%,3
4168,change,change,3
4167,fatty,fatty,3
4166,reinfection,reinfection,3
4165,apparent cure,apparent cure,3
4164,late relapses,late relapses,3
4163,7–53%,7–53%,3
4161,initial decades,initial decades,3
4160,experience,experience,3
4158,females,females,3
4173,30 years,30 years,3
4155,10–50%,10–50%,3
4151,elevated liver enzymes,organ type,3
4150,liver injury,organ type,3
4149,acute liver failure,organ type,3
4147,claycoloured stools,claycoloured stools,3
4146,jaundice,clinical sign,3
4145,weight loss,weight loss,3
4144,pains,pains,3
4143,4–12 weeks,4–12 weeks,3
4142,20–30%,20–30%,3
4139,hcv recurrence,hcv recurrence,3
4137,cure rates,cure rates,3
4136,velpatasvir,chemical compound medication,3
3853,n2 n9 proteins,group class chemical substances second-order class,3
4152,laboratory findings,laboratory findings,3
4174,schistosoma,schistosoma,3
4175,alcoholics,alcoholics,3
4176,male sex,male sex,3
4208,pancreatic cancer,constellation zodiacal constellation,3
4207,central nervous disorders,central nervous disorders,3
4206,associated abnormal heart rhythms,associated abnormal heart rhythms,3
4205,cardiomyopathy,cardiomyopathy,3
4204,possible associations includehyde sprurigonodularisand membranoproliferative glomerulonephritis,possible associations includehyde sprurigonodularisand membranoproliferative glomerulonephritis,3
4203,possible associations,possible associations,3
4202,antibody,family protein complexes,3
4201,insulin resistance,insulin resistance,3
4200,necrolytic acral erythema,necrolytic acral erythema,3
4199,porphyria cutanea tarda,porphyria cutanea tarda,3
4197,lichen planus,lichen planus,3
4195,autoimmune disorders,autoimmune disorders,3
4193,inflammation,inflammation,3
4192,mixed cryoglobulinemia,mixed cryoglobulinemia,3
4191,common problem,common problem,3
4190,extrahepatic complications,extrahepatic complications,3
4189,stage,stage,3
4188,cognitive impairment,cognitive impairment,3
4187,syndrome,syndrome,3
4186,varices,varices,3
4185,bleeding,bleeding,3
4184,ascites,ascites,3
4183,portal hypertension,portal hypertension,3
4182,liver cirrhosis,organ type,3
4181,1–3%,1–3%,3
4180,transformation,transformation,3
4179,20fold greater risk,20fold greater risk,3
4178,developing cirrhosis,developing cirrhosis,3
4177,excess alcohol,excess alcohol,3
4133,cyclophilin inhibitors,cyclophilin inhibitors,3
4132,immunomodulators,immunomodulators,3
4131,special populations,special populations,3
4130,needles,needles,3
4085,michael houghton,michael houghton,3
4084,decade,decade,3
4083,international research efforts,international research efforts,3
4081,alter transfusion medicine,alter transfusion medicine,3
4080,mid1970s,mid1970s,3
4077,hcv elimination,hcv elimination,3
4076,track,track,3
4074,higher cure rates,higher cure rates,3
4070,8–12 weeks,8–12 weeks,3
4069,extremely effective medication,extremely effective medication,3
4068,improperly sterilized glass syringes,improperly sterilized glass syringes,3
4067,schistosomiasis,schistosomiasis,3
4066,nowdiscontinued masstreatment campaign,nowdiscontinued masstreatment campaign,3
4065,high prevalence,high prevalence,3
4064,particularly high rates,particularly high rates,3
4063,contracts,contracts,3
4062,abbvie,abbvie,3
4061,dohme,dohme,3
4060,merck sharp,merck sharp,3
4059,large procurement exercise,large procurement exercise,3
4058,2025 nhs england,nation uk cultural area country,3
4057,bid,bid,3
4056,needle exchange,needle exchange,3
4055,half,half,3
4054,3%,3%,3
4053,percentage,percentage,3
4052,hcv testing,hcv testing,3
4051,infectious death,stock character psychopomp literary character,3
4050,single greatest cause,single greatest cause,3
4086,quilim choo,quilim choo,3
4210,salivary duct stones,salivary duct stones,3
4087,george kuo,george kuo,3
4089,daniel w. bradley,daniel w. bradley,3
4129,275 patients,275 patients,3
4128,spanish anaesthetist juan maeso,spanish anaesthetist juan maeso,3
4127,2010–2012 data,2010–2012 data,3
4126,wealthier groups,wealthier groups,3
4122,1998 usd,1998 usd,3
4121,united states costs,united states costs,3
4118,average lifetime cost,average lifetime cost,3
4117,individual,individual,3
4116,economic costs,economic costs,3
4113,physiology,physiology,3
4112,nobel prize,nobel prize,3
4111,charles m. rice,charles m. rice,3
4110,houghton,houghton,3
4109,appeals court,appeals court,3
4108,suit,suit,3
4107,royalty income,royalty income,3
4106,damages,damages,3
4105,coinventor,coinventor,3
4104,bradley,bradley,3
4103,chiron,chiron,3
4102,competing patent application,competing patent application,3
4100,lasker award,lasker award,3
4097,articles,articles,3
4096,nanbh specimens,nanbh specimens,3
4095,panel,panel,3
4093,alter,alter,3
4092,diagnostic test,diagnostic test,3
4091,unknown organism,unknown organism,3
4090,novel molecular cloning approach,novel molecular cloning approach,3
4088,chiron corporation,chiron corporation,3
4049,2%,2%,3
4211,crusted lesions,crusted lesions,3
4214,ultrasensitive tests,ultrasensitive tests,3
4335,immunoblot,immunoblot,3
4332,recombinant immunoblot assay,recombinant immunoblot assay,3
4330,confirmatory test,confirmatory test,3
4329,enzyme immunoassay,enzyme immunoassay,3
4326,serology,academic discipline academic major,3
4324,infected mother nipples,infected mother nipples,3
4323,long labor,long labor,3
4322,delivery,delivery,3
4321,gestation,gestation,3
4320,pregnancies,pregnancies,3
4319,fewer 10%,fewer 10%,3
4317,kissing,kissing,3
4316,hugging,hugging,3
4336,recombinant immunoblot,recombinant immunoblot,3
4315,casual contact,casual contact,3
4313,cuts,cuts,3
4311,appropriate caution,appropriate caution,3
4310,items,items,3
4309,equipment,equipment,3
4308,manicuring,manicuring,3
4307,toothbrushes,toothbrushes,3
4306,razors,razors,3
4305,personalcare items,personalcare items,3
4304,shared personal items,shared personal items,3
4303,licensed facility,licensed facility,3
4302,unsterilized tattooing equipment,unsterilized tattooing equipment,3
4301,prison,prison,3
4300,nearly half,nearly half,3
4314,sores,sores,3
4337,previous infection,previous infection,3
4338,6–8 weeks,6–8 weeks,3
4339,care testing,care testing,3
4374,12 weeks,12 weeks,3
4372,directacting antivirals,chebi ontology term,3
4370,initial recommended treatment,initial recommended treatment,3
4369,liver scarring,organ type,3
4368,highest complication risk,highest complication risk,3
4367,chronic cases,chronic cases,3
4366,approximately 90%,approximately 90%,3
4365,single screening test,single screening test,3
4363,sign,sign,3
4362,long term hemodialysis,long term hemodialysis,3
4361,jail,jail,3
4358,united states preventive services task force,united states preventive services task force,3
4357,routine,routine,3
4356,canada status,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,3
4355,5–50%,5–50%,3
4354,hepatic fibrosis,hepatic fibrosis,3
4353,blood tests,biogenic substance type,3
4352,bile ducts,bile ducts,3
4351,changes,changes,3
4350,portal triad,portal triad,3
4349,lymphoid follicles,lymphoid follicles,3
4348,parenchyma,parenchyma,3
4347,typical changes,typical changes,3
4346,procedure,procedure,3
4345,liver damage,organ type,3
4344,biopsy,biopsy,3
4342,elevation,elevation,3
4341,seven weeks,seven weeks,3
4340,initial,initial,3
4299,larger tattoos,larger tattoos,3
4298,settings,settings,3
4297,sterile techniques,sterile techniques,3
4296,particular concern,particular concern,3
4255,intact skin,intact skin,3
4254,blood exposure,biogenic substance type,3
4253,mucosal exposures,mucosal exposures,3
4252,puncture wound,puncture wound,3
4251,needle,needle,3
4250,1.8% chance,1.8% chance,3
4249,needle stick injury,needle stick injury,3
4246,11–70 days,11–70 days,3
4245,unit,unit,3
4244,200 units,200 units,3
4243,universal screening,universal screening,3
4241,hcv screening,hcv screening,3
4240,organ transplants,organ transplants,3
4237,healthcare exposure,healthcare exposure,3
4236,risk factor,risk factor,3
4234,nonsterile equipment,nonsterile equipment,3
4233,idu,idu,3
4232,prisons,prisons,3
4231,highrisk behavior,highrisk behavior,3
4230,general population,general population,3
4229,prison inmates,prison inmates,3
4228,highest absolute totals,highest absolute totals,3
4226,major risk factor,major risk factor,3
4223,persistently moderately elevated serum liver enzymes,organ type,3
4222,ultracentrifugation,ultracentrifugation,3
4219,antibody test,family protein complexes,3
4218,newer methods,newer methods,3
4217,liver biopsies,organ type,3
4215,original method,original method,3
4256,hospital equipment,hospital equipment,3
4213,conventional testing,conventional testing,3
4257,reuse,reuse,3
4259,multipleuse medication vials,multipleuse medication vials,3
4295,mid1980s,mid1980s,3
4294,piercings,piercings,3
4293,tattoos,tattoos,3
4292,dyes,dyes,3
4291,contamination,contamination,3
4290,improperly sterilized equipment,improperly sterilized equipment,3
4289,body modification,body modification,3
4288,single partner,single partner,3
4287,relationships,relationships,3
4286,multiple partners,multiple partners,3
4283,veterans affairs,veterans affairs,3
4282,united states department,united states department,3
4280,hiv genital ulceration,organisms known particular common,3
4279,concurrent sexually transmitted infection,concurrent sexually transmitted infection,3
4278,anal penetrative sex,anal penetrative sex,3
4276,trauma,trauma,3
4275,higher levels,higher levels,3
4274,sexual practices,sexual practices,3
4272,heterosexual partners,heterosexual partners,3
4271,hcv transmission,hcv transmission,3
4269,sexual intercourse,sexual intercourse,3
4267,primary cause,primary cause,3
4266,public private medical dental facilities,public private medical dental facilities,3
4265,stringent standard precautions,stringent standard precautions,3
4264,enforcement,enforcement,3
4263,implementation,implementation,3
4262,limitations,limitations,3
4261,improperly sterilized surgical equipment,improperly sterilized surgical equipment,3
4260,infusion bags,infusion bags,3
4258,syringes,syringes,3
4048,north america,north america,3
10862,chinese patients,chinese patients,3
3921,infected mother baby,infected mother baby,3
3885,critical component,critical component,3
3913,occasionally cirrhosis,occasionally cirrhosis,3
3991,sterile syringes,sterile syringes,3
3958,percutaneous contact,percutaneous contact,3
3990,insufficient supply,insufficient supply,3
3883,pa codes,pa codes,3
3899,convalescent sera,convalescent sera,3
3989,healthcare facilities,healthcare facilities,3
3960,method,method,3
3962,primary route,primary route,3
3987,national level,national level,3
3900,monoclonal antibodies,family protein complexes,3
3985,screening,screening,3
3983,maternal antibodies,family protein complexes,3
3988,universal precautions,universal precautions,3
3964,diagnostic tests,diagnostic tests,3
3957,lymphocytes,lymphocytes,3
3995,acetaminophen,acetaminophen,3
3949,seven major genotypes,seven major genotypes,3
4002,coffee consumption,coffee consumption,3
3950,genotypes,genotypes,3
4001,accompanying cirrhosis,accompanying cirrhosis,3
4000,hepatocellular carcinoma,hepatocellular carcinoma,3
3999,ultrasound surveillance,ultrasound surveillance,3
3993,effective preventive measure,effective preventive measure,3
3951,half life,half life,3
3898,antigenic fingerprinting,antigenic fingerprinting,3
3955,infected person,infected person,3
3871,matrix encoding gene segments,matrix encoding gene segments,3
3886,viral polymerase,group class enzymes,3
3997,nonsteroidal antiinflammatory drugs,nonsteroidal antiinflammatory drugs,3
3996,reduced doses,reduced doses,3
3954,45 minutes,45 minutes,3
3946,chimpanzees,chimpanzees,3
3911,chronic infection,chronic infection,3
3982,infant,infant,3
3890,rivera y,rivera y,3
3905,infectious disease,infectious disease,3
3880,np codes,np codes,3
3908,abdominal pain,abdominal pain,3
3889,suguitan al,suguitan al,3
3977,chronic infections,chronic infections,3
3891,simmons cp,simmons cp,3
3879,nucleoprotein encoding gene segments.,group class proteins,3
3970,diagnosing patients,diagnosing patients,3
3906,liver,organ type,3
3974,transition,transition,3
3907,dark urine,dark urine,3
3972,acute illness,acute illness,3
3877,different reading frames,different reading frames,3
3975,chronic,chronic,3
3882,polymerase encoding gene segments,group class enzymes,3
3875,capsid,cellular component,3
3904,doi:10.1371/journal.pmed.1000049. pmc,doi:10.1371/journal.pmed.1000049. pmc,3
3965,hcv antibody,family protein complexes,3
3981,acute chronic infections,acute chronic infections,3
3966,immunoassay,immunoassay,3
3872,m codes,m codes,3
3902,diagnostic targets,diagnostic targets,3
3909,yellow tinged skin,yellow tinged skin,3
3969,pcr,pcr,3
3980,highrisk individuals,highrisk individuals,3
3967,elisa,female given,3
3922,birth,birth,3
3979,routine screening,routine screening,3
3978,elevated liver enzyme levels,organ type,3
3881,nucleoprotein,group class proteins,3
3903,e1000049,e1000049,3
3892,lanzavecchia,lanzavecchia,3
4004,prognosis,prognosis,3
3870,related information,related information,3
3971,challenge,challenge,3
3893,sallusto f,sallusto f,3
3936,leading reason,leading reason,3
4019,hcv genotypes,hcv genotypes,3
3919,transfusion,transfusion,3
3928,simeprevir,chemical compound medication essential medicine,3
3894,manischewitz j,manischewitz j,3
4021,higher rate,higher rate,3
3895,king lr,king lr,3
4023,24 weeks treatment,24 weeks treatment,3
3937,liver transplantation,organ type,3
3896,subbarao k,subbarao k,3
4024,lower dosages,lower dosages,3
4030,acute infections,acute infections,3
4016,48 weeks,48 weeks,3
4032,rates,rates,3
4034,reused poorly sterilized medical equipment,reused poorly sterilized medical equipment,3
3855,existing drugs,existing drugs,3
3929,peginterferon,peginterferon,3
3933,access,access,3
4035,subsaharan africa,continent,3
4036,andean,andean,3
3857,loop,loop,3
3897,golding h,golding h,3
4041,20 years,20 years,3
4037,southern latin america,southern latin america,3
4040,australasia,australasia,3
4038,caribbean,caribbean,3
4039,oceania,oceania,3
4047,improved screening,improved screening,3
4015,hcv genotype,hcv genotype,3
4018,70–80%,70–80%,3
3865,host organism,host organism,3
4046,1990s,1990s,3
3923,superficial contact,superficial contact,3
3945,1970s,1970s,3
3867,possible paths,possible paths,3
4043,~1–4%,~1–4%,3
4008,24 weeks,24 weeks,3
4042,difference,difference,3
3942,central,central,3
4010,undetectable levels,undetectable levels,3
3926,harm reduction efforts,harm reduction efforts,3
3938,transplantation,transplantation,3
4012,future risk,future risk,3
3935,liver transplant,organ type,3
3920,infected mother,infected mother,3
3941,low middleincome countries,low middleincome countries,3
3858,conformation,conformation,3
3914,liver cancer,organ typeconstellation zodiacal constellation,3
3859,internal encoding gene segments,internal encoding gene segments,3
3927,95%,95%,3
3916,esophagus,esophagus,3
3861,gene segments,gene segments,3
4014,40–50%,40–50%,3
7551,quadrivalent influenza vaccines,infectious disease,4
6804,potential influenza epidemics,infectious disease,4
10027,previous influenza strains,infectious disease,4
3100,influenza cases,infectious disease,4
351,influenza territories,infectious disease,4
9596,recombinant influenza vaccines,infectious disease,4
7556,recombinant influenza vaccine,infectious disease,4
786,influenza subtype,infectious disease,4
3744,pandemic influenza vaccine development,infectious disease,4
8314,h3n2 human influenza,subtypeorganisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
8511,symptomatic influenza,infectious disease,4
10250,deadly 1918 influenza,infectious disease,4
6420,known influenza,infectious disease,4
7552,20182019 influenza season,infectious disease,4
8628,narcolepsy following pandemrix influenza vaccination,influenza vaccineinfectious disease,4
6419,human influenza virus,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
7232,veterinary influenza vaccination,infectious disease,4
6695,a/h1n1 influenza,infectious disease,4
7554,recombinant cellgrown flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,4
1378,laboratoryconfirmed 2009 influenza,infectious disease,4
6701,global influenza preparedness plan,infectious disease,4
7528,influenza vaccination levels,infectious disease,4
6349,human influenza pandemics,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
7512,approved inactivated vaccines,approved inactivated vaccines,4
5663,influenza conference,infectious disease,4
5928,influenza research database—database,infectious disease,4
7847,heatinactivated influenza virustreated membranes,infectious disease,4
3887,influenza vaccine,infectious disease,4
7194,yearly influenza vaccination,infectious disease,4
1370,associated influenza symptoms,infectious disease,4
7485,eggbased influenza vaccines,infectious disease,4
7521,plantbased influenza vaccines,infectious disease,4
1810,influenza symptoms,infectious disease,4
10001,unusually deadly influenza,infectious disease,4
7236,inactivated influenza vaccine information statement,infectious disease,4
10000,1918 influenza,infectious disease,4
6377,influenza virus pleomorphy,infectious disease,4
254,1557 influenza,infectious disease,4
5145,influenza surveillance program,infectious disease,4
7509,experimental influenza vaccines,infectious disease,4
1702,second influenza vaccination program,infectious disease,4
8332,influenza d,infectious disease,4
2649,influenza medication,infectious disease,4
7213,influenza costeffectiveness models,infectious disease,4
2652,uncomplicated influenza,infectious disease,4
2653,influenza complications,infectious disease,4
776,influenza virus,infectious disease,4
10622,influenza pandemic canadian soldiers,infectious disease,4
8179,influenza parents,infectious disease,4
5281,influenza a/h3n2 virus,infectious disease,4
3321,influenza transmission,infectious disease,4
2664,influenza therapeutic agent,infectious disease,4
7178,2019–2020 influenza seasons,infectious disease,4
6311,h9n2 influenza virus,infectious disease,4
7843,live influenza virus,infectious disease,4
8540,neuraminidaseresistant influenza,infectious disease,4
754,influenza von,infectious disease,4
2408,influenza strains,infectious disease,4
6901,influenza virus proteins,infectious diseasegroup class chemical substances second-order class,4
8042,heterologous human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
6631,new influenza,infectious disease,4
4783,pandemic vaccines,pandemic vaccines,4
7350,influenza outbreaks,infectious disease,4
1471,influenza division,infectious disease,4
9500,influenza resistance,infectious disease,4
7063,combat influenza,infectious disease,4
651,1889 influenza,infectious disease,4
3868,influenza research database – database,infectious disease,4
43,1510 influenza,infectious disease,4
44,influenza,infectious disease,4
5376,influenza infections,infectious disease,4
6641,new influenza pandemic changes,infectious disease,4
496,languedoc influenza,infectious disease,4
7960,inactivated recombinant influenza vaccines,infectious disease,4
7616,oral influenza vaccine,infectious disease,4
6827,influenza countermeasures,infectious disease,4
3869,influenza genomic sequences,infectious disease,4
6822,influenza research,infectious disease,4
7562,pandemic influenza vaccines,infectious disease,4
9490,influenza activity,infectious disease,4
5391,equine influenza virus tsurviveoutsideof horse,infectious disease,4
5052,influenza doctor,infectious disease,4
8287,new influenza virus,infectious disease,4
3009,new influenza medication,infectious disease,4
7368,modern influenza vaccines,infectious disease,4
2984,novel influenza,infectious disease,4
3156,2009 pandemic influenza,infectious disease,4
5027,influenza research database database,infectious disease,4
7366,annual influenza epidemic,infectious disease,4
7669,canine influenza,infectious disease,4
1630,pandemic a/h1n1 influenza,infectious disease,4
5080,swine influenza virus,swine diseaseinfectious disease,4
7667,swine influenza vaccines,swine diseaseinfectious disease,4
5075,influenza a/ussr/90/77,infectious disease,4
5446,equine influenza virus infection,infectious disease,4
7665,filtered purified influenza vaccine,infectious disease,4
5417,aerosolized influenza virus,infectious disease,4
6577,> 100 influenza genomes,infectious disease,4
10699,influenza virus type,infectious disease,4
6132,investigational h7n9 influenza vaccine,taxoninfectious disease,4
4884,spanish influenza pandemic virus,infectious disease,4
906,influenza epidemic,infectious disease,4
6561,influenza evolution,infectious disease,4
5028,influenza sequences,infectious disease,4
2454,influenza treatment,infectious disease,4
9534,seasonal influenza vaccine brands,infectious disease,4
884,1957 influenza,infectious disease,4
7606,m001 h1ssf3928 universal influenza vaccine candidates,infectious disease,4
941,1968 influenza,infectious disease,4
6814,updated pandemic influenza plan,infectious disease,4
6954,h5n1 influenza vaccine,subtypeinfectious disease,4
5315,influenza genome sequencing project,infectious diseasescientific model natural environment,4
2329,influenza a.,infectious disease,4
1558,annual influenza epidemics,infectious disease,4
6455,b. influenza,infectious disease,4
416,pandemic influenza fastmoving unrestricted epidemics,infectious disease,4
415,pandemic influenza,infectious disease,4
7415,inactivated vaccines,inactivated vaccines,4
7472,quadrivalent vaccines,quadrivalent vaccines,4
107,origin 1510 influenza,infectious disease,4
1875,swine influenza,swine diseaseinfectious disease,4
402,influenza epidemics,infectious disease,4
1760,influenza expert,infectious disease,4
1289,influenza pandemic,infectious disease,4
110,influenza pandemics,infectious disease,4
8542,oseltamivirresistant influenza,infectious disease,4
9591,splitvirion influenza vaccines,infectious disease,4
7273,seasonal influenza vaccine,infectious disease,4
5302,influenza vaccines,infectious disease,4
383,identification influenza,infectious disease,4
1728,normal reported influenza cases,infectious disease,4
8481,annual influenza,infectious disease,4
10491,pandemic influenza deaths,infectious disease,4
7410,united states routine influenza vaccination,infectious disease,4
7945,20182019 influenza,infectious disease,4
5354,equine influenza,infectious disease,4
7402,influenza vaccination strategy,infectious disease,4
5051,influenza vaccination,infectious disease,4
4932,future influenza,infectious disease,4
6894,influenza coat protein,infectious disease,4
8377,pandemic seasonal influenza,infectious disease,4
7329,laboratoryconfirmed influenza,infectious disease,4
6482,influenza virus infections,infectious disease,4
7404,influenza circulation,infectious disease,4
10071,influenza disease,infectious disease,4
7405,human influenza sickness,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
8369,seasonal pandemic influenza,infectious disease,4
7257,annual influenza vaccination,infectious disease,4
1452,human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,4
8379,seasonal pandemic outbreaks,seasonal pandemic outbreaks,4
6477,influenza virus c.,infectious disease,4
5355,equine influenza virus,infectious disease,4
8543,h5n1 avian influenza bird flu,subtypeinfectious diseasetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8549,pandemic mockup vaccine,pandemic mockup vaccine,5
5896,h5n8 type bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3129,seasonal flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
182,flu nickname,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5030,1977 russian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
975,seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5905,called bird flu virus,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
824,1957–1958 asian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6247,h7n9 flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3143,flu epidemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
119,flu human beings,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzaorganisms known particular common homo sapiens homo sapiens sapiens homo,5
6240,h7n9 bird flu,taxontaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6812,avian flu scare,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6865,future avian flu pandemic current high pathogenic set,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9571,novartis flu vaccine unit wassoldto,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6176,earlier bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
79,recorded flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7330,nonpandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
944,1977 russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6862,avian flu experts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1579,2009 flu pandemic strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7339,highdose flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1588,1918 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5061,1976 swine flu outbreak,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7390,injectionbased flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3818,flu virus affinity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6856,flu research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9542,biocsl flu vaccine brands,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9539,novartis flu vaccine unit in2014andtransferto,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6084,h7 avian flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
30,1510 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3847,flu drugs tamiflu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzachemical compound neuraminidase inhibitor medication essential medicine,5
6849,1918 flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
908,new flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6098,yettobedeveloped pandemic vaccine,yettobedeveloped pandemic vaccine,5
14,flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3854,flu drugs,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
11,1510 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5,chronicled interregional flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6842,spanish flu research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9545,flu vaccines brand,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6785,bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1680,swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1684,national pandemic flu service,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
834,asian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6878,universal flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3799,flu virus genes,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6877,new flu vaccine manufacturing methods,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8532,seasonal flu samples,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3119,flu vaccinations,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1510,universal flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5930,bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1511,flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3113,flu seasons,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
850,1918 spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6873,wild bird avian flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5140,swine working populations,swine disease,5
7414,seasonal flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8515,h1n1 flu swine flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzaswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5984,avian bird flu characteristics,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3811,flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3090,major flu activity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6803,specific pandemic flu plan,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6806,flu related research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
950,h1n1 flu strain,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1690,h5n1 avian flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7418,pandemic flu vaccination uptake,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1543,pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9586,standard flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1544,flu complications,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5129,g4 swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6809,pandemic flu search,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6870,new flu vaccine manufacturing factories,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3151,h1n1 swine flu,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6722,strategies prevent flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5177,asian flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4931,spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5573,future pandemic flu virus strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5571,related flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10459,flu ports,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1917,2009 pandemic h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7093,resistance flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3646,seasonal flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1919,h1n1 flu strains,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1920,circulating flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4924,potential flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6647,nature flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4746,h5n1 flu cases,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10302,typical flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6971,conventional flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7615,flu illness,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5578,pandemic vaccine,pandemic vaccine,5
4712,mao flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1073,2008 bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1250,h5n1 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4680,avian viruses,avian viruses,5
422,flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6950,pandemic flu vaccine planning,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6678,flu pandemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10495,1889–1890 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5320,fujian flu (2003–2004),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5605,h5n1 avian flu outbreaks,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
487,flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
691,flu end,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5322,fujian human flu strain,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6670,management flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4700,flu activity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4701,flu infection,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5324,fujian bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6667,1889–90 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4705,1957 asian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5321,fujian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3399,h5n1 bird flu virus,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7617,oral flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1948,normal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6571,flu genomes,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2035,bird flu insamplesfromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluin samples,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1122,site wasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfromthesitewasfoundnottobe bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4840,1918 spanish pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7666,commonly bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4843,seasonal flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4845,predominant human flu,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7668,swine flu vaccines,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7016,potential h5n1 avian flu outbreak,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4850,annual flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4853,annual flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2402,avian flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4855,h5n1 bird flu infection,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7009,2009 h1n1 swine flu neuraminidase weretoacquire,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzagroup class enzymes,5
600,flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7654,human seasonal flu vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6619,existing flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2451,2009 pandemic flu samples,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1976,h1n1 swine flu strain,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7963,flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4912,lowest severity flu pandemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5528,avian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7630,human flu vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5518,chief avian flu coordinator,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4908,pandemic flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5515,possible flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7622,horse flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1959,confirmed h1n1/09 pandemic flu death,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzastock character psychopomp literary character,5
639,russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7638,flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
638,asiatic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1176,h5n1 bird flu strains,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5491,humanized h5n1 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1971,2009 h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5487,avian flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8896,april2009 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3152,common flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5310,annual flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4675,h3n2 pandemic flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7491,worldwide spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5229,swine h2n3,swine disease,5
3740,pandemic flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3739,current flu vaccine manufacturing plants,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5239,swine h2n3 virus,swine disease,5
5773,august 2017 bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6343,avian h9n2 viruses,avian h9n2 viruses,5
9702,combat bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1388,regular seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5761,lowpathogenic h5n2 avian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
749,putative flu remedy,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1381,pandemic h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1816,h1n1 flu virus,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5261,typical hostbird flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5268,seasonal h3n2 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3223,flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1006,bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7244,flu vaccine strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3204,flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3166,available flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1473,avian flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5178,1889–1890 russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5179,earliest flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3776,pandemic flu january 2007,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3775,bird flu november 2006,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1464,new swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4965,initial flu pandemic strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5184,category 2 flu pandemic outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1754,global swine flu campaign,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1449,different flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3196,flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10673,avian flu birds,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
794,1918 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8593,pandemrix flu vaccination,influenza vaccineinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3203,seasonal flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3181,mild flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7573,h5n1 flu virus,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7531,swine flu scare,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7182,flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1866,swine flu threat,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1309,yearly seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
389,1557 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6691,h1n1/09 flu pandemic (2009–2010),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1297,term swine,swine disease,5
1295,human flu viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1294,swine,swine disease,5
6689,relatively benign flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6688,russian flu (1977–1979),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1288,2009 swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4663,1968 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6685,category 2 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6684,asian flu (1957–1958),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1878,swine flu,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4674,avian human viruses,organisms known particular common homo sapiens homo sapiens sapiens homo,5
7150,flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3363,future avian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7151,flu jabs,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7560,rapid response pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5724,flu outbreaks,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7533,potential swine flu,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7534,potential swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6938,novartis cellbased flu vaccine,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5288,swine populations,swine disease,5
1341,new swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10244,flu mortality,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7184,flu spread,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3686,conventional flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7548,quadrivalent flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6942,cellculture flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3340,h5n1 caused flu outbreaks,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3345,bird flu species,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7553,regulardose eggbased flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7555,regulardose flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7156,flu return,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7547,quadrivalent vaccines seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5078,2009 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
